{
  "doc_id": "LG149_Polmone_agg2024",
  "created_date": "2024",
  "country": "IT",
  "source_type": "clinical_guideline",
  "chunks": [
    {
      "heading": "",
      "text": "GUIDA GUIDA DELL'Sistema Sistema National",
      "start_page": 1,
      "end_page": 2
    },
    {
      "heading": "March March 2020",
      "text": "3, 3, 202",
      "start_page": 2,
      "end_page": 2
    },
    {
      "heading": "October October 2024",
      "text": "Novello Novello (Passig Passig (Bertolaccini Bertolaccini (Chirugo) Re Re (Farmacologa) Francesca Facchinetti (Onocologo Polico) Roberto Ferrara (Oncolgo Medico) Tindara Francina (oncologist Medical) Paolo Graziano (Patologo) Larici Larici (Radiologo) Umberto Malapelle (Biologist Molecular) Jessica Menis (Onconologia Medico), Antonio Passaro (Oncologia Medicalo) Sara Pilotto (Oncogologia Doctoro) co) of of Turin; Gonzaga Gonzaga (TO) Rendina (Chirurgo) Vieri Scotti (Radioterapista) Versitario Versitario . Fano Fano (PU) Sometimes Sometimes \"spinous,\" ask ask is: \"something something better?\" difference. difference.",
      "start_page": 2,
      "end_page": 5
    },
    {
      "heading": "Table of Contents",
      "text": "recommendations recommendations ... First-line First-line treatment: immunotherapy ... First-row First-row treatment: chemotherapy ... lines lines ... 2 2 ... ari . KRAS KRAS . LINE ET . cancer cancer (_MEDTERM5__) ... treatment treatment ... treatments treatments ... cancer. cancer...",
      "start_page": 6,
      "end_page": 8
    },
    {
      "heading": "recommendations recommendations *",
      "text": "method method (see specific chapter), Recommendation Recommendation (2) tests tests (1) Recommendation (3) Patients with pN+ lymphadenectomy lymphadenectomy (<D2) radiochemotherapy radiochemotherapy (1) OF OF TESTS: process process (MOLTO MOLTO BASSA).",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "(2) CLINICAL RECOMMENDATION",
      "text": "an an intervention/the the PICO* question question (comparison, comparison, outcome). symbol symbol √.",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "FORMAL FORMAL APPROACH",
      "text": "below. below.",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "RECOMMENDATION:",
      "text": "the the recommendation: Reasons/comments to benefit/damage balance: been been identified: motivate motivate benefit/deal balance:",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "Quality of tests",
      "text": "following following reasons:",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "(3) CLINICAL CLINICAL RECOMMENDATION",
      "text": "four four levels: Terminology Terminology - with with (selection criteria) option option (intention intention - damage)",
      "start_page": 9,
      "end_page": 10
    },
    {
      "heading": "CONFLICT OF INTEREST",
      "text": "indicated indicated (see example below). melanoma melanoma (1 1 mm), favour favour dabrafenib+option option COI: of of interest: YY YY * site site = process process (when applied) document. document.",
      "start_page": 10,
      "end_page": 10
    },
    {
      "heading": "the the Guideline",
      "text": "Guidelines Guidelines are: and and comorbidity) 6 6 (advanced advanced disease) PLA PLA ASIE",
      "start_page": 11,
      "end_page": 18
    },
    {
      "heading": "1. Epidemiological data",
      "text": "(Source: 2023. 2023. AIOM-AIRTUM)",
      "start_page": 19,
      "end_page": 19
    },
    {
      "heading": "1.1 Incidence",
      "text": "Italy Italy (in in women): men men (15%) women women (6%). 14. 14.3% 7. 7.4% 1. 1.3% genders. genders.",
      "start_page": 19,
      "end_page": 19
    },
    {
      "heading": "1.2 Mortality",
      "text": "Italy Italy (men: 23,600; women: 12,100). 18. 18.7%. the the 2007‐of of 16%.",
      "start_page": 19,
      "end_page": 19
    },
    {
      "heading": "1.3 Survival",
      "text": "is is 16% and and 23% is is 37% and and 44% diagnosis. diagnosis.",
      "start_page": 19,
      "end_page": 20
    },
    {
      "heading": "1.4 Prevalence",
      "text": "cancer cancer (600 600 women) Italy. Italy. 34% years, years, 23% years, years, 17% only only 25% be be 8% and and 13% in women.",
      "start_page": 20,
      "end_page": 20
    },
    {
      "heading": "Risk Risk factors",
      "text": "the the 20-year-olds and 15-0% country. country. (1) factors factors including: duration duration (in years) cigarettes cigarettes (2). smokers smokers (considered as total) smokers smokers (per per day) years years (3-4). between between 20% and 50%, men men (5-6). on on nicotine: working working and/the the market; tobacco tobacco smoke; upon upon nicotine: oral oral nicotine; and and / substances substances (and and chloro- methyl ether, chloro) and and chloroat-and and other) and and others) A A 55% non-smokers non-smokers (9), etiology etiology (10).",
      "start_page": 21,
      "end_page": 22
    },
    {
      "heading": "Primary Primary prevention",
      "text": "measures measures \"MPOWER\" programme programme \"Language,\" Directive Directive 2014/40/least least 65% studies studies (n=662) e-Cig e-Cig (no nicotine) of of e- nicotine nicotine (abstention 9% vs 4%; 2. 2.29; CI95% 96 96 respectively). studies studies (observational, observational, n=1722) e e - devices devices (12). reported reported (13). compounds compounds (carbon carbon dioxide) cigarettes cigarettes (14). nicotine nicotine (containing containing Nicotine) S. S.",
      "start_page": 22,
      "end_page": 25
    },
    {
      "heading": "Secondary Secondary prevention",
      "text": "Trial Trial (NLST) CT CT (LDCT) subjects subjects (of of enrollment) a a 20% X-ray X-ray (15). with with FEV1/FVC ratio <by by 37% (16). Services Services (USPSFT) Network Network (NCCN). years years (year year old), 20 20 pakLGDI/years years earlier? RECOMMENDATION: Recommendation Recommendation Force: of of Motivazioni/comments to benefit/damage balance; screening screening (NS) radiography radiography (CXRR) 895 895 million; in in fatality; 8, 8,1050; women women (p=0.21; I2=33.6%) world world (24). of of tests: MODERATA COI: approved approved and/2. 2.1% 43. 43.5%, 0. 0.2% and 15% field field (27). Oncology Oncology (ESMO) the the EU'project, project, 4-IN-THE-LUNG-RUN (4-iTLR), cancers cancers (first first LDCT) risk. risk.",
      "start_page": 25,
      "end_page": 28
    },
    {
      "heading": "Invasive Invasive cancers",
      "text": "Organization Organization (WHO) than than 95% main main histotypes: squamous carcinoma (CS), adenocarcinoma (ADC), carcinoma carcinoma (CGC) carcinomas carcinomas (microcytoma) (29). increasing increasing (>50%), reduced reduced (29). cancers cancers (Cancer, Cancer, __MEDTERM4_) histology histology (29-32). colorations colorations (e.g. May-Grunwald-Giemsa) investigations investigations (carcinoma carcinoma (Carcinoma, Carcinoma, LCNEC) characterization characterization (Cd56), that that >50% pattern pattern (36). markers markers (and and synaptophysin) sample sample (surgical surgical resection) (42-44). Table 3.1: WHO WHO - 2021.",
      "start_page": 29,
      "end_page": 31
    },
    {
      "heading": "Variants Variants Notes",
      "text": "Palilloma - Pneumocytoma Pneumocytoma - Pattern: properties properties (cd. Adenoma - species species Bronchyolary-Grossic-Glass-Grass-Cross-glassed-Gastic-Glypian-Galiphous-Galent-Glossy-Global-Glimatic-Glue-Gulcan-Gallstone-Ghiant-Gilan-Gilitary-Militious-Golitative-Gossips-Adeno-Carcinoma-Gilet-Glorian-Geliot-Gribal-Filit-Vilitarian-Gliot-Lypyl-Grypular-Gild-Glime-Dilitable-Gliat-Golf-Gold-Gill-Gloud-El-Folit-Pilotose-Gustile-Glausive-Gilat-Hiper-Girthypious-Filkly-Gleplish-Glaebileon-Glorious-Oly-Flue, and Minimum-Gelo-Gro-Filen-Fly-Blue",
      "start_page": 31,
      "end_page": 32
    },
    {
      "heading": "molecular molecular pathology",
      "text": "the the patient'IIIB-IIIC IIIB-IIIC (locoregional locoregional treatments) MEDTERM17__ MEDTERM17__ (Factor Factor Receptor), BRAF (B-Raf proto-oncogene) and KRAS (Sarcoma Sarcoma virus), __medTERM18_ __medTERM18_ (Anaplastic Lymphoma Kinase), studies studies (kinase kinase ROS), __MEDTERMW20_ (REarranged during Transfection), _ ==See also==*Centraline==References===External links== for for PD- L1 ≥50% Score Score (TPS) (68). stage, stage, l/TPS TPS ≥1%. PQC PQC (69), __ __ MEDTERM17_; of of _MEDTERM18___; strategy strategy (Algorith. 2). of of {MEDTERMM17___; _ _ • 52_ 52_ NAS; suspected suspected and/component component (adenosquamous) procedure procedure (61): • and and / or metastasis (61); • and and non-",
      "start_page": 33,
      "end_page": 37
    },
    {
      "heading": "for for ALK",
      "text": "with with ADC",
      "start_page": 37,
      "end_page": 37
    },
    {
      "heading": "NAS NAS (75-76):",
      "text": "• tumor tumor and/or metastasis (75-76); • smokers smokers (<15 packets/year or ≤per per day) and ex-smoking (≥15 years) determination determination (75/76). FISH FISH (In In Situ-Hybridization) test test (RT-PCR RT-PCR treatment). MEDTERM20__ MEDTERM20__ ultimicenti; __medterm3_ __ ‐ ‐ - ‐- − • • - • . • * • \" • i • o ■ • a •",
      "start_page": 37,
      "end_page": 38
    },
    {
      "heading": "rearrangements rearrangements RET",
      "text": "histotype histotype (62-63): • tumor tumor and/or metastasis (62-66); • __médterm0_ __médterm0_ (62-63, 96).",
      "start_page": 39,
      "end_page": 39
    },
    {
      "heading": "rearrangements rearrangements NTRK",
      "text": "histotype histotype (67): • tumor tumor and/or metastasis (67); • NGS NGS (67, 96). 15th 15th , NAS NAS (64-65): • tumor tumor and/or metastasis (64-64); • NGS NGS (medicinal medicinal products; • 100 100 (97). 48 48 (DAKO), ULTRA ULTRA (Ventana) ULTA ULTA (Vantana) Ultra Ultra (Ventana) Score Score (TPS). Oncology Oncology (ESMO), use use programs/enlarged access and/Italy Italy (96). Cancer Cancer (98).",
      "start_page": 39,
      "end_page": 42
    },
    {
      "heading": "3 3 Diagnostic/of of malignancy",
      "text": "history history (for for malignancies) adenosis adenosis (90-100). disease disease (99-100), not not affected; about about 10% TC TC (hepatic hepatic cysts) ultrasound ultrasound and/imaging imaging (RM) adenocarcinoma adenocarcinoma __MEDTERM0_+, 6. 6.9% IA IA (0.5%) of of 55%, radiology radiology (8.1%), of of 58% metastases metastases (106-109). stagement stagement (N-parameter), cautions cautions (102) negligible negligible (up to 20% of cases) (102). methods methods (negative, negative, mediastinoscopy) and and ESTS/requirements requirements (size size >Radiology Radiology (ESR), an an SR: the the report; organisation. organisation.",
      "start_page": 42,
      "end_page": 46
    },
    {
      "heading": "of of disease",
      "text": "site site (central or peripheral) airways airways (endobronchial vs peribronchial) metastases metastases and/or remotely (114).of of 90% (112-15). has has endotracheal/with with transbronchyal/oesophagal needles (TBNA) less-used, less-used, non-between between 60% and 90% used used (119-120), TC-guided TC-guided (TTNA) effective effective (approximately approximately 90%) pneumothorax pneumothorax (10-30% sampled sampled lesions), lesions lesions <pathological pathological (size >PET-TC PET-TC positive). procedure procedure ... ..neoplasm neoplasm (125-126).",
      "start_page": 46,
      "end_page": 48
    },
    {
      "heading": "parameter parameter N",
      "text": "years years \"8\" the the aspiration/agobiopsy transbronchial (TBNA) paratracheal paratracheal (4R, 4L), subcarenal (7), 10 10 (R and L) and 11 (R &amp; L) (ilari). such such as: nod nod (Sound, Sound, EBUS) involved involved (and and 7), and the operator'Surgeons Surgeons (10th-century) tumors tumors >nodes nodes >PET PET (SUV >2) node node <with with cN0/transbronchial transbronchial (EBUS) and transesophageal (EUS); the the EBUS-TBNA/EUS of 93%, is is 97% (129-130). with with EBus/mediastinoscopy. mediastinoscopy.",
      "start_page": 48,
      "end_page": 50
    },
    {
      "heading": "NMW NMW Classification",
      "text": "tumour tumour (T factor), involvement involvement (N factor) metastases metastases (M factor). system system (see subsequent tables) 2017 2017 (133-136). new new classification",
      "start_page": 50,
      "end_page": 50
    },
    {
      "heading": "(IX edition), 2024 2024 (137) 2025. 2025.",
      "text": "Edition Edition (Clinical classification)",
      "start_page": 50,
      "end_page": 50
    },
    {
      "heading": "primitive primitive tumor",
      "text": "lobar lobar (by by disease) T1a(mi) larger larger size",
      "start_page": 50,
      "end_page": 51
    },
    {
      "heading": "Edition Edition (Clinical classification)",
      "text": "I'cm cm long; long. long. • nodule nodule (i) neoplastic (ii) separated (i), following following structures: chest wall (upper upper five-footer).",
      "start_page": 51,
      "end_page": 52
    },
    {
      "heading": "General General principles",
      "text": "activity activity (138). lung lung resections: to to 150±Stage Stage IIIA/IIIB (multi-disciplinary multi-disciplinary groups), operability operability include: operability operability (the the stage); operability operability (the the radicality); operabilità operabilità (respiratory respiratory function). therefore therefore defined: 1. operable: surgical surgical trauma; 2. repeatable: intervention. intervention.",
      "start_page": 53,
      "end_page": 54
    },
    {
      "heading": "Functional Functional operability",
      "text": "mainly mainly with: spirometry; Modified Modified by: al. al. ERS/patients patients (surgery and chemo-radiotherapy). 2013; 143:cardiological cardiological evaluation: ppoFEV1% ppoFEV1% >60% & ppoDLCO%>60% or or ppoDLCO% treatment treatment •ppoFev1% or psoDLCO %<60% pred",
      "start_page": 54,
      "end_page": 56
    },
    {
      "heading": "ppoFEV1% or ppoDLCO%<30% predicted",
      "text": "•ppoFEV1% <30% pred&",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "ppoDLCO%<30% pred",
      "text": "VO2max<35% pred. or CPET: VO2max VO1max>75% <10 ml/Kg/or or >20 ml/kg/VO VO 2max35-75% preds. or 10-20ml/K g/min SCT>or or SWT<not not recommended; to to pneumonectomy",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "Surgical Surgical options",
      "text": "tumor tumor (Tis or T1a). glass glass (Opacities, Opacities, GGO) stages stages (T T 1a). rates rates (143). bronchoplasty bronchoplasty (sleeve lobectectomy) of of disease; losses losses (p <0.71), arrhythmias (p<0.86), lungitis (p>0.09) and mortality (p=0.49).",
      "start_page": 56,
      "end_page": 58
    },
    {
      "heading": "COI: No conflict declared",
      "text": "stage stage (IA), recommended recommended (the the plebectomy)? RECOMMENDATION: phase phase (IA) the the recommendation: CONDITIONAL FOR MOtivations/comments on benefit/damage balance: The The JCOG0802/period period (III III controlled). studies studies (Ottawa Ottawa Scale), the the trials: MODERATA COI: no conflict declared",
      "start_page": 58,
      "end_page": 59
    },
    {
      "heading": "4.2 Radiotherapy",
      "text": "conventional conventional radiotherapy? radiotherapy radiotherapy (Therapy Therapy - Radiotherapy Radiotherapy - SABR) disease disease (of of PRISma). work work (SBRT 7395; RTC 10.578). survival survival (HR 0.66; CI95% 0.62-0.70; p <0,001), survival survival ( HR 0.42; IC95% 0.35-0.50; p<0,001) and __MEDTERM1_ (HR 0.34; CI95% 0.25-0.48; p (<0,001). grades grades (155). Limits: propose. propose. Benefit/damage balance: medical medical contraindications",
      "start_page": 59,
      "end_page": 60
    },
    {
      "heading": "COI: No conflict declared",
      "text": "1. 1.5%, standard standard (156).analysis analysis (157) and and toxicity; and and short- VALOR VALOR (Sureotactic Sureotactic Radiotherapy). (ClinicalTria igoventiate: survival survival (OS) survival survival (DSS), expected. expected.",
      "start_page": 60,
      "end_page": 61
    },
    {
      "heading": "adjuvant adjuvant therapy",
      "text": "approximately approximately 90% about about 60% II II (139). about about 1/operated. operated.",
      "start_page": 62,
      "end_page": 62
    },
    {
      "heading": "Adjuvant Adjuvant therapy",
      "text": "is is recommended? excluded excluded < following following reasons: studies studies (were were included). LACE LACE (Cisplatin Cisplatin Evaluation), observation observation (159). 0. 0.7%; 86 86 (IC95% 0.81-0,92; p <0,0001), of of 4% (increase from 60% to 64%) (160). arms arms (CI95% 0.64-1,08; p=0.12) (161). guidelines guidelines (163-164) stage stage (TNM TNM stage) of of >the the risk/benefit benefit (165).survival survival (p=0.01) trials trials (15.000) toxicity toxicity (34% patients patients <vs vs 41% in patients >70 years) evidence evidence (elderly elderly patients), population population ≥with with ≥clinical clinical studies; caution caution (167-68). studies studies (stage stage (T2N0) (161), IIIA, IIIA, (N2) of of 24-T3N1 T3N1 (VII edition TNM) survival survival (HR 1.01; IC95% 0.62-1.65; p=0.97) survival survival ( HR 0.96; IC95% 0.75-1,22; p=0.74). However, only 66% arms arms (170). cisplatin cisplatin + vinorelbine vinorelbine (95.5%; IC95% 75. 75.4%; CI95% 63,1-85,2; p=0.001) (173). 16-2, 16-2,1; b=0.42), survival survival (0.83: CI95% 0.31-2,17; p=0.001) survival survival (HR 0.59; CI95% 0.16-2,1; p=0.42) (174). III III (JIPANG) cysplatin cysplatin + operated operated (edition edition TNM) receive receive cisplatin+precision precision (confidence confidence intervals) results results (metanalysis metanalysis [159] analysis analysis [160]). chemotherapy chemotherapy < a a >patients patients (of of age). trials trials (im lie). aged aged >pre-emptive pre-emptive half-year; five-year five-year phase; first first two-first first phase; second second stage; selected selected (post-operative post-operative recovery); IIA IIA (T >4 cm) well-selected (post-operational post-operational recovery). be be usable",
      "start_page": 62,
      "end_page": 68
    },
    {
      "heading": "COI: No conflict declared",
      "text": "years years (176) year year (177) survival survival (_MEDTERF0__: HR 0.90; IC95% 0.74-1,10; p=0.32; _MEDTERH1_; P=0.48; CI95% 0.92-1,76; p = 0.0014) survival survival (__MEDTERMM0 _: HR 1.13; IC95% 0.88-1,44; p=0.33; __medTERM1,8_ study: HR 1,24; IC95% 0.90-1,71; p=0.18) operated operated (IB-IIIA) study study (WJOG6410L) survival survival (HR 0.92; p=0.63) survival survival ( HR 1.03; p=0.0089) (181). Of Of relapse- free survival (hr 0.36; IC95% 0.24-0.55; p <0.0001), survival survival [HR 0.91; IC95% 0.42-1.94; p=0.80) (182). of of −of of •study study (see Appendix 2: of of studies). IB-IIIA IB-IIIA (of of TNM) MEDTERM25_ MEDTERM25_ (exone exone 21) II-IIIa II-IIIa (HR 0.16; IC95% 0.10-0.26), 02, 02,0; 0, 0,2; p <0,0001) therapy therapy (0, 0, 0; 26, 26, 26), and 26), with with full-2 2 (3 3 (from from five-study study (study study (1 1 (in in 23% __MEDTERM15_ __MEDTERM15_ (skin skin dryness) and 14% were were 27%, 12% and 13% (186), years years was",
      "start_page": 68,
      "end_page": 71
    },
    {
      "heading": "COI: No conflict declared",
      "text": "benefit benefit (DFS) patients patients (HR 0.24; CI95% 0.13-0.45; p <0.0001) population population (stage IB-IIIa) (HR 0,24; IC95% 0.10-3.43; p<0.0001). disease disease (HR 022; CI95% 0.08-0.58). in in 30% with with •of of 5% and 31% chemotherapy chemotherapy (188). PD-L1 PD-L1 ≥1% cells cells (SP263) (HR 0.66; CI95% 0.50-0.88) stage stage II- IIIA patients (HR 0.79; CI95% 0.64-0.96), patients patients (hr 0.81; IC95% 0.67-0.99) (189). II II - survival survival (follow-up 45 months), at at PD- to to 50% (Phase Phase I: HR 0,43; CI95% 0.24-0.78",
      "start_page": 71,
      "end_page": 73
    },
    {
      "heading": "COI: No conflict declared",
      "text": "a a PD-1/PD-L1 (_MEDTERM0_) an an anti-PD-1 inhibitor (__MEDTERM1_) study study PEARLS/stage stage (≥4 cm)-IIIA (TNM TNM stage) placebo placebo (in in 86% of cases). population population (IB-IIIa stage: HR 0,76; IC95% 0.63-0.91; p=0.0014), option option (P18-150); the the time; 5501. 5501.",
      "start_page": 73,
      "end_page": 73
    },
    {
      "heading": "Adjuvant Adjuvant radiotherapy",
      "text": "L07 L07 (L10) to simple observation? I-III I-III (1998 1998 (192) 2016 2016 (193). I-iii I-iii (this this paragraph), trials trials (to to 2011/8 July 2016) alone alone (12 12 [CId95% 1.01-1,24] 13 13 [IC95% 1,02-1,24], respectively) a a general; option option (192-193)",
      "start_page": 74,
      "end_page": 75
    },
    {
      "heading": "primary primary therapy",
      "text": "is is 60-80%, of of 40-60%, is is 20-40% (194). year year (195). between between 6% and 10% per person/and and 2% years years (196), 3. 3.5% and 15% (197). primary primary treatment's end.",
      "start_page": 76,
      "end_page": 76
    },
    {
      "heading": "5.1 Imaging",
      "text": "treatment treatment . in in unfit/lesions lesions (helpful helpful (1strous) disease disease (percentive patients <1 cm). as as \"minimal\" , up up (maximal) TC TC chest/ the the 5° the the follow- up (maximal) followup followup (n=888). I-II I-II (82% in each arm). a a Follow-up",
      "start_page": 76,
      "end_page": 77
    },
    {
      "heading": "Survival Survival care",
      "text": "radiotherapy radiotherapy and/of of 25-40% (201). frameworks frameworks (a a \"mass-like\" or \"scar-like-like\") is is available; interruption interruption (203) lifestyles lifestyles (physical physical activity) of of content/uploads/2021/01/2021_Racc_vacc_antiinfluenza_AIOM_agg.pdf).",
      "start_page": 77,
      "end_page": 78
    },
    {
      "heading": "of of follow-up",
      "text": "risks risks (false false positives). recommended. recommended.",
      "start_page": 78,
      "end_page": 79
    },
    {
      "heading": "5.4 Organisation",
      "text": "the the patient'radiotherapy radiotherapy and/are are recommended: PET/nervous nervous system; Strong Strong positive",
      "start_page": 79,
      "end_page": 80
    },
    {
      "heading": "advanced advanced disease",
      "text": "should should include: disease disease (or or IIIC), alterations alterations (III III C), prediction prediction (long long dose) and oesophageal.",
      "start_page": 81,
      "end_page": 81
    },
    {
      "heading": "Surgical Surgical therapy",
      "text": "therapeutic therapeutic terms: IIIA (T3-T4, N1; T1-T2, N2); IIIB (T3), station station (R4,5), therapies therapies (chemotherapy or chemo-radiotherapy) setting setting (204). IIIA IIIA - undergo. undergo.",
      "start_page": 81,
      "end_page": 83
    },
    {
      "heading": "Neoadjuvant Neoadjuvant chemotherapy",
      "text": "recommended recommended (surgery surgery alone)? data data (2385 patients), surgical surgical resection; of of 13%, treatment treatment (HR 0.87; IC95% 0.78-0.96; p=0.007), survival survival (HR 0.87; CI95% 0.81-0,94; p <0,001) survival survival ( HR 0.86; CI95% 0.78-0.96; p=0.005). 2 2 (RR 1.07; IC95% 1.02- 1.12; p=0.007) years years (RR 1.16; CI95% 1.06-1.27; p=0.011). enrolled enrolled ≥less less than",
      "start_page": 83,
      "end_page": 84
    },
    {
      "heading": "III. III.",
      "text": "Limits: results results (indirectness). analysis analysis (205) size size (80 80 participants), I-IIIA I-IIIA (N1), disease disease (cN2) (TNM VIII edition) the the risk/patient patient (206-207)",
      "start_page": 84,
      "end_page": 85
    },
    {
      "heading": "Neoadjuvant Neoadjuvant chemio-radiotherapy",
      "text": "response response (pathological pathological response). surgery surgery (208). significant significant (22 22 months). pneumonectomy pneumonectomy (the the patient'trimodal trimodal treatment; induction induction study; study study (disease disease (cN2), group. group.",
      "start_page": 85,
      "end_page": 86
    },
    {
      "heading": "Postoperative Postoperative radiotherapy",
      "text": "phase phase (pN2), methanalysis methanalysis (Post-Operative Radio-Therapy) III III (217).justified justified (radiotherapy radiotherapy planning), the the late-separation separation (1.8- 2 Gy/die), of of •8% (HR 0.73; CI95% 0.58- 0.92; p=0.008), survival survival (HR 0,70; CI95% 0.60-0,83; p <0.0001) relapse relapse (HR 0.37; CI95% 0.24-0.58; p<0.0001). survival survival ( HR 0.85; CI95% 0.79-0,92) and disease- free survival (hr 0.57; IC95% 0.38-0.85) involvement involvement (221). G3-G4 G3-G4 (33.7% vs 15%) 5. 5.3% 14. 14.6% IIIA IIIA (pN2). that that 18% respectively respectively 13% and 32% total. total. All/volume volume (223). for for 66% and and 47% difference difference (HR 0.46; IC95% 0.3-0.7). station station (conlaterally) setting. setting.",
      "start_page": 86,
      "end_page": 88
    },
    {
      "heading": "chest chest wall",
      "text": "about about 5% wall wall (healthy healthy margins) lymphadenectomy. lymphadenectomy.",
      "start_page": 88,
      "end_page": 88
    },
    {
      "heading": "Pancoast Pancoast cancer",
      "text": "arm arm (ulnar side), of of Claude-stagement stagement (TC, RM, PET), to to mediastinoscopy/tomia and/approaches approaches (EBUS, EUS). involvement involvement (N0-N1) chemo-radiosurgery chemo-radiosurgery (of of patients) (224-226). medicine. medicine.",
      "start_page": 89,
      "end_page": 89
    },
    {
      "heading": "pulmonary pulmonary vessels",
      "text": "hull hull and/airway airway and/ or vessels.",
      "start_page": 89,
      "end_page": 89
    },
    {
      "heading": "advanced advanced disease",
      "text": "stage stage IIIA/IIIB IIIB (N3) the the −IIIA IIIA / recommended recommended (compared to sequential)? methanalysis methanalysis (227) studies studies (1024 patients) of of 13%, al. al. (702 patients) survival survival (HR 0.84; CI95% 0.74-0.95; p=0.004), 5. 5.7% 4. 4.5% control control (HR 0.77; IC95% 95, 95, p=0.01), characteristics characteristics (histology, histology, stage) in in 4-18% of cases. Limits: analysis analysis (227) met-analysis met-analysis (228) therapy. therapy.",
      "start_page": 90,
      "end_page": 92
    },
    {
      "heading": "COI: No conflict declared",
      "text": "stage stage IIIA/with with radiotherapy? following following reasons: studies studies (4 4 RCT) stage stage IIIa/al. al. (29) studies studies (230-231) drugs drugs (paclitaxel or docetaxel) al. al., treatment treatment with: cisplatin cisplatin (n=153), carboplatin carboplatin (no=152), carbomune carbomune (n=156). survival survival (months months respectively) years years (17,5%, 17.8% and 19,8% respectively) cysplatin cysplatin (of of 31% cisplatin cisplatin -vs vs 25% carboplatin carboplatin - paclitaxel arm (p=0.50). al. al., __M5 __M5 - arms arms (_MEDTERM5_: 8 8 months; HR 0.98; CI95% 0.79-1.20; p=0.831), pemetrexed pemetrexed (64% versus 76.8%; p=0.01). Limits: outcomes. outcomes. Benefit/damage balance: stage stage IIIA/IIIA IIIA / combination combination (2-29 patients)",
      "start_page": 92,
      "end_page": 95
    },
    {
      "heading": "COI: No conflict declared",
      "text": "to to 1%, to to observation? RECOMMENDATION: of of PD- equalto equalto 1%, of of recommendation: FORTE AWELO Motivations/comments to benefit/day balance balance: III III - before before benefit/benefit/day benefit balance: balance balance (the benefit balance/day/balance balance balance/Da: The 3 days: 3 3 , with with non- __MEDTERM0_ __MEDTERM0_ (29.9% vs 26.1%) treatment treatment (15.4% vs 9.8%). MEDTERM0__ MEDTERM0__ (7 7 months; HR 0.68; IC95% 0.53-0.87; 2 2 years: 66.3% vs 55.6%; p=0.005), __medterm15_ __medterm15_ (HR 0.51; CI95% 0.41- 0.63; p=0.001). of of −status status (HRTERM0) of of 25%, about about 63% of patients: Cut-off ≥ 25% (HRTerM0_ medicinally) these these (arm arm (HR 0.71; CI95% 0.57-0.88) and 35.3% vs 19.5% with with PD- L1 ≥1%, in in 63% study study (237). 42. 42.9% 33. 33.4% of of 33% vs 19% (238).",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "Quality of tests",
      "text": "following following reasons: interest. interest.",
      "start_page": 96,
      "end_page": 97
    },
    {
      "heading": "Advanced Advanced Disease",
      "text": "__MEDTERM0_ __MEDTERM0_ (stage IIIB/stage stage IV) following following parameters: • histology (squamosa vs non-squammosa); • driver driver alterations; • PD-L1 expression level; ■ number (s) of metastatic lesions; â ¢ the the patient: status status (PS), approaches. approaches.",
      "start_page": 98,
      "end_page": 98
    },
    {
      "heading": "oligometastatic oligometastatic disease",
      "text": "disease disease (241). 20-50% disease disease (OM) treatment treatment (LAT) between between 12% and 52% (242-243). studies studies (246-249) staging staging (EBUS/mediastinoscopy), used used (in 55% OM OM disease), stereotaxic stereotaxic (SBRT) 1212 1212 articles; al. al. (250), with with ≤randomised randomised (treatment treatment (surgery or radiotherapy) months months (28,3-61,4), clinically clinically (local local treatment). analisys analisys (II II (PEMBRO-RT and MDACC) __MEDTERM0_ __MEDTERM0_ (3 3 weeks) PEMBRO PEMBRO - session session (3 3 fractions), MDACC MDACC l'treatment treatment (15 15 fractions). survival survival (5 5 months; p < 0.0001) 4 4 months; P < 0.001); Only 6% survival survival (5 5 month; p< 0.001); __MEDTERRM19__ __MEDTERRM19__ (4 4 months;p < 0.001; p < 0.0001); only 6% trials trials (HR: 0.1 - 0, - 12, - 10, - 5, - 8 - 6, - 9 - 5 - 5), - 45 -, -, 52 -, 2 - 3, - 3 - 5 and - 5 *the the evidence: LOW COI: no conflict declared",
      "start_page": 98,
      "end_page": 101
    },
    {
      "heading": "oncogene-addicted oncogene-addicted disease",
      "text": "These These include: gene gene (20-30%), __ MEDTERM0_ (10-15% to to 40% of Asian patients), BRAF (2-4%), __medTERM1_ __medTERM1_ (3-7%), _MEDTERM2_ (1-2%), _MEDTERm3_ (1-2%), __MDTERM4_ (0.5-1%) __médterm5_ __médterm5_ (2%).",
      "start_page": 101,
      "end_page": 101
    },
    {
      "heading": "disease disease EGFR-mutated",
      "text": "of of •exone 20 (Algorithm 5) (254-263).of of −approximately approximately 85% remaining remaining 15% a a __médterm24=English 19 (Ex19desone) alterations alterations (single or complex), rare rare (10-12) 20 20 (3-6%) (264). the the recommendation: ADVANTAGE ADVANTAGE Motivations/comments to benefit/damage balance: __MEDTERM0_ __MEDTERM0_ (80 mg/day) inhibitors inhibitors (150 150 mg/250 250 mg/die) __AMTERM24_ __AMTERM24_ (Ex19dels, L858R) (263). arm arm (midian: 2 2 months; HR 0,46; CI95% 0.37-0.57; p <0,001). brain brain (subgroup subgroup analysis) __medterm0_ __medterm0_ (medial: 9 9 months; HR 0,48; IC95% 0,26-0,86; p=0,014). RR RR (66% vs 43%; OR 2,5; IC95% 1,2-5,2; p=0.011). events events (34% vs 45%).",
      "start_page": 101,
      "end_page": 102
    },
    {
      "heading": "Quality of tests",
      "text": "following following reasons: of of tests: BASS_ COI: recommended recommended (to to chemotherapy)? study study (see Appendix 2: of of studies). 1 1 (RR 71.1%; 7 7 months; 4 4 months), patients patients (RR 14,3%; 9 9 months; .9 9 month; outcomes outcomes (n=315) 7 7 months; -2 2 months). trial trial KCSG-LU15-09 (II II trials), with with non-of of •22 22 (61%) months months (272). patients patients (n=46) who received −molecule molecule (275). Limits: interest. interest. Benefit/damage balance: __medTERM20_ __medTERM20_ (changes/exons exons 18-21); of of • deute_moderations/also also , into into medically",
      "start_page": 103,
      "end_page": 105
    },
    {
      "heading": "COI: No conflict declared",
      "text": "of of •of of −recommended recommended (compared to chemotherapy)? patients patients (62 62 years), by by 37%, 13. 13.7% (276). evaluated, evaluated, 13% (n=15) years years (277). in in 13% and 4% of patients (276) Limits: results. results. Benefit/status. status.",
      "start_page": 105,
      "end_page": 107
    },
    {
      "heading": "COI: No conflict declared",
      "text": "__MEDTERFX58_ __MEDTERFX58_ (73% vs 47%) alone alone (7 7 months; HR 0.40; IC95% 0.30-0.53; p < 0.001). in in 75% combination combination (of of 69%) and in 54% chemotherapy chemotherapy (of of 36%) (278). T790M T790M mutation; randomised randomised (2:1) __medTERM6_ __medTERM6_ (80 mg/day) pemetrexed pemetrexed (500 mg/g. g. 1) cisplatin cisplatin (75 mg/ mq ed. g). MEDTERM6_ MEDTERM6_ (means: 6 6 months; HR 0.32; IC95% 0.15-0.69; p=0.004). outcomes outcomes (PRO) of of −degree degree >__médterm6_ __médterm6_ were: diarrhea (41%), rash (34%), skin xerosis (23%) and paronicia (22%). in in 4% with with •Overall Overall benefit/damage ratio: among among which: __MDTERM38_ __MDTERM38_ (e.g. C797F), microcytoma microcytoma (282). MEDTERM3_ MEDTERM3_ (285). RECIST RECIST (primary endpoint) with with −MEDTERM2_ (secondary endpoint) patients patients −__AMTERM38_ __AMTERM38_ (months months (received received radiotherapy) months months (287). respectively respectively (288-289). therapies therapies (radiology radiology techniques) today. today.",
      "start_page": 107,
      "end_page": 111
    },
    {
      "heading": "disease disease ALK-rearranged",
      "text": "__MEDTERM108_ __MEDTERM108_ (present in 3-7% pulmonary pulmonary malignancies) habit habit (292). study study \"PROFILE 1014\" 2014 2014 (293) 2018 2018 (294), 1029 1029 (and and Malaysia) inhibitor inhibitor (295). in in 78%, only only 3% 600 600 mg/750 750 mg/die in fasting; the the benefit/450 450 mg/_MEDTERN135_ _MEDTERN135_ (with with _MEDTERMO0_; HR 0,34; IC95% 0,17-0,71; p <0,0001). __MDTERM12_ __MDTERM12_ (92% vs 79%), baseline baseline (stratification stratification factor) lesions lesions (n=122) MEDTERM0_ MEDTERM0_ (some some patients). progression progression (HR 0.18; IC95% at at baseline; HR 0.14; IC95% at at baseline) (303). the the →with with −Overall Overall benefit/damage balance: chemotherapy chemotherapy (74%) regimen regimen (26%). __medTERM56_ __medTERM56_ (180 mg/90 90 mg/die) or __MDTERM0_ (d. d.). analysis analysis (303) 2020 2020 (306) (_MEDTERM56_ _MEDTERM56_ (6 6 months; HR 0.31; IC95% 0.17-0.56; p <0,0001). arms arms (99% vs 100% of patients), the the ›MEDTERM57_ (73% vs 610%). overall overall health/ALTA-1L ALTA-1L (307). 5 5 million; last last group: recommended recommended (compared to __medTERM0__)? of of •to to −2020 2020 (308). review review (BICR). were were 82% vs vs 23% which which 71% years years 60% MEDTERM0_ MEDTERM0_ , with 83% and and 92% __medTERM79_ __medTERM79_ (310). Limits: conduction conduction (independent independent reviewers).Background/damage: treated. treated.",
      "start_page": 111,
      "end_page": 117
    },
    {
      "heading": "COI: No conflict declared",
      "text": "recommended recommended (compared to chemotherapy)? RECOMMENDATION: Recommendation Recommendation Force: AWAREER AWAREER Motivations/the the benefit/al. al., phase phase I/of of −95. 95.3% and 48.1% degree degree (84.4% and 67.1% respectively) 4 4 (18% in both cases) Overall Overall benefit/damage balance: effects effects (brain brain activity) and undesirable (drug-specific adverse events) following following reasons: al. al., RECIST RECIST (generation generation pre-inhibitions) (Media: 9 9 months; HR 0.27; IC95% 0.17-0.42; p <0,0001), __MEDTERMI_10_ __MEDTERMI_10_ (Medium: 8 8 months; H 0.30; CI95% 0.19-0.46; p<0.0001). 5, 5, (314). progression progression (318). ALK-rearranged. ALK-rearranged.",
      "start_page": 117,
      "end_page": 119
    },
    {
      "heading": "disease disease ROS1-rearranged",
      "text": "is is recommended? grade grade were: visual disturbances (87%), diarrhoea (45%), nausea (51%), peripheral oedemas (47%), constipation (34%), vomiting (38%), transaminase increase (36%) and asthenia (21%), hypophosphataemia hypophosphataemia (15%), neutropenia (9%), transaminases transaminases (4%) and vomiting (4%). patients patients (5 5 years), female sex (64.5%) and non-smoking (67.7%). 1 1 months; trial trial (321). patients patients (324). 47. 47.2% 69. 69.4% (325). is is recommended? RECOMMENDATION: with with −with with benefit/damage adjustments: studies studies (growth growth (n=17; 8.1%), ALT rise (n=7; 3.3%) and diarrhea (n = 6; 2.9%), 7 patients (3.3%) events events (hyperuricaemia; hypertriidemia; limbic cephalitis; myocardiate; creatinine elevation. Benefit/damage balance: The risk/following following reasons: number number (improvement of estimates) studies studies (and and indirectness), phase phase I/of of 62% and and 35% in in pre‐than than 50% with with •MEDTERm22_ (64% and and 50% with with −MEDTERMM0_) (330). strategies. strategies.",
      "start_page": 119,
      "end_page": 122
    },
    {
      "heading": "BRAF-V600 BRAF-V600 disease",
      "text": "of of serine/about about 5% 15 15 (in particular V600E), is is recommended? patients patients (64%), with 2 (6%) 21 21 (58%) at at 60%. 25 25 (69%) grade grade 3-4: companies companies (11%), 3 3 (8%). al. al., 3 3 (0.8%). following following reasons: of of tests: VERY LOW COI: dabrafenib dabrafenib + chemotherapy chemotherapy (331). to to be: 68.4%, respectively. respectively.",
      "start_page": 122,
      "end_page": 124
    },
    {
      "heading": "disease disease NTRK-rearranged",
      "text": "is is recommended? included included (see Appendix 2: of of studies). studies studies (STARTRK-2, ALKA-and and STARTRK-NG) of of −study study I/STARTRk-1 STARTRk-1 (333) safety safety (332-333).al. al. (335) tumours tumours (17 histologies) of of -_MEDTERM7_.",
      "start_page": 124,
      "end_page": 125
    },
    {
      "heading": "disease disease RET-rearranged",
      "text": "trial trial (i.e., from __MDTERM10) to to platinum- Therefore, Therefore, l/mmunotherapy (with with chemotherapy) these these patients: from from •__MEDTERM10_ __MEDTERM10_ (Funded or Mutations).of of −latter, latter, 58% with with anti-PD-1/anti-PD‐0-1 0-1 (97%, n=20447) to to 33% at at enrollment; was was 85% including 27% remaining remaining 15% 0. 0.7% access access program",
      "start_page": 126,
      "end_page": 127
    },
    {
      "heading": "LIBRETTO-201 (340-341).",
      "text": "==References===External links==* http://www.interpol.int/en/notice/search/un_en/LIB__MEDTERM5_TO-001 LIB__MEDTERM5_TO-001 (340), PROs PROs (344-345). access access program/SIREN SIREN (346), these these 27% (n=10) and 35% (n=13) the the →was was 68% ( 24% disease disease stability) was was 100% emerged. emerged.",
      "start_page": 128,
      "end_page": 129
    },
    {
      "heading": "COI: No conflict declared",
      "text": "Phase Phase I/II (ARROW) of of activity/MEDTERM10_ MEDTERM10_ (347- 349). of of −of of •transcription transcription (exon skipping) of of →medterm14 of ›about about 2-4% alteration alteration are: sex sex (60-70%), smoking smoking (54-64%), metastases metastases 37% (350-351). advanced advanced (pre-treated pre-treated patients) 2 2 lines) l/o_MEDTERM22_ was 41%, the the −53. 53.8%.",
      "start_page": 129,
      "end_page": 131
    },
    {
      "heading": "COI: No conflict declared",
      "text": "of of •immunotherapy immunotherapy and/recommended recommended (compared to chemotherapy)? following following reasons: combination with −MEDTERM1_ (2), __MDTERM2_ (1) study study (1). of of {biopsy biopsy and/was was 46%, event event (67.1%); 11. 11.2%. Limits: estimates. estimates. Benefit/damage balance: skipping skipping of",
      "start_page": 131,
      "end_page": 132
    },
    {
      "heading": "of of KRAS",
      "text": "about about 10-12% immunotherapy immunotherapy and/recommended recommended (compared to chemotherapy)? 960 960 mg/day (356). grade grade ≥3 were 33% vs 40% grade grade ≥ diarrhoea diarrhoea (12%), ALT ALT (8%) and AST (5%); neutropenia neutropenia (9%), fatigue (6%) neutropaenia neutropaenia (5%). 23 23 (13%) 2 2 (1%) immunotherapy immunotherapy and/considered considered (compared to chemotherapy) (355-357)",
      "start_page": 132,
      "end_page": 135
    },
    {
      "heading": "not not oncogene-addicted",
      "text": "expression. expression.",
      "start_page": 135,
      "end_page": 135
    },
    {
      "heading": "First-line First-line treatment: immunotherapy",
      "text": "PD-L1 PD-L1 ≥50%, status status (0-1), recommended recommended (compared to chemotherapy)? RECOMMENDATION: of of −MEDTERM27_, or re‐arrangement of •the the PD- L1 ≥ 50%, with with {the the recommendation: FORTE AVOID Motivations/the the benefit/damage balance: MEDTERM40_ MEDTERM40_ (6 6 months; HR 0,50; IC95% 0,37-0,68; p <0,001). the the •of of −chemotherapy chemotherapy (HR 0,62; IC95% 0,48-0,81; p=0,001) of of •31, 31,9% with •16, 16,3% responses responses (46,1% vs 31,1%) response response (3 3 months) (370). following following reasons: open open (independent independent reviewers; provided the crossover; the the manuscript; study study (of of __MEDTERM41_). of of testing: MODERATA COI: PD-L1 PD-L1 ≥50%, of of −of of • status status (0-1), recommended recommended (based based chemotherapy)? with with high/PD-M1 PD-M1 expression; a a high-38. 38.3% HR8. HR8.6% with with −had had high- of of −SP1 SP1 -L1 ≥50% 22C3 22C3 (11 11 months; HR 0.60; CI95% 0.42-0,86) SP3 SP3 -expression expression ≥50%, status status (0-1), considered considered (platinum-based platinum-based chemotherapy) (360)",
      "start_page": 135,
      "end_page": 137
    },
    {
      "heading": "COI: No conflict declared",
      "text": "PD-L1 PD-L1 ≥50%, status status (01-1), with with −MEDTERF0_ < is recommended (based based chemotherapy)? PD-l1 PD-l1 ≥ 50% (tested with 22C3) of of I-with with , including , i-week-with with {-of of , with •-1 1 study; 1 1 trial-t-test-PD-L1 PD-L1 ≥50%, survival survival (2 2 months; HR 0.57; CI95% 0.42-0.77), progression-free survival (7 7 months; H 0.54; IC95% 0.43- 0.78) for for PD- a a 46% with with PD-L1- ≥90% longer-lasting longer-lasting responses; the the progression- months months (HR 0.28; IC95% 0.17-0.56), stage stage IIIB/PD-L1 PD-L1 >50% practices. practices. Limits: indirectness. indirectness. Benefit/damage balance: of of PD- L1 ≥50%, status status (0-1), consideration consideration (respect to platinum) (to to chemotherapy)",
      "start_page": 138,
      "end_page": 139
    },
    {
      "heading": "COI: No conflict declared",
      "text": "of of •PD-L1 PD-L1 <50% status status (0-1), and and •and and −recommended recommended (compared to chemotherapy)? RECOMMENDATION: the the →MEDTERM34_, or re‐of of {of of P-L1-50% Status Status (NO- 1). with with __MEDTERM0_==Film ==__ __ MEDTERM5==Volume 5=Further reading: __medTERM2=Firth-First-Fridays; __Mer-Ferce-Far, __Ferme 5=Hierarchy and __Metro-Front-Fracials===The median-Fifth-Serge 4=Fercent-Faith==*Ferse-Français, −Fermo-Florence, ‐Fertimes, •Ferber-Flight, 1⁄2=Emergency, versus 33=Friendwards, and −Ever-Fernth-Lenth-Cer. __All-Forpouse==References= including including PD- L1 negative (n=190; HR 0.55; IC95% 0.39-0.76) and PD-l1 1-49% (n=86; HR 0.65; CI95% 0.46-0.90). 19. 19.4% 11. 11.3% alone alone (52. 52.1% vs 42.1%), events events (27. 27.7%, 12. 12.6%) of of −Walktop Walktop (3-5. 3-5.6%). the the trials: MODERATA COI: expression expression <50% status status (0-1), with with −recommended recommended (to to chemotherapy)? RECOMMENDATION: PD PD - L1 <50%, Status Status (0-1), of of LOD/treatment treatment cycles; treatment treatment options: PD-L1 PD-L1 (PD-L1-1% vs <1%), taxan taxan (paclitaxel vs nab-paclitaxel) region region (the the world). after after l'MEDTERM0_ MEDTERM0_ (6 6 months; HR 0.71; CI95% 0.59-0.85), 18. 18.4% 9. 9.4% of of evidence: BASSA COI: PD-L1 PD-L1 <50% status status (0- 1), week week −72 72 (IC95% 0.61-0.86). 68 68 (CI95% 0.57-0.82). lesions lesions (371-372). survival survival (_MEDTERM53_), with 21% __medTERM25_ __medTERM25_ + to to 16% 000 000 [34], mutations mutations l[expression expression <50% status status (0-1), with with −option option (371)",
      "start_page": 140,
      "end_page": 143
    },
    {
      "heading": "COI: No conflict declared",
      "text": "__ __ MEDTERM4_; PD-L1 PD-L1 1-49% status status (0-1), recommended recommended (compared to chemotherapy)? of of › responses responses (22, 22,7%; p <0,0001) 56 56 (CI95% 44-0, 44-0,70). 42. 42.7% ___MEDTERM0_ ___MEDTERM0_ + 27. 27.3% 42. 42.7% 47. 47.7% with with [__MEDTHERM0_] + 2-27. 27.3% PD-L1 PD-L1 <1% (HR: 0.74; CI95%) 3-4 3-4 3-4- the the chem/3 3 /were were 3% were were anaemia3; 3; 8, 8,8% arm, arm,8%, 8.8% the the five-to- to 8% 10. 10.8% in favour,8- to 8.8%,arms, arms,8; the the last- the the two- and and seventy- mutations mutations l\"__ __ MEDTERM5__/expression expression 1-49% status status (0-1), option option (374-375).",
      "start_page": 144,
      "end_page": 145
    },
    {
      "heading": "First-line First-line treatment: chemotherapy",
      "text": "chemotherapy chemotherapy (cisplatin-based cisplatin-based schemes) MEDTERM15_ MEDTERM15_ (primary endpoint) (383). with with non- IIIB IIIB (curative curative purposes) or IV (384). randomised randomised (receive receive cisplatin/gemcitabine (cisplatin 75 mg/1250 1250 mg/ 3 3 weeks) or cysplatin/8 8 months; the the cisplatin/toxicity toxicity (neutropenia: 15% vs 27%; anaemia: 6% vs 10%; thrombocytopenia: 4% vs 13%; p <0,001) and alopecia (any grade 12% vs 21%; p=0.002), nausea nausea (7% vs 4%; p=0.000). cisplatin cisplatin / with with I-2 2 phases: phase phase (induction phase) 1-line 1-line cisplatin/pemetrexed (cisplatin 75 mg/500 500 mg/ following following reasons: of of tests: BASSA COI: non-squamosa non-squamosa › histology histology (387). __MEDTERM0_ __MEDTERM0_ (and and headache; treatment treatment (control control arm), metastatic metastatic (or or IV) (389). of of Cisplatin/gemcitabine (cisplatin 80 mg/1250 1250 mg/ grade grade ≥three three arms; Grade Grade ≥with with •MEDTERM19_ advanced",
      "start_page": 145,
      "end_page": 149
    },
    {
      "heading": "treatment treatment lines",
      "text": "vinorelbine vinorelbine (393-394). line line (395). second-line second-line (395) of of , at at [_; chemotherapy, chemotherapy, −_MEDTHERM4__ _MEDTHERM4__ (PD-L1 PD-L1 ≥ 1%) of of recommendation: FORT MOtivations/comments to benefit/damnance balance: randomized randomized (prior prior approval). MEDTERM91_ MEDTERM91_ (medial: 6 6 months; HR 0.59; IC95% 0.44-0.71; p <0,001), __medTERM96_ (mediated: 8 8 months; H 0.62; CI95% 0.47-0.81; p<0.001) and RR (20% vs 9%, p=0.008) with with −grade grade (58% vs 86%), grade 3-4 (7% vs 55%) 5 5 (0% vs 2%), selected selected (immune immune aetiology) study study were: hypothyroidism (4% with •MEDTERMI3_ vs 0% with docetaxel), diarrhoea (8% vs 20%), pneumonia (5% vs 0%), creatinine creatinine (3% vs 2%) and rash (4% vs 6%). either either PD-imediental) on on platinum; also also allowed; of of mutation; −__EDTERM77_ __EDTERM77_ (401). __Temperm3_3_ __Temperm3_3_ (3 mg/2 2 weeks); or docetaxel (75 mg/3 3 weeks). observed observed were: rash (9% vs vs 3% for docetaxel), pruritus (8% vs 1%) erythema (1% vs 4%), diarrhoea (8% versus 23%), hypothyroidism (7% versus 0%), ALT increase (3% versus 1%) and AST (3% vs 1%), infusional reactions (3% v 1%) pneumonia pneumonia (3% against < 1%). patients patients (≥1%, ≥5%, ≥ 10%). of of __MEDTERM3_; pre-specificated pre-specificated (≥10%, ≥10%) confirmed confirmed (402). phase phase II/expression expression ≥1% (antibody antibody 22C3), doubles doubles (of of −of of •MEDTERM77_) (403). About 30% randomised randomised (1:1:1) MEDTERM4_2 MEDTERM4_2 mg/10 10 mg/ kg; ==References===External links==* http://www.interpol.int/en/notice/search/un_en/represented represented by: open-label design (monitoring monitoring committee), trial trial (with with l'immunotherapy in II-line). drivers drivers (the the study) of of PD/practice practice (1-49). __MEDTERM91_ __MEDTERM91_ (intention-to-treat, ITT) PD-L1 PD-L1 (as % expressing expressing PD- L1: TC3 TC3 ≥50%, TC2 ≥5% and <50%, CT1 ≥1% and <5%, and TC0 <1%; immune cells infiltrating: CI3 ≥10%, IC2 ≥ 5% and <10%; IC1 ≥ 1% and <5 percent; and IC0 <1%) population population (7 7 months; HR 0,73; IC95% 0,53-0,99; p=0.04). represented represented by: chemotherapy chemotherapy (of of __medTERM3; ¡tv. (1200 mg/tv) or docetaxel (75 mg/mq), disease disease (n=222; HR 0.73; CI95% 0.54-0.98) and non-squamosa (n=628; 73, 73, CI95% 0.60-0.89), non-smoking patients (n=156; HR 0,71; IC95% 0.47-1.08) metastases metastases (n =85; HR 0.54; IC95% 0.31-0.94), PD-L1 PD-L1 (TC3 or IC3), __medTERM5_ __medTERM5_ (HR for −MEDTERMC96__ 0.63; IC95% 0,43-0.91). ITT ITT (l8_MEDTM5). Every 2 weeks) PD-L1 PD-L1 expression; __ MEDTERM4_ (2 2 mg/3 3 weeks) Advanced Advanced PD- therapy therapy ≥1% chemotherapy chemotherapy (receiving receiving __MDTERM4___); __méMEDTERM5_ (every every 3-week) of of PD‐L1-expression (receiving receiving _MEDTERm5_annually).",
      "start_page": 150,
      "end_page": 153
    },
    {
      "heading": "Quality of tests",
      "text": "by by MODERATA: in in open-label; of of non- of of trials: MODERATA COI: docetaxel docetaxel alone? weeks weeks + nintedanib (d. d.) days days 2-21; i = 10,000; i= 10,000, i=10,000; I = 1,000; i: and and i=1 1 million; 5, 5,000; e = 1 1 year; i#2, 2,000; placebo placebo were: diarrhea (all grades: 42.3% vs 21.8%; grade ≥3: 6.6% vs 2.2%), transaminases transaminases (ALT, all grades: 26.8% vs 8.4%; grade >3: 7.8% vs 0.9%; AST, all degrees: 22.5% vs 6.6%; grade < 3.4% vs 0.5%), nausea (all levels: 24.2% vs 18%; grade>3: 0.8% vs 0.9%) papetite papetite (all classes: 22.2% vs 15.6%; degree ≥3 1.4% vs 1.2%). life life (410). data, data, __medterm0_% schedule schedule (HR 0,97; IC95% 0,68-1,18; p=0,8439) schedules schedules (HR 0,88; IC95% 0,48-1,61; p=0.31). the the study: lines. lines. Limits: log__ log__ MEDTERM25_; furthermore, the sponsor'study study ( range range 53-67) pathology. pathology. Benefit/damage: therapy. therapy.",
      "start_page": 154,
      "end_page": 157
    },
    {
      "heading": "status status 2",
      "text": "agent agent (vinorelbine) agents agents (gemcitabine/winorelbine), mono-hemotherapy mono-hemotherapy (411-412). patients patients (of of age) 0-2 0-2 (413). carboplatin carboplatin (4 4 weeks) + paclitaxel (90 mg/4 4 weeks). carboplatin carboplatin (HR 0.67; IC95% 0.59-0.78) cisplatin cisplatin ( HR 0.91; IC95% 0.77-1.08), compared to mono-chemotherapy; age age ≥0-1 0-1 (415). receive receive cisplatin/gemecitabine (cisplatin 60 mg/1200 1200 mg/ 2 2 (416). status2 status2 (i.e., non-amplified non-amplified efficacy) randomised randomised (with with carboplatin/paclitaxel (200 200 mg/3 3 weeks) or cisplatin/gemcitabine (cisplatin 60 mg/ 1000 1000 mg/3 3 week), arms arms (RR 25% vs 23%; 8 8 months; 9 9 months) with with −trials trials (418-420). strategy. strategy.",
      "start_page": 157,
      "end_page": 160
    },
    {
      "heading": "cancer cancer (SCLC)",
      "text": "system system (TNM edition VIII) Cancer Cancer (IASLC), a a \"Limited\" stage (as as homo- therapy therapy field) stage stage (remote remote metastasis) implications. implications.",
      "start_page": 161,
      "end_page": 161
    },
    {
      "heading": "disease disease treatment",
      "text": "disease disease (T1-T2, N0), approximately approximately 5% SCLC SCLC (421-422). the the patient'conditions, conditions, chemo‐is is recommended? included included (1 1 RCT). of of age; as as 16% approximately approximately 90% radiotherapy radiotherapy (in in others) radiation radiation (in in others), control control (L50, L50, L) and L) only only 1; 1. 1.2% (IC95% 0.6-3) years years (26% vs 16%; p=0.04) (425). 45 45 Gy: 1.8 Gy/fractions fractions (5 weeks) fractions fractions (3 weeks) years years 44% and 23% Gy Gy (BID BID fractions) doses doses (66 Gy), cycles cycles (426). The The 30-al. al. (425). chemotherapy chemotherapy (late late administration). al. al.427) first first day-used. used. Benefit/damage balance: a a −disease disease (428). Index Index (CICs) rates rates (p=0.20), survival survival (p =09) toxicity toxicity (G5).",
      "start_page": 161,
      "end_page": 166
    },
    {
      "heading": "COI: No conflict declared",
      "text": "population population (PCI); included included (see Appendix 2: of of studies). metastasis metastasis (PPI) with with −a a limited/to to PCI; chemo-radio chemo-radio (HR 0.94; CI95% 0.74-1.18; p=0.59), examination examination (HR 0.70; IC95% 0.57-0.85) (429). dose dose (430). study study (431).",
      "start_page": 166,
      "end_page": 167
    },
    {
      "heading": "BM.",
      "text": "study study (432) radiotherapy radiotherapy (WBRT) hippodampus hippodampus (HA-WBrt) radiotherapy radiotherapy (\"PCI\"). today today (433-434) months months (the the study), Netherlands Netherlands (primary study) has many similarities: CC003 CC003 (ClinicalTrials.gov: NCT02635009) plans. plans. Limits: included. included. Benefit/damage: Encephalus Encephalus (PCI) option option (430, 432-434)",
      "start_page": 167,
      "end_page": 168
    },
    {
      "heading": "extended-stage extended-stage disease",
      "text": "than than 60% platinum-based platinum-based chemotherapy? RECOMMENDATION: and and −MEDTERMM0__, and • ___MEDTERM0 ___MEDTERM0 #, a a recommendation: FOR WIT Motivations/Comed/third third year;, the the last;, three three years:: a a clinical;; three three years; studied studied 3; 56. 56.6% 56. 56.1% patient patient (PRO) life life (HRQoL) __medTERM0_ __medTERM0_ (436). EMA EMA (September 2019) MIFA MIFA (with September 2020) following following reasons: of of tests: LOWER COI: based based chemotherapy? RECOMMENDATION: 12_, 12_, multiyear: chemotherapy-__MEDTERM12_ chemotherapy-__MEDTERM12_ (5 5 months), maintaining a 25% alone alone (HR 0,75; IC95% 0.62-0.91; p=0.0032) to to etoposide-cisplatin/alone alone (5 5 months; HR 0.82; CI95% 0.68-1.00; p = 0.005). trial trial (HR 0.71; 3 3 years). following following reasons: of of tests: BASS AI: with with platinum/etoposide is recommended? following following grounds: 87 87 (CI95% 0.75-0.98; p=0.03) 80 80 (IC95% 0.69-0.93; p=0.002), studies studies (1579 patients), 4 4 phase-polychememiotherapy polychememiotherapy (and and carboplatin) 2015 2015 (443), 18 18 studies; platinum-treated platinum-treated population; at at 6-, 12- treated treated population; the the study; of of study; had had included: topic topic (444), studies studies (2027 patients), irinotecan-platin irinotecan-platin (Cyro-Family) States States (46-447), survival survival (4 4 months) countries. countries. Limits: study. study. L'rate rate (449).",
      "start_page": 168,
      "end_page": 174
    },
    {
      "heading": "COI: No conflict declared",
      "text": "the the brain'encephalum (PCI) recommended? RECOMMENDATION: brain brain (CPI) of of recommendation: CONDIED MOtiva/the the benefit/dam benefit balance: disease disease (PCI) study study (450) to to chemotherapy; benefit benefit (27. 27.1% 1. 1.3% caution caution (452). 2018 2018 (453) survival survival (HR 0.57; CI95% 0.47-0.69; p <0.01) metastases metastases (HR 0.47; IC95% 0.33-0.69); p <0.01). 93. 93.7% different different tests: survival survival (454-455). other other therapies? following following reasons: 24. 24.3% (IC95% 16,2-32,4) versus 18.3% (CI95% 10,8-25,7) CAV CAV (p=0,285). progression progression (weeks weeks respectively; p=0,552) survival survival (weeks, weeks, respectively; P=0,795), 3-4 3-4 L=arm arm (neutropenia 37.8% vs 51,4% (p <0,001); 9. 9.8% vs 1.4% (p<0,001) treatment treatment regimen; anemia 17,7% vs 7.2% (p to <0,001). comparison comparison detected: Grade 2: 14% vs 12% infections; sepsis 4% vs 1%; vomiting 3% diarrhoea diarrhoea 6% vs 0; dyspnoea 3% vs 9%, pain 3% vs 6%. al. al. (459) 4 4 (to to 2% responses responses respectively). topotecan topotecan (__MEDTERM8_: 8 8 months; HR: 0.880; CI95% 0.733-1.057; p=0.170; __MEDTERM9_: 5 5 months; HU 0.802; IC95% 0.667-0,965; p=0.018), amrubinicin amrubinicin (31% vs 16.9%; OR 2.223; p < 0.001). severe severe toxicity: neutropenia (41% vs 54%; p = 0.004), plateletopenia (21% vs 54; p=0.000), anaemia (16% vs 31%; p (= 0.001), infections (16% versus 10%; p=103), febrile neutropenias (10% vs 3%; p=2003), transfusion rate 32% vs 53% (p=0.001). study. study.",
      "start_page": 174,
      "end_page": 178
    },
    {
      "heading": "COI: No conflict declared",
      "text": "good good activity/pre-treated pre-treated (461), lurbindectin lurbindectin (with with irinotecan) the the Investigator's Choice (topotecan or iriotecan) relapsed. relapsed.",
      "start_page": 178,
      "end_page": 178
    },
    {
      "heading": "lung lung cancer",
      "text": "survival survival (462). 2009 2009 (463). survival survival (9 9 months; p=0.02) intensive intensive end-arm arm (33% compared to 54%). disease disease (to to death), simultaneous_in_Oncologia. simultaneous_in_Oncologia.pdf] oncology oncology .",
      "start_page": 179,
      "end_page": 180
    },
    {
      "heading": "Bibliography",
      "text": "long long cancer: Oncol. Oncol. 2005; 23:3175- Robotic-assisted Robotic-assisted bronchoscopy: system system functions",
      "start_page": 181,
      "end_page": 186
    },
    {
      "heading": "Diagnostics. Diagnostics. 2024; 14:399.",
      "text": "[of of print]. mortality mortality (screening screening (follow up: 35 35 years) mortality mortality - disease disease - screening screening ( Follow up: 5 5 years) rate rate - selection selection (follow up: 35 35 years; rated with: LOLK. LOLK.",
      "start_page": 194,
      "end_page": 204
    },
    {
      "heading": "Explanation",
      "text": "inprecision. inprecision.",
      "start_page": 204,
      "end_page": 204
    },
    {
      "heading": "APPLICATION 1",
      "text": "to to non-screening? POPULATION: Lung cancer INTERVENTION: LDCT screening COMPARISON: MAIN MAIN OUTCOMES: related related mortality; All-cause mortality; Early stage detection; Late stage disease; Resectability rate; Overdia",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "SETTING:",
      "text": "PERSPECTIVES: Population",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "BACKGROUND:",
      "text": "CONFLICT OF INTERESTS: TC TC chest; dose dose VALUTAZION",
      "start_page": 205,
      "end_page": 206
    },
    {
      "heading": "Problem",
      "text": "JUDIZI JUDIZI • No • Probably no •Probably yes • Yes • Varies • Don'JUDICES JUDICES • Trivial • Small • Moderate • Large • Various • NE NE rity? • cancer cancer (LC) tomography tomography (LDCT) achieved a 20% Trial Trial (NLST), radiography radiography [1], trials trials (RCT) Italy Italy (6, 10, 13) Netherlands Netherlands (14), Germany (11), and Denmark (8). perf perf and/b b . PO PO OLMONE",
      "start_page": 206,
      "end_page": 209
    },
    {
      "heading": "Undesirable effects",
      "text": "anticipated anticipated effects? follow up: rate rate - positive positive - 8635 • screening screening - 53 53 (2 RCT) follow ups: 0 0 (09 09 greater) performance performance and/among among (I-squared=65%) Falses Falses positive",
      "start_page": 210,
      "end_page": 213
    },
    {
      "heading": "Certainty of evidence",
      "text": "of of effects?",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "Values",
      "text": "main main outcome? inconsistentness, inconsistentness, , EVIDEN EVIDEN TESTS",
      "start_page": 213,
      "end_page": 214
    },
    {
      "heading": "Balance of effects",
      "text": "OF OF EVIDEN'S TESTS",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "Equity",
      "text": "health health equity?",
      "start_page": 214,
      "end_page": 215
    },
    {
      "heading": "Acceptability",
      "text": "JUDIZI JUDIZI • No ♪ Probably no ● Probable yes • Yes • Varies • Don't know",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "Feasibility",
      "text": "JUDIZI JUDIZI • No -Probably no ● Probably yes • Yes - Varieties • Don'obvious obvious implementation? • fou fou s? ADDING ADDING ONI",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "COURTS",
      "text": "the the Favor'probabilities probabilities Probally",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "TYPE OF RECOMMENDATION",
      "text": "intervention intervention Don't know Don' Don Don 't know",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "Recommendation",
      "text": "screening screening examination",
      "start_page": 217,
      "end_page": 217
    },
    {
      "heading": "QUESITE 3",
      "text": "Author: ACT Question: stage stage Setting: inpatients Bibliography: results results (follow up: median 7 years) randomized randomized important",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "Overall Survival",
      "text": "RCT RCT (follow up: median 7 years) randomized randomized important",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "Disease free Survival",
      "text": "life life - not reported",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "Harvested Harvested Lymphonodes",
      "text": "segmentectomy segmentectomy (95% CI) (95% CIs) 148/892 (16.6%) 182/911 (20.0%) Critical Critical (1. 1.02) per 100 (0 0 minus) ne -/0 -/CRITIC CRITIC (1. 1.28) per 100 (and and less) oc 234/892 (26.2%) 239/911 (26.2%) 0 0 less",
      "start_page": 218,
      "end_page": 219
    },
    {
      "heading": "Postoperative air leaks",
      "text": "investigations investigations observational: median 7 years) in in 171/1966 (8.7%) 185/3500 (to to (95% CI) (95% CI), - Bottom Bottom (than than below) - Bottoms Bottoms (below below greater) %) CRITIC CRITIC (2. 2.31) 100 (9 9 3%) studies studies (2 2 PORTs)",
      "start_page": 219,
      "end_page": 220
    },
    {
      "heading": "Lymph node relapse",
      "text": "important important observational",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "Postoperative complications RCT) (follow up: 3 3 years)",
      "text": "randomized randomized important",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "Postoperative complications",
      "text": "important important observational",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "Rehospitalization - not reported",
      "text": "CI: Confidence interval; HR: Hazard Ratio; MD: Mean difference; OR: Odds ratio; RR: segmentectomy segmentectomy (95% CI) (95% CI), 36/552 (6.5%) 21/554 (3.8%) more more per",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "Explanation",
      "text": "studies studies . events. events.",
      "start_page": 221,
      "end_page": 221
    },
    {
      "heading": "References",
      "text": "H. H., Okada, M., R. R., Suzuki, K., Aokage, K ., Aoki, T., Wakami, J., Yoshino, I., N. N., Mitsudomi, T ., H H .. peripheral peripheral non-cancer cancer (JCOG0802/WJOG4607L): With With Non-Cancer Cancer ≤ or or &gt; Wedge Wedge Resection: A. A., I I non-small-cell long cancer: Cardiothorac Cardiothorac Surg; A. A., S. S., S. S., A. A., B. B., D'Cunha, J.. lung lung cancer: Thorac Thorac Surg; C. C., Fang, W., Mao, T., Yao, F., Chen, w., Hu, D.. Cardiovasc Cardiovasc Surg; Y. Y., Sakai, T., Kimura, D., Tsushima, Tt., lung lung cancer: Jorrac Jorrac Dis; M. M., Ojanguren, A., Forster, V., resection resection margins--M. M., Cardiothorac Cardiothorac Surg; C. C., Yoder, G., Thorac Thorac Surg; A. A., Matsunaga, T., Takamochi, K., Oh, S., solid solid non-Cardiothorac Cardiothorac Surg; P. P., Daddi, N., L. L., Ardò, M., Ragusma, P.",
      "start_page": 221,
      "end_page": 222
    },
    {
      "heading": "APPLICATION",
      "text": "stage stage POPULATION: stage stage INTERVENTION: The segmentectomy COMPARISON: Lobectomy MAIN OUTCOMES: Overall survival RCT; Overall Survival; survival survival RTC; Diseasefree Survival; Quality of life; Harvested Harvested Lymphhonodes; Lenght hospital stay; Local Local recurrence; Postoperative air leaks; leaves leaves (RCT); Lymph node relapse; Postoperational complications RCT); Postoperative complications; Rehospitalization SETTING: Inpatients",
      "start_page": 222,
      "end_page": 222
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "Desirable effects",
      "text": "anticipated anticipated effects? CO CO • 121 121 ●that that • lobectomy. lobectomy. •to to • Don'Effect Effect Early* (95% CI) follow follow up: 7 7 (14 to 20) 100 100 (-- a --) Follow Follow up: 7 7 (23 to 30) 100 100 ( -- a) POLMO POLMO % parts parts (studies) CI) 1803 1803 (to to (2 RCT) 1,09 (20 studies (1803 1803 (to to (2RCT) 08 08 (bone bone (ipanti ipanti i) initial initial tests) 58 58 - 1412 • lower lower (9 observational studies) 0 0 (K. K., Aoki, T., Okami, J., Yoshino, I., Ito, H., Ukumura, N., Yamaguchi, M., Verbeda, No., Wakabayashi, Ml., S. S., Dai, C., Y. Y., Zhong, S., Zeng, H., He, J., K. K., Liang, W., Jiang, G., Yang, P., H. H., Cl. Cl., Rocco, G ., Brunelli, A., Shen, Y ., C-, He; With With Non-Small-Cell Lung ≤ or or &gt; Wedge Wedge Resection: Clin Clin Oncol; M. M., V. V., T. T.. long long cancer: Cardiothorac Cardiothorac Surg; R. R., Zurek, W., Marjanski, T., Rudzinski, P., M. M., M. M. , Polannska, J., I I non-small-cell lung cancer: Cardithorac Cardithorac Surg; A. A., Groth, S., Cardithorac Cardithorac Surg; M. M., S. S., P. P., Chin, C., Cardiovasc Cardiovasc Surg; after after robotic- J J Surg; studies studies . Noost Noost dell'eff",
      "start_page": 223,
      "end_page": 228
    },
    {
      "heading": "DFS (RCT)",
      "text": "direction. direction.",
      "start_page": 228,
      "end_page": 228
    },
    {
      "heading": "_MEDTERM0__",
      "text": "anticipated anticipated effects? 5466 5466 • 40 40 (100 100 (to to observational) segmentectomy segmentectomy (5 to 10) 2.08) 4127 4127 • 22,27 • 28 • NEOPLAS NEOPLAS (8 to 16) 1.75) leaks leaks (RCT) complicated complicated RCT) followed up: NEOPLAS NEOPLAS (16) Akada, M., J., Nakajima, R., Suzuki, K., T. T., I. I., Ikuda, H., S. S., Mitsudomi, T-, H. H.. peripheral peripheral non-cancer cancer (JCOG0802/WJOG4607L): Cardithorac Cardithorac Surg; W. W., Yoshimura, M., Maniwa, Y., Kitamura, Y ., Tane, K., Takenaka, D., Adachi, S., L. L., Pennathur, A., R. R., P. P., Daddi, N., Loizzi, D., Ampollini, L., Ardò, No., Ventura, Ll., Carbognani, P.; Potenza, R., Ardissone, F., S. S., Puma, F-, Santini, M., Ragusa, Mn.. long long cancer: elderly elderly patients?. Surg Today; SR. SR., Schuchert, Mj., Pennathur, A., Wilson, D'O., Siegfried, J., M. M., Koike, T., Higashiyama, M ., Yamato, Y., Kodama, K., Tsubota, N.. lung lung cancer: Cardiovasc Cardiovasc Surg; H. H., long long cancer: Cardiothorac Cardiothorac Surg; F. F., O. O., P. P., C. C., R. R., POLMO POLMO NEO",
      "start_page": 229,
      "end_page": 239
    },
    {
      "heading": "Certainty of evidence",
      "text": "of of effects?",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "Values",
      "text": "variability variability ● GIUDIZI GIUDIZI \" comparison comparison \" compare compare \" comparison comparison ● intervention intervention \" participation participation \" Varies \" Don'SEARCh SEARCh \"found. found.",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "Equity",
      "text": "JUDICES JUDICES • Reduced • Probably reduce • imp imp ● Probaby increa • Increased • Varies • Don'JUDIZI JUDIZI • No ♪ ProbaBly yes • Yes • Various • Do not know",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "Feasibility",
      "text": "JUDIZI JUDIZI • No • Probably no ● Probable yes • Yes • Varies • Don'health health equity? to to implementation? No No variables",
      "start_page": 241,
      "end_page": 242
    },
    {
      "heading": "COURTS",
      "text": "Varieses Varieses Don't know Don'Don Don 'studies studies Don' t know Don'.t know Don't Know Don'ts know Don?t know",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "TYPE OF RECOMMENDATION",
      "text": "intervention intervention interventions",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "CONCLUSIONS",
      "text": "on on ale",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "QUESITE 12",
      "text": "Author(s): MC Date: September 2019 Question: to to placebo/with with PD-L1<HR HR Setting: inpatients Bibliography: Med Med 2018; 379:2342-50; 2018 2018 EMA/CHMP/548232/Imprecision Imprecision (Q1)_MEDTER_Patients",
      "start_page": 244,
      "end_page": 244
    },
    {
      "heading": "Local control - not reported",
      "text": "NEOPLASE",
      "start_page": 245,
      "end_page": 245
    },
    {
      "heading": "Objective response",
      "text": "response response (follow up: 8 8 months) life life - pneumonia pneumonia (follow up: 5 5 months; anemia anemia (fullowup: 5 5 months; assembled with: NCI-CTCAE 4.03) months months (30.0%)",
      "start_page": 245,
      "end_page": 246
    },
    {
      "heading": "Treatment related death",
      "text": "thousand thousand thousand; thousand. thousand.",
      "start_page": 246,
      "end_page": 247
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND:",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "Problem",
      "text": "a a priority? JUDICES • No • to to 1%, with with •to to observation? Patients with −to to 1% •Overall Overall survival; disease-free survival; distance metastases; local disease control; objective response rate; duration of response; quality of life; adverse adverse events; Grade 3-4 lungitis; Grade 5 - with with {JUDIANCES JUDIANCES (THE THE MERCE) assessed assessed with: followed followed up: 100 100 (29 to 46) DELLute DELLute effects* (95% Risk withtion (Q1) 100 100 (2 to 41) 100 100 (9 to 49) 100 100 (3 to 46). JUDIZI JUDIZI - Possibdenum Possibdenum - Variant - ffetti ffetti indusibile? with with placebo/assessed assessed by: follow follow up: 100 100 with: metastasis metastasis (DELLute DELLute effects* (95% partition partition (Q1) 100 100 (22 to 41) 100 100 (2 to 49) 100 100 (25 to 46) L POLM % CILAPE) 709 709 (to to (1 RCT) 2. 2.03) (1 to 7) including including (to to (1RCT) 1. 1.51) (23 to 39) 709 709 (to to (1rCT) 4. 4.41) (0 to 6) the the survival/central central review; bias bias ) LOWa) JUDI JUDI • Bassa Bassa /the the p",
      "start_page": 247,
      "end_page": 255
    },
    {
      "heading": "Values",
      "text": "main main outcomes? JUDICIAL TEST SEARCH",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "Budget of effects",
      "text": "comparison comparison \" confrontation confrontation \" discussion discussion \" intervention intervention \" in in favour\" operation operation \"Varia \" I don'D D ronto? to to 1%.",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "Fair",
      "text": "of of equity? SEARCH SEARCH • found found • impact impact • equity equity • Improves fairness • Vary • I don't know",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "Acceptance",
      "text": "main main stakeholders?",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "Feasibility",
      "text": "do do l'impl JUDIZI • No • Probabilmen • Si Si • Varia • RIA RIA PROBLEM",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "EFFECTS",
      "text": "SIDE EFFECTS",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "LI",
      "text": "probably probably doesn'EQUITA EQUITA (no no equity) occur. occur.",
      "start_page": 258,
      "end_page": 259
    },
    {
      "heading": "Recommendation Recommendation Recommendation",
      "text": "of of intervention",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "Recommendation",
      "text": "to to 1%, MEDTERM0__ MEDTERM0__ d",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "Recommendation",
      "text": "of of euthic",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "QUESITE 13",
      "text": "Author: ACT Question: Locoregional treatment + stage stage Setting: inpatients Bibliography: considerations considerations + distortion distortion (95% CI) (95% CI), none none 0/0-0/randomised randomised (0. 0.72) 100 (0 0 less)",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "Progression-free survival",
      "text": "none none 74/176 (42.0%) 140/183 (76.5%) randomized randomized (0. 0.35) 100 (37 37 less) life life - not reported",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "_MEDTERM0__",
      "text": "none none 30/72 (41.7%) 15/76 (19.7%) more more per",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "treatment treatment component",
      "text": "CRITIC CRITIC ... important important randomizedb",
      "start_page": 261,
      "end_page": 262
    },
    {
      "heading": "Loco-regional progression",
      "text": "Polmonites Polmonites (follow up: 6 6 months) 11 non-relevant non- b b randomized",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "Grade 3-5 toxicity",
      "text": "randomized randomized CI: Confidence interval; HR: Hazard Ratio; RR: Risk ratio",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "Explanation",
      "text": "loco-regional loco-regional + systemic considerations (95% CI) (95% CI), no one 1/68 (1.5%) 1/65 (1.5%). per per (14. 14.97) 100 (21 21 more) none 6/68 (8.8%) 29/65 (44.6%) less less per",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "References",
      "text": "S. S., F. F., Verma, V., L. L., L. L., Zhu, Q., Liu, H., C. C., M. M., X. X., Metastatic Metastatic Non-Small-Cell Lung Cancer: JAMA JAMA Oncol; R. R., R. R., Jr., J. J., Hernandez, M., Ye, R. , D. D., C. C., Skoulidis, F., E. E., Gibbons, D",
      "start_page": 263,
      "end_page": 263
    },
    {
      "heading": "APPLICATION",
      "text": "treatment treatment + treatment treatment POPULATION: therapy therapy INTERVENTION: Loco-Regional treatment + Systemic therapy COMPARISON: MAIN MAIN OUTCOMES: Overall survival; Progression-free survival; Quality of life; ORR; treatment treatment component; Loco-regional progression; Polmonites; toxicity toxicity SETTING: Inpatients",
      "start_page": 263,
      "end_page": 263
    },
    {
      "heading": "BACKGROUND:",
      "text": "CONFLICT OF INTERESTS:",
      "start_page": 263,
      "end_page": 263
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "Desirable Effects",
      "text": "anticipated anticipated effects? TESTS TESTS → 202 202 • records. records. • Modernised) metastatic metastatic (3 3 lesions), systemic systemic treatment/al al . only. only. (-- a --) 359 359 • treatment treatment (to to (4 RCT) 0. 0.35) survival survival (34 to 40) life life - - -- - - 148 148 − loco loco treatment- (to to (1 RCT), 3, 3,58) rate. rate. (24 to 71) S. S., F. F., Verma, V., L. L., Tian, W., L. L., Q. Q., V. V., R. R., C. C., Skoulidis, F., E. E., W. W., L. L., A. A., D. D., S. S., G. G., Oligotastatic Oligotastatic Non-Small-Cell Lung Cancer: Clin Clin Oncol; P. P., Wardak, Z., oligomethastatic oligomethastatic (Immunotherapy + RT) al al . Cancer Cancer Inst; Comments Comments → or or loco‐regional treatment. • loco loco - regional progression. − L. L., Zhu, Q., Liu, H., Pan, X.,C. C., M. M., NEO NEO toxicity",
      "start_page": 264,
      "end_page": 271
    },
    {
      "heading": "Certainty of evidence",
      "text": "of of effects?",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "Values",
      "text": "TESTS TESTS • variableity variableity • variability variability ● variable variable • variables variables • e e mes? imprecisio one.",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "Balance of effects",
      "text": "TESTS TESTS • comparison comparison • appearance appearance • comparison comparison - intervention intervention ● participation participation • Varies • Don't know",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "Equity",
      "text": "health health equity?",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "Acceptability",
      "text": "key key stakeholders?",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "EVIDENCE EVIDENCE TESTS",
      "text": "• found. found. • Probably no ● Probable yes • Yes • Varies • Don't know",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "Feasibility",
      "text": "to to implementation?",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "EVIDENCE EVIDENCE TESTS",
      "text": "• found. found. • Probably no ● Probable yes • Yes • Varies • Don't know",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "SUMMARY OF JUDGEMENTS",
      "text": "PROBLEM No",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "DESIRABLE",
      "text": "Trivia",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "EFFECTS",
      "text": "NsideRATIONS NsideRATIONS Don't know Don'T know",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "EFFECTS",
      "text": "BALANCE BALANCE OF",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "EFFECTS",
      "text": "EQUITY ACCEPTABILITY FEASIBILITY",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "COURTS",
      "text": "Varies Varies Don'studies studies Don'T know Don' Don Don 'not not know",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "TYPE OF RECOMMENDATION",
      "text": "intervention intervention intervention",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "Recommendation",
      "text": "Loco-regional treatment + consideration. consideration.",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "Justification",
      "text": "LINES LINES GUIDE",
      "start_page": 275,
      "end_page": 276
    },
    {
      "heading": "QUESITE 14",
      "text": "Author(s): MC Date: September 2019 Question: advanced advanced non-cancer cancer Setting: inpatients Bibliography: ESMO ESMO 2019; C. C. \"__MDTERM3. __MDTERM3._- Mutated Advanced non- small-cell long cancer\", Med Med 2018; 378:113-25; Apr Apr 1;25 (7):2058-2063; Oncol Oncol 36:Absolute. Absolute.",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "Overall survival",
      "text": "none none 128/279 155/fewer fewer (45.9%) (56.0%) (0. 0.997) (0 0 feet)",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "Objective response rate",
      "text": "I'none none 223/279 211/000 000 (79.9%) (76.2%) (1, 1,90) LOW LOW (10 10 more) rate rate (assessed with: full analysis set) live live - cough (assied seriously by: QLQ-C30; Scale from: 0 to 100) alive alive - cous (assessed with: QlQ-D30; Scale from:0 to 100)",
      "start_page": 276,
      "end_page": 278
    },
    {
      "heading": "Treatment interruption",
      "text": "acne acne (assessed with: NCI-CTCAE) 247 247 - MD 0.5",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "213/28 28 feet",
      "text": "(76.9%) (0. 0.56) MODER MODER (21 21 feet)",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "19/277 (6.9%)",
      "text": "(0. 0.52) LOW LOW (3 3 feet)",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "25/277 (9.0%) 9 9 feet",
      "text": "(0. 0.29) LOW LOW (6 6 feet) DA • CRITICAL RATE • Critical RATE - W W • LINEE LINEE • GUIDE • elevation elevation (assessed with: NCI-CTCAE) • b b • serious c •d none • 2/279 (0.7%) • 12/277 (4.3%) RR • feet feet • trials (0. 0.73) Low Low (1 1 feet)",
      "start_page": 278,
      "end_page": 279
    },
    {
      "heading": "adverse adverse events",
      "text": "none none 89/279 (31.9%) 114/Infarce Infarce (41.2%) (0. 0.97) LOW LOW (1 1 feet) CI: months months (21 21 months) month month (1 1 month) population population (62%) events events (OIS <300) QUESITO QUESITO 14: Medevals Medevals (OS <300).",
      "start_page": 279,
      "end_page": 280
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND: generation generation __medTERM1__/__DEMM3_ __DEMM3_ (Dels19, L858R).",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "ADDITIONAL ADDITIONAL TESTS",
      "text": "I'm sorry. (forty-five forty-five thousand) (fifty-five fifty-five million) (thirty-five thirty-five years) (Don'hundred hundred thousand) D. D. (056 056 0HF) follow up: 0. 0.57) months months (40 to 54) population population (62%) events events (OIS <300) LOWA, LOWA,b",
      "start_page": 280,
      "end_page": 286
    },
    {
      "heading": "Quality of tests",
      "text": "moderated moderated - High - No studies included",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "Values",
      "text": "JUDITIONS JUDITIONS - variation variation - volatility volatility - safety safety N? main main outcomes? ADDITIONAL ADDITIONAL IONES",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "Budget of effects",
      "text": "comparison comparison - confrontation confrontation - comparison comparison - intervention intervention - Varia - not not know",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "Fair",
      "text": "of of equity?",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "Acceptance",
      "text": "R R \" No \" Probably no \" PROV PROV Olders? D D RONTO? X X Yes",
      "start_page": 288,
      "end_page": 289
    },
    {
      "heading": "Feasibility",
      "text": "case case (s) \" No ... Probably no ... probably no ... X Yes ... Vary ... to to intervention? PROBLEM PROBLEM EFFECTS",
      "start_page": 289,
      "end_page": 290
    },
    {
      "heading": "DESIDERABLES",
      "text": "EFFECTS",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "SIDES",
      "text": "equity equity l/I I don'Not Not know",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "Recommendation",
      "text": "MEDTERM1__ MEDTERM1__ (Ex19dels, L858R), option. option.",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "QUESITE 17",
      "text": "0vervall4_ _details (0vervalm4_) mutated (Ex19del, L858R) an an anti- -_MEDTERM2_ Setting: inpatients Bibliography: Med Med 2017; 376:A. A., et al",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "brain brain metastasis",
      "text": "anyone anyone 50/51 (98.0%) d 46/93 (49.5%) randomized randomized (0. 0.49) 100 (21 21 less)",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "Objective response rate",
      "text": "of of Reproducibility: life life - symptom symptom (evaluated by: QLQ-LC13; Scale from: 0 to 100) to to ,Life Life - symptom symptom (assessed with: QlQ- LC13); scale from:0 to 100) to to .sympton sympton (as assessed by: qlq-Lc13; at at all",
      "start_page": 292,
      "end_page": 294
    },
    {
      "heading": "Diarrhea grade <= 3",
      "text": "g g randomized",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "Nausea grade < 3",
      "text": "g g randomized",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "Thrombocytopenia grade <= 3",
      "text": "chemotherapy chemotherapy (95% CI) (95%CI) 228 113 - than than lower) 239 97 - than than below) 3/279 (1.1%) 1/140 (0.7%) less less per",
      "start_page": 294,
      "end_page": 295
    },
    {
      "heading": "Neutropenia grade < 3",
      "text": "nobody nobody 1/279 (0.4%) 15/140 (10.7%) randomized randomized (0. 0.25) 100 (to to LOW)",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "Anaemia grade <=3",
      "text": "nobody nobody 1/279 (0.4%) 13/140 (9.3%) per per ... randomized (0. 0.29) 100 (7 7 less) CI: Confidence interval; HR: Hazard Ratio; RR: Risk ratio; MD: Mean difference",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "Explanation",
      "text": "outcome. outcome.",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "References",
      "text": "S. S., Y. Y., J. J., Delmonte, A., S. S., W. W., J J ., H. H., prior. prior.",
      "start_page": 295,
      "end_page": 296
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND: mechanism. mechanism.",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "ADDITIONAL ADDITIONAL TESTS",
      "text": "• 1 1 (42 to 65)b follow up: 419 419 (_MEDTERM15_) (to to (1 RCT) follow-up: 1. 1.08) months months (8 to 20) 2. 2.90) (55 to 91) es es (GRADE) ) 1 1 (42 to 65)b follow up: 68 68 (_MEDTERM15_) (to to (1 RCT) followed up: 1. 1.08) months months (8 to 20) metastasis metastasis (to to (1RCT) 0. 0.49) (13 to 28) rate rate (from from (1 RTC) 2. 2.90) (55 to 91) evidence evidence es) (GRADE) f f ),I I ADDI) conducted. conducted.",
      "start_page": 296,
      "end_page": 303
    },
    {
      "heading": "Quality of tests",
      "text": "safety safety tests? was was judic",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "Budget of effects",
      "text": "comparison. comparison.",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "Fair",
      "text": "of of equity?",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "Acceptance",
      "text": "not. not.",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "Feasibility",
      "text": "JUDENCIES JUDENCIES • No • Probably no • X Yes • Vary • I don'stakeholders stakeholders ?",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "FACTIVITY",
      "text": "Large Very low",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "Important",
      "text": "No No No",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "Moderat Irrelevant",
      "text": "probably probably not",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "LINES GUIDE",
      "text": "Augen Augen l'I I don'not not know",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 307,
      "end_page": 307
    },
    {
      "heading": "Recommendation",
      "text": "MEDTERM4__ MEDTERM4__ (Ex19dels, L858R), mutation mutation (liquid liquid biopsy) option. option.",
      "start_page": 307,
      "end_page": 307
    },
    {
      "heading": "QUESITE 18",
      "text": "Author: ACT Question 14: __medTERM4_ __medTERM4_ Setting: inpatients Bibliography: Lancet Lancet 2017; 390:29-39; Med Med 2017; 377:JTO JTO 2019; information information (95% CI) (95% CI). none none 1/103 (1.0%) 3/104 (2.9%) randomized randomized (1. 1.28) 100 (1 1 more) the the \"Critical SSA\" (criticism)",
      "start_page": 308,
      "end_page": 308
    },
    {
      "heading": "Alanine aminotransferase increase- grade 3-4",
      "text": "none none 10/380 (2.6%) 40/317 (12.6%) randomized randomized (0. 0.45) 100 (7 7 less) increase increase - nobody nobody 9/255 (3.5%) 21/255 (8.2%) randomised randomised (0. 0.91) 100 (1 1 less)",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "Nausea - grade 3-4",
      "text": "none none 2/381 (0.5%) 7/316 (2.2%) randomized randomized (1. 1.07) 100 (0 0 less)",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "Toxic deaths",
      "text": "none none 7/381 (1.8%) 10/316 (3.2%) randomized randomized (1. 1.46) 100 (1 1 more) CI: Confidence interval; HR: Hazard Ratio; RR: Risk ratio",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "Explanation",
      "text": "b. b. I2=44% __medTERM0__ __medTERM0__ (al. al. trials). J J -the the 36% sadness. sadness.",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "References",
      "text": "C. C., W. W., Reungwetwattana, T., Zhou, J., Lhang, Y., H. H., Bu, L., Xu, T-, T T -, N. N., Lu, Y; Zhang, L ... lymphoma-positive lymphoma-positive non-cancer cancer (ALESIA): Respir Respir Med; K. K., Hida, T ., Nokihara, H.",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "APPLICATION 18",
      "text": "meta-stage meta-stage __MEDTERM4_POPULATION: MEDTERM5_ MEDTERM5_ INTERVENTION: _MEDTERM2_ COMPARISON: __medTERM3__ MAIN OUTCOMES: __PFS; __EDTERM9_; •MEDTERM10__; progression progression - al. al., Gadgeel 2018; death death - et et at; increase increase - grade 3-4; Nausea - grade3-4; Toxic death - and and al; aminosferase aminosferase - grade; N nausea - Grade 3-4; or or death",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "Problem",
      "text": "a a priority? No No • Probably no → Probaby yes ● Yes • Varies • Don'ncrease-grade ncrease-grade 3-4; Trivial Trivial @ Moderate Moderate ● Large ♪ Varies - Don'anticipated anticipated effects? Advanced Advanced Comments* (95% CI) trials trials (95% (studies) (GRADE) Risk CI) 100 100 (37 to 50) 510 510 → follow-up follow-up months: (to to (2 RCT) 0. 0.79) kinase-positive kinase-positive non-small-cell cancer (ALESIA): Respir Respir Med; K. K., Hida, T., Yoshioka, H., Kumagai, T ., Hotta, K ., Watanabe, S., Goto, K",
      "start_page": 310,
      "end_page": 313
    },
    {
      "heading": "by by an",
      "text": "b. b. I2=44% alectinib alectinib (etc. etc. trials). J J -the the 36% is is rare",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "_MEDTERM0__",
      "text": "substant substant JUDIZI",
      "start_page": 313,
      "end_page": 314
    },
    {
      "heading": "_MEDTERM0__",
      "text": "MEDTERM1_Further MEDTERM1_Further reading: _MEDTERM5_Found_Fair_Fal_Failure_Flat_Fix_Floor_Ful_Furnish_Flan_Fund_Frank_Fro_Fros_Famila_Fat_Flag_Flexit_Freadsheet_Fruition_Fotories_Fatishing_File_Flihood_Fl_Fon_Fert_Fold_S_F _MEDTERM5_Found_Fair_Fal_Failure_Flat_Fix_Floor_Ful_Furnish_Flan_Fund_Frank_Fro_Fros_Famila_Fat_Flag_Flexit_Freadsheet_Fruition_Fotories_Fatishing_File_Flihood_Fl_Fon_Fert_Fold_S_F ==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/A. A., Seto, T., Takiguchi, Y., Nishio, M., Yoshioka, H., Kumagai, T ., Hotta, K., Watanabe, S., M M ., Kozuki, T ... __medTERM18_-positive __medTERM18_-positive non-Lung Lung Cancer; Tr. Tr., R. R., Gadgel, S",
      "start_page": 314,
      "end_page": 318
    },
    {
      "heading": "Certainty of evidence",
      "text": "of of effects?",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "Values",
      "text": "EVIDENZ EVIDENZ 'found found □ variability variability ● variables variables ► ris ris mes? ne ne (attrition attrition bias), ADDUNTIVATIVE ADDUNTIVATIVE SIDERATIONS",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "Balance of effects",
      "text": "JUDIZI JUDIZI \" comparison comparison \" compare compare \" comparison comparison ● intervene intervene \" intervention intervention \" Varies \" Don't know",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "Equity",
      "text": "h h JUDIZI",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "Acceptability",
      "text": "JUDICES JUDICES • No • Probably no • health health equity? aDDONTIVE aDDONTIVE ● Yes • Varies - Don'TO TO IMPLEMENT?",
      "start_page": 319,
      "end_page": 322
    },
    {
      "heading": "TYPE OF RECOMMENDATION",
      "text": "the the participation",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "Recommendation",
      "text": "NEOPLASI NEOPLASI option",
      "start_page": 322,
      "end_page": 323
    },
    {
      "heading": "QUESITE 19",
      "text": "Author: ACT Question: treated treated Setting: Outpatients Bibliography: R. R., et al. (2020). __MEDTERM9_ __MEDTERM9_ (follow up: 9 9 months)",
      "start_page": 323,
      "end_page": 324
    },
    {
      "heading": "spelling spelling inGHS/QoL",
      "text": "I'grade grade < 3 (follow up: 9 9 months) grade grade (follow up: 9 9 mesi) AST AST (G3 (full7 up:9 9 mi) grade grade <3 ( followup: 9 9 mei) rate rate (fogliow up; 9 9 mei).",
      "start_page": 324,
      "end_page": 325
    },
    {
      "heading": "Explanation",
      "text": "bias bias (open label study). data data (sponsor bias). 1-L 1-L 27% indirectiness indirectiness (inadequate inadequate follow-ups). imprecision imprecision (an an interim-analysis). 1-l 1-l 27% treatment. treatment.",
      "start_page": 325,
      "end_page": 325
    },
    {
      "heading": "References",
      "text": "R. R., J. J., H. H., Han, Jj., A. A., W. W., Griesinger, F., Felip, E., Califano, R. , Spira, A ., N. N., Tiseo, M ., M. M., j. j., Ni, Q., Zhang, P., Popat, S .. Cancer. Cancer.",
      "start_page": 325,
      "end_page": 325
    },
    {
      "heading": "APPLICATION 19",
      "text": "NSLC NSLC POPULATION: OSHC OSHC INTERVENTION: __medTERM2__ CONFRONENT: _MEDTERM3__ Main outcomes: Progression free survival; Overall survival; __MDTERM4__; Intracranial __MEDTERm5__; CNS __méMEDTERM4_; rate rate SETTING: Inpatients PROSPECTIVE: BACKGROUND: interest. interest.",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "Problem",
      "text": "a a priority? ==See also==*Source==References===Further reading==External links== GUIDA GUIDA (a. a. ZCT) 1 MOLTO inGHS/for for (0. 0.56) prior prior (49 to 210) chemotherapy follow up: P. P., R. R., J. J., H. H., Hochmair, MJ., H. H., Delmonte, A., W. W., Griesinger, F., Felip, E., 1-L 1-L 27% indirectiness indirectiness (inadequate inadequate follow-up). accuracy accuracy (an an interim-analysis). bias bias (open label study). data data (sponsor bias). expected undesirable? in in full-283 283 records; of of full-Phase-of Phase-of full-to-text. In Phase-_ _ . the the following: of of Precipitation* (95% CI) Relative Particip (95% (studies) Risk CI) grade grade > 19 19 (1 RCT) 99 99 (months months (97 to 100) 1.01) AST < follow follow up: 0.56 (1 RTC) per per (1, 1,60) (12 to 107) ezza ezza ADED) MEDTERM30__ MEDTERM30__ Inhibitor- Lung Lung Cancer: Clin Clin Oncol; stu stu 27% __medTERM0_ __medTERM0_ in",
      "start_page": 326,
      "end_page": 333
    },
    {
      "heading": "Certainty of evidence",
      "text": "safety safety tests?TESTS TESTS ● been been identified: Low - distortion distortion (sponsor sponsor bias); Moderate - of of generalization; High - imprecision. imprecision.",
      "start_page": 333,
      "end_page": 333
    },
    {
      "heading": "Values",
      "text": "main main outcomes? EVIDENCE EVIDENCE TESTS",
      "start_page": 333,
      "end_page": 333
    },
    {
      "heading": "Budget of effects",
      "text": "comparison. comparison. ● intervention. intervention.",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "Fair",
      "text": "JUDICES JUDICES \" Reduce equity \" equity equity ● equity equity \" Improving equity \" Vary \" or or comparison? life. life.",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "Acceptance",
      "text": "no_BAR__BAR_ no_BAR__BAR_ It'yes yes ● Yes ^I I don't know",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "Feasibility",
      "text": "DOUBLES DOUBLES (probably) found. found. ENTO? no no matter",
      "start_page": 335,
      "end_page": 337
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "Recommendation",
      "text": "option option (__ __ MEDTERM1__).",
      "start_page": 338,
      "end_page": 339
    },
    {
      "heading": "QUESITE 20",
      "text": "Author(s): MC Date: 2019 Question: __medTERM19__ __medTERM19__ Setting: inpatients Bibliography: Oncology Oncology 0: 1-8; Oncology Oncology 2017; 18: __medTERM26_ __medTERM26_ 0/1 (91.7% vs 85.7% metastasis metastasis (34.7% vs 25.7%). to to followed-up; patients patients (70% and and 59% chemotherapy chemotherapy arm) and ex-smokers (34% and and 44% in the SETTING: Ambulatorials",
      "start_page": 339,
      "end_page": 341
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND: inhibitors inhibitors (Ceritinib or alectinib) __MDTERM2__. __MDTERM2__.",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "ADDITIONAL ADDITIONAL TESTS",
      "text": "as as follows: (a) survey, survey, (b) and and (c) of of Auditors; (c); (d) 3 3 (2) of Regulation (EEC) No 1408/71; (d), (e) Member Member States; (f) carried carried out; (g) the the programmes; (h) the the programme; (i) the the projects; (ii) the the objectives; (iii) of of projects; MEDTERM9__ MEDTERM9__ 0/1 (91.7% vs 85.7% metastasis metastasis (34.7% vs 25.7% vs 24.7%). patients patients (70% and and 59% chemotherapy chemotherapy arms) and ex-smokers (34% and and 44% chemotherapy chemotherapy arm). yesterday yesterday 34% and and 44% chemothertherapy chemothertherapy arm).but but __",
      "start_page": 341,
      "end_page": 343
    },
    {
      "heading": "I2=89%",
      "text": ", , . . . , (. . .) , 1 1 , 6 6 , 8 8 , 15 15 , 14 14 , 28 28 , 30 30 , 16 16 , 27 27 , 34 34 , 37 37 , 57 57 , 74 74 , 60 60 , 43 43 , 85 85 , 95 95 , 93 93 , 96 96 , 50 50 , 68 68 , 56 56 , 48 48 , 84 84 , 87 87 , 35 35 , 94 94 , 33 33 , 102 102 , 120 120 , ___MEDTHERM9__ ___MEDTHERM9__ 0/1 (91.7% vs 85.7% metastasis metastasis (34.7% vs 25.7%). patiences patiences (70% and and 59% chemotherapy chemotherapy arm) and ex-smokers (34% and and 44% __MERTM8__to_MEDTEM11_ __MERTM8__to_MEDTEM11_ & chemotherapy. chemotherapy.",
      "start_page": 343,
      "end_page": 345
    },
    {
      "heading": "Quality of tests",
      "text": "safety safety tests? Ps Ps - estimates estimates - moderated - high - no studies included",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "Values",
      "text": "Ps Ps - variation variation - variableness variableness - been been assessed? IONSI IONSI ADDITIONAL",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "Budget of effects",
      "text": "JUDIZI JUDIZI R",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "Fair",
      "text": "of of equity?",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "Acceptance",
      "text": "R R - No - Probably no - HolderS HolderS ? PLASIE PLASIE frontale? favori favori l'ACTION. ACTION.",
      "start_page": 347,
      "end_page": 348
    },
    {
      "heading": "Feasibility",
      "text": "JUDICIAL JUDICIAL • No • Probably no • Yes Yes • Vary • Summary Summary PROBLEM",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "EFFECTS",
      "text": "Prohibitions",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "BILLS",
      "text": "THE THE SUPERVISION? I I don'EQUITA EQUITA FACTIVITY",
      "start_page": 348,
      "end_page": 349
    },
    {
      "heading": "COURTS",
      "text": "probably probably don'Aumen Aumen l/not not know",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "Recommendation Recommendation Recommendation",
      "text": "of of intervention",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "Recommendation",
      "text": "option. option.",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "Strong recommendation",
      "text": "__ __ MEDTERM2__",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "QUESITE 21",
      "text": "Author: ACT Question: __medTERM2__ __medTERM2__ Setting: inpatients Bibliography: et et al: _MEDTERMM0__ in non-___MEDTERAM7__ ___MEDTERAM7__ rearrangement: single-arm single-arm first-Oncol Oncol 18:1590-1599, 2017; et et at: page page 18:159-1599.; etc, etc, et: Intra-centralE/the the following: About 35",
      "start_page": 351,
      "end_page": 352
    },
    {
      "heading": "grade grade 3-4",
      "text": "and and observational",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "nervous nervous system",
      "text": "and and observational",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "Hypercholesterolaemia grade 3-4",
      "text": "and and observational",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "Grade 3-4 hyperglycemia",
      "text": "of of AST",
      "start_page": 352,
      "end_page": 353
    },
    {
      "heading": "Explanation",
      "text": "et et al'TKI. TKI.",
      "start_page": 353,
      "end_page": 353
    },
    {
      "heading": "References",
      "text": "E. E., T. T., Bearz, AA., R. R., J. J., R. R., M. M., Peters, S., Toffalorio, F., Abbattista, A:, Thurm, H., Peltz, G., Wiltshire, R. , SS. SS., Toffalorio,F., Tabbattisista, A ., Thurm,H., Pellz,G., Wiltshire, Ru., Wilthshire, Ra., patients patients without-small-in in patient;: E E - Cancer, E/, Fel, Fel, F",
      "start_page": 353,
      "end_page": 353
    },
    {
      "heading": "APPLICATION 21",
      "text": "progress progress POPULATION: INTERVENTION: COMPARISON: MAIN EXITS: SETTING: PROSPECTIVE: BACKGROUND: CONFLICTS OF INTEREST",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "Problem",
      "text": "JUDICES JUDICES • Probably not • Yes • Varia • from from •study study • MEDTERM1_ or •Stage Stage Chemotherapy; Duration of response; Progression free survival; Objective response; the the SNC; grade grade 3-4; Hyperglycaemia Grade 3-4; al. al., months months (95%6-16. 6-16.7). F., J. J., P. P., A. A., in in non-RO_MEDTERM26_ RO_MEDTERM26_ rearrangement: single-arm single-arm first-Lancet Lancet Oncol; De. De., M. M., Peters, S., Toffalorio, F., H. H., R. R., Besse, B., MEDTERM15__-positive MEDTERM15__-positive non-Oncol. Oncol., A A .T., Felip, E., J., P. P., JUDI JUDI ● Gainor, Jr., Johnson., Dietrich., L. L., LL.",
      "start_page": 354,
      "end_page": 359
    },
    {
      "heading": "Values",
      "text": "main main outcomes? EVIDENCE EVIDENCE TESTS",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "Budget of effects",
      "text": "or or comparison? TESTS TESTS • months months (95%1-30. 1-30.3). • comparison comparison (95%6-16. 6-16.7). • months months (95%CI 6.8-NR). comparison comparison (<6 6 -16.7).",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "Fair",
      "text": "JUDIZI JUDIZI • Reduce equity • equity equity ● impact impact ■ Probably improves equity",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "Acceptance",
      "text": "JUDICIAL JUDICIAL • No • Probably no • Yes • Vary • I don't know",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "Feasibility",
      "text": "INTERVIEWS INTERVIEWS \" No \" Probably no • exist exist ● It doesn't exist? found. found. stakeholder? TESTS. TESTS. ento? No No matter",
      "start_page": 361,
      "end_page": 362
    },
    {
      "heading": "COURTS",
      "text": "Varies Varies yes",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "Recommendation",
      "text": "chemotherapy. chemotherapy.",
      "start_page": 363,
      "end_page": 364
    },
    {
      "heading": "QUESITE 22",
      "text": "Author(s): IDS Date: September 2019 Question: with with Setting: inpatients Bibliography: Med Med 2014; 371:1963-71; Oncol Oncol 2015; 33:992-9 Show A: Oncology Oncology 30: life life (L. L.) Life Life - al al - life life - al. al. - not reported Diarrhea/Nausea/Constipation grade <=3 - at at (METROS) mone mone y/50 ceation 17/retrospective retrospective - reduction. reduction.\"",
      "start_page": 364,
      "end_page": 366
    },
    {
      "heading": "Explanations",
      "text": "and and Landi; grade 3; grade 5; of of 7/b. b. 76% patients patients (89%) and and 42% sufferants sufferants (80.7%) chemotherapy chemotherapy QUE-Lifeline?",
      "start_page": 366,
      "end_page": 367
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND: rearrangements. rearrangements.",
      "start_page": 367,
      "end_page": 367
    },
    {
      "heading": "CONFLICTS OF INTEREST",
      "text": "VALUATION",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "Problem",
      "text": "JUDICIAL JUDICIAL • No • Probably no − Probably yes",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "X Yes",
      "text": "(Q6)1000 1000 (0 to 0) t t (METROS) - per per 1/for for 1/00 00 (0 to 0) not not ---ble ble (1 observat study) ble (observat study) ble (1 observed study) 00 00 (0 to 0) 1. 1..00 ( 00 00 (0. to 0), 000 000 (0) BLE BLE (1 observat study) ble (1 observed study) BLE (observat studies) ble (1) observato study) ble (Wabexive Wabexive study) pati pati (80.7%) LINE LINE (LOMEVAL) (LIVER) (LOVERFUL LINE IENSES) JUDITIONS JUDITIONS - Major - Modern - Irrelevant Irrelevant - Varian - erevival erevival - al al (METROS) survival survival - - all all - survivor survivor - survival survival - al al (METROS) - (METRO) - life life - et et - al - Life Life - reported reported Diarrhea/Nausea/grade grade <3 - al al (MITROS) 00 00 Diarrhea/N nausea/00 00 (0 to 0)000 000 (0to 0) 000 000 (to to 2) _ _ (reduction. reduction.\" of of 8/observat observat study) ble (1 observatt study) ble (1 observed study) blue (1observat studied) ble (observant study) observate study) of of 7/L. L.",
      "start_page": 368,
      "end_page": 375
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "Budget of effects",
      "text": "action action • Vary • I don'PLASIE PLASIE frontale? GU GU CONSI",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "Fair",
      "text": "of of equity?",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "Acceptance",
      "text": "JUDIZI JUDIZI • No • Probably no • X Yes • Varia • I don't know • RICERC keepers?",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "Feasibility",
      "text": "intervention intervention feasible?",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "SIDES",
      "text": "I I don'FACTIVITY FACTIVITY No",
      "start_page": 378,
      "end_page": 379
    },
    {
      "heading": "TYPE OF RECOMMENDATION",
      "text": "DEL DEL POLMONE",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "COURTS",
      "text": "fairness. fairness.",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "Recommendation",
      "text": "option. option.",
      "start_page": 380,
      "end_page": 380
    },
    {
      "heading": "QUESITE 23",
      "text": "__MEDTERM2_ __MEDTERM2_ Setting: inpatients Bibliography: et et al: Fusion-Positive Fusion-Positive Non-Oncol Oncol 39:Duration Duration (follow up: 8 8 months) months months (IC95% 13.9-28.6) • observational Very low",
      "start_page": 381,
      "end_page": 382
    },
    {
      "heading": "Explanation",
      "text": "cases. cases.",
      "start_page": 382,
      "end_page": 382
    },
    {
      "heading": "References",
      "text": "R. R., G. G., F. F., Siena, S., Drilon, A., C. C., Patel, M-R., C. C., V. V., J. J., H. H., Farago, A",
      "start_page": 382,
      "end_page": 382
    },
    {
      "heading": "APPLICATION 23",
      "text": "by by POPULATION: __medterm2__ __medterm2__ INTERVENTION: __MDTERM1__ CONFRONTO: Main chemotherapy: Overall survival; Progession free survival; Objective response; c c SETTING: Inpatients PROSPECTIVE: BACKGROUND: interest. interest.",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "Problem",
      "text": "a a priority? TESTS TESTS • completed. completed. • Probably no • avanz avanz alica; • Irrelevant • Modern • Large • Variano • siderable siderable effects? • V. V., N. N., JUDITIONS JUDITIONS N:modern modern ● Small • Irrelevants Varian () Varian ? response response (1 study- months months (IC95% 13.9-28.6) observational) follow follow up: months months (1 study - follow-ups: median of 81%, observationally observationally deceased) the the follow- on on patient'b. b.",
      "start_page": 383,
      "end_page": 386
    },
    {
      "heading": "Certainty of evidence",
      "text": "safety safety tests?",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "Budget of effects",
      "text": "comparison. comparison. ● intervention. intervention.",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "Fair",
      "text": "JUDIZI JUDIZI \" Reduces equity \" equity equity \"impact impact \" fairness fairness \" Improved equity \" Vary \" I don'or or comparison? months months (11-21.1), ento ento (IC95% 13.9-28.6). followed-up. followed-up. uità? from from 108/of of 8/2. 2.5% baseline baseline (both with abilities). of of 81%, co-EDELES. co-EDELES.",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "Acceptance",
      "text": "no_BAR__BAR_ no_BAR__BAR_ It'yes yes ● Yes ^I I don't know",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "Feasibility",
      "text": "Isn'JUDITIONS JUDITIONS ? not not ? Probably yes ● projects projects ? found found ? POLMONE POLMONE JUICES",
      "start_page": 388,
      "end_page": 390
    },
    {
      "heading": "COURTS",
      "text": "Don Don 'w w Don'Don Don 'w w don't kno w",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 391,
      "end_page": 391
    },
    {
      "heading": "Recommendation",
      "text": "option option (compared to chemotherapy).",
      "start_page": 391,
      "end_page": 391
    },
    {
      "heading": "QUESITO 24",
      "text": "with with −BRAF-V600 BRAF-V600 Setting: inpatients Bibliography: Lancet Oncol 2017; 18: 1307/Survival Survival (follow up: 9 9 months; assessed with: each each cause) 36 36 (47%) survival survival (follow up: 9 9 month; evaluated with: or or death) VOLLOW VOLLOW UP: 9 9 months) 25 25 (69%) events events (8 [22%)), disease disease (14 [39%)), investigator investigator (2 [6%)) patient patient (1.3%) nine nine (36%) one one (4%) two two (8%) three three (12%) ten ten (40%) 3-4 3-4 (follow-up: 9 9 months) non-occurrence non-occurrence studies",
      "start_page": 392,
      "end_page": 393
    },
    {
      "heading": "Explanations",
      "text": "been been decreased: not not achieved",
      "start_page": 393,
      "end_page": 393
    },
    {
      "heading": "References",
      "text": "M M D'untreated untreated BRAFV600E- mutant metastatic non-small-cell lung cancer: Lancet Lancet Oncol; 2017.",
      "start_page": 393,
      "end_page": 393
    },
    {
      "heading": "APPLICATION 24",
      "text": "POPULATION: mutation mutation INTERVENTION: _MEDTERM1__ _MEDTERM1__ CONFRONTO: Only primary chemotherapy: Overall Survival; Progression free survival; Response rate; Quality of life; Any discontinuation; Grade Grade 3-4; SETTING deaths: Inpatients PROSPECTIVE: Population",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "BACKGROUND:",
      "text": "the the vote: Dr. Novello",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "Problem",
      "text": "a a priority? siderabili siderabili expected? CENTRAL, CENTRAL, PubMed/months months (95% of of 7· (010 [16.16·6), being being 72% followed up: following following up: Median (8 8 (22.22.0), 27 27 (75%, 95% 25 25 (69%) episodes episodes (four [1%)), Aminotransferase Aminotransferase (four [11%), hypertension (four (11%)) and vomiting (three [8%). BA BA onal) were were sought; trial trial (thirty-five thirty-five years). included included (1) oral oral (twice twice daily) oral oral (once once daily) life life - participants participants (studies) (observed observed (at at (the the (GR onal) 1 MO BA_onal) onal onal 1) 25 25 (69%) events events (8 [22%), followed up: progression progression (14 [39%), decision decision (2 [6%)) decision decision (1.3%) nine nine (36%) treatment treatment (12 percent) two two (8%) three three (1.4%) treatment treatment (less). NE o (observed observed (Juli Juli ,c c onale) onale onale 1) bA bA onale) untreate untreate cancer: arm. arm.",
      "start_page": 394,
      "end_page": 401
    },
    {
      "heading": "Quality of tests",
      "text": "safety safety tests?",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "ADDITIONAL ADDITIONAL TESTS",
      "text": "arm. arm.",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "ADDITIONAL ADDITIONAL TESTS",
      "text": "• found found • variable variable • or or variability",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "Budget of effects",
      "text": "the the comparison",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "Fair",
      "text": "JUDIZI JUDIZI • Reduce equity • impact impact • equity equity ■ Improves fairness • Vary • nto nto uità? OPLAS OPLAS onfronto? GIUNTIVE GIUNTIVE GUIDE",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "Acceptance",
      "text": "JUDICES JUDICES • No − Probably no • Yes Yes • Varia • I don't know",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "Feasibility",
      "text": "JUDICIAL JUDICIAL • No • Probably no • X Yes • Vary • DESIDERABLE DESIDERABLE EFFECTS",
      "start_page": 403,
      "end_page": 404
    },
    {
      "heading": "SIDES",
      "text": "I I don'No No yes",
      "start_page": 404,
      "end_page": 405
    },
    {
      "heading": "Recommendation Recommendation Recommendation",
      "text": "of of intervention",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "Recommendation",
      "text": "option option (benefit/damage balance vote: favor surgery 4; surgery surgery 3; I don'vote vote recommendation: positive strong 3; positive weak 5) te yes",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "Strong recommendation",
      "text": "I I don'MEDTERM1__ MEDTERM1__ alone",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "QUESITE 30",
      "text": "Author(s): MC Date: September 2019 Question: status status (0-1) Setting: inpatients Bibliography: Med Med 2016; none none 63/154 (40.9%) 126/interruption interruption reasons: Continuation Continuation reasons: CRITICAL CRITICAL CRITICAL",
      "start_page": 406,
      "end_page": 407
    },
    {
      "heading": "APPLICATION 30",
      "text": "expression expression ≥ 50%, status status (0-1), recommended recommended (to to chemotherapy)? POPULATION: PDL1 PDL1 ≥ 50% of of −of of •status status (01) INTERVENTION: __medTERM1_ CONFRONTO: MAIN MAIN RESULTS: Progression-free survival; overall survival; objective response rate; to to 3; discontinuation discontinuation rate: Ambulatorial",
      "start_page": 408,
      "end_page": 408
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND: expression expression ≥ 50%, status status (0-1).",
      "start_page": 408,
      "end_page": 408
    },
    {
      "heading": "CONFLICTS OF INTEREST",
      "text": "VALUTAZION",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "Problem",
      "text": "JUDICES JUDICES • No • Probably no • X Yes • Varieties • Effects Effects • JUDITION JUDITION • Irrelevant • Small • Moderate • Large • Variant • Don'how how much? • Resumes • Depth • Discovery • outcomes outcomes • Overall survive effects*: months months • NEOPLA • population population • Absolute Absolute effects* (95% CI) a a (95% first first CI) 0. 0. (0. 0.69) (29 to 50) evidence evidence (GRAD to (1 RCT) 50 50 (to to (1 RCT) 305 305 + (1 Rct) 304 304 + (to to (1RCT) 305 305 + (to to (1 RTT) JUDIZI JUDIZI • 100 • 50 • 30 • 5 • 10 • 15 • 6 • 9 • 8 • 7 • 11 • 12 • 13 • 17 • 16 • 25 • 24 • 28 • 14 • 20 • 21 • 22 • 45 • 55 • 52 • 36 • 40 • 35 • 60 • 38 • 65 • 33 • 59 • 53 • 80 • 56 • 70 • 102 • 37 • 3 • 34 • 61 • 2 • 51 • 57 • 4 • 47 • 54 • 74 • 75 • 85 • 95 • 67 • 63 • 105 • 78 • 48 • 72 • 68 • 64 • 44 • 90 • 66 • 97 • 150 • 500 • 0 • 42 • 43 • 125 • 58 • 103 • 23 • bias. bias.",
      "start_page": 409,
      "end_page": 412
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "Budget of effects",
      "text": "action action • Vary • I don'PLASIE PLASIE frontale? GU GU CONSI",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "Fair",
      "text": "JUDICIAL JUDICIAL • Reduces equity • impact impact • fairness fairness • Improves equity - • Vary • I don't know",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "Acceptance",
      "text": "Principles Principles • No − Probably no • Yes Yes • Varia • I don't know",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "Feasibility",
      "text": "JUDICIES JUDICIES • No • Probably no • X Yes • Vary • I don'equity equity ? work work • • Ricerc or ? • P P • OF OF PROBLEM",
      "start_page": 414,
      "end_page": 415
    },
    {
      "heading": "SIDES",
      "text": "LINEE LINEE GUIDE",
      "start_page": 415,
      "end_page": 416
    },
    {
      "heading": "COURTS",
      "text": "institution institution EQUITA-L'equity equity L'No No Yes",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "Recommendation",
      "text": "expression expression ≥ 50%, option. option.",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "QUESITE 33",
      "text": "Author(s): MC Date: September 2019 Question: expression expression <50% status status (0-1) Setting: infectiouss Bibliography: Med Med 2018; 378:Oncol Oncol 2016; 17: 14977508",
      "start_page": 417,
      "end_page": 417
    },
    {
      "heading": "patients patients Effect",
      "text": "chemotherapy chemotherapy (95% CI) __ MEDTERM0/none none 112/315 (35.6%) 113/17 17 feet",
      "start_page": 417,
      "end_page": 418
    },
    {
      "heading": "Progression free survival",
      "text": "a, a,e",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "Objective response rate",
      "text": "a, a,e",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "any any AEs",
      "text": "apia apia (95% CI) (95% CI), feet feet . CRITICAL ) (0. 0.80) (7 7 feet) 25 25 more",
      "start_page": 418,
      "end_page": 419
    },
    {
      "heading": "Explanations",
      "text": "189 189 study: following following reasons: clinical clinical progression; following following reasons: monitoring monitoring reasons: clinical clinical progression; proportion proportion score",
      "start_page": 420,
      "end_page": 420
    },
    {
      "heading": "APPLICATION 33",
      "text": "expression expression <50% mutation mutation l",
      "start_page": 421,
      "end_page": 421
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 421,
      "end_page": 421
    },
    {
      "heading": "ADDITIONAL ADDITIONAL CONSIDERATIONS",
      "text": "\"1 1 (PD-1) metastatic metastatic non-smal-cell - cancer cancer (__MEDTERM12_) __MEDTERF0__ __MEDTERF0__ (Keytruda, Merck), __MEDTHERM1__ • Probably yes (Opdivo, Bristol-Myers Squibb), and_MEDTRAM2__ (Tecentriq, Genentech) therapy. therapy. [...] your your password?Anticipating effects? absolute absolute effects* (95% CI) at at (95% (Studies) (GRADE) and and CI) 499 499 (to to (2 RCTs) 0. 0.83) (35 to 55) rate rate (to to (2RCTs), MODERATEa,c;0. 0.80) (56 to 73) the the 95% g. g. I2=53% j. j. KYNOTE/following following reasons: in in the",
      "start_page": 421,
      "end_page": 424
    },
    {
      "heading": "_MEDTERM0__:",
      "text": "Objective response rate: grade grade 3-5: Discussation rate: JUDGEMENT JUDGEMENT • Large • absolute absolute effects* (95% CI) treatment treatment (95% (studies) (GRADES) and and CI) 189 189 study: following following reasons: clinical clinical progression; following following reasons: Following Following factors: clinical clinical progression; For For Plot",
      "start_page": 424,
      "end_page": 428
    },
    {
      "heading": "_MEDTERM0__:",
      "text": "Objective response rate: grade grade 3-5: Continuation rate: DEL DEL POL",
      "start_page": 428,
      "end_page": 430
    },
    {
      "heading": "Certainty of evidence",
      "text": "of of effects?",
      "start_page": 430,
      "end_page": 430
    },
    {
      "heading": "Values",
      "text": "main main outcome?",
      "start_page": 430,
      "end_page": 430
    },
    {
      "heading": "Balance of effects",
      "text": "RESEAR RESEAR • comparison comparison • compare compare • appearance appearance • intervention intervention • Varies • Don't know",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "Equity",
      "text": "health health equity?",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "Acceptability",
      "text": "JUDGEMENT JUDGEMENT RESEAR",
      "start_page": 431,
      "end_page": 432
    },
    {
      "heading": "Feasibility",
      "text": "No No - Probably no - Yes Yes - Varieces → Don'to to implement? NS NS Don' t know Don'i i Favorn't known don't rever",
      "start_page": 432,
      "end_page": 434
    },
    {
      "heading": "Recommendation",
      "text": "expression expression <50% mutation mutation l",
      "start_page": 435,
      "end_page": 435
    },
    {
      "heading": "QUESITE 34",
      "text": "Author: ACT Question: status status (0-1) Setting: inpatients Bibliography: patients patients + Paclitaxel Paclitaxel + none none 181/338 (53.6%) 211/344 (61.3%) randomized",
      "start_page": 436,
      "end_page": 436
    },
    {
      "heading": "Progression free survival",
      "text": "none none 240/338 (71.0%) 285/344 (82.8%) rate rate (answers answers + partial answers) none none 207/338 (61.2) 126/344 (36%) life life (follow up: 9 weeks; rated with: Life Life Questionnaire- Core 30 (global health status/life life score); Scale from: 0 to 100) living living (follow up: 18 weeks; evaluated with:Life Life Questionaire- Core30 (global healthy status/life life scores); Scales from:0 to 100) Assoluto Assoluto (95% CI) (95% CI), less less for",
      "start_page": 436,
      "end_page": 437
    },
    {
      "heading": "Any breakdown",
      "text": "death death (treatment related deaths) serious serious randomized",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "adverse adverse events: Anaemia",
      "text": "and and randomized",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "adverse adverse events: Neutropenia",
      "text": "and and randomized",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "adverse adverse events: Thrombocytopenia",
      "text": "and and randomized",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "Immunotherapy-related adverse events",
      "text": "CBDCA CBDCA + or or Nab- Beta Beta + (95% CI) (95% CI), for for ... (0. 0.85) 100 (11 11 less) none 32/337 (9.5%) 21/342 (6.1%) 100 100 • (2. 2.64) (10 10 more) none none 51/337 (15.1%) 67/342 (19.6%) CRI CRI (1. 1.07) 100 (1 1 more) none 66/337 (19.6%), 70/342 (20.5%) CRIA CRIA (1. 1.77) 100 (plus plus BASS335L)",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "patients patients Effect",
      "text": "CBDCA CBDCA + Paclitaxel Paclitaxel + (95%CI) (95% CI) none none 111/337 (32.9%) 32/342 (9.4%) randomized randomized (5. 5.96) 100 (BASSA BASSA plus) CI: Confidence interval; HR: Hazard Ratio; RR: Risk ratio; MD: Mean difference",
      "start_page": 438,
      "end_page": 438
    },
    {
      "heading": "Explanation",
      "text": "distortion distortion (sponsor sponsor bias: Merck Merck & the the sponsor; Sharp Sharp & data data analysis). population population (or or IV; RTC RTC KEYNOTE-407: stage stage IV). biases biases (trial trial & Ohme.",
      "start_page": 438,
      "end_page": 438
    },
    {
      "heading": "References",
      "text": "J. J., Kowalski, D., Luft, A., M. M., Laktionov, K., Hermes, B., Cicin, I., T. T., Paz-Ares, L.. Squamous Squamous Non-Clin Clin Oncol; Borghaek. Borghaek.",
      "start_page": 438,
      "end_page": 439
    },
    {
      "heading": "Problem",
      "text": "a a priority? chemotherapy chemotherapy + of of chemotherapy+ platinum platinum + Platinum Platinum + absolute absolute effect* (95% of of CI) relative participation (95% (studies) Risk with CI) chemotherapy CBDCA + Nab-Paclitaxel Nab-Paclitaxel + 72 72 (2 RCT) 100 100 (a a (43 to 57) 0.88) major major - 386 life (the the (to to (1 RCT) 3, QLQ-C30) greater greater with: Life Life Questionnaire- Core 30 (global health status/life life score) Scale from: follow follow up: life life Questionnaire- core 30 (Global Health Status/Life Life score) scale from:follows follows up: J. J., M. M., Borghaei, H., F. F., D. D., L. L., Piperdi, B., Li, X., Burke, T., Squamous Squamous Non-Jlin Jlin Oncol; distortion distortion (Sponsor bias survey: Merck Merck & The The study'the the sponsor; Sharp Sharp & RCT RCT MED14",
      "start_page": 439,
      "end_page": 443
    },
    {
      "heading": "_MEDTERM0__",
      "text": "JUDICES JUDICES - Varies Varies Don'the the undesir",
      "start_page": 443,
      "end_page": 444
    },
    {
      "heading": "_MEDTERM0__",
      "text": "anticipated anticipated effects? carboplatin carboplatin + paclitaxel/PDL-1 PDL-1 <50% status status (0-1), absolute absolute anticipated* of of (95% CI) relative participated (95% (studies) with with CI) chemotherapy CBDCA + nab-paclitaxel nab-paclitaxel + 76 76 (2 RCT) 100 100 (a a (50 a 62) 0.85) 679 679 (55 55 (2 Rct) 1.3 treatment) 100 100 (a a (6 a 16) 2.64) grade grade 3-4: 0.77 (2 RTC) 100 100 (+a a (11 a 21) 1.07) tests tests (Commenti Commenti E) , or or Nab- Pacilitaxel + B. == Demographic evolution =References== Paz-Ares, L., Luft, A., Vicente, D., M. M., Mazières, J., Hermes, B., F. F., Csőszi, T., Fülzep, S., Rodríguez-Cid, X., M. M., D D .Squamous Squamous Non-J J Med; for for inaccuracy: eneity eneity (I2= 55%) legato legato all'PO PO OLMONE",
      "start_page": 444,
      "end_page": 449
    },
    {
      "heading": "Certainty of evidence",
      "text": "of of effects?",
      "start_page": 450,
      "end_page": 450
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 450,
      "end_page": 450
    },
    {
      "heading": "Balance of effects",
      "text": "Varies Varies Don't know",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "Equity",
      "text": "Varies Varies Don'the the comparison? CBDCA CBDCA + Nab-Paclitaxel Nab-Paclitaxel + CBDCa CBDCa + Nab-Paclitaxel Nab-Paclitaxel + A A + nab-Paclitaxel nab-Paclitaxel + CBDCO CBDCO + Beta Beta + 3-4. 3-4.",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "Acceptability",
      "text": "JUDIZI JUDIZI • No ♪ Probably no • Probabilly yes ● Yes • Varies • Don't know",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "Feasibility",
      "text": "JUDIZI JUDIZI \" no no \" Probabyly yes ● Yes - Varieties Don'key key stakeholders? SEARCH OF EVIDENZ'to to implement? SEVERATION OF EVIDENZ'GTS GTS JUBLY",
      "start_page": 452,
      "end_page": 453
    },
    {
      "heading": "COURTS",
      "text": "Vari Vari 'kno kno w",
      "start_page": 454,
      "end_page": 454
    },
    {
      "heading": "TYPE OF RECOMMENDATION",
      "text": "intervention intervention intervention",
      "start_page": 454,
      "end_page": 454
    },
    {
      "heading": "Recommendation",
      "text": "status status (0-1).",
      "start_page": 454,
      "end_page": 454
    },
    {
      "heading": "QUESITE 37",
      "text": "I'm sorry. Author(s): IM Date: 2021 Question: NSCLC1 NSCLC1 Settings: Pemetrexed Pemetrexed Bibliography: Oncol Oncol 2012;13:2012, 2012,7:1713-1721 Paz - JCO JCO 2013;Survival Survival (5 5 months; appointed with: not detected) non non 255/359 inaccience",
      "start_page": 455,
      "end_page": 456
    },
    {
      "heading": "transfusion (5 5 months)",
      "text": "none none 48/359 9/67 67 (100 100 (imprecision imprecision (13.4%) (5%) 22 22 more) HIGH G-CSF (5 5 months; appointed with: G-GF OR GM-CSF) none none 20/359 1/03 03 (10 10 (indirectness8 indirectness8 (5.6%) 15 (0.56) 74. 74.13) 41 41 more) HIGHenzagrade 3-4 (5 5 months; assigned with: grade grade 3-4) available available 88% Investigator Investigator -> months months (3,2-4.6), 8 8 (2,6-3,1); Indipendent -> months months (3- 4,2) , 6 6 (2.2-2,9) Wide Wide 95% (2,6-3,1); confidence confidence 9",
      "start_page": 456,
      "end_page": 457
    },
    {
      "heading": "APPLICATION 37",
      "text": "used used POPULATION: Advanced NSCLC INTERVENTION: Pemetrexed Pemetrexed COMPARISON: Main Placement: Overall Survival; Progression free survival; Objective response rate; life life -EQ-5D; Qual grade 3-4; Neutropenia Neutropenia SETTING: PERSPECTIVE: BACKGROUND: INTEREST CONFLICTS",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "Problem",
      "text": "a a priority? TESTS TESTS - No ... probably no - probably not - Probably yes ● Yes • life life -VAS; Toxicity Toxicity (CONSIDE CONSIDE ratory); Fatigue grade 3-4; trans- ADDENTIONAL HERATIONS disfusion; G-CSF ; Consid Consid JUDICICITI: three three weeks) + placebo placebo + Comments Comments * (95% CI) participants participants (95% (Studies) (GRADE) Risk with CI) 539 539 = Survival (__MEDTERM2_) 0.78 (1 RCT) ALTA evaluated with: 100 100 (100 100 (62 a 76) 0.96) follow up: 100 100 (_MEDTERM3_) assessed with: 0 0 follow-up: rate rate (_medTERM4_) the the following: 0 0 follow-ups: median",
      "start_page": 458,
      "end_page": 461
    },
    {
      "heading": "38 38 - 134",
      "text": "-VAS (_MEDTERM0__) lower average (1 RCT) BASSAd,f",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "SEA - life life - a 0.01",
      "text": "was was greater) available available 88% Wide Wide 95% e. e. 95% and and lower",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "difference difference (MID= 0.08",
      "text": "index index score); f. f. 95% difference difference (MID= 7 VAS) expected? Advanced Advanced Comments* (95% CI) trials trials (95% (studies) (GRADE) CI CI (luxury) 539 539 • Toxicity (51 51 (1 RCT) ALTA laboratory) 100 100 (a a (ST) 100 (4 a 20) 5.91) evaluated by: N° follow follow up: 100 100 (1 to 20) assessed by: follow follow up; follow-up follow-up study: 100 100 (7 to 27) evaluated evaluated with: G- 100 100 (1 a 41) followed up: 12 12 months",
      "start_page": 461,
      "end_page": 464
    },
    {
      "heading": "Certainty of evidence",
      "text": "safety safety tests?EVIDENCE EVIDENCE TESTS",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "Budget of effects",
      "text": "comparison. comparison. ● intervention. intervention.",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "Fair",
      "text": "equ equ JUDIZI",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "Acceptance",
      "text": "JUDICES JUDICES • No • Probably no ● Probably yes • Yes • Vary • I don't know",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "Feasibility",
      "text": "NEOPLAS NEOPLAS stakeholders? found. found. ento? found. found.",
      "start_page": 466,
      "end_page": 468
    },
    {
      "heading": "ABILITY",
      "text": "I I don'yes yes Yes",
      "start_page": 468,
      "end_page": 468
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 468,
      "end_page": 468
    },
    {
      "heading": "Recommendation",
      "text": "status status (0-1), considered. considered.",
      "start_page": 468,
      "end_page": 469
    },
    {
      "heading": "QUESITE 38",
      "text": "Author: MC Question: the the Setting: Inpatients Bibliography: Open Open 2017; 2:e000236; Lancet Lancet 2016; 387: 1837-46 ; none none randomized",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "Progression free survival",
      "text": "nobody nobody randomized",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "Overall response rate",
      "text": "AE AE (or or 4) nobody nobody randomized",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "Continuation rate",
      "text": "Oncology Oncology 29: 959 • 965, 2018; al. al. / 107 107 (2019) 124e132; 510; or or (95% CI) (95% CI), __medTERM2__ 1384/1874 (73.9%) 1316/1525 (86.3%) less less for",
      "start_page": 469,
      "end_page": 470
    },
    {
      "heading": "Explanation",
      "text": "studies studies (POPLAR POPLAR studies) c. c. I2=61% found found (I2=82%), of of effects",
      "start_page": 470,
      "end_page": 470
    },
    {
      "heading": "References",
      "text": "J. J., Rittmeyer, A., Gadgeel, S., Hida, T., L. L., F. F., Yu, W., Matheny, C., Ballinger, M., __ __ MEDTERM9_: Thorac Thorac Oncol; S. S. , Baas, P., Kim, D-W., Fellip, E., M QUESITE 38: recommended recommended (second-line second-line chemotherapy)? POPULATION: chemotherapy. chemotherapy. INTERVENTION: _MEDTERM5__ _MEDTERM5__ CONFRONTO: Main EXIT Chemotherapy: Progression-free Survival; Overall Survival; Objective Response Rate; to to 3; adverse adverse events: Ambulatorial",
      "start_page": 470,
      "end_page": 471
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND: chemotherapy. chemotherapy.",
      "start_page": 471,
      "end_page": 471
    },
    {
      "heading": "Problem",
      "text": "a a priority?",
      "start_page": 471,
      "end_page": 471
    },
    {
      "heading": "ADDITIONAL ADDITIONAL TESTS",
      "text": "It'not. not.",
      "start_page": 471,
      "end_page": 471
    },
    {
      "heading": "X Yes",
      "text": "(61 to 67) 037 037 (studies) (with with CI) _ _ [Studies] (with with CI). with with Q10: (95% (studies) (with with CI), __ __ -0 0 77) (61/ 67) to to 67* 3024 3024 077) survival (to to (4 CCTs) years years (to to 57) progressive) 0 0 0; 0 0 98) 0 0, 85) to to 66) 0 0 0) 0) 5 5 ( ( ( to 59) surve) 0 0 - 0 0 ( (69 69 ( (to to ( (79) to (0 0 79) to (to to (4 to (79 79 ( (44 to (to to (4 74, 79) studies) to to (45, 45, 60) 100 100 64) 3 3 ( ( 3 3 ( 100 100 64",
      "start_page": 472,
      "end_page": 473
    },
    {
      "heading": "I2=61%",
      "text": "found found (I2=82%), conside conside GIUDIZI",
      "start_page": 473,
      "end_page": 477
    },
    {
      "heading": "I2=61%",
      "text": "studies studies (POPLAR POPLAR studies) found found (I2=82%), compless compless JUDIZIONI",
      "start_page": 477,
      "end_page": 480
    },
    {
      "heading": "Values",
      "text": "main main outcomes? JUDICIAL TEST SEARCH",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "Budget of effects",
      "text": "comparison comparison \" confrontation confrontation \" discussion discussion \" It'intervention intervention \" in in favour\" operation operation \"Varia \"I don'D D onto?\" participation participation \"vole. vole.",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "Fair",
      "text": "of of equity?",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "Acceptance",
      "text": "JUDIZI JUDIZI • No • Probably no • X Yes • Varia • I don't know • RICERC keepers?",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "Feasibility",
      "text": "of of intervention? I I don'Confr. Confr.",
      "start_page": 482,
      "end_page": 483
    },
    {
      "heading": "COURTS",
      "text": "I I don'LINE LINE GUID",
      "start_page": 483,
      "end_page": 484
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 484,
      "end_page": 484
    },
    {
      "heading": "Recommendation",
      "text": "option. option.",
      "start_page": 484,
      "end_page": 484
    },
    {
      "heading": "QUESITE 42",
      "text": "Author: MGL,MC Question: cancer cancer Setting: inpatients Bibliography: 1) Annane. Annane. 2018;379(23) 2220- 9. 2) treatment treatment (Fifth Non-Important treatment) with with (95%CI) (95% CI) survival survival (follow up: 9 9 months) none none 104/201 (51.7%) 134/202 (66.3%) randomised randomised (0. 0.91) 100 (MODERATA MODERATA less) studies studies 13/none none 171/201 (85.1) 189/202 (93.6%) above above 80% 34 34 (8%) arm arm (mostly <10 points) none none 124/201 (61.7%) 142/202 (70.3%) 100 100 (1. 1.01) (1 1 plus) MODERAT none 21/155 (13.5%) 5/163 (3.1%) for for 100",
      "start_page": 485,
      "end_page": 486
    },
    {
      "heading": "patients patients Effect",
      "text": "with with (95% CI) (95% CI), 3-4 3-4 - none none 45/198 (22.7%) 48/196 (24.5%) randomized randomized (1. 1.32) (8 8 more) events events - anyone anyone 28/198 (14.1%) 24/196 (12.2%) randomised randomised (1. 1.92) (11 11 more) 3-4 3-4 - neutrophils neutrophils 1-10%) studies studies (to to 12",
      "start_page": 487,
      "end_page": 487
    },
    {
      "heading": "Explanation",
      "text": "distortion distortion (sponsor sponsor bias: Hoffmann Hoffmann - La Roche / of of data). for for imprecision: RR RR calculation: stage. stage.",
      "start_page": 487,
      "end_page": 488
    },
    {
      "heading": "References",
      "text": "L. L., S. S., Szörksna, A ., Havel, L ., Krzakowski, M., J. J., Huemer, F., Losonczy, G., Reck, Reck, M; Lin, W., V. V., J J Med; Mansfields, Mansfields, A: Każarnowicz, A! Au. Au.",
      "start_page": 488,
      "end_page": 488
    },
    {
      "heading": "APPLICATION 42",
      "text": "lung lung cancer? POPULATION: stage stage INTERVENTION: A first- CONFRONTO CONFRONTO Treatment: Main ESITI chemotherapy: Overall survival; Progression free survival; Response rate (partial partial responses) ; life life (_MEDTERM4_); Any discontinuion (of of treatment).",
      "start_page": 489,
      "end_page": 489
    },
    {
      "heading": "BACKGROUND:",
      "text": "CONFLICTS OF INTEREST",
      "start_page": 489,
      "end_page": 489
    },
    {
      "heading": "Problem",
      "text": "a a priority? JUDICES • No • Probably no • X Yes • Vary • Effects Effects (Fifth Century Centuries) • Fifty-Fifteenth Centennials (Fixth Census) {Fifteen Centorals] • follow follow up: effect effect early* of of (95% CI) relative participation (95% (studies) CI) than than 80% hundred-grade hundred-grade (Menth to 12-population) 34 34 (8%) of of RCT)1 RCT 1) interruption interruption (of of treatment) Any discontinuion (to to discontinuation) - 100 100 (53 to 71) arm arm (to to 528) 403 403 (to to (1 RCT). Horn, L., S. S., J. J., Huemer, F., Losonczy, G., 99 99 (a a (1 RCT) 394 394 (a a (1RCT) A A ., Havel, L ., L. L., M. M., Ho k., air, air, , T., RR RR calculation: by by imprecision: as as follows: (i) and and (ii) following following languages: (ii), (iii), (iv), (v), (vi), (vii), (viii), (e) and (vi); (iv) the the results; (v) the the studies; (vi) the the survey; (iii) the the findings; (iv). 1 1 RCT) discontinuation discontinuation (of of treatment) Any interruption (of of treatment). - arm arm (mostly <10 points) 403 403 (a a (1 RCT), 100 100 (53 a 71) 318 318 (a a (1RCT) 100 100 (5 a 35) 318 318 (a a (1 RTT) 100 100 (1 a 24) 100 100 mg/ J. J., Huemer, F., Losonczy, G., 99, 99, (to to (1 RCT) 394 394 (to to (1RCT)394 394 (to to (1rCT) (1) 334, 334, (to to (1 rCT) 1) 318 318 (to to (1 rect) A. A., Havel, L., Mio, Mio, M-, Reck M., m. m., T. T., S. S., two two levels: and and safety? ADDITIONAL ADDITIONAL HERATIONS",
      "start_page": 490,
      "end_page": 501
    },
    {
      "heading": "Values",
      "text": "C) JUDICES JUDICES • variation variation • variable variable • or or variability",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "Budget of effects",
      "text": "main main outcomes? or or comparison? SELLING THE POLMONE'ADDING ADDING HERATIONS",
      "start_page": 501,
      "end_page": 502
    },
    {
      "heading": "Fair",
      "text": "JUDIZI JUDIZI - Reduces equity - impact impact - fairness fairness - Improves equity",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "Acceptance",
      "text": "JUDICIAL JUDICIAL • No • Probably no • and and •with with •with with −treatment treatment . low low . uity?",
      "start_page": 502,
      "end_page": 503
    },
    {
      "heading": "Feasibility",
      "text": "JUDICES JUDICES • No • Probably no • Yes Yes • Vary • I don'do do this? • ADDITIONAL ADDITIONAL HERATIONS",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "SUMMARY OF COURTS",
      "text": "FACTIVITY FACTIVITY No",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "COURTS",
      "text": "Probably Probably doesn'I I don'not not know",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "in in favour",
      "text": "the the intervention",
      "start_page": 505,
      "end_page": 505
    },
    {
      "heading": "Recommendation",
      "text": "cancer. cancer. (benefit/damage balance vote: favors intervention 8; weak weak 5; Strong positive 6)",
      "start_page": 505,
      "end_page": 505
    },
    {
      "heading": "QUESITE 43",
      "text": "1DER/i: ACT Question: __MEDTERM0_ + etoposide etoposide (disease disease Setting: Inpatients Bibliography: W. W., et al., Lung Cancer 149: 46-52, 2020; et et al",
      "start_page": 506,
      "end_page": 506
    },
    {
      "heading": "patients patients Effect",
      "text": "Durvalumab Durvalumab + and and (95% CI) (95% CI), none none 171/265 (64.5%) 173/266 (65.0%) randomized randomized (1. 1.12) 100 (8 8 more) interruption interruption (follow up: 1 1 months) None None 27/265 (10.2%) 25/266 (9.4%) randomized randomized (1. 1.82) (8 8 plus) MODERATA CI: Confidence interval; HR: Hazard Ratio; RR: Risk ratio",
      "start_page": 507,
      "end_page": 507
    },
    {
      "heading": "Explanation",
      "text": "investigator investigator unmasked",
      "start_page": 507,
      "end_page": 507
    },
    {
      "heading": "References",
      "text": "W. W., Dvorkin, M., Chen, Y., Reinmuth, N., Hotta, K., Trukhin, D., Statsenko, G., O. O., Poltoratskiy, A., Ponce, S., Verderame, F., Havel, L., Bondarenko, I., Każarnowicz, A",
      "start_page": 507,
      "end_page": 508
    },
    {
      "heading": "Problem",
      "text": "JUDICES JUDICES • Probably no • probably probably • Varia • Non-Varie_of patients • __MEDTERM0_ __MEDTERM0_ + disease disease • PlatterM1_ + Overall Overall survival; survival survival study; •MEDTERM22_; AE any grade; AE grade<3; ACTION ACTION • p p n; effect effect anticipated* Comments Comments (95% CI) trials trials (95% (studies) (GRADE) with with CI) Sola __Medterm1_ + 537 537 • Nruvelz • survival. survival. • 547 547 • • median median (70 to 83) • GCT. ■ 100 100 (follow follow up: (79 to 89) 0.96) __MEDTERM24_seems. __MEDTERM24_seems. ♪ JUDICES JUDICES • Large Moderates ●Small • Irrelevant • Variano • effects effects expected? age age > treatment treatment arms: effect effect anticipated* Comments Comments (95% CI) participants participants (95% (studies) (GRADE) chemotherapy chemotherapy + 531 531 ›MEDTERM1_ follow up: 1.01 (1 RCT) 1 + 100 100 (months months (95 to 100) 1.04) grade grade <RR RR 531",
      "start_page": 508,
      "end_page": 513
    },
    {
      "heading": "Certainty of evidence",
      "text": "safety safety tests?TESTS TESTS • Low Low (detection detection bias). ● Moderate • High • No studies included",
      "start_page": 513,
      "end_page": 513
    },
    {
      "heading": "Values",
      "text": "main main outcomes?",
      "start_page": 513,
      "end_page": 513
    },
    {
      "heading": "Budget of effects",
      "text": "JUDICES JUDICES RICE",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "Fair",
      "text": "of of equity?",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "Acceptance",
      "text": "no_BAR__BAR_ no_BAR__BAR_ It'yes yes ● Yes ^I I don't know",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "Feasibility",
      "text": "JUDITIONS JUDITIONS • No • Probably no • does does • Vary • main main stakeholders' ella ella intervento? • NEO DERS? ■ EVIDENTS. EVIDENTS. • EQUITACY EQUITACY • ACCEPTABILITY ♪ Various Various interventions",
      "start_page": 515,
      "end_page": 516
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 517,
      "end_page": 517
    },
    {
      "heading": "Recommendation",
      "text": "__Durvalumab __Durvalumab + option option (only only chemotherapy).",
      "start_page": 517,
      "end_page": 517
    },
    {
      "heading": "QUESITE 45",
      "text": "Author(s): MC Date: September 2019 Question: L'radiazione prostitutiva dell'encephalo (PCI) chemotherapy chemotherapy Setting: inpatients Bibliography: No. No.: Oncology Oncology (2018) 13:Effect Effect l'irradiation irradiation (95% CI) (PCI) - Brazil not - free - Brain reports",
      "start_page": 518,
      "end_page": 518
    },
    {
      "heading": "Overall survival",
      "text": "none none 748/1859 644/feder feder ? a a (40.2%) f (11.6%) f (0. 0.66) LOW LOW (4 4 feet)",
      "start_page": 518,
      "end_page": 518
    },
    {
      "heading": "Progression free survival",
      "text": "261 261 (0.0%) 0/406 (0.0%) 76 76 -- per 100 • g g (0. 0.89) (from -- to VERY LOW",
      "start_page": 518,
      "end_page": 518
    },
    {
      "heading": "Quality of life",
      "text": "that that \"the the quality-of-life \" 93. 93.7% 46. 46.3% groups groups (P = 0.00)\" Function Function (neurological damage) - not reported - - -",
      "start_page": 518,
      "end_page": 519
    },
    {
      "heading": "lethargy lethargy (any grade)",
      "text": "none none 52/386 (13.5%) 16/570 (2.8%) more more ...l l (8. 8.44) LOW LOW (209 209 more) CI: Confidence interval; HR: Hazard Ratio; RR: Risk ratio",
      "start_page": 519,
      "end_page": 519
    },
    {
      "heading": "Explanations",
      "text": "d. d. I2=84% treatment. treatment.",
      "start_page": 519,
      "end_page": 520
    },
    {
      "heading": "PROSPECTIVE:",
      "text": "BACKGROUND:",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "CONFLICTS OF INTEREST",
      "text": "VALUE",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "Problem",
      "text": "priority priority JUDICITIS: \" No ... no no . \" Yes Yes ? Varia → brain brain (PCI) of of progression; overall survival; to to 3; cerebral cerebral testes; q alo (PCI) groups groups (P = Impered - - - evidence evidence (GRADE) Function Function (neurological damage) - 3-5 3-5 - - AES - afthargy afthargy (any (to to (2 grade) 8. 8.44) observational (80 to 237) studies)Forest Forest plot: OS:",
      "start_page": 520,
      "end_page": 523
    },
    {
      "heading": "_MEDTERM0__:",
      "text": "Grandi Grandi ...Moderati (21 0.66) effects effects expected? metastases metastases - free survival - solute solute effects* (95% CI) with with l'encefa encefa (PCI) 100 100 (7 to 8) 100 100 (N to NaN) ne ne (95% (studies) alo CI) 7395 7395 (to to (21 0.76) CEAN, CEAN, B/N) studies",
      "start_page": 523,
      "end_page": 525
    },
    {
      "heading": "Mr VERY",
      "text": "that that \"with with - (1 RCT)j = the quality-93. 93.7% 46. 46.3% groups groups (P = Impered - - -- - - Cognitive Function (neurological damage) - 3-5 3-5 - -",
      "start_page": 525,
      "end_page": 525
    },
    {
      "heading": "(80 to 237) studies",
      "text": "d. d. I2=84% the the Newcastle- Ottawa scale.",
      "start_page": 525,
      "end_page": 527
    },
    {
      "heading": "_MEDTERM0__:",
      "text": "Fatigue or lethargy: and and safety? ADDANTIVE ADDANTIVE N",
      "start_page": 527,
      "end_page": 528
    },
    {
      "heading": "Values",
      "text": "main main outcomes? JUDICIAL TEST SEARCH",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "Budget of effects",
      "text": "TESTS TESTS • comparison comparison • confrontation confrontation • intervention intervention •operation operation • Varia • D D onto?",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "Fair",
      "text": "JUDICIAL JUDICIAL • Reduces equity • impact impact • fairness fairness • Improves equity - • Vary • I don'Judici Judici • No • Possibly no • X X • Other • Not so",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "Feasibility",
      "text": "judicatures judicatures or? RICERC keholders ? RICEREC o? intervention. intervention.",
      "start_page": 529,
      "end_page": 530
    },
    {
      "heading": "Strong Strong Recommendation",
      "text": "of of intervention",
      "start_page": 531,
      "end_page": 531
    },
    {
      "heading": "Recommendation",
      "text": "brain brain (PCI) ice ice 2: POLMONE POLMONE Q1: years years before? MEDLINE (PubMed) (August August 2023) (!(( (( (...) (() \"Lung Neoplasms\"[Mesh] OR \"Clinoma,\" Non-Small-Cell Lung\"[Ash] Or",
      "start_page": 531,
      "end_page": 533
    },
    {
      "heading": "Selected 1 Record",
      "text": "Q2: approach approach (VATS or robotics) or toracotomy? MEDLINE (PubMed) (·c(\"Carcinoma, Non-Small-Cell Lung/Surgery\"[Mesh]) OR \"Lung Neoplasms/Surgiry\"[Mesh] OR ((\"lung cancer\"[Title/Abstract] OR \"lung lung cancer\" [Titler/Attract])",
      "start_page": 533,
      "end_page": 533
    },
    {
      "heading": "Records: 197",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'long long cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'lung lung cancer' Or 'lung lung cancer') OR nsclc:ti,ab #3 #1 OR #2 #4 'grade ia' OR'stage ia':b b #5 #3 AND #POLMONE POLMONE #6 'vats lobectomy' OR OR 'thoracic surgeries, video-assisted' OR -video surgery (vats) lobectomy' OR",
      "start_page": 533,
      "end_page": 534
    },
    {
      "heading": "Selected 3 records",
      "text": "Q3 GRADE: stage stage (IA), segment segment (compared to lobectomy)? MEDLINE (PubMed) (August August 2023) ((\"Lung Neoplasms\"[Mesh]) OR \"Carcinoma, Non-Small-Cell Lun Neoplasmas\"[Mesh]) Or \"lung cancer\"[Title/Abstract] OR \"lung neoplasms' tumor\"[Title/Attract] or \"Non-small-cell long cancer\" [Title/abstract]. OR cancer\"[1Title/ Abstract] OR NSCLC_[Title /abstraction]",
      "start_page": 534,
      "end_page": 534
    },
    {
      "heading": "Records:70",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'not-long long cancer' or nsclc:ti,ab",
      "start_page": 534,
      "end_page": 534
    },
    {
      "heading": "Selected 2 records",
      "text": "Q4: MEDLINE MEDLINE (PubMed) radio station (āb(\"Carcinoma, Non-Small-Cell Lung/surgery\"[Mesh]) OR \"Lung Neoplasm ((\"lung cancer\"[Title/Abstract] OR \"lung neoplasms\"[Title/Attract] Or \"long t \"Non-small-cell lung cancer\" [Titler/Aptract] or \"Don'lung lung cancer\"\"[T_MEDTERF0_[Tittel/App]",
      "start_page": 534,
      "end_page": 534
    },
    {
      "heading": "Selected 3 records",
      "text": "entec entec ng\"[M \"[Title R \"oterap oterap ms/sur tumor Title/A 0\" (thoracic thoracic ctomy' è è Mesh]) OR \"Lung e/Abstract] OR \"lung lung er' OR 'pia pia conventionale? rhey\"[Mesh] OR (\"[Title/Ambs] OR Abstract])))",
      "start_page": 534,
      "end_page": 535
    },
    {
      "heading": "Records: 116",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 #1 OR #2 #4 'adjuvant chemotherapy'/esp/mj #5 #3 AND #4",
      "start_page": 535,
      "end_page": 535
    },
    {
      "heading": "Selected 19 records",
      "text": "Q6: is is recommended? MEDLINE (PubMed) (August August 2023) (·(( \"Carcinoma, Non-Small-Cell therapy\"[Mesh] OR \"Carcinoma, Not-Small-Cello Lung/pathology\"[Mesh]) OR ((\"Lung Neoplasms/Drug therapy\"[ Mesh] Or ((\"\"lung-cell cancer\" [Title/Abs] or \"Lung neoplasms\"[Titler/Aabs] OR (\"Lung tumor\")",
      "start_page": 535,
      "end_page": 535
    },
    {
      "heading": "Records: 107",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'grade iii' OR'stage iii 'OR OR 'advanced disease' NEAR/7 (egfr OR '_MEDTHERM2___ mutated') #4 (#1 OR #2) AND #3 #5 '_medTERM0__'/Exp #6 osimertinib_:POLMNONE POLMNONE #8 #4 AND #5 OR6",
      "start_page": 535,
      "end_page": 536
    },
    {
      "heading": "Selected 1 Record",
      "text": "Q7: L1 L1 ≥50% is is recommended? MEDLINE (PubMed) (August August 2023) ([(( [(( -(( (( _ [( [ (( [ [( (0] [( \" (( - [ [ [ ... [ [ ] [ [ \" \" Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcino Long/pathology\"[Mesh]))) OR (( ([Mesh] Or \"Lung Neoplasms/drug therapy\"[ Mesh]]) OR [(\"lung lung cancer]]] [Title/Ab] OR or \"lung neoplasms\"[Titgle/Ang Neoplasplasms][Tile/A abstract] OR\"Lung neoplasm][Notle/Or \"lung tumor\"[Title/Atle]] /Ab/ab] OR, [Tat] OR non-ab] or \"Non-) or \"non-ill/ab/ab [ ( ( (;]] OR,\" Non-health/ab]. OR \"Non, or \"Dat]] or\" (Non-health-cell-cell,)) or or \"N,) or ( ()) ( (L))]] ( (or)) [ (non-rel) or,) (Lan))), or \"not)) as, or (no-health) or not) or\" or \" (Lat)) / (L,) [or ( (a)) nor,)]) () or))). ( (n,) if ( (G or \"F)) =)) ] or \"L) or (\" ( (. ( (!))",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "Records: 98",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-lung lung Cancer' OR nsclc:ti,ab #3 'grade iii' iii iii 'OR OR 'advanced disease' NEAR/7 (__MEDTERM2_) #4 (#1 OR #2) AND #3 #5 '_MEDTERM0__/exp/mj #6 __MEDterm0_:i,ab#7 #4 AND (#5 OR #6)",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "Selected 1 Record",
      "text": "Q8: simple simple observation? MEDLINE (PubMed) (August August 2023) ([(( [(( ((·(( -((\"Carcinoma, Non-Small-Cell Lung/radiotherapy\"[Majrra/Abstr neoplasm]) OR ((!(( (...) (( (.(() \"Carcinomas, Not-Smalle) Lung tumor*[Madle/Abrative] OR lung tumour*[Title/abstr neoplast]] long long cancer*[Tritle/Abbsto] lu lu cancer]*[Title/abstral]] [Titler/Agr]] ] lung lung cancer**[title/ab] OR __MED/ab].",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "Records: 238",
      "text": "oma, oma, Non-Small- long long pt]) OR cer' OR 'postoperat postoperat (?lung ract]) ung ung C*[Title/Abstract] Title/Ambs] OR)) AND \"radical cal Trial\" [Publica OR sh]) AND l PD- or la -Embase Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR #limterM1_su_lung neoplasms' OR'lung tumor' OR \"non-small-cell lung cancer'.",
      "start_page": 536,
      "end_page": 537
    },
    {
      "heading": "Selected 2 records",
      "text": "OR9: recommended recommended (only only Fields)? ((\"neoadjuvant therapy\"[MeSH Terms] OR (\"neoadiuvant\"[All Fields] AND \"neoaddjuvants\"[all Fields]] OR \"neodjuvations\"[ All Fields=] OR \"newfield\"[All Fields].",
      "start_page": 537,
      "end_page": 537
    },
    {
      "heading": "Selected 2 records",
      "text": "Q10: stage stage IIIA/recommended recommended (compared to sequential)? MEDLINE (PubMed) (August August 2023) (with Carcinoma, Non-Small-Cell Lung/radiotherapy\"[Majr:noexp]) OR ((áz((õlung cancer*[Title/Abstract]) Or long tumor*[Title/Ambstract]] lung lung cancer* [Titler/Abbs])",
      "start_page": 537,
      "end_page": 537
    },
    {
      "heading": "Records: 171",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/POLMONE POLMONE #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR \"non-small-cell lung cancer\" OR 'long long cancer' or nsclc:ti,ab #3 #31 OR #32 #4 ('grade iii' OR'stage iii') OR OR 'locally-advanced disease') NEAR/5 ('inoperable' Or 'surgically unreectable') #5 #33 AND #34 #6 'radiotherapy'/esp/mj OR 'chemotherapy'/Exp/mJ #7 'radiotherapeuticly unresectable'",
      "start_page": 537,
      "end_page": 538
    },
    {
      "heading": "Selected 3 records",
      "text": "Q11: stage stage IIIA/with with radiotherapy? MEDLINE (PubMed) (August August 2023) (⁄((\"Carcinoma, Non-Small-Cell Lung/radiotherapy\"[Majr:noexp]) OR ((áz((õlung cancer*[Title/Abstract]) Or long tumor*[Title/Approach]) lung lung cancer* [Title/abstract]] lung lung Cancer*[Tritle/Attract]",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "Records: 261",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung disease' OR nsclc:ti,ab #3 #31 OR #32 #4 ('grade iii' OR'stage III' OR OR 'locally-advanced disease') NEAR/5 ('inoperable' OR surgically unresponsive') #5 #3 AND #4 #Protocols Protocols #7 #5 AND #6",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "Selected 6 records",
      "text": "Q12: to to 1%, with with −to to observation? MEDLINE (Pubžežalm) (August August 2023) (!((\" Carcinoma, Non-Small-Cell Lung/Drug therapy\"[Mesh] OR \"L Neoplasms-Clung-Cathology\"[Mesh]) OR ((\"Tung Cancer\"[Title/Abs] OR",
      "start_page": 538,
      "end_page": 539
    },
    {
      "heading": "Records: 21",
      "text": "Embase (Embase.com) (2018) 2023 2023 #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 #31 OR #32 #4 durvalumab #5 #3 AND #4 AND ([cochrane review]/lim OR [systemic review] / lim OR [meta analysis]/lem OR [ranmed controlled trial]/LIM OR 'controlled clinical trial'/de)",
      "start_page": 539,
      "end_page": 539
    },
    {
      "heading": "Selected 3 records",
      "text": "Q13 GRADE: recommended recommended (therapy therapy only)? MEDLINE (PubMed) (March March 2021) ((\"Lung Neoplasms\"[Mesh]) OR \"Carcinoma, Non-Small-Cell Lung\"[Mesh]) Or \"Lung neoplasms'[Mesh] OR \"lung cancer\"[Title/Abstract] OR (\"lung neoplasmas\"[Title/Attract] or \"lung tumor\"[Textle/abstract]. OR \"Non-small-cell lung cancer\" [Title/ abstract] OR 'lung lung cancer'[Tittle/ Abstract] OR NSCLC[Title/Att.]",
      "start_page": 539,
      "end_page": 539
    },
    {
      "heading": "Records:38",
      "text": "Embase (Embase.com) (March March 2021) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'long long cancer' or 'lung lung Cancer' OR nsclc:ti,ab",
      "start_page": 539,
      "end_page": 539
    },
    {
      "heading": "Selected 4 Record",
      "text": "Q14: MEDTERM5_ MEDTERM5_ (Ex19dels and L858R), __medterm5_ __medterm5_ __MEDTERMO) recommended recommended (__DETERM1_ __DETERM1_ and/or __EDTERM2_)? MEDLINE (PubMed) (August August 2023) (·((!((\" Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Lung Neoplasms/pathology\"[Mesh] OR",
      "start_page": 539,
      "end_page": 540
    },
    {
      "heading": "Records: 69",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'grade iii' OR'stage iii 'OR OR 'advanced disease' NEAR/7 (egfr OR '_MEDTHERM2___ mutated') #4 (#1 OR #2 AND #3 #5 '_medTERM0_'/Exp #6 '__MEDTERMO0__':OR6 OR6 #8 #4 AND #7 AND ([corangema] review] [medterm]",
      "start_page": 540,
      "end_page": 540
    },
    {
      "heading": "Selected 3 records",
      "text": "Q15: MEDTERM2_ MEDTERM2_ (of of •exone 20), of of {recommended recommended (compared to chemotherapy)? MEDLINE (PubMed) (December December 2023) (\"Carcinoma, Non-Small-Cell Lung\"[Majr]) AND \"__MEDTERM 2_, uncommon\"[Mayr]\") OR ((!((lung cancer*[Title/Abstract]) OR lung tumor*[Title/Ambral]",
      "start_page": 540,
      "end_page": 540
    },
    {
      "heading": "Records: 203",
      "text": "Embase (Embase.com) (December December 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'long long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 #1 OR #2 #4 '_MEDTERM0___ uncommon': ti,ab#5 #3 AND #4",
      "start_page": 540,
      "end_page": 540
    },
    {
      "heading": "Selected 1 Record",
      "text": "POLMONE POLMONE Q16: of of •with with __MEDTERMO]recommended recommended (compared to chemotherapy)? MEDLINE (PubMed) (August August 2023) ( (...) \"Carcinoma, Non-Small-Cell Lung/Drug Therapy\"[Mesh] OR \"Lung Neoplasms/Pathology\"[Mesh] OR (\"Tung cancer\"[Title/Abstract] OR\"lung neoplasms\"[tell] or \"Long Neoplasm-Patology\"",
      "start_page": 541,
      "end_page": 541
    },
    {
      "heading": "Records: 69",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'grade iii' OR'stage iii 'OR OR 'advanced disease' NEAR/7 (egfr OR '_MEDTHERM2___ mutated') #4 (#1 OR #2 AND #3 #5 '_medTERM0_'/Exp #6 '__MEDTERMO0__':OR6 OR6 #8 #4 AND #7 AND ([corangema] review] [medterm]",
      "start_page": 541,
      "end_page": 541
    },
    {
      "heading": "Selected 1 Record",
      "text": "OR17 GRADE: MEDTERM7_ MEDTERM7_ (Ex19dels, L858F) identified identified (liquid liquid biopsy) with with −recommended recommended (compared to chemotherapy)? MEDLINE (PubMed) (August August 2023) (!((\" Carcinoma, Non-Small-Cell Lung/Drug therapy\"[Mesh] OR \"Lung Neoplasms/pathology\" (Non-Small-Lung Lung-Long/Pathology)",
      "start_page": 541,
      "end_page": 542
    },
    {
      "heading": "Records: 69",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'grade iii' OR'stage iii 'OR OR 'advanced disease' NEAR/7 (egfr OR '_MEDTHERM2___ mutated') #4 (#1 OR #2 AND #3 #5 '_medTERM0_'/Exp #6 '__MEDTERMO0__':OR6 OR6 #8 #4 AND #7 AND ([corangema] review] [medterm]",
      "start_page": 542,
      "end_page": 542
    },
    {
      "heading": "Selected 1 Record",
      "text": "MEDTERM8_ MEDTERM8_ () ===Further readings===;;;:;;*;; being recommended (compared to __medTERM1_)? MEDLINE (PubMed) (August August 2023) (Mesh] OR \"Carcinoma, Non-Small-Cell therapy\"[Mesh];;# \"Lung Neoplasms/Drung-Lumpy][Mech] Or \"Long Neoplasm/Pathology\"[Non-Th]) OR ((\"lung cancer\"[Title/Abs] OR\"Lung neoplasms\"[Mesh].",
      "start_page": 542,
      "end_page": 542
    },
    {
      "heading": "Records: 117",
      "text": "Embase Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'long long cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"lung tumore' OR or 'non-lung lung cancer' Or 'cancer cancer ' OR nsclc:ti,ab #3 'grade iii 'lung tumor ' OR 'lung lung cancer'Or 'longer longer cancer'OR 'long long cancer\" bi, bi,ab#3 'degree iii' OR'r 'stage III 'stage 3' OR OR ('advanced disease' NEAR/7 ('advanced disease' NAAR/rearrangeme rearrangeme #4 (#1 OR] AND #2) AND 3 #3 #5 '5 '_5 ' '__5 __ [__[__*__^__",
      "start_page": 543,
      "end_page": 543
    },
    {
      "heading": "Selected 3 records",
      "text": "Q19: recommended recommended (respect __MDTERM1_)? MEDLINE (PubMed) (August August 2023) ((0(arCarcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcinomas, Not-Small-Chell Long/pathology\"[Mesh] Or \"lung neoplasms\"[Title/Abstract] \"lung tumor\"[Title/abs] OR (\"non-small-cell cancer\"[Triple/Ambs]",
      "start_page": 543,
      "end_page": 543
    },
    {
      "heading": "Records: 40",
      "text": "Embase_ (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"lung tumor\" OR 'long tumor 'non-cancer cancer ' OR 'don' long long cancer' Or nsclc_:ti,ab #3 'gene rearrangement'/esp/mj/mJ #OR OR '_MEDTHERM4_ OR'__MEDTERMM4___ reactionment':ti",
      "start_page": 543,
      "end_page": 544
    },
    {
      "heading": "MEDLINE (PubMed) (September September 2024)",
      "text": "((_TER_Terz] [Mesh] OR \"Carcinoma, Non-Small-Cell Lung/Drug Therapy\"[Mesh) OR \"Lung Neoplasms/pathology\"[Mesh]) OR ((\"lung cancer\"[Title/Abstract] Or \"lung neoplasms\"[Title/Attract] OR (\"Lung neoplasmas\") [Titles/Aptract] or \"Non-small-cell cancer\"[1Titler/Autsume] OR\"Non-small cung carcinoma\"[English]",
      "start_page": 544,
      "end_page": 544
    },
    {
      "heading": "Embase (Embase.com) (September September 2024)",
      "text": "#1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'lung cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'not-small-cell lung cancer') OR 'don'lung lung Cancer' OR _MEDTERM9__:ti,ab #3 'grade iii' iii iii 'OR OR 'advanced disease' NEAR/7 (RET) #4 (#1 OR #2) AND #3 #5 '__medTERM0__'/Exp/mj OR '_MEDTHERM1__'/esp/mJ OR 'capmatinib___OR_OR_DETERM2___MEDTERS2__EXTEM2_FRIEN_FRlG",
      "start_page": 544,
      "end_page": 544
    },
    {
      "heading": "Selected 3 records",
      "text": "Q21 GRADE: recommended recommended (compared to chemotherapy)? MEDLINE (PubMed) (August August 2023) (\"Carcinoma, Non-Small-Cell Lung/Drug therapy\"[Mesh] OR \"Lung Neoplasms/Pathology\"[Mesh] Or \"Long cancer\"[Title/Abstrac] OR",
      "start_page": 544,
      "end_page": 544
    },
    {
      "heading": "Records: 28",
      "text": "Embase (Embase.com) (August August 2023) chin mall- ment ment ct] POLMONE POLMONE #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'not-or or 'long long cancer' Or _ nsclc:ti,ab #3 'gene rearrangement'/xp/mj #OR OR '_ _ response':ti",
      "start_page": 544,
      "end_page": 545
    },
    {
      "heading": "Selected 1 Record",
      "text": "==References===External links==*http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 545,
      "end_page": 545
    },
    {
      "heading": "Records: 9",
      "text": "THE POLM'S EOPLASIE",
      "start_page": 546,
      "end_page": 546
    },
    {
      "heading": "Selected 1 Record",
      "text": "I'm sorry. OR: is is recommended? MEDLINE (PubMed) (August August 2023) (l. l.)",
      "start_page": 546,
      "end_page": 547
    },
    {
      "heading": "Records: 17",
      "text": "==References===External links==* Official website",
      "start_page": 547,
      "end_page": 548
    },
    {
      "heading": "Records: 50",
      "text": "Embase/Embase.com (August August 2023) #35 'lung lung cancer'/exp/mj (36 'lung cancer' / exp/ mj #37 'long cancer' OR 'lung neoplasms' OR \"lung tumor' OR - n-small-cell cancer' or 'non-small metals' OR __MEDTERM11_:ti,ab #38 #35 OR - lung tumors - OR #37 #39 'metastasis'/expaly_mj_e_i_g_b_f_d_ed_en_v_o_de_t_ad_er_n_e",
      "start_page": 548,
      "end_page": 548
    },
    {
      "heading": "Records:82",
      "text": "Embaseter (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'lung cancer' OR 'lung neoplasms' OR \"lung tumor' OR' meta 'stage iii' OR OR 'advanced disease' NEAR/7 (_MEDTERM14_) #4 (#1 OR #2) AND #3 #5 '_MEDTERMI0__an advanced OR' stage ̈/exp/mj OR'_MEDTERM1___/Exp/QJ #6 __MEDTHERM1_:ti,ab #7 &amp; OP_4 AND/mJ OR (#5 OR_M)",
      "start_page": 548,
      "end_page": 549
    },
    {
      "heading": "Records: 326",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'long long cancer' Or 'lung lung Cancer' OR RET) #4 (#1 OR #2) AND #3 #5 '_MEDTERM0_/exp/mj OR '__MEDTHERM1___EXP/MOR_M_DEMM2_MEDTERS2_MOR lorlatinibExp_MER_M5_MEDTEM6_M",
      "start_page": 549,
      "end_page": 549
    },
    {
      "heading": "Selected 5 records",
      "text": "GRADE Q30: PDL1 PDL1 ≥ 50%, of of {status status (0- 1), recommended recommended (compared to chemotherapy)? MEDLINE (PubMed) August August 2023) ( (...)((!(([((\"Lung Neoplasms\"[Mesh]) OR \"Carcinoma, Non-Small-Cell Lung\"[Mesh] OR (\"Lung Cancer\"[Title/Abstract] OR \"Lung neoplasms\"\"[Tytle/Ambs]",
      "start_page": 549,
      "end_page": 550
    },
    {
      "heading": "Records: 245",
      "text": "ORbase (Embase.com) (2018) #1 'lung tumor'/exp OR 'long long cancer'/exp #2 'lung cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'not-small-cell lung cancer' or \"lung lung cancer\" OR nsclc:ti,ab #3 'stage 4' OR'stage iv' OR OR recurrence* OR relapse*: ti,ab#4 'recurrent disease'/Exp/mj #5 (#1 OR #2) AND (#3 OR #4) #9 'tumor marker'/esp/mmj #7 ('pd-l1' OR pd l1') NEAR/5 (OR OR diagnostic* OR75 testing_8 #8_EXP/MJ #10'",
      "start_page": 550,
      "end_page": 550
    },
    {
      "heading": "Selected 2 records",
      "text": "Q31: PDL1 PDL1 ≥50%, recommended recommended (platinum platinum chemotherap)? MEDLINE (PubMed) (August August 2023) ( (...)((!(([((0] \"Carcinoma, Non-Small-Cell Lung/Drug therapy\"[Mesh] OR \"Lung Lung /pathology\"[Mesh]) OR (\"Lung Neoplasm/Drug therapy] OR (\"Ang lung-Lung neoplasm\"[ Mesh] Or \"Long Neoplasms/Pathology\" [Tm]",
      "start_page": 550,
      "end_page": 550
    },
    {
      "heading": "Records: 98",
      "text": "Embase (Embase.com) (August August 2023) stretch] OR a- a Trial\" on small s]/s s (0-1), POLMONE POLMONE #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'lung cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'long long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'grade iii' iii iii 'OR OR 'advanced disease' NEAR/7 (__MEDTERM2_) #4 (#1 OR #2) AND #3 #5 '__medTERM0___/exp/j #6_MEDTERD_7_6_8",
      "start_page": 550,
      "end_page": 551
    },
    {
      "heading": "Records: 118",
      "text": "Q32: PDL1 PDL1 ≥50%, status status (0- 1), recommended recommended (on on platinum)? MEDLINE (PubMed) (August August 2023) ( (...)((!((·((¡((Í((0]((\" \"Carcinoma, Non-Small-Cell Lung/Drug therapy\"[Mesh] OR \"Lung Neoplasms/pathology\"[Mesh]) OR ((lung-lung l) cancer\"[Tung Neoplasmas/Tugtherapy]",
      "start_page": 551,
      "end_page": 551
    },
    {
      "heading": "Records: 528",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'long long cancer' Or 'lung lung Cancer' OR RET) #4 (#1 OR #2) AND #3 #5 (atezolizumab__/exp/mj OR",
      "start_page": 551,
      "end_page": 551
    },
    {
      "heading": "Records: 220",
      "text": "OR33 (A) PD-L1 PD-L1 <50% status status (0-1), MEDLINE MEDLINE (PubMed) (August August 2023) (?((!((¡(( lung-cancer\" (( (...)(( (()((\"Lung Neoplasms/Abstract] Or \"Carcinoma, Non-Small-Cell Lung\"[10]",
      "start_page": 551,
      "end_page": 552
    },
    {
      "heading": "Records:21",
      "text": "Embase (Embase.com) 2023 2023 #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'non‐squamous' OR'non squamous';ti,b #4 (#1 OR #2) AND #3 #5 ('_MEDTERM0__'/Exp/mj AND 'pemetrexed trial]/exp/mJ) OR ('__MEDTM0__' AND 'petetrexed': ti,ab) #6 #4 AND #5 AND ([randomized controlled trial]/lim OR 'contested clinical trial'/de)",
      "start_page": 552,
      "end_page": 552
    },
    {
      "heading": "Selected 1 Record",
      "text": "I'Q34 Q34 GRADE: expression expression <50% status status (0-1), with with −recommended recommended (compared to chemotherapy)? MEDLINE (PubMed) (August August 2023) (!(([((0] [(( _((Í((\"((·\"Lung Neoplasms\"[Mesh]) OR \"lung tumor\" (non-Small) cell] Lung (Mesh) OR (\"Lung Cancer\"[Title/A abstract] OR \"Lung neoplasms\"\"",
      "start_page": 552,
      "end_page": 553
    },
    {
      "heading": "Records: 4",
      "text": "ORz-diflyus ORz-diflyus ORj-diz-ož-eštím oštápía (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'non-small-ell lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"lung tumor' OR'n-cell carcinoma'/Exp/mj #4 'cell cell cancer' or 'lung lung carcinoma':ti,ab #5 (#1 OR_PH)",
      "start_page": 553,
      "end_page": 553
    },
    {
      "heading": "Selected 2 records",
      "text": "Q35: PD-L1 PD-L1 <50% status status (0-1), recommended recommended (compared to chemotherapy)? Q36: of of .recommended recommended (1-49% compared to chemotherapy)?",
      "start_page": 553,
      "end_page": 554
    },
    {
      "heading": "Records: 528",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'lung neoplasms' OR \"long tumor\" OR 'long long cancer' Or 'lung lung Cancer' OR RET) #4 (#1 OR #2) AND #3 #5 (atezolizumab__/exp/mj OR",
      "start_page": 554,
      "end_page": 554
    },
    {
      "heading": "Records: 220",
      "text": "(OR) ==References===External links==* Official website* http://www.interpol.int/en/notice/search/en_en/index_en.htm",
      "start_page": 554,
      "end_page": 554
    },
    {
      "heading": "Records:21",
      "text": "Embase (Embase.com) (2018) #1 'lung tumor'/exp OR 'lung lung cancer'/exp #2 'long cancer' OR 'long neoplasms' OR \"long tumor\" OR 'not-small-cell long cancer' Or 'lung lung Cancer' OR nsclc:ti,ab #3 'nonsquamous' OR'non squamous';POLMONE POLMONE #4 (#1 OR #2) AND #3 #5 ('_MEDTERMM0___/exp/mj AND 'pemetrexed'/Exp/mJ) OR ('pembrolizumab' AND 'permetrexed':ti",
      "start_page": 554,
      "end_page": 555
    },
    {
      "heading": "Selected 2 records",
      "text": "I'Q38 Q38 GRADE: line line chemotherapy? MEDLINE (Pubplated) (August August 2023) (!((·(([((0](( CH((Í((¡((\"Lung Neoplasms\"[Mesh]) OR \"Carcinoma, Non-Small-Cell Lung\"[Mesh] OR (\"lung cancer\"[Title/Abstract] OR \"Lung neoplasms]\"[Title/Azro]",
      "start_page": 555,
      "end_page": 555
    },
    {
      "heading": "Records: 4",
      "text": "Olypea Olypea (Embase.com) (August August 2023) #1 'lung tumor'/exp OR'non-small-cell cancer' OR 'n' small-cell lung cancer' Or __MEDTERM3_:ti,ab #3 'lung lung carcinoma' OR \"lung squamous cacinoma' #5 (#cell cell cancer' or 'squamous cell carcinoma' or \"epidermoid carcinoma'",
      "start_page": 556,
      "end_page": 556
    },
    {
      "heading": "Records: 15",
      "text": "OR39: stage stage (or) \"Applece\" or \"Application\" by by itself? MEDLINE (PubMed) (August August 2023) (···Cell Lung/Cell Therapy] OR \"Lung Neoplasms/Pathology\"[Mesh] Or \"Long Neoplasm/Patology\" [Mesh].",
      "start_page": 556,
      "end_page": 556
    },
    {
      "heading": "Records: 27",
      "text": "==References===External links==*http://www.interpol.int/en/notice/search/en_en/index_en.htm",
      "start_page": 556,
      "end_page": 557
    },
    {
      "heading": "Records: 47",
      "text": "Embase (Embase.com) (August August 2023) #1 'lung lung cancer'/exp/mj #2 'non-small-cell long cancer' OR 'lung lung Cancer' OR nsclc:ti,ab #3 #50 OR #51 #4 'chemoradiotherapy'/exp/mJ #5 'chemosradiotherapy';ti,b #6 #53 OR #54 #7 #3 AND #6 AND ([cochrane review]/lim OR [systemic review] /lim OR (meta analysis]/im OR [controlled clinical trial]/rim OR [controlled controlled trial]",
      "start_page": 557,
      "end_page": 557
    },
    {
      "heading": "Selected 4 records",
      "text": "OR41: brain brain (PCI) is recommended? MEDLINE (PubMed) (August August 2023) (((\"Lung Lung Carcinoma\"[Mess]) OR (",
      "start_page": 557,
      "end_page": 558
    },
    {
      "heading": "Records: 86",
      "text": "I'Ombase Ombase (Embase.com) (August August 2023) #1 'lung lung cancer'/exp/mj [\"long long cancer\" OR 'long long Cancer' OR 'the the lung' OR \"lung lung \" OR \"of of lung\":ti,ab #3 #1 OR #2 #4 'skull irradiated'/exp/mJ #5 \"skull ion\" OR \"grain cell ion\": ti,b #4 OR #5 #3 AND #6 AND ([cochrane review]/lim OR [systemic first report]/lem OR [meta analysis]/Lim OR [trial trial cells]/LIM OR [randomized controlled trial]/limi]",
      "start_page": 558,
      "end_page": 559
    },
    {
      "heading": "Records: 88",
      "text": "I'oastomorphomorphus oastomorphomorphus (or phoenix)",
      "start_page": 559,
      "end_page": 560
    },
    {
      "heading": "Records: 65",
      "text": "Q43: platinum-based platinum-based chemotherapy? MEDLINE (PubMed) (2018) (!((\"Lung Lung Carcinoma\"[Mesh]) OR (\"Long Long Cancer\"[Title/Abstract] OR",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "Records: 16",
      "text": "Embase (Embase.com) (2018) (August 2023) #1 'lung lung cancer'/exp/mj #2 'long long cancer' OR 'lung lung Cancer' OR \"of of theung' OR'cell cell lung' Or 'of of lung':ti,ab #3 #50 OR #51 #4 ('etoposide'/exp/mJ OR ethoposide) AND AND ('durvalumab'/esp/mg OR durvalumab: ti,ab) #5 #4 AND #6",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "Records: 9",
      "text": "Q44: with with platinum/ethoposis] recommended? MEDLINE (PubMed) (August August 2023) ([(( [(( ((\"Lung Lung Carcinoma\"[Mesh]) OR (.[Mesh] [Long Long Cancer[Title/Abs] OR",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "Records: 83",
      "text": "Embase (Embase.com) (August August 2023) #1 'long long cancer'/exp/mj (T) 'non-small-cell lung cancer' OR 'lung lung cancer'. OR __MEDTERM0_:ti,ab #3 #50 OR #51 #4 'etoposide'/exp/mJ OR ethoposide:ti;ab #5 platinum: DEL DEL POLMONE#6 #4 AND #6 #3 AND ([cochrane review]/lim OR [meta analysis]/lem OR [controlled clinical trial]/Lim OR [randominated controlled trial]",
      "start_page": 560,
      "end_page": 561
    },
    {
      "heading": "Records: 68",
      "text": "Embase (Embase.com) (May May 2019) #1 'lung lung cancer' OR nsclc:ti,ab #3 #50 OR #51 #4 'skull irradiated'/exp/mj #5 'skulll furan' OR 'cranial ovulation': ti,ab#6 #4 OR #5 #7 #3 AND #6 AND ([cochrane review]/lim OR [systemic review] /lim OR (meta analysis]/lem OR [controlled clinical trial]/limi OR [randomized controlled trial]",
      "start_page": 561,
      "end_page": 561
    },
    {
      "heading": "Selected 4 records",
      "text": "Q46: tera tera (PubMed) (June June 2018) (?((\"Lung Lung Carcinoma\"[Mesh]) OR (",
      "start_page": 561,
      "end_page": 561
    },
    {
      "heading": "Records: 89",
      "text": "Embase (Embase.com) (June June 2018) #1 'lung lung cancer' OR nsclc:ti,ab #3 #50 OR #51 #4 'topotecan'/exp/action, action, pe]) a, un apie? Cell #5 'toombacan': ti,ab#6 #4 OR #5 #7 #3 AND #6 AND [emba #9 #3 And #6 and [embah analysis]/lim OR [controlles]",
      "start_page": 561,
      "end_page": 562
    },
    {
      "heading": "Selected 4 records",
      "text": "E ase]]/lim ase]/lim AND ([clinical clinical trial]/lim OR [random w]/limi OR [controlled controlled trial] /lim) A view]/OR OR [n n e",
      "start_page": 562,
      "end_page": 563
    },
    {
      "heading": "I",
      "text": "r r c",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "S",
      "text": "i i lE",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "LASIE DE",
      "text": "PR",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "do",
      "text": "EL EL PO",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "ANSWER",
      "text": "ovreb mato giornima? 15 15 cigars",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "search database",
      "text": "(n = 172) Reco",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "records records id",
      "text": "sou sou (n = 0)",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 137)",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "Records screened",
      "text": "(n = 137)",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "Full-text articles assigned",
      "text": "for eligibility (n = 1)",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "UIDA",
      "text": "10 10 cigarettes",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "dentified",
      "text": "urces",
      "start_page": 563,
      "end_page": 563
    },
    {
      "heading": "Records excluded",
      "text": "(n = 136) n n e",
      "start_page": 563,
      "end_page": 564
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "PRIS",
      "text": "L L POLMONE",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "rectomy shouldb",
      "text": "otico) or thoracot",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "in in t",
      "text": "previous version (n = 2)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "w Diag",
      "text": "tomic tomic the",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "a a mini-approach",
      "text": "Co?",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "search database",
      "text": "(n = 13)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 13)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "Records screened",
      "text": "(n = 13)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 2)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 2)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "n stad",
      "text": "-invas",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "d",
      "text": "FROM",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "god clin",
      "text": "sivo (V)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "S o",
      "text": "R",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 564,
      "end_page": 564
    },
    {
      "heading": "ds excluded",
      "text": "n = 13) e e d",
      "start_page": 564,
      "end_page": 565
    },
    {
      "heading": "I",
      "text": "lc lc n",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "LASIE",
      "text": "EL EL PO",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "ANSWER",
      "text": "s s (n = am am Q3: recommended recommended (remov remov (n= 121) Records screened (n=0 121) eligibility eligibility (n=12)",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 2)",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 2)",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "LINES GUI",
      "text": "sou sou (n = 0) see",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "IDA",
      "text": "Record Record (n nizial a)? n n = 119",
      "start_page": 565,
      "end_page": 565
    },
    {
      "heading": "le (IA),",
      "text": "n n e",
      "start_page": 565,
      "end_page": 566
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "PRIS",
      "text": "L L POLMON",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "SMA 2009",
      "text": "2N0 inoper",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "ords includes",
      "text": "previous ve (n = 3) or or resp",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "and t",
      "text": "ersion",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "w Diag",
      "text": "a a the",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "search database",
      "text": "(n = 8)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n =8)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "Records screened",
      "text": "(n =8)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 3)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 3)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "GUID",
      "text": "oplasia ament",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "d",
      "text": "assico assico Re",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "_MEDTERM0__",
      "text": "or is",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "ecords",
      "text": "(n° C)",
      "start_page": 566,
      "end_page": 566
    },
    {
      "heading": "s excluded",
      "text": "n = 8) n n e",
      "start_page": 566,
      "end_page": 567
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "LASIE",
      "text": "AND THE",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "PRIS",
      "text": "L L POL",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "SMA",
      "text": "mutes",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "ords in",
      "text": "previous (n LMON erapia",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "nclude",
      "text": "n n = 9 9 Flow",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "and t",
      "text": "ersion",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "w Diag",
      "text": "uvent the",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "search database",
      "text": "(n = 10)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n =10)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "Records screened",
      "text": "(n =10)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 19)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 19)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "adical",
      "text": "atine",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "d",
      "text": "o o rac",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "d",
      "text": "ccom ccom erato",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "send",
      "text": "an an ata?",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 567,
      "end_page": 567
    },
    {
      "heading": "ds excluded",
      "text": "n = 10) n n e",
      "start_page": 567,
      "end_page": 568
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "stad",
      "text": "L L POLMONE",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "and and mutation",
      "text": "is is rac",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "in in the",
      "text": "previous version (n = 0)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "search database",
      "text": "(n = 153)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n =138)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "Records screened",
      "text": "(n =138) Full-text articles boarded",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 1)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "adical",
      "text": "R, a",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "IDA",
      "text": "lmen na tera",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "d",
      "text": "a a perate",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "adjuv",
      "text": "vantage vantage point",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 568,
      "end_page": 568
    },
    {
      "heading": "ds excluded",
      "text": "n = 137) n n e",
      "start_page": 568,
      "end_page": 569
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "EXP {MM/ YY}",
      "text": "L L POLMONE",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "in in the",
      "text": "previous version (n = 0)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "gram:",
      "text": "Expree atezo or?",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "search database",
      "text": "(n = 216)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n =165)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "Records screened",
      "text": "(n =165) Full-text articles boarded",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 1)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 1)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 1)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "root",
      "text": "ttame",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "IDA",
      "text": "almen ento",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "d",
      "text": "in in erapic",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "Record",
      "text": "(a)",
      "start_page": 569,
      "end_page": 569
    },
    {
      "heading": "ds excluded",
      "text": "n = 164) n n e",
      "start_page": 569,
      "end_page": 570
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "PRIS",
      "text": "L L POLMON",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "SMA 2009",
      "text": "r r ervation?",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "ords includes",
      "text": "previous ve (n = 1) NE 9 Flow",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "and t",
      "text": "ersion",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "w Diag",
      "text": "terap the",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "search database",
      "text": "(n = 17)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n =17)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "Records screened",
      "text": "(n =17)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "n stad",
      "text": "rip",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "d",
      "text": "FROM",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "god I-II",
      "text": "hecto a",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "Roots",
      "text": "entre entre ce",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 570,
      "end_page": 570
    },
    {
      "heading": "ds excluded",
      "text": "n = 17) n n e",
      "start_page": 570,
      "end_page": 571
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "PRIS",
      "text": "yield (L L POLMONE)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "only only who",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "in in t",
      "text": "previous version (n = 2)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "w Diag",
      "text": "emiot",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "Surgery",
      "text": "the",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "by by who",
      "text": "(a)?",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "search database",
      "text": "(n = 87)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 87)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "Records screened",
      "text": "(n = 87)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 2)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 2)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "d",
      "text": "FROM",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "god II-I",
      "text": "ia è ra",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "III",
      "text": "common",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "mand",
      "text": "R",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 571,
      "end_page": 571
    },
    {
      "heading": "ds excluded",
      "text": "n = 87) n n e",
      "start_page": 571,
      "end_page": 572
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "PRIS",
      "text": "L L POL",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "SMA",
      "text": "ecabil ncomi",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "ords in",
      "text": "Before LMONE",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "a a trat",
      "text": "itante è raccom",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "ncluded in the",
      "text": "ous version (n = 3)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "gram",
      "text": "ttame",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "at at doses",
      "text": "uth (compared to sequential?)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "search database",
      "text": "(n = 234)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 187)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "Records screened",
      "text": "(n = 187)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 3)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 3)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "IIA/II",
      "text": "decrease",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "IIB no",
      "text": "R on",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 572,
      "end_page": 572
    },
    {
      "heading": "ds excluded",
      "text": "n = 187) n n e",
      "start_page": 572,
      "end_page": 573
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "PRIS",
      "text": "L L POL",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "SMA",
      "text": "ecabil ociazi",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "ords in",
      "text": "previous (Flow Flow Dia",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "ncluded in the",
      "text": "n n = 6)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "chemotherapy chemotherapy regimen",
      "text": "Therapy?",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "search database",
      "text": "(n = 102)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 87)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "Records screened",
      "text": "(n = 87)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 6)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 6)",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "AND GUID",
      "text": "CLC in human",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "d",
      "text": "FROM",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "esegu",
      "text": "R",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "IB not",
      "text": "uire in",
      "start_page": 573,
      "end_page": 573
    },
    {
      "heading": "Records excluded",
      "text": "(n = 87) e e d",
      "start_page": 573,
      "end_page": 574
    },
    {
      "heading": "I",
      "text": "r r c",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "S",
      "text": "lc lc n",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "PRISMA",
      "text": "previous previous (n = 1- version version -3 records)",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "LINES",
      "text": "Q12 GRADE: with with PD-1% consolidation consolidation therapy? searching searching (n = 29) rem rem (n=29) Records screened (n=18) eligibility eligibility (n=21) included included (n=01).",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 4)",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 4)",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "AND GUID",
      "text": "• t t h",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "from NS",
      "text": "with with d",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "_MEDTERM0__",
      "text": "rvalum rvalum R",
      "start_page": 574,
      "end_page": 574
    },
    {
      "heading": "adio III",
      "text": "hemio- excluded excluded (n = 28) n n e",
      "start_page": 574,
      "end_page": 575
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "PRIS",
      "text": "L L POLMON",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "Nthrate oligo",
      "text": "emica è ra",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "ords includes",
      "text": "previous ve (n =0) NE 9 Flow",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "and t",
      "text": "Dia Dia tastat",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "send",
      "text": "the",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "tico, locoregional treatment",
      "text": "uth (therapy therapy alone)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "search database",
      "text": "(n = 34)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n =27)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "Records screened",
      "text": "(n =27)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "for eligibility",
      "text": "(n = 4)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 4)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 4)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 4)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "AND GUID",
      "text": "ass ass mica)?",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "d",
      "text": "FROM",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "gives you",
      "text": "socioz",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "NSCL",
      "text": "t t R",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "stages",
      "text": "terapi",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "Record",
      "text": "(a)",
      "start_page": 575,
      "end_page": 575
    },
    {
      "heading": "ds excluded",
      "text": "n = 23) n n e",
      "start_page": 575,
      "end_page": 576
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "PRISMA 2009",
      "text": "locally av",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "(Ex19dels and L8)",
      "text": "EGFR osimert and/or __ MEDTERM0__)",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "Records includ",
      "text": "previus ve (n =o o 858R), is is rac",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "ded in the",
      "text": "ersion",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "agram Q14 GRADE: In patients with",
      "text": "active active mutations",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "search database",
      "text": "(n = 157)",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 145)",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "Records screened",
      "text": "(n = 145) Full-text articles boarded",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "AND GUI",
      "text": "bitore bitore tiros",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "gives you",
      "text": "assich and spin-c",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "he de",
      "text": "osino- quinas",
      "start_page": 576,
      "end_page": 576
    },
    {
      "heading": "Records excluded",
      "text": "(n = 145) e e d",
      "start_page": 576,
      "end_page": 577
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "PRIS",
      "text": "mut (L L POLMONE",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "Flow Flow Diag",
      "text": "previous previous version",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "gram Q15: with with NSCLC",
      "text": "EGFR (Ex19dels, L858R), and with change",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "Ida or liquid) of of prog",
      "text": "is is recomm",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "search database",
      "text": "(n = 157) removed removed (n=145) Records screened (n=145) Full-text articles assigned",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0)",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "IDA",
      "text": "in in T7",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "entries",
      "text": "ato ato (M M dimo",
      "start_page": 577,
      "end_page": 577
    },
    {
      "heading": "ge",
      "text": "excluded excluded (n = 145) n n e",
      "start_page": 577,
      "end_page": 578
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "PRIS",
      "text": "L L POL",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "SMA",
      "text": "erz ttame coma",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "ords in",
      "text": "2009 2009 Flow",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "6 6 mm",
      "text": "ento chem",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "ncluded in",
      "text": "ous version (n = 1) vetto vetto the",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "a a treatem",
      "text": "or chemotherapy)?",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "search database",
      "text": "(n = 157)",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 145)",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "Records screened",
      "text": "(n = 145) Full-text articles boarded",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "from NS",
      "text": "expon ment",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "I don't.",
      "text": "or with",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "d",
      "text": "co, co, with",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "transferor",
      "text": "amab is",
      "start_page": 578,
      "end_page": 578
    },
    {
      "heading": "Records excluded",
      "text": "(n = 145) n n e",
      "start_page": 578,
      "end_page": 579
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "PRIS",
      "text": "ava",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "gefi",
      "text": "L L POLMONE",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "anzato with mute",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "ntified (medium",
      "text": "itinib, __ MEDTERM1__",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "ords included in",
      "text": "previous version (n = 0)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "a a tratam",
      "text": "compared to chemotherapy)?",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "search database",
      "text": "(n = 157)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 145)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "Records screened",
      "text": "(n =145) Full-text articles boarded",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 1)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "AND GUI",
      "text": "(R) and",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "gives you",
      "text": "with m",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "of the",
      "text": "or",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "NSCL",
      "text": "LC LC inction",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "ogress",
      "text": "simert R",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "n stage",
      "text": "tinib tinib is",
      "start_page": 579,
      "end_page": 579
    },
    {
      "heading": "Records excluded",
      "text": "(n = 144) n n e",
      "start_page": 579,
      "end_page": 580
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "PRIS",
      "text": "L L POLMONE",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "with with ale",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "ords included in",
      "text": "previous version (n = 3) ectini ectini the",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "search database",
      "text": "(n = 109)",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 106)",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "Records screened",
      "text": "(n = 106) Full-text articles boarded",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 3)",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 3)",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "AND GUI",
      "text": "afett",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "of AL",
      "text": "_MEDTERM0__",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "gives you",
      "text": "LK, a b)?",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "NSCL",
      "text": "ttame ttame R",
      "start_page": 580,
      "end_page": 580
    },
    {
      "heading": "Records excluded",
      "text": "(n = 106) n n e",
      "start_page": 580,
      "end_page": 581
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "PRIS",
      "text": "L L POLMONE",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "with with br",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "ords included in",
      "text": "previous version (n = 1) ato ato o",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "ridatin",
      "text": "the",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "search database",
      "text": "(n = 109)",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 106)",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "Records screened",
      "text": "(n = 106) Full-text articles boarded",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "AND GUI",
      "text": "afett",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "of AL",
      "text": "zotini",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "gives you",
      "text": "LK, an ib)?",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "NSCL",
      "text": "ttame ttame R",
      "start_page": 581,
      "end_page": 581
    },
    {
      "heading": "Records excluded",
      "text": "(n = 106) n n e",
      "start_page": 581,
      "end_page": 582
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "PRIS",
      "text": "riar (L L POLMON",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "rrangiamen",
      "text": "chest to cr",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "ords includ",
      "text": "previous ve (n = 1) Flow Flow Dia",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "nti of Jan",
      "text": "rizotinib)?",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "ded in the",
      "text": "ersion",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "search database",
      "text": "(n = 386)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 356)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "Records screened",
      "text": "(n = 356)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "for eligibility",
      "text": "(n = 2)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 2)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 3)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 3)",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "SCLC m",
      "text": "_MEDTERM0__",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "d",
      "text": "co, co, with",
      "start_page": 582,
      "end_page": 582
    },
    {
      "heading": "Records excluded",
      "text": "(n = 352) n n e",
      "start_page": 582,
      "end_page": 583
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "PRIS",
      "text": "Loca tera (L L POLMONE)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "the the chem",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "ords included in",
      "text": "previous version (n = 1)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "w Diagram",
      "text": "cer cer myotherapy) the",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "LINES GUI",
      "text": "Q21 GRADE: In patients affected",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "of of ALK",
      "text": "with with lorlat",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "search database",
      "text": "(n = 48)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 39)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "Records screened",
      "text": "(n = 39)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 1)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 1)",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "gives you",
      "text": "pr pr tinib",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "rogres",
      "text": "ccoma ccoma R",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "n stage",
      "text": "in one",
      "start_page": 583,
      "end_page": 583
    },
    {
      "heading": "Records excluded",
      "text": "(n = 396) n n e",
      "start_page": 583,
      "end_page": 584
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "PRIS",
      "text": "L L POLMONE",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "with with cri",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "ords included in",
      "text": "previous version",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "(n = 6; 7 records)",
      "text": "the the L",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "Searc database",
      "text": "(n = 214)",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "Records after duplicate",
      "text": "(n = 179)",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "Records screen",
      "text": "(n = 179) Full-text articles as",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "incl. incl.",
      "text": "(n = 1)",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 7)",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 7)",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "LINES GUI",
      "text": "Affected entities",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "sssed",
      "text": "y",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "NSCL",
      "text": "Ttame Ttame R",
      "start_page": 584,
      "end_page": 584
    },
    {
      "heading": "Records excluded",
      "text": "(n = 178) n n e",
      "start_page": 584,
      "end_page": 585
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "PRIS",
      "text": "L L POLMONE",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "SMA 2009 Flow",
      "text": "with with en",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "in in t",
      "text": "previous version (n = 1) ntrect ntrect the",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "search database",
      "text": "(n = 43)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 42)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "Records screened",
      "text": "(n = 43)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "AND GUID",
      "text": "afett",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "d",
      "text": "FROM",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "NSCL",
      "text": "ttame ttame R",
      "start_page": 585,
      "end_page": 585
    },
    {
      "heading": "Records excluded",
      "text": "(n = 43) n n e",
      "start_page": 585,
      "end_page": 586
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "PRISM",
      "text": "L L POLMONE",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "009 Flow Diagram",
      "text": "con con tramet",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "in in t",
      "text": "previous version (n = 1) is is the",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "search database",
      "text": "(n = 17)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 17)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "Records screened",
      "text": "(n = 17)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 1)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "tadio",
      "text": "but lin",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "d",
      "text": "nea nea co",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "d",
      "text": "lment",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "no",
      "text": "enib enib in",
      "start_page": 586,
      "end_page": 586
    },
    {
      "heading": "Records excluded",
      "text": "(n = 17) n n e",
      "start_page": 586,
      "end_page": 587
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "PRI",
      "text": "E E DEL",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "ISMA",
      "text": "osino- metast metast -kinase",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "ords includ",
      "text": "previous ve (n = 4) NE",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "ow Diagram",
      "text": "tatico, with",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "ded in the",
      "text": "fusion fusion entrec",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "search database",
      "text": "(n = 207)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 156)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "Records screened",
      "text": "(n = 156)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 4)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 4)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "IDA",
      "text": "lin lin ato?",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "tadio",
      "text": "almen almen nibito",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "Record",
      "text": "(nt hours)",
      "start_page": 587,
      "end_page": 587
    },
    {
      "heading": "ds excluded",
      "text": "n = 156) n n e",
      "start_page": 587,
      "end_page": 588
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "PRISM",
      "text": "MA MA 20",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "of p",
      "text": "L L POLMONE",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "in in prog",
      "text": "treated treated apia)?",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "in in the",
      "text": "previous version (n = 3) Q26:",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "entries",
      "text": "chin",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "previous previous treatment",
      "text": "is is racc",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "search database",
      "text": "(n = 302)",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 256)",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "Records screened",
      "text": "(n = 256) Full-text articles boarded",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 3)",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 3)",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "AND GUI",
      "text": "chin chin coma",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "stad",
      "text": "or with",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "god av",
      "text": "chem o (to to alla",
      "start_page": 588,
      "end_page": 588
    },
    {
      "heading": "Records excluded",
      "text": "(n = 256) n n e",
      "start_page": 588,
      "end_page": 589
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "PRISM",
      "text": "L L POL",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "ords in",
      "text": "9 9 Flow",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "nclud",
      "text": "ous ve (n = 5) NE w Dia",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "ded in",
      "text": "ersion",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "agram",
      "text": "the m: Q",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "St",
      "text": "Q27-29. Q27-29.",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "Searc database",
      "text": "(n = 386)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "Records after duplicate",
      "text": "(n = 276)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "Records screen",
      "text": "(n = 276) Full-text articles as",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "incl. incl.",
      "text": "(n = 0)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 5)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 5)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "LINES",
      "text": "throu",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "chin",
      "text": "e.g. rem",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "ned",
      "text": "sisse y",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "d",
      "text": "R",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 589,
      "end_page": 589
    },
    {
      "heading": "ds excluded",
      "text": "n = 276) n n e",
      "start_page": 589,
      "end_page": 590
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "PRIS",
      "text": "AND AND POLMONE",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "PDL1 output ≥50",
      "text": ", is is raccom",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Records included in",
      "text": "previous version",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "gram",
      "text": "0% if rform",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "mand",
      "text": "L Q30 GRADE: In patients",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "the the gen",
      "text": "mance status (0-1), a trat",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Searc database",
      "text": "(n = 294)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Records after duplicate",
      "text": "(n = 256)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Records screen",
      "text": "(n = 256) Full-text articles as",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "incl. incl.",
      "text": "(n = 0)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 2)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 2)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "or _MEDTERM0__",
      "text": "What's the plan?",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "sssed",
      "text": "y",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "SCLC m",
      "text": "R o r",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "d",
      "text": "first first astatic",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "ngiam",
      "text": "co, co, with",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "States. States.",
      "text": "ea with",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "Records excluded",
      "text": "(n = 256)",
      "start_page": 590,
      "end_page": 590
    },
    {
      "heading": "PRIS",
      "text": "n n e",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "I",
      "text": "AND THE",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "SMA",
      "text": "2009 2009 Flow",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "one of PD-L",
      "text": "n good for",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "ords includ",
      "text": "previous ve (n = 0) L1 L1 ≥50 rform spett",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "ded in",
      "text": "ersion",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "iagram",
      "text": "0%, alla alla the",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "search database",
      "text": "(n = 578)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 366)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "Records screened",
      "text": "(n = 366)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 1)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "IDA",
      "text": "inea inea c",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "d",
      "text": "at at static",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "ngiam",
      "text": "co, co, with",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "States. States.",
      "text": "_MEDTERM0__",
      "start_page": 591,
      "end_page": 591
    },
    {
      "heading": "Records excluded",
      "text": "(n = 365) n n e",
      "start_page": 591,
      "end_page": 592
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "PRISM",
      "text": "Flow Flow D",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "PD-L1",
      "text": "good good perf",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "Records includ",
      "text": "previous ve (n = 0) NE",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "Diagr",
      "text": "Hector shape",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "ded in",
      "text": "ersion",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "search database",
      "text": "(n = 578)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 366)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "Records screened",
      "text": "(n = 366)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "for eligibility",
      "text": "(n = 1)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 1)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "stage",
      "text": "e e c",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "or IIIB-",
      "text": "ce ce -C and",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "ngiam",
      "text": "emipl R",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "States. States.",
      "text": "limab is",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "Records excluded",
      "text": "(n = 365)",
      "start_page": 592,
      "end_page": 592
    },
    {
      "heading": "PRISM",
      "text": "L1 stage <pembri pembri (e e d",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "I",
      "text": "r r c",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "S",
      "text": "lc lc n",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "I",
      "text": "suit suit 0% version version (n = 1)",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "Q33 GRADE: a a isto",
      "text": "status status (0-1), treatment treatment (a)? searching searching (n = 28) removed removed (n= 26) Records screened (n=16) for for eligibility",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "(n = 0)",
      "text": "NEW studies included",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1)",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "IDA",
      "text": "ologia non-, d d -excluded excluded (n = 26)",
      "start_page": 593,
      "end_page": 593
    },
    {
      "heading": "PRISM",
      "text": "e e d",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "LINES GUIDE",
      "text": "AND THE POLMONE",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "Q34 Q34 GRADE: with with NSCLC",
      "text": "expression expression <50% based, based, paclitaxel",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "maintenance maintenance therapy",
      "text": "it it therapy)?",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "database database searching",
      "text": "(n = 1; 2 records) (2019-2023) (n= 19) removed removed (n=18) Records screened (n=01) Full-text articles assigned",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0)",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1) manda manda d",
      "start_page": 594,
      "end_page": 594
    },
    {
      "heading": "ologia",
      "text": "ato ato (tus tus (uamosa uamosa 0-1), excluded excluded (n = 19) n n e",
      "start_page": 594,
      "end_page": 595
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "PRISM",
      "text": "009 009 Fl",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "cords i",
      "text": "low low D",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "includ",
      "text": "ous ve (n = 0) NE",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "ded in",
      "text": "ersion am: L L Q35-36",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Searc database",
      "text": "(to-2023) (n = 748)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Records after duplicate",
      "text": "(n = 676)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Records screen",
      "text": "(n = 676) Full-text articles as",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "for eligibility",
      "text": "(n = 3)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "NEW studies inc",
      "text": "(n = 3)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 3)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (Q 35: 1; Q36: 2)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "chin",
      "text": "tes rem",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "ned",
      "text": "sisse ty",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "cluded",
      "text": "E OJ",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "ugh",
      "text": "Move",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "and",
      "text": "R",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Record",
      "text": "(n)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "ds excluded",
      "text": "n = 673)",
      "start_page": 595,
      "end_page": 595
    },
    {
      "heading": "Stadium squamous",
      "text": "a a tratam",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Records includes",
      "text": "it it (n = 1 -n n e",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "I",
      "text": "NE",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Diagram Q",
      "text": "ment ment imm",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "ed in the",
      "text": "ersion",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Q37 GRADE: with with NSC",
      "text": "with with contrain",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "one one tera",
      "text": "Ata (observation observation only)?",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "search database",
      "text": "(n = 28)",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "duplicates duplicates removed",
      "text": "(n = 26)",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Records screened",
      "text": "(n = 26)",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 1)",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 1) DA",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "ologia",
      "text": "a a non-olute; or",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "I'later. later.",
      "text": "imento",
      "start_page": 596,
      "end_page": 596
    },
    {
      "heading": "Records excluded",
      "text": "(n = 26) n n e",
      "start_page": 596,
      "end_page": 597
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "PRISM",
      "text": "è è racc",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "Records includes",
      "text": "previous ve (n = 1 -3 rec NE",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "Diagr",
      "text": "atico immu coma",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "and t",
      "text": "ersion",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "(cords)",
      "text": "in in prunite",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "gone",
      "text": "the Q38 G",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "rogres",
      "text": "erapia a risp",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "first first line",
      "text": "nivol nivol treatment",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "search database",
      "text": "(n = 19)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 19)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "Records screened",
      "text": "(n = 19)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "tudies included in",
      "text": "visual synthesis (n = 1)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 1)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "of ch",
      "text": "_MEDTERM0__",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "d",
      "text": "b, b, pe",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "tadio",
      "text": "oterap embro nea? mab mab o",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "Records excluded",
      "text": "(n = 19)",
      "start_page": 597,
      "end_page": 597
    },
    {
      "heading": "doceta",
      "text": "n n e",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "I",
      "text": "Flow Flow D",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Records includ",
      "text": "previous ve (n = 2) NE",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Diagra",
      "text": "and avant-garde,",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "ded in",
      "text": "the the L",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Searc database",
      "text": "(n = 261)",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Records after duplicate",
      "text": "(n = 247)",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Records screen",
      "text": "(n = 247) Full-text articles as",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "incl. incl.",
      "text": "(n = 0)",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 2)",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 2)",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "one of mal",
      "text": "Axel is racc",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "sssed",
      "text": "y",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "log",
      "text": "milk coma",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "gone",
      "text": "to to the",
      "start_page": 598,
      "end_page": 598
    },
    {
      "heading": "Records excluded",
      "text": "(n = 247) n n e",
      "start_page": 598,
      "end_page": 599
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "cond",
      "text": "AND THE",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "•",
      "text": "2009 2009 F",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "ords in",
      "text": "neural, neural,",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "nclud",
      "text": "ous ve (n = 4) NE",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "Diagr",
      "text": ", the",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "ded in",
      "text": "attam attam the",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "search database",
      "text": "(n = 697)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 577)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "Records screened",
      "text": "(n = 577) Full-text articles boarded",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 4)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 4)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "n stad",
      "text": "oman",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "d",
      "text": "Mimito o? n n buono",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "Record",
      "text": "(n/o)",
      "start_page": 599,
      "end_page": 599
    },
    {
      "heading": "ds excluded",
      "text": "n = 577) n n e",
      "start_page": 599,
      "end_page": 600
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "ig",
      "text": "i lE",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "d",
      "text": "and",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "d",
      "text": "u lc n",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "PRIS",
      "text": "L L POLMON",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "ords includ",
      "text": "previous ve (n = 4) chem chem a?",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "ded in",
      "text": "ersion",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "w Diag",
      "text": "mio-r the",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "Stu",
      "text": "here",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "search database",
      "text": "(n = 358)",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "duplicates duplicates rem",
      "text": "(n = 269)",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "Records screened",
      "text": "(n = 269) Full-text articles boarded",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0)",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "NEW studies included",
      "text": "(n = 0)",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "hearings included in",
      "text": "alitative synthesis (n = 4)",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "tudies included in",
      "text": "antitative synthesis (n = 4)",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "_MEDTERM0__",
      "text": "lactic",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "IDA",
      "text": "in sta",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "adio l",
      "text": "L'and and in",
      "start_page": 600,
      "end_page": 600
    },
    {
      "heading": "Records excluded",
      "text": "(n = 269) e e d",
      "start_page": 600,
      "end_page": 601
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "y",
      "text": "t ib",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "PRIS",
      "text": "Reco Reco p",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "LINES",
      "text": "L POLMONE",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "Q42 Q42 GRADE: In patients",
      "text": "of of prim",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "by by therapy",
      "text": "identified identified throu",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "(n = 1) (2019-2023)",
      "text": "(n = 153) rem rem (n= 139) Records screened (n=0 139) Full-text articles assembled",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0)",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "AND GUIDE",
      "text": "D D tino?",
      "start_page": 601,
      "end_page": 601
    },
    {
      "heading": "ugh",
      "text": "(n = 139) e e d",
      "start_page": 601,
      "end_page": 602
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "S",
      "text": "y t ilib",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "PRIS",
      "text": "L L POLMONE",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "Flow Flow Diag",
      "text": "version version (n = 3)",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "gram Q43 GRADE: In affect patients",
      "text": "of of prim",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "mante mante therapy",
      "text": "trat trat eropia?",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "search database",
      "text": "(n = 25) rem rem (n= 25) Recorded (n=15) Full-text articles assigned",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0)",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "Studies included in",
      "text": "qualitative synthesis (n = 3)",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "Studies included in",
      "text": "quantitative synthesis (n = 3)",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "AND GUID",
      "text": "enime enime ttame",
      "start_page": 602,
      "end_page": 602
    },
    {
      "heading": "g",
      "text": "e e d",
      "start_page": 602,
      "end_page": 603
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "y",
      "text": "t ib",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "PRISM",
      "text": "oindic oindic o/prior prior (n LMONE",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "Flow Diag",
      "text": "n n = 8)",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "gram",
      "text": "the the Q44: oterap dabile",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": ": with with SCL",
      "text": "sistam sistam e? Records identified throu",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "search database",
      "text": "(n = 157) rem rem (n= 155) Records screened (n=155) Full-text articles assembled",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0) colleges included in",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "visual synthesis",
      "text": "(n = 8) tudies included in",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "antitative synthesis",
      "text": "(n = 8)",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "AND GUI",
      "text": "LC comico",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "ugh",
      "text": "Moved and",
      "start_page": 603,
      "end_page": 603
    },
    {
      "heading": "IDA",
      "text": "excluded excluded (n = 155) e e d",
      "start_page": 603,
      "end_page": 604
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "y",
      "text": "t ib",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "PRISM",
      "text": "previous previous (n = 4) NE",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "Diagra",
      "text": "a, a, l'irr",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "RADE: with with S",
      "text": "identified identified throu",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "search database",
      "text": "(n = 283) rem rem (n= 268) Records screened (n=1 268) Full-text articles assembled",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0) colleges included in",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "visual synthesis",
      "text": "(n = 4) tudies included in",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "antitative synthesis",
      "text": "(n = 4)",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "_MEDTERM0__",
      "text": "cephalus",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "ugh",
      "text": "Moved and",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "IDA",
      "text": "with m",
      "start_page": 604,
      "end_page": 604
    },
    {
      "heading": "or (PCI)",
      "text": "d malat ) excluded excluded (n = 268) e e d",
      "start_page": 604,
      "end_page": 605
    },
    {
      "heading": "g",
      "text": "r r c",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "y",
      "text": "t ib",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "ig",
      "text": "lc lc n",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "PRISM",
      "text": "previous previous (n n = 4) NE",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "Diagr",
      "text": "the the Q46: attem",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "St",
      "text": "This isn't it.",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "St",
      "text": "here",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "with with SCLC",
      "text": "identified identified throu",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "search database",
      "text": "(n = 144) rem rem (n=121) Records screened (n=0121) Full-text articles assembled",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "for eligibility",
      "text": "(n = 0) included included (n= 0) colleges included in",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "(n = 4)",
      "text": "tudies included in",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "n prog",
      "text": "send",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "ugh",
      "text": "Moved and",
      "start_page": 605,
      "end_page": 605
    },
    {
      "heading": "entries",
      "text": "apt? Record Record (n n = 121) 3 3 : da da AIOM",
      "start_page": 605,
      "end_page": 607
    },
    {
      "heading": "Table of Contents",
      "text": "AIOM AIOM 2021: FEATURES FEATURES ... ... ... ...",
      "start_page": 608,
      "end_page": 608
    },
    {
      "heading": "AIOM AIOM 2021: PURPOSES AND CHARACTERISTICS",
      "text": "Guidelines Guidelines (LG) based based medicine; consideration. consideration.",
      "start_page": 609,
      "end_page": 609
    },
    {
      "heading": "TARGET TARGET USERS",
      "text": "Guidelines Guidelines are: practice practice • of of • best care • and and •payers • patients. patients.",
      "start_page": 609,
      "end_page": 609
    },
    {
      "heading": "A. ORGANISATIONAL STRUCTURE",
      "text": "LG. LG.",
      "start_page": 609,
      "end_page": 609
    },
    {
      "heading": "LG LG SINGLES",
      "text": "alone alone (the the patient). WHO WHO (al. al., 2006), figures figures (health health economists) rights. rights.",
      "start_page": 609,
      "end_page": 610
    },
    {
      "heading": "C. METHODOLOGY",
      "text": "methodology methodology (only only diagnostic/moment moment concerning: ✓ clarified clarified definitively; ✓ drugs/finally finally clarified; diversamente medicinal products/efficacy efficacy and/O. O. (P=population; I=intervention; C=confront; O=Outcome), questions questions (e.g.: of of ... this this way: P: with with (etc. etc.) I: treatment with (the the question) C: to to (under under consideration) the the recommendations: O: outcomes outcomes (considered considered essential/therapeutic therapeutic proposal) • Group Group (multidisciplinary group) clinic clinic proposal; • databases databases (database database area-specific) literature literature (paho, paho, etc). • dimensions dimensions (publication publication bias), levels levels (very very low), Framework Framework (EtD) etc. etc. •the the benefit/question question (vote) further further discussion/followed. followed. • a a \"good practice statement\" been been met: − care care situation; − of of resources; ‐ such such \"good practices statement\" the the issue; - recommendations recommendations (current current recommendations) • reported. reported. • an an intervention/levels levels (Table 1). Clinical Clinical ..with with (selection criteria) xxx xxx (selected criteria) proposed proposed (on on damages), intention intention (selective criteria) x x shouldn't be intended; patient patient (on on benefits) • threshold threshold (for for benefit) outcome outcome (benefit or damage), correct correct cost/effectiveness analysis (treatment treatment alternatives) (Guyatt GH, 2008; al, al, 2013) aspects aspects (the the studies). • CNN CNN (non-negotiated C band), text. text. • tests tests \"low\" or \"very low\" ... damage damage (intervention intervention High) intervention intervention (the the harmful/costy intervention) costs costs (of of resources) cost cost (or or resources) if if harmful/increases increases (of of resources), lower lower (or moderated).",
      "start_page": 610,
      "end_page": 613
    },
    {
      "heading": "OF OF DOCUMENTS",
      "text": "any any revision/modifications/addition/trials. trials.",
      "start_page": 614,
      "end_page": 614
    },
    {
      "heading": "OF OF INTEREST",
      "text": "following following cases: ✓ recommendation recommendation ✓ be be \"declared. declared.\"",
      "start_page": 614,
      "end_page": 614
    },
    {
      "heading": "F. PERIODIAL UPDATE",
      "text": "practice. practice.",
      "start_page": 614,
      "end_page": 614
    },
    {
      "heading": "AIOM AIOM SITE",
      "text": "mobility. mobility.",
      "start_page": 614,
      "end_page": 614
    },
    {
      "heading": "OF OF IMPLEMENTATION",
      "text": "practice practice (RIGHT Projects), practice. practice.",
      "start_page": 614,
      "end_page": 615
    },
    {
      "heading": "AIOM Guidelines",
      "text": "Oncology Oncology Association",
      "start_page": 615,
      "end_page": 615
    },
    {
      "heading": "RIGHT-1 RIGHT-2 RIGHT-3",
      "text": "RIGHT RIGHT Projects",
      "start_page": 615,
      "end_page": 615
    },
    {
      "heading": "INTERNATIONAL INTERNATIONAL GUIDES",
      "text": "alone alone (NCCN NCCN - standard version) heterogeneity heterogeneity (see Lines ESMO) data data (extrapolation of evidence) revision revision - still ongoing - literature literature (GRAde GRAde method) target target (etc. etc.) Users Users (other other √ stakeholder, etc). LG) \"Target Target population: oncologist (different different figures) target target populations: oncologian (various various figures) question question (PICO); appropriate appropriate engines; bibliographical bibliographical entries; methodological quality assessment; evidence evidence (tables of evidence) questions questions (GRADE GRADE Questions) expressed expressed √ defined defined √ √ 3 Population (etc. etc.) clearly clearly √ figures figures √ & population population (patient, doctors; etc. etc.). √& users users (etc etc .) LG LG √ available available √ evidence evidence √ standards standards (quality of evidence) recommendation recommendation √ support support √experts experts √ document document √",
      "start_page": 615,
      "end_page": 617
    },
    {
      "heading": "4. BIBLIOGRAPHY",
      "text": "==References===External links==* Official website",
      "start_page": 617,
      "end_page": 617
    },
    {
      "heading": "AIOM AIOM GUIDES",
      "text": "Giovanni Giovanni Pappagallo",
      "start_page": 618,
      "end_page": 618
    },
    {
      "heading": "AND AND SCOPE",
      "text": "Groups Groups (WG) Guidelines Guidelines (LG) SIGN SIGN (Guidelines Guidelines Network) GRADE GRADE (and and Evaluation) two two parts: editing. editing.",
      "start_page": 618,
      "end_page": 618
    },
    {
      "heading": "Clinical Clinical Quesito",
      "text": "generic generic (condition condition Y) of of application; to to PIC(O) and and (Outcome). of of PIC( O: − with with (etc. etc.) • treatment with (the the question) − to to (under under consideration) ? − (or or damage) (therapeutic therapeutic proposal)) group group (trial trial (the group, and/Tab. Tab. 1: studies studies (RCTs) revisions revisions (RS) etc. etc., average, average, it'successful successful (presence presence (and traceability) tools tools (checklists) search search (and and reducible) databases databases (area-specific area-specific databases) g. g., search search (increase increase sensitivity), search search (etc. etc.) (Strategy Strategy Manual).",
      "start_page": 618,
      "end_page": 619
    },
    {
      "heading": "of of studies",
      "text": "results results (damage damage observed) outcomes outcomes (damages damages observed).error error (bias) less less credible/questions questions (with SIGN evaluation), evidence evidence (3, 3,4) bias bias (++,+++, +,-) sufficiently sufficiently near/subdivided. subdivided. − text. text. − strength. strength. Important: study study (indicated by: 1 or 2), negative negative (-) negative negative (should should not/be be administered), sign sign (-) non-reliable non-reliable results; sense sense (for example: intervention should/be be given), sign sign (+) sign sign (-) study. study. 3) letters letters (C, C, D) terms terms (HR, RR, OR) or absolutes (etc. etc.). summary summary the",
      "start_page": 619,
      "end_page": 621
    },
    {
      "heading": "opinion. opinion.",
      "text": "Tab. 3: Evidence Evidence - of of evidence-",
      "start_page": 621,
      "end_page": 622
    },
    {
      "heading": "assessed assessed 1++ and directly",
      "text": "target target population; or",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "A",
      "text": "assessed assessed 1+ evaluated evaluated 2++ evaluated evaluated 1++ or 1+ includes includes 2+ assessed assessed 2+ + or or 4",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "D",
      "text": "evaluated evaluated 2+",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "of of evidence",
      "text": "following following characteristics: patients patients -> etc. etc.",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "1 1 (randomized study) bias bias (++), event event of",
      "text": "overall overall quality",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "a a critic",
      "text": "evidences evidences (body of evidence), given given below: ✓ Study design - the the study: adverse adverse effects; type type are: − control control (location conceptualment). patients patients (allocation) 2 2 RCT- produced. produced. − positive positive (statistically significant). verification. verification. ✓ Precision ✓ same same objective: single single study; explanation explanation (studied studied populations) intervention intervention (systematic systematic revision). ▪ the the data: results. results. ▪ a a case-quality quality (very very high).",
      "start_page": 622,
      "end_page": 624
    },
    {
      "heading": "Meaning Meaning Consequences",
      "text": "is is limited: very very limited: outcomes outcomes (critical) of of behaviour: ✓ directions directions (undesirable undesirable effects), quality quality (as critical) same same (i.",
      "start_page": 624,
      "end_page": 625
    },
    {
      "heading": "and and damages",
      "text": "given given intervention/drug/treatment/positive positive (benefit) and negative (harmful effects) following following elements: ✓ importance of outcomes: therapeutic therapeutic proposal; ✓ to to reduce; significant significant impact; effect effect (clinical-epidemiological relevance): effects effects (the clinical/treatment).",
      "start_page": 625,
      "end_page": 625
    },
    {
      "heading": "Framework Framework (EtD)",
      "text": "question question (comparison, comparison, outcome). levels levels (Table 6): Tab. Tab. 6: Meaning Meaning - with with (be be selection) favor favor (on on damage) be be − benefit. benefit. ✓ the the benefit/Recommendation. Recommendation. − effects effects (negative negative recommendations) uncertainty. uncertainty. • considered. considered.",
      "start_page": 625,
      "end_page": 626
    },
    {
      "heading": "clinical clinical recommendations",
      "text": "green green (Table 7). GRADE GRADE (outcomes, outcomes, benefit/the the recommendation) orange orange (Table 8). Tab. 7: effects. effects. (3)5 Tab. 8: Paracetamol. Paracetamol.",
      "start_page": 626,
      "end_page": 627
    },
    {
      "heading": "RECOMMENDATION:",
      "text": "Strength of recommendation:",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "Reasons/sheet sheet Benefit/Danno:",
      "text": "been been identified: the the benefit/damage balance:",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "Certainty of evidence",
      "text": "judged judged ... following following reasons: of of evidence: ... COI: reference reference (s) recommendation. recommendation.",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "3.2. GRADE-Adolopment",
      "text": "Health Health (GRADE-ADOLOPMENT GRADE-ADOLOPMENT (EtD) framework. framework.",
      "start_page": 628,
      "end_page": 628
    },
    {
      "heading": "LINES LINES GUIDE",
      "text": "Guidelines Guidelines (SNLG), Law Law 24/Care Care (CNEC) social. social.",
      "start_page": 628,
      "end_page": 628
    },
    {
      "heading": "5. CRITICAL APPRAISAL",
      "text": "Tab. Tab. 10: Critical apraisal RCT/Systematic Reviews (meta-analysis) RECLUTATION: population population (recommended recommended methods)? ALLOCATION: randomization randomization sequence? (first two) was was hidden? STUDIES STUDIES INCLUSI: properly properly assessed? OF OF RESULTS: results results (plot. plot...) light. light.",
      "start_page": 628,
      "end_page": 630
    },
    {
      "heading": "CORTE STUDY CASE-CONTROL",
      "text": "population population (recommendation recommendation refers)? method method section",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "RECLUTION",
      "text": "populations populations (only difference = factor factor studied) and and controls",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "KEEPING",
      "text": "parties parties / eligible eligible subjects",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "MEASURING",
      "text": "detection detection (to to (exposure exposure factor) risk factor)",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "FOLLOW-UP",
      "text": "Drop-out content",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "CONFUNDMENT",
      "text": "observed observed effect",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "ASSOCIATION",
      "text": "formal formal checklists: AMSSTAR: review. review. PRISMA: and and Meta-Analyses: CONSORT CONSORT 2010: Explanation and Elaboring: Al. Al. It'studies. studies.",
      "start_page": 630,
      "end_page": 631
    },
    {
      "heading": "6. Bibliographical entries",
      "text": "chapter chapter (after algorithms). way way (example: 1 to N).) numbering numbering (Chapter Chapter 1: to to 22; etc. etc.) method method \"Vancouver\" (by by Pubmed) below. below. Link:",
      "start_page": 631,
      "end_page": 631
    },
    {
      "heading": "Example",
      "text": "C. C., metastatialcell metastatialcell carcinoma? 2a 2a (RAPSODY). 2013 2013 Feb;63(2):254-61. doi: 10.1016/PubMed PubMed SMED: and and 4: the the panel'following following amendments:",
      "start_page": 631,
      "end_page": 634
    },
    {
      "heading": "heading heading October October 2024 (from previous page)",
      "text": "Row 1:\nRowRow 2:\nBoston, Massachusetts",
      "start_page": 3,
      "end_page": 3
    },
    {
      "heading": "heading heading October October 2024 (from previous page)",
      "text": "Row 1:\nMartino-Minas, Messina;Row 2:\nRowRow 3:\nEvolutionary G. Barresi/of of Messina",
      "start_page": 3,
      "end_page": 3
    },
    {
      "heading": "heading heading October October 2024 (from previous page)",
      "text": "Row 1:\nPolyclinic Polyclinic AOU;Row 2:\nRowRow 3:\nof of Rome",
      "start_page": 3,
      "end_page": 3
    },
    {
      "heading": "heading heading October October 2024 (from previous page)",
      "text": "Row 1:\nHospitaller Hospitaller Company-Row 2:\nof of Verona",
      "start_page": 3,
      "end_page": 3
    },
    {
      "heading": "heading heading (3) CLINIC RECOMMENDATION FORCE",
      "text": "Row 1:\n• Overall quality •Clinical recommendation (2) •Row 2:\n•Test strength (1) •Recommendation (3) •Row 3:\n• ALTA •PN+ lymphadenectomy lymphadenectomy (<D2) radiochemotherapy radiochemotherapy (68.73) •of of •",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "heading heading (3) CLINIC RECOMMENDATION FORCE",
      "text": "Row 1:\n\"Quesito xx: ...\"Row 2:\nRECOMMENDATION:\"Row 3:\nStrength of recommendation:\"Row 4:\nReasons/comments to benefit/damage balance: been been identified: motivate motivate benefit/ damage balance: \"Row 5:\nfuture future research: \"Row 6:\njudged judged ... following following reasons: \"Now 7: of of tests: ...\"",
      "start_page": 9,
      "end_page": 9
    },
    {
      "heading": "heading heading CONFLICT OF INTEREST",
      "text": "Row 1:\n\"Clinical\"Row 4:\nStrong in favor\"with with (selection criteria) option option (on on damage)Row 5:\nfavour favour (selected criteria) to to Yyy'alternatives alternatives (harm harm benefits)Row 6:\nhave have (selective criteria) to to yy'y'consideration consideration shouldn't be considered; benefit benefit (s) use use (the the non-perspective)",
      "start_page": 10,
      "end_page": 10
    },
    {
      "heading": "heading heading CONFLICT OF INTEREST",
      "text": "Row 1:\nforce force \"Row 2\" the the \"Raw 3\" recommendation:",
      "start_page": 10,
      "end_page": 10
    },
    {
      "heading": "heading heading 1.3 Survival",
      "text": "Row 1:\nRowRow 2:\n14.3% RowRow 3:\n7. 7.4% RowRow 4:\nage. age.",
      "start_page": 19,
      "end_page": 19
    },
    {
      "heading": "heading heading 1.3 Survival",
      "text": "Row 1:\nRowRow 2:\n18. 18.7%. RowRow 3:\nthe the 2007‐RowRow 4:\nof of 16%.",
      "start_page": 19,
      "end_page": 19
    },
    {
      "heading": "heading heading 1.4 Prevalence",
      "text": "Row 1:\nRowRow 2:\nlung cancer (600 600 women) Italy. Italy. 34% RowRow 3:\n23% years, 17% only only 25% RowRow 4:\nlung lung cancer: be be 8% and and 13% Row",
      "start_page": 20,
      "end_page": 20
    },
    {
      "heading": "heading heading Secondary Secondary prevention (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nRowRow 4:\nbefore?Row 5:\nRECOMMENDATION: RowRow 6:\nStrength of recommendation: RowRow 7:\nMotivations/comments to benefit/damage balance: screening screening (NS) radiography radiography (CXR) associated associated with: mortality mortality (0. 0.87; CI95% 0.78-0.98; 0, 0,80; CI95% 0.69-0.92); diagnosis diagnosis (2. 2.84; CI95% 1.76-4.58; 3. 3.33; IC95% 2.27-4.89; 1. 1.52; CI95% 1.04-2.23); diagnosis diagnosis (0. 0.75; IC95% 0.68-0.83; 0. 0.67; IC95% 0.56-0.80); rate rate (2. 2.57; 76-3. 76-3.74); mortality mortality (0. 0.99; CI95% 0.94-1.85); rate rate (NS 38%; CI95% 14-63).",
      "start_page": 26,
      "end_page": 26
    },
    {
      "heading": "heading heading Variants Variants Notes",
      "text": "==References===External links==* Official website",
      "start_page": 31,
      "end_page": 31
    },
    {
      "heading": "heading heading Variants Variants Notes (column 1)",
      "text": "Row1: RowRow 3:\nSclerosis pneumocytoma (so-called sclerosing hemangioma) • • Patterns: bleeding bleeding (of of patterns) ♪Row 4:\nAdenoma- • AdenocarcinomaAdenomatosa atypical (AAH); situ situ (AIS) invasive invasive (MIA) glands glands • solid solid Mucino-Mucino; • Carcinoso-Faculous (Basso/Alto-Cheese)",
      "start_page": 31,
      "end_page": 31
    },
    {
      "heading": "heading heading Variants Variants Notes (from previous page)",
      "text": "Row-Low-Centro-Cinto-Pleomorphic Pleomorphic (cells cells and/or giants) Carcinosarcoma (presence of _MEDTERma) Meso-Cyno-with with sarcoma: osteo/condro/leiomio/radbdo/angio-sarcoma) Blastoma-Row 2:\nOther epithelial tumors",
      "start_page": 32,
      "end_page": 32
    },
    {
      "heading": "heading heading T • primitive tumor",
      "text": "Row 1:\nEdition Edition (Clinical Classification)",
      "start_page": 50,
      "end_page": 50
    },
    {
      "heading": "heading heading Edition Edition (Clinical classification)",
      "text": "I'm sorry. == Demographic evolution =References==",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "heading heading Edition Edition (Clinical classification) (column 1)",
      "text": "Row 1:",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "heading heading Edition Edition (Clinical classification) (column 2)",
      "text": "Row 1:\nEdition Edition (Clinical Classification)",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "heading heading Edition Edition (Clinical classification) (column 2)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nperibronchial peribronchial and/RowRow 4:\nnodes nodes and/ RowRow 5:\nsupraclavear supraclavear ipsis- or contralaterals",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "heading heading Edition Edition (Clinical classification) (column 2)",
      "text": "Row 1:\nRowRow 2:\nprimitive primitive tumor; cancer with pleural/RowRow 3:\nRowRow 4:\nmore more organs",
      "start_page": 51,
      "end_page": 51
    },
    {
      "heading": "heading heading Edition Edition (clinical classification) (from previous page)",
      "text": "Row 1:\nStadium N0M0Row 4:\nM0M7Row M0M7Row 5:\nS0MRow S0MRow 6:\nR0ORow R0ORow 7:\nM0RW M0RW 8: M02Row M02Row 10:\nm0Raw m0Raw 10: N0 N0 - you you doing?",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "heading heading Edition Edition (clinical classification) (column column 12)",
      "text": "Row 1:\n... M. M.",
      "start_page": 52,
      "end_page": 52
    },
    {
      "heading": "heading heading Surgical Surgical options",
      "text": "Row 1:\nSCT>or or SWT<Row",
      "start_page": 56,
      "end_page": 56
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n• Overall quality •Clinical recommendation •Row 2:\n•Recommendation •Row 3:\nModerate •with with •thoracotomy thoracotomy (148-150) •Condicted for •row 4: • COI: declared declared •",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nstage stage (IA), RowRow 2:\nrecommended (compared to lobectomy)?Row 3:\nRECOMMENDATION: phase phase (IA) RowRow 4:\nStrength of recommendation: RowRow 5:\nMotivations/comments to benefit/damage balance: segmentectomia segmentectomia (cell cell cells).",
      "start_page": 58,
      "end_page": 58
    },
    {
      "heading": "heading heading 4.2 Radiotherapy",
      "text": "Row 1:\nOverall Overall benefit/damage balance: stage stage (IA), complications complications (aerial aerial losses).Row 2:\nstudies studies (Ottawa Ottawa Scale), RowRow 3:\nof of tests: MODERATERow 4:\nCOI: no conflict declared",
      "start_page": 59,
      "end_page": 59
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n\"Clinical recommendation\" =Row 2:\nOverall quality \"Row 3 strength\": \"Raw 4: \"Rown 5: \"therapy therapy (153, 155) \"RowRow 6:\nModerateRow 7:\n\"Row 8:\n\"Row 9:\nCOI: no declared conflict\"",
      "start_page": 60,
      "end_page": 60
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "==References===External links==* usable usable (171-175)",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading COI: no conflict declared (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading COI: no conflict declared (column 2)",
      "text": "Row 1:\n Row 2:\nQuality of",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading COI: no conflict declared (column 3)",
      "text": "Row 1:\nRowRow 2:\nprov",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading COI: no conflict declared (column 4)",
      "text": "Row 1:\nBaleRow 2:\nve",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading COI: no conflict declared (column 5)",
      "text": "Row 1:\nwell-selected well-selected (postoperative postoperative recovery) option option (161)Row 5:\nusable usable (171-175).",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading COI: no conflict declared (column 6)",
      "text": "Row 1:\nRowRow 2:\nRecommendation",
      "start_page": 68,
      "end_page": 68
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\ntrials trials (Clinical recommendation) •RowRow 2:\nModerate (Del19/L858R), chemotherapy chemotherapy (if indicated) (185-187) • RowRow 3:\nCOI: declared declared • account. account.",
      "start_page": 71,
      "end_page": 71
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 71,
      "end_page": 71
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 71,
      "end_page": 71
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\ntests tests (Clinical recommendation) •RowRow 2:\nModerate • __ __ MEDTERM1__/PD-L1 PD-L1 ≥50% treatment with −chemotherapy chemotherapy (189) ■ RowRow 3:\nCOI: declared declared •",
      "start_page": 73,
      "end_page": 73
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 73,
      "end_page": 73
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 73,
      "end_page": 73
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\ntests tests (i) Clinical recommendation (ii) RowRow 2:\nModerate (iii) option option (192-193)",
      "start_page": 75,
      "end_page": 75
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 75,
      "end_page": 75
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 75,
      "end_page": 75
    },
    {
      "heading": "heading heading 5.4 Organisation",
      "text": "Row 1:\ntreatment treatment (s) RowRow 4:\nradiotherapy radiotherapy and/RowRow 5:\n...RowRow 6:\n.. RowRow 7:\n. . .thereafter. thereafter. ...Row 8:\nRowRow 9:\n..\"Row",
      "start_page": 79,
      "end_page": 79
    },
    {
      "heading": "heading heading 5.4 Organisation (from previous page)",
      "text": "Row 1:\ntreatment. treatment.",
      "start_page": 80,
      "end_page": 80
    },
    {
      "heading": "heading heading 5.4 Organization (column column 1)",
      "text": "Row 1:\nProceedRow 2:\n Row 3:\nSpiromRow 4:\ncomplRow 5:\ncurrencyRow 6:\npopularRow 7:\nSurvivRow 8:\n Row 9:\nProceed row 10: confam",
      "start_page": 80,
      "end_page": 80
    },
    {
      "heading": "heading heading 5.4 Organization (column column 2)",
      "text": "Row 1:\nduraRow 2:\n Row 3:\n Row 4:\nRowRow 5:\nRowRow 6:\nRowRow 7:\nRowRow 8:\n Row 9:\nRowRow 10:\nsend",
      "start_page": 80,
      "end_page": 80
    },
    {
      "heading": "heading heading 5.4 Organization (column column 3)",
      "text": "Row 1:\n\"RowRow 2:\n\"Row 3\" to \"treatment. treatment.\" .Row 4:\n\"Rop 5\": \"to to favour\" 1Row 6:\n\"of of lifestyles\" 7: \"Salutari.\"Row 8:\n\" and and vaccination\"Row 9:\n\"anti-pneumococca.\"Row 10:\n\"L\" RowRow 11:\n\"routinely.\" a a \"Raw 12\" should be performed: \"T\" mdc. mdc.",
      "start_page": 80,
      "end_page": 80
    },
    {
      "heading": "heading heading 5.4 Organization (column column 4)",
      "text": "Row 1:\nRowRow 2:\nrecommendationRow 3:\nRowRow 4:\n Row 5:\nRowRow 6:\n Row 7:\nRow",
      "start_page": 80,
      "end_page": 80
    },
    {
      "heading": "heading heading Chemio-radiotherapy Chemio-radiotherapy neoadjuvant",
      "text": "Row 1:\nOverall Quality (Clinical Recommendation) *Row 2:\nTrial Strength (Row 3:\nLow Recommending) the the risk/patient patient (206-207)",
      "start_page": 85,
      "end_page": 85
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n\"Clinical recommendation\" = \"Row 2:\nOverall quality\" *Row 3:\nRowRow 4:\n\"Rop 5: Moderate\" *stage stage IIIA/conditions conditions (__MEDTERM1_ 0-1) option option (226-228) *RowRow 6:\n\"COI\": no conflict declared",
      "start_page": 92,
      "end_page": 92
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n\"Clinical recommendation\" = \"Row 2:\nOverall quality\" =Row 3:\ntesting strength = \"RecommendationRow 4:\n\"Row 5:\nModerata\" = ...\"stage stage IIIA/therapy therapy (229-234) \"RowRow 6:\nCOI: no declared conflict\"",
      "start_page": 95,
      "end_page": 95
    },
    {
      "heading": "heading heading Quality of tests",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nto to 1%, RowRow 4:\nto to observation?Row 5:\nRECOMMENDATION: with with chemo‐as as 1%, RowRow 6:\nStrength of recommendation: RIGHT RIGHT 7: Motivations/comments to benefit/danno balance: placebo placebo (6 6 months; HR 0.52; IC95% 0.42-0.65; p=0.001). __MDTERM01_29. __MDTERM01_29.9% vs 26.1%), discontinuation discontinuation (15.4% vs 9.8%; HR 0.68; IC95% 0.53-0.87; 2 2 years: 66.3% vs 55.6%. EMA EMA (September 2018) AIFA AIFA (December December 2018) expression expression ≥1%. arm arm (HR 0.71; CI95% 0.57-0.88) 35. 35.3% vs 19.5% the the PD- with with PD-L1- ≥1%, in in 63% study study (237). trial. trial.",
      "start_page": 96,
      "end_page": 96
    },
    {
      "heading": "heading heading Quality of tests (from previous page)",
      "text": "Row 1:\nof of evidence: LOWRow 2:\nCOI: No conflict declared",
      "start_page": 97,
      "end_page": 97
    },
    {
      "heading": "heading heading oligometastatic oligometastatic disease (from previous page)",
      "text": "Row 1:\nROW ROW 3: recommended recommended (RowRow 4:\nsystemic therapy only)?Row 5:\n Row 6:\nRECOMMENDATION: RowRow 7:\nStrength of recommendation: RowRow 8:\nMotivations/comments to benefit/damage balance: _12 _12 articles; al. al. (250), with with .to to ≤al. al. (251) and and non-day day 15; analisys analisys (252) studies studies (PEMBRO-RT and MDACC) trial trial (3 3 weeks) __MEDTERM0_ __MEDTERM0_ (0,67; CI95% 0.54-0,84; p=0.0004). al. al. (253), TKi TKi (TKI TKI (adult adult population). mode mode (20-12) lesions lesions (of of lesions).",
      "start_page": 100,
      "end_page": 100
    },
    {
      "heading": "heading heading disease disease EGFR-mutated",
      "text": "Row 1:\nrate rate (1. 1.36; CI95% 0.52-3.51), lung rate (1. 1.59; IC95% 0.96-2.61) interruptions interruptions (0. 0.95; IC95% 0.06-14.97). RowRow 2:\nestimates. estimates. *RowRow 3:\nof of testing: BASSaRow 4:\nCOI: no conflict declared: considered. considered.",
      "start_page": 101,
      "end_page": 101
    },
    {
      "heading": "heading heading disease disease EGFR-mutated (from previous page)",
      "text": "Row 1:\nRowRow 2:\nMEDTERM24_ MEDTERM24_ (Ex19dels and L858R), RowRow 3:\nrecommended recommended (__Medterm1_ __Medterm1_ and/or _MEDTERM2_===the the trial:Row 5:\nRecommendation: of of −of of •endpoints endpoints (266), __MEDTERM34_ __MEDTERM34_ (e.g., of of treatment), MEDTERM0__ MEDTERM0__ _Media: 0, 0,58; IC95% 0,44-0,78; p=0.0004). a a •MEDTERm34_ cerebral (subgroup subgroup analysis) profile profile (than than 3) favourable.",
      "start_page": 102,
      "end_page": 102
    },
    {
      "heading": "heading heading Quality of tests",
      "text": "Row 1:\nfollowing following reasons: RowRow 2:\nof of tests: LOWRow 3:\nCOI: no conflict declared",
      "start_page": 103,
      "end_page": 103
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n• Overall quality • Clinical recommendation •Row 2:\n•Test strength •Recommendation •Row 3:\n• Very low •__MEDTERM3_ __MEDTERM3_ (changes/of of • Exon 20), of of ♪MEDTERM3__ •option option •Row 4:\n• __DETERM3. __DETERM3. • (275)Row 5:\nCOI: no declared conflict",
      "start_page": 105,
      "end_page": 105
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\ntests tests (Clinical recommendation): considered considered (276)",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 107,
      "end_page": 107
    },
    {
      "heading": "heading heading COI: no conflict declared (from previous page)",
      "text": "RowRow 2:\n(Ex19dels, L858R) T790M T790M (liquid liquid biopsy) RowRow 3:\nof of •RowRow 4:\nrecommended (compared to chemotherapy)?Row 5:\nRECOMMENDED: mutation mutation (fluid fluid biopsy). __MEDTERM32_ __MEDTERM32_ (chemotherapy chemotherapy respectively; HR 0,87; IC95% 0.67-1,12; p=0.277). 73% of of −disease disease (brain brain disease: 70% vs 31% [OR 5,13; IC95% 1,44-20,64; p = 0.0015], cerebral cerebral metastases: 40% 17% [OR 3,24; CI95% 1,33-8,81; p=0.014] 44 44 - 20,64 - 50; P=References=Row 8:\nfollowing following reasons: bias bias (of of results), RowRow 9:\nOverall test quality: RowRow 10:\nCOI: no conflict declared",
      "start_page": 108,
      "end_page": 108
    },
    {
      "heading": "heading heading disease disease ALK-re-arranged (from previous page)",
      "text": "Row 1:\nRowRow 2:\nrecommended recommended (compared to __MDTERM1_)?Row 3:\nRECOMMENDED: with with −with with •RowRow 4:\nStrength of recommendation: RowRow 5:\nMotivations/the the benefit/day balance: ›__MDTERM1_ __MDTERM1_ (2 2 months; HR 0.37; IC95% 0.26-0.52), over-reachable over-reachable (medium not reached; HR 1.03; IC95% 0.67-1.58), considering that 79% 0-2 0-2 (299) status performance.",
      "start_page": 113,
      "end_page": 113
    },
    {
      "heading": "heading heading disease disease ALK-re-arranged (from previous page)",
      "text": "Row 1:\n+ 0.60; CI95% 0.37-0.99) RowRow 2:\nl/of of •Row 3:\n__medterm1_. __medterm1_.",
      "start_page": 113,
      "end_page": 113
    },
    {
      "heading": "heading heading disease disease ALK-re-arranged (from previous page)",
      "text": "Row 1:\nOverall benefit/damage balance: survival survival (ALEX ALEX study) profile profile (than than 3).Row 2:\nfollowing following reasons: RowRow 3:\nof of tests: MODERATARow 4:\nCOI: no conflict declared",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "heading heading disease disease ALK-re-arranged (from previous page)",
      "text": "Row 1:\nRowRow 3:\nrecommended recommended (compared to __MDTERM1_)?Row 4:\n Row 5:\nRECOMMENDATION: of of _MEDTERM19_; Motivations/comments on benefit/damn balance: with with •progression, 1⁄arms arms (two two arm; HR 0,92; CI95% 0.57-1,47; p=0.771). baseline baseline (e.g. n=41, 78% vs 26%; OR 11,67; CI95% 2,15-6,27; p = 0.0014); treatment treatment (n=98, 66% vs. 11,75; L95% 4,19-32,91; p <0,0001).",
      "start_page": 114,
      "end_page": 114
    },
    {
      "heading": "heading heading disease disease ALK-re-arranged (from previous page)",
      "text": "Row 1:\nOverall benefit/damage balance: RowRow 2:\nfollowing following reasons: distortion distortion (sponsor sponsor bias), RowRow 3:\nof of evidence: RowRow 4:\nCOI: no conflict declared",
      "start_page": 115,
      "end_page": 115
    },
    {
      "heading": "heading heading disease disease ALK-re-arranged (from previous page)",
      "text": "Row 1:\nRowRow 2:\nrecommended recommended (compared to __MDTERM1__)?",
      "start_page": 115,
      "end_page": 115
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\ntests tests ...Clinical recommendation: \"RowRow 2:\nModerate\" considered considered (compared to __MDTERM1_) (308-310).\"RowRow 3:\nCOI: no declared conflict\"",
      "start_page": 117,
      "end_page": 117
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 117,
      "end_page": 117
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 117,
      "end_page": 117
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "RowRow 2:\nRowRow 3:\nrecommended recommended (compared to chemotherapy)?Row 4:\nRECOMMENDING: RowRow 5:\nthe the recommendation: RIGHT RIGHT 6: Motivations/comments to benefit/damn balance: al. al., Phase Phase I/of of −95. 95.3% and 48.1% degree degree (84.4% and 67.1% respectively) 4 4 (18% in both cases) Overall Overall benefit/damage balance: effects effects (brain brain activity) and undesirable (drug-specific adverse events) RowRow 7:\nfollowing following reasons: imprecision. imprecision.",
      "start_page": 117,
      "end_page": 117
    },
    {
      "heading": "heading heading disease disease ROS1-rearranged",
      "text": "==References===External links==* patients patients (5 5 years), female (64.5%) and non-smoker (67.7%). approximately approximately 80%, 1 1 months; identified identified (321).",
      "start_page": 119,
      "end_page": 119
    },
    {
      "heading": "heading heading disease disease ROS1-re-arranged (from previous page)",
      "text": "rate rate (the the study) was 71.7%. __ROS1. __ROS1. Benefit/damage balance: The risk/of of •RowRow 2:\nfollowing following reasons: number number (improvement of estimates) studies studies (and and indirectness), RowRow 3:\nof of testing: RowRow 4:\nCOI: no declared conflict: reported. reported.",
      "start_page": 120,
      "end_page": 120
    },
    {
      "heading": "heading heading disease disease ROS1-re-arranged (from previous page)",
      "text": "RowRow 2:\nis is recommended?Row 3:\nRECOMMENDED: with with •with with −RowRow 4:\nStrength of recommendation: RIGHT RIGHT 5: Motivations/comments to benefit/damage: studies studies (and and STARTRK-NG) dysgeusia dysgeusia (n=90; 42.9%), malaise (n = 72; 34.3%); constipation (n=166; 31.4%). growth growth (n=27; 8.1%), ALT rise (n=0; 3.3%) and diarrhoea (n (=6; 2.9%); 7 patients (3.3%) events events (hyperuricaemia; hypertridemia; limbic cephalitis; myocardial infarction; creatinine elevation). Benefit/damage balance: The benefit/RowRow 6:\nfollowing following reasons: number number (improportion of estimates) studies studies (and and indirectness), overall overall trials:",
      "start_page": 121,
      "end_page": 121
    },
    {
      "heading": "heading heading disease disease mutated (from previous page)",
      "text": "==References===External links==* patients patients (22%), 25 25 (69%) adverse adverse event: cases cases (11%), 3 3 (8%). al. al., 63. 63.9%, respectively respectively (332), was was 22%. the the trial: patients patients (n=36). with with chemo(immuno) results. results.",
      "start_page": 123,
      "end_page": 123
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\ntests tests (Clinical recommendation): Very low (Row 2:\nVery low) option option (333-336)",
      "start_page": 125,
      "end_page": 125
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 125,
      "end_page": 125
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 125,
      "end_page": 125
    },
    {
      "heading": "heading heading disease disease RET-re-arranged",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nrecommended recommended (compared to chemotherapy)?",
      "start_page": 126,
      "end_page": 126
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\ntests tests (Clinical recommendation): considered considered (338-339, 343, 346)",
      "start_page": 129,
      "end_page": 129
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 129,
      "end_page": 129
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 129,
      "end_page": 129
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\ntests tests (Clinical recommendation): immunotherapy immunotherapy and/considered considered (350)",
      "start_page": 131,
      "end_page": 131
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 131,
      "end_page": 131
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 131,
      "end_page": 131
    },
    {
      "heading": "heading heading  p. p.G12C",
      "text": "Row 1:\ntests tests (Clinical recommendation): immunotherapy immunotherapy and/considered considered (351)",
      "start_page": 132,
      "end_page": 132
    },
    {
      "heading": "heading heading  p. p.G12C",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 132,
      "end_page": 132
    },
    {
      "heading": "heading heading  p. p.G12C",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 132,
      "end_page": 132
    },
    {
      "heading": "heading heading  p. p.G12C",
      "text": "Row 1:\nRowRow 2:\nimmunotherapy immunotherapy and/orRow 3:\nrecommended recommended (compared to chemotherapy)?",
      "start_page": 132,
      "end_page": 132
    },
    {
      "heading": "heading heading First-line First-line treatment: immunotherapy",
      "text": "Row 1:\nClinical recommendation: \"RowRow 2:\nimmunotherapy immunotherapy and/considered considered (compared to chemotherapy) (355-357).\"",
      "start_page": 135,
      "end_page": 135
    },
    {
      "heading": "heading heading First-line First-line treatment: immunotherapy",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 135,
      "end_page": 135
    },
    {
      "heading": "heading heading First-line First-line treatment: immunotherapy",
      "text": "Row 1:\nPD-L1 PD-L1 ≥50%, RowRow 2:\nstatus status (0-1), aRow 3:\nrecommended recommended (compared to chemotherapy)?Row 4:\nRECOMMENDING: of of −MEDTERMO7_, or re‐arrangement of •RowRow 5:\nthe the recommendation: RIGHT RIGHT 6: Motivations/the the benefit/danno balance: multi-year multi-year trial: __médterm16_ __médterm16_ (6 6 months; HR 0.50; IC95% 0.37-0.68; p <0,001) (369). at at •of of −with with •chemotherapy chemotherapy (HR 0.62; CI95% 0.48-0.81; p=0.001) of of {31. 31.9% 16. 16.3% responses responses (46.1% vs 31.9% at 31.0% with @MEDTERMA6_",
      "start_page": 135,
      "end_page": 135
    },
    {
      "heading": "heading heading First-line First-line treatment: immunotherapy (from previous page)",
      "text": "==See also==*Topology==References===External links==",
      "start_page": 136,
      "end_page": 136
    },
    {
      "heading": "heading heading First-line First-line treatment: immunotherapy (from previous page)",
      "text": "Row 1:\nexpression expression ≥50%, withoutRow 2:\nRowRow 3:\n(0-1), recommended recommended (RowRow 4:\nplatinum based)?",
      "start_page": 136,
      "end_page": 136
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\ntests tests (clinical clinical recommendation): \"RowRow 2:\nModerate\" (ii) expression expression ≥50%, status status (iii)), considered considered (platinum platinum chemotherapy) (360) \"RowRow 3:\nCOI: No conflict declared\" (iii.",
      "start_page": 137,
      "end_page": 137
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 137,
      "end_page": 137
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 137,
      "end_page": 137
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\ntrials trials (Clinical recommendation) •RowRow 2:\nModerate • IV IV • PD-L1 PD-L1 ≥50% • __MEDTERM1 __MEDTERM1 • of of •MEDTERM2_ • status status (0-1) • considered considered (platinum platinum chemotherapy) (362) • RowRow 3:\nCOI: declared declared •",
      "start_page": 139,
      "end_page": 139
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 139,
      "end_page": 139
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 139,
      "end_page": 139
    },
    {
      "heading": "heading heading COI: no conflict declared (from previous page)",
      "text": "without without Row: PD-L1 PD-L1 <50% RowRow 3:\nperformance status (0-1), RowRow 4:\nRowRow 5:\nrecommended recommended (compared to chemotherapy)?Row 6:\nRECOMMENDATION: least least 50% of of −MEDTERME14__, using PD- L150; with with __MEDTERM0_==Film ==__medTERM24_ __medTERM24_ (58% vs 33%) MEDTERM25_ MEDTERM25_ (9 9 months; HR 0.54; IC95% 0.35-0.83) and __MDTERM26_ (1 1 months; HR 0.71; IC95% 0.45-1.12), despite a 70% was was 39% versus versus 31% chemotherapy chemotherapy (365). study study (including including PD- patients patients (n=190; HR 0.55; IC95% 0.39-0.76) and PD-l1 1-49% (n=86; HR 0.65; CI95% 0.46-0.90). 19. 19.4% 11. 11.3% alone alone (52. 52.1% vs 42.1%), events events (any 27.7%, 12. 12.6%) of of −Milanese Milanese (16.2%, grade 12.2%) placebo_M2. placebo_M2.",
      "start_page": 140,
      "end_page": 140
    },
    {
      "heading": "heading heading COI: no conflict declared (from previous page)",
      "text": "RowRow 2:\nPD-L1 expression <50% status status (0-1), RowRow 3:\n_ _ 0; RowRow 4:\nis is recommended: (compared with chemotherapy)?Row 6:\nRECOMMENDATION: with with PD- L1 expression<50% status status (0.-1), of of carbo-RowRow 5:\n(with with chemotherapy)? PD-L1 PD-L1 (PD-L1-1% vs <1%), events events (paclitaxel vs nab-paclitaxel) region region (the the world). after after l'__medTERM0_ __medTERM0_ (6 6 months; HR 0.71; CI95% 0.59-0.85), 18. 18.4% 9. 9.4% RowRow 10:\nof of evidence: LOWRow 11:\nCOI: no conflict declared",
      "start_page": 141,
      "end_page": 141
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\ntests tests ...Clinical recommendation: \"RowRow 2:\nModernised\"mutations mutations l[expression expression <50% status status (0-1), with with {option option (371) forRow 3:\nCOI: whatsoever. whatsoever.",
      "start_page": 143,
      "end_page": 143
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 143,
      "end_page": 143
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 143,
      "end_page": 143
    },
    {
      "heading": "heading heading First-line First-line treatment: chemotherapy",
      "text": "Row 1:\n• Overall quality •Clinical recommendation •Row 2:\n•Test strength •Recommendation •Row 3:\nModerate •__MEDTERM4_ __MEDTERM4_ • mutations mutations •of of •MEDTERM2_/PD-L1 PD-L1 1-49% status status (0-1), with with • option option (374-375) •RowRow 4:\n• COI: declared declared •",
      "start_page": 145,
      "end_page": 145
    },
    {
      "heading": "heading heading First-line First-line treatment: chemotherapy (from previous page)",
      "text": "Rowult 1: RowRow 2:\nRowRow 3:\nRowRow 4:\nrecommended recommended (5 5 alone: observation)?Row 6:\nRECOMMENDATION: status status (0-1), RowRow 7:\nthe the recommendation: ROW ROW 8: Motivations/comments to benefit/danno balance: Phase Phase III/patient. patient.",
      "start_page": 147,
      "end_page": 147
    },
    {
      "heading": "heading heading First-line First-line treatment: chemotherapy (from previous page)",
      "text": "Row 1:\nweeks) phase phase (maintenance phase), induction induction (n=539) pemetrexed pemetrexed (500 mg/3 3 weeks) + placebo placebo (8 8 months; HR 0.62; IC95% 0.49-0.79; p <0,0001) committee committee (6 6 months); HR 0.64; CI95% 0.51-0.81; p=0.0002).",
      "start_page": 148,
      "end_page": 148
    },
    {
      "heading": "heading heading treatment treatment lines",
      "text": "Rowter 1: __Row __Row 2:\na a •Row 3:\nMEDTERM0_, •MEDTERM1_ or •a a ♪Row 4:\nII-line Chemotherapy? •ROW 5: RECOMMENDATION: with with •_MEDTERN0__ (PD-L1 PD-L1 ≥ 1%) shouldRow 7:\nRowRow 8:\nStrength of recommendation: Plus Plus • RIGHT 9: Motivations/the the −year: of of ‐therapy. therapy.",
      "start_page": 150,
      "end_page": 150
    },
    {
      "heading": "heading heading Quality of tests",
      "text": "Row 1:\nfollowing following reasons: open-label open-label design; nor nor non- inferiority.Row 2:\nOverall test quality: MODERATARow 3:\nCOI: no conflict declared",
      "start_page": 154,
      "end_page": 154
    },
    {
      "heading": "heading heading status status 2",
      "text": "Row 1:\ntests tests (Clinical recommendation): Very low: therapy therapy (408-409) •RowRow 3:\nCOI: no declared conflict",
      "start_page": 157,
      "end_page": 157
    },
    {
      "heading": "heading heading status status 2",
      "text": "Row 1:\n Row 2:\nof of Tests",
      "start_page": 157,
      "end_page": 157
    },
    {
      "heading": "heading heading status status 2",
      "text": "Row 1:\nRow Force 2: Recommendation",
      "start_page": 157,
      "end_page": 157
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n\"Clinical recommendation\" = \"Row 2:\nOverall quality\" =Row 3:\nevidence \"RecommendationRow 4:\n\"Row 5:\n\"option option (423-426) \"RowRow 6:\nModerateRow 7:\n\"Row 8:\n\"Raw 9: COI: no declared conflict\"",
      "start_page": 166,
      "end_page": 166
    },
    {
      "heading": "heading heading stage stage disease",
      "text": "Row 1:\n\"Clinical recommendation\" =Row 2:\nOverall quality \"Row 3 strength\": \"Raw 4: \"Rown 5: \"chemo-radiotherapy, chemo-radiotherapy,\" brain brain (PCI) option option (430, 432-434) \"Strong in favor\"Row 6:\n\"Moderata\"Row 7:\n\"Row 8:\n\"Row 9:\nCOI: no declared conflict\"",
      "start_page": 168,
      "end_page": 168
    },
    {
      "heading": "heading heading stage stage disease (from previous page)",
      "text": "RowRow 2:\nRowRow 3:\nRowRow 4:\nplatinum-based platinum-based chemotherapy?Row 5:\nRECOMMENDATION: RowRow 6:\nStrength of recommendation: were were 7: Motivations/comments to benefit/danno: 56. 56.6% 56. 56.1% patient patient (PRO) life life (HRQoL) __medTERM0_ __medTERM0_ (436). EMA EMA (September 2019) MIFA MIFA (with September 2020) RowRow 8:\nfollowing following reasons: RowRow 9:\nOverall test quality: LOWRow 10:\nCOI: no conflict declared",
      "start_page": 169,
      "end_page": 169
    },
    {
      "heading": "heading heading stage stage disease (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nRowRow 4:\nplatinum-based platinum-based chemotherapy?Row 5:\nRECOMMENDATION: RowRow 6:\nStrength of recommendation: RowRow 7:\nMotivations/comments to benefit/damn: beta-cells beta-cells treatment; chemotherapy-_MEDTERM0_ chemotherapy-_MEDTERM0_ (5 5 months), maintaining a 25% alone alone (HR 0,75; IC95% 0.62-0.91; p=0.0032) with with etoposide-cisplatin/alone alone (5 5 months; HR 0.82; CI95% 0.68-1.00; p = 0.005). RowRow 8:\nfollowing following reasons: RowRow 9:\nOverall test quality: LOWRow 10:\nCOI: no conflict declared",
      "start_page": 170,
      "end_page": 170
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n\"Clinical recommendation\" \"Row 2:\nOverall quality\" \"Row 3:\nstrength\" \"RecommendationRow 4:\n\"Raw 5: \"I-line I-line platinum/option option (441- 442, 444-449) \"RowRow 6:\nModerateRow 7:\n\"Row 8:\n\"Rop 9: COI: no declared conflict\"",
      "start_page": 174,
      "end_page": 174
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\nRowRow 2:\nbrain brain (PCI) is recommended?Row 3:\nRECOMMENDATION: radiation radiation (CPI) RowRow 4:\nStrength of recommendation: RowRow 5:\nMotivations/comments to benefit/damage balance: study study (450) benefit benefit (27, 27,1% 1. 1.3% the the results",
      "start_page": 174,
      "end_page": 174
    },
    {
      "heading": "heading heading COI: no conflict declared (from previous page)",
      "text": "Row 1:\nmoment moment (452). half-analysis half-analysis (453) survival survival (HR 0.57; CI95% 0.47-0.69; p < 0.001) metastases metastases (HR 0.47; IC95% p p <0.01). 93. 93.7% 46. 46.3% groups groups (p=0.10). 92 92 (RASS RASS tests: the the BowT: as as follows:",
      "start_page": 175,
      "end_page": 175
    },
    {
      "heading": "heading heading COI: no conflict declared",
      "text": "Row 1:\n•Clinical recommendation •Row 2:\nOverall quality •Row 3:\nevidence strength •RecommendationRow 4:\n•Row 5:\nModerate • with with •option option (457- 460) •RowRow 6:\nCOI: declared declared •",
      "start_page": 178,
      "end_page": 178
    },
    {
      "heading": "heading heading Bibliography",
      "text": "Row 1:\nlong long cancer: RowFolkLowLightLowWildLoverLowSwimmedLowRow RowFolkLowLightLowWildLoverLowSwimmedLowRow 2:\n85.FollowRow 3:\nMed. Med. 2014; 370(1):60-8.Row 6:\nlung lung cancer: a •Row 7:\nCancer. Cancer. 2000; 27:long long cancer: RowRow 42:\nMed. Med. 2015; 191(10):1166-75.Row 43:\nRowRow 44:\ntrial trial (DLCST). Lung Cancer 2015; 87(1):65-72.",
      "start_page": 181,
      "end_page": 181
    },
    {
      "heading": "heading heading Bibliography (from previous page)",
      "text": "Row 1:\nv1. v1.1: negativeRow 2:\nRadiol. Radiol. 2021; 31(4):1956-68.Row 3:\nRowRow 4:\nRowRow 20:\nRowRow 21:\nRes. 2016; 22:3618-29.Row 22:\nRowRow 25:\nCancer. Cancer. 2012; 76:1-18.Row 26:\nRw Rw 25: sample.Row 40:\nlung lung cancer: RowRow 41:\ncytological cytological species: Series Series ›driver driver alterations:Row 44:\nOH OH (CCO) Oncol. Oncol. 2021; 39:1040-91.Row 45:\nunderling. underling.",
      "start_page": 182,
      "end_page": 182
    },
    {
      "heading": "heading heading Bibliography (from previous page)",
      "text": "Row 1:\nadvanced advanced non-RowRow 2:\nMed. Med. 2018; 378:113-25.Row 3:\nRowRow 4:\nnon non - and and _MEDTERM23__‐RowRow 5:\n2018; 36 (22):2244-50.Row 6:\nMed. Med. 2014;Row 23:\n371:1963-71.Row 24:\nRowRow 25:\nfusion-positive fusion-positive non-Oncol. Oncol. 2021; 39:1253-63.Row 26:\nRowRow 27:\nBRAFV600E-mutant metastatic non-small-cell Lung Cancer: Incol. Incol. 2017;Row 28:\n18(10) from from DESTINY-Lung01: RowRow 44:\n(T-DXd) in patients (Pts) with HER2-mutated (HER2m) cancer cancer (__MEDTERM39_). AnnRow 45:\nOncol. 2021; 32(suppl_5):S1283-S1346.Row 46:\nRowRow 47:\nRes. Res. 2012; 18:6658-67.Row 48:\nNV-Bulg. NV-Bulg.",
      "start_page": 183,
      "end_page": 183
    },
    {
      "heading": "heading heading Bibliography (from previous page)",
      "text": "Row 1:\nRoche Roche cobas® RowRow 2:\nDiagn. Diagn. 2017; 17:209-15.Row 3:\neasy easy RT-RowRow 4:\nlong long adenocarcinomas: RowRow 5:\nCancer. Cancer. 2016; 99:11-6.Row 6:\nnon-Row non-Row 18:\nsmall-cell lung cancer: RowRow 19:\nOncol. Oncol. 2013; 8:352-8.Row 20:\nRowRow 21:\nadvanced non-Cancer. Cancer. 2019; 131:62-8. row 22: RowRow 37:\nRowRow 38:\nCancer. Cancer. 2015; 6:413-20.Row 39:\nRowRow 40:\nPathol. Pathol. 2013; 37:1441-9.Row 41:\nclone clone (m.",
      "start_page": 184,
      "end_page": 184
    },
    {
      "heading": "heading heading Bibliography (from previous page)",
      "text": "Row 1:\nsequencing sequencing (NGS) RowRow 2:\nwith metastatic cancers: Oncol. Oncol. 2020;Row 3:\n31(11):1491-505.Row 4:\nlong long cancer:Row 5:\nPathol. Pathol. 2019; 72:412-7.Row 6:\nadvanced advanced __MEDTERM0_: RowRow 7:\nRowRow 20:\nClin. Clin. 2016; 11:243-59.Row 21:\nof of 18F-RowRow 22:\nRes. Res. 2000; 20:2189-92.Row 23:\nRowRow 24:\nMed. 2004; 45:2058-62.Row 25:\nall. all. 2018: 54:134-40.Row 40:\ncancer cancer staging; RowRow 41:\n2021; 11:1569.Row 42:\nAG. AG. Up-of of non-Row 43:\nAvailable Available from: http://shc.amegroups.com/articles/view/3933/4711Row 44:\nCancer. Cancer.",
      "start_page": 185,
      "end_page": 185
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399.",
      "text": "Row 1:\nRobotic-assisted Robotic-assisted bronchoscopy: RowRow 2:\nDiagnostics. Diagnostics. 2024; 14:399.Row 3:\nRowRow 4:\nlesions: Roentgenol. Roentgenol. 2015; 204(1):29-34.Row 5:\nRowRow 6:\nnode node sampling: RowRow 20:\nRowRow 21:\nSurg. Surg. 2011; 142:1393-400.Row 22:\ncancer cancer (Score Study). RowRow 23:\n2019; 53:1800.Row 24:\nRowRow 40:\nStaging Staging Project: RowRow 41:\nRowRow 42:\nOncol. 2017; 12:1109-21.Row 43:\nLowRow 44:\n: Cancer Stagging Project: forthcoming forthcoming (ninth) RowRow 45:\ncancer. cancer.",
      "start_page": 186,
      "end_page": 186
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\nRowRow 2:\ncancer cancer surgery: Surg. Surg. 2020; 58(1):70-7.Row 3:\nRowRow 4:\nRowRow 5:\n2015; 7:2003-9.Row 6:\nstaging staging Row: 7-lung lung cancer: RowRow 21:\ned. ed.: RowRow 22:\nguides. Chest. 2013; 143:e278S-e313S.Row 23:\nperipheral peripheral non-RowRow 24:\ncancer (JCOG0802/WJOG4607L): RowRow 25:\nLancet. 2022; 399:1607-17.Row 26:\nlong long cancer: aRow 40:\nPhys. Phys. 2018; 101(1):186-94.Row 41:\ncisplatin cisplatin evaluation: RowRow 42:\nOncol. Oncol. 2008; 26:3552-9.Row 43:\nRowRow 44:\nRev. Rev. 2015; 3:CD011430.Row 45:\nMadulg. Madulg.",
      "start_page": 187,
      "end_page": 187
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\nRowRow 2:\nOncol. Oncol. 2017; 3:610-9.Row 3:\nAzzoli Azzoli non-RowRow 5:\nOnco. Onco. 2007; 25:5506-18.Row 6:\nRowRow 7:\nresected resected non-small-of of early-stage: _MEDTERM7__Row 20:\nand and vinorelbine: RowRow 21:\nOncol. 2013; 24(4):986-92.Row 22:\nRowRow 23:\nNquelbine Nquelbine (theRow 24:\nstage stage II-Row 40:\nIIIA (N1-N2) __ MEDTERM5__-mutant __medTERM7__: RowRow 41:\n2021; 39(7):713-22",
      "start_page": 188,
      "end_page": 188
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\n\"RowRow 2:\nII-IIIA II-IIIA non-mutation mutation (IMPACT). J Clin\"Row 3:\nOncol. 2022; 40(3):231-41.",
      "start_page": 188,
      "end_page": 188
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\nRowRow 2:\nMEDTERM3__ MEDTERM3__ mutations: RowRow 3:\n2014; 21(6):2091-6Row 4:\nRowRow 5:\nOne. One. 2015; 10(10):e0140794.Row 6:\nrest. rest.",
      "start_page": 188,
      "end_page": 188
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "==Filmography===References== non-Row non-Row 21:\nOncol. Oncol. 2015; 26:902-7.Row 22:\nfor for non-small-cell lung cancer: RowRow 23:\noncol. oncol. 2012; 7:723-30.Row 24:\nRowRow 25:\nSurg. Surg. 2013; 145(1):75-81.Row 26:\ninternship internship non-Row 38:\nsmall-cell lung cancer: Oncol. Oncol. 2015; 10(8):1195-200.Row 39:\nRowRow 40:\n3rd 3rd Ed: RowRow 41:\nChest. Chest. 2013; 143(Suppl):e437-54.Row 42:\nradiotherapy. radiotherapy.",
      "start_page": 189,
      "end_page": 189
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\nSAKK SAKK 16/00 Trial: RowRow 2:\nstage stage IIIA/N2 non-Oncol. Oncol. 2014;Row 3:\n25(Suppl. 4):1v417.Row 4:\nRowRow 5:\nThorac Surg. 2005; 80(4):1224-30.Row 6:\nRowRow 22:\nnon-small-cell lung cancers: RowRow 23:\nOncol. 2014; 15(1):e42-50.Row 24:\nLlact. Llact. 1998; 352:257-63.Row 26:\npost-Loc. post-Loc. 2018; RowRow 27:\nRowRow 40:\nradiotherapy (PORT) cancer cancer (_MEDTERM0_) andRow 41:\nmediastinal N2 involvement: ART ART (NCRI, SAKK). AnnRow 42:\nOncol. 2021; 32(Suppl 5): S939.Row 43:\nRowRow 44:\nRowRow 45:\n2000; 48:34-54.Row 46:\nKappers comb.",
      "start_page": 190,
      "end_page": 190
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\ncomparing comparing second- RowRow 2:\nIII III non-small-cell lung cancer: RowRow 3:\nOncol. Oncol. 2010: 28(23):3739-45.Row 4:\nRowRow 5:\nRowRow 6:\navanced non-small-cell long cancer: RowRow 21:\n__ MEDTERM10_: Oncol. Oncol. 2021; 16(5):860-7.Row 22:\nSpigel Row. 2019;Row 41:\n393(10185):2051-8.Row 42:\nRowRow 43:\nRowRow 44:\n2018; 13(9:1383-92.Row 45:\nRowRow 46:\ndisease disease (NCCTG N107C/CEC·3).",
      "start_page": 191,
      "end_page": 191
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\nmetastatic metastatic non-small-Row 2:\ncell long cancer: Med. Med. 2021; 9(5):467-75.Row 3:\nRowRow 4:\nInst. Inst. 2023;Row 5:\n115(742-8. Erratum in: RowRow 6:\nRowRow 21:\nRowRow 22:\nOncol. Oncol. 2013; 31:3327-34.Row 23:\nRowRow 24:\nwith advanced non-mutations mutations (LUX-Lung 6): RowRow 25:\nOncol Oncol . 2014; 15:213-22.Row 26:\nWul-Long Wul-Long 6): advanced advanced non-RowRow 41:\nMEDTERM18_ MEDTERM18_ mutations: LUX LUX -RowRow 42:\nLUX/Oncol. Oncol. 2015; 16:830-8.Row 43:\nEGFR EGFR changes: aRow 44:\noncol. oncol. 2020; 15(803-15.Row 45:\nPopat Popat S",
      "start_page": 192,
      "end_page": 192
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\nRowRow 2:\nMEDTERM20__ MEDTERM20__ changes: Oncol. Oncol. 2024; 10(1):43-Row 3:\n51.Row 4:\nRowRow 5:\nLung Lung Cancer- 2020; 141:9-13.Row 6:\nRowRow 21:\nCommun. Commun. 2023; 14(1):1070.Row 22:\nRowRow 23:\nprogressive disease: RowRow 24:\n2012; 7(11):1722-7.Row 25:\nwith with 41: RowRow 42:\nmetastatic non-RowRow 43:\ninhibitors: Oncol. Oncol. 2024; 42(11):1252-64.Row 44:\nwith with non-small-cell low 45: Oncol Oncol 2009; 27(26):4247-53.Row 46:\nthe. the. MEDM_Mline",
      "start_page": 193,
      "end_page": 193
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\n__MEDTERM0_ __MEDTERM0_ (450 mg/600 600 mg/de) RowRow 2:\n750-mg/Oncol. Oncol. 2019; 14(7):__MEDTERM1_ __MEDTERM1_ (ALC) vs __MEDTERM2_ (CRZ) patients patients (pts) with treatment- 2017; 18(12):1590-9.?Row 40:\nRowRow 41:\nnon-Oncol. Oncol. 2021; 32(5):620-30.",
      "start_page": 194,
      "end_page": 194
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\nROS1-rearranged ROS1-rearranged non-Med. Med. 2014;Row 2:\n371(21):1963-71.Row 3:\nOncol. Oncol. 2019; 30(7):1121-6.Row 5:\nRowRow 21:\nRowRow 22:\nfusion-positive fusion-positive non-Oncol. Oncol. 2021; 39:1253-63.Row 23:\npositive positive non- RowRow 24:\nMed. 2024; 390(2):118-31.Row 25:\n__MEDTERR27_-positive __MEDTERR27_-positive not-fusion-positive fusion-positive tumours: RowRow 40:\nphase phase 1/Oncol. Oncol. 2020; 21(4):531-40.Row 41:\nfusion-Row fusion-Row 42:\nMed. Med. 2023; 389(20):1839-50.Row 43:\nAl. Al.",
      "start_page": 195,
      "end_page": 195
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\nMEDTERM20_ MEDTERM20_ fusion-Row 2:\npositive non-small-cell cancer: trial trial (LIB___MEDTERM20_TO-321). Oncol. Oncol. 2022;Row 3:\n14:17588359221105020.Row 4:\nof of •__medTERM2__ __medTERM2__ Fuss-Row 5:\npositive not-trial. trial. == References = External links ==* Med. Med. 2020; 383(14):1328-39.Row 43:\nfrom from IMpower110: RowRow 44:\nRowRow 45:\n2021; 16(11):1872-82.Row 46:\nadvanced advanced non-small-cellRow 47:\nleast least 50%: trial. trial.",
      "start_page": 196,
      "end_page": 196
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\ncohort cohort G: pemetrexedRow 2:\nRowRow 3:\nOncol. 2021; 16(1):162-8.Row 4:\nmetastatic metastatic non-small-cellRow 5:\nMed. Med. 2018; 378 (22):078-92. stuw 6: from from KLEY-NOTSma89: _MED First-line (L) _MEDTERM6_ (N) + _MEDTERM7_ (I) + chemotherapy (C)Row 23:\npatients patients (pts) __MEDTERM14_ __MEDTERM14_ (m_medTERM14_) from CheckMate 9LA: RowRow 24:\nsubtype subtype (THS). Oncol. Oncol. 2023; 41(17_suppl.): RowRow 25:\nRowRow 42:\nadvanced advanced non-small-cell lung cancer: RowRow 43:\n08975. 08975.",
      "start_page": 197,
      "end_page": 197
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\nal. al. PARAMOUNT: RowRow 21:\npatients with non-Oncol. Oncol. 2000;Row 22:\n18:2095-103.Row 23:\nRowRow 24:\nadvanced advanced non- small-RowRow 25:\nRowRow 41:\nnonsquamous nonsquamous non-RowRow 42:\nMed. Med. 2015; 373:1627-39.Row 43:\nRowRow 44:\ncheckMate 017/057: 2019. 2019. [Internet].Row 45:\nAvailable from: https://.jto.org/article/S1556-0864(19)31169-4/abstractRow 46:\n47. 47.",
      "start_page": 198,
      "end_page": 198
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\ntreated treated non-Row 2:\ncancer cancer (OAK): et et 389:255-Row 3:\n65.Row 4:\nadvanced advanced non-RowRow 5:\nverse verse Docetaxel: Cancer. Cancer. 2019;Row 6:\n107:124-32.Row 7:\nRowRow 21:\nadvanced advanced non-small-cell lung cancer: RowRow 22:\nLancet. 2011; 378:1079-88.Row 23:\nnon non - RowRow 24:\nRev. Rev. 2015; (10):CD010463.Row 25:\nadvanced advanced non-Row 26:\nsmall-cell long cancer: MILE-4 MILE-4 (C)Row 40:\nRowRow 41:\nOncol. Oncol. 2010; 5(2):215-9.Row 42:\nlow low 43: cancer: be be re-evaluated? Cancer. 2010); 116(5):1350-7.Row 44:\nMed. Med. 1992;Row 45:\n327 (23):16-24.",
      "start_page": 199,
      "end_page": 199
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "== References = External links ==* Med. Med. 2018; 379:2220-9.Row 20:\nRowRow 21:\ncancer cancer (IMpower133): RowRow 22:\nAnn Oncol. 2020; 31(2):310-7.Row 23:\nRowRow 24:\netoposide etoposide (IMpower133). RowRow 25:\nOncol ==References===External links==* Official website",
      "start_page": 200,
      "end_page": 200
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "Row 1:\nRowRow 2:\nOncol. Oncol. 2009;Row 3:\n27(28:4787-92.Row 4:\nextende extende small- Now Now 5: Med. Med. 2007; 357:664-72.Row 6:\nex ex cul: trigranal trigranal furan: RowRow 7:\nlung lung cancer: Oncol. Oncol. 1999; 17(2):658-67.Row 21:\nRowRow 22:\noncol. oncol. 2006; 24(34): 5441-7.Row 23:\nRowRow 24:\ncancer. cancer.",
      "start_page": 201,
      "end_page": 201
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (column column 1)",
      "text": "Row 1:\n... ...the the results: ... RowRow 6:\n- \"Row 7:\nmortality mortality - screening screening (follow up: 35 35 years)Row 8:\n•Row 9:\nnon-important non-important [non important] not important [non-important] Not important\" RowRow 10:\nAll-case mortality -no no screening: year year old)Row 12:\nRowRow 13:\nserious serious - screening screening (follow up: 35 35 age)",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (column column 2)",
      "text": "Row 1:\n•Row 2:\n•patients patients •Effect •CertainRow 3:\n•Row 4:\nOther considerations •LDCT screening •LDCT screening −Relative (95% CI) •Absolute (95% CI), •row 5: • row 6: ♪Row 7:\n■",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (column column 2)",
      "text": "Row 1:\n346/15917 (2.2%) •416/15189 (2.7%) •80 80 (0. 0.92) •000 000 (2 2 less)",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (column column 2)",
      "text": "Row 1:",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (column column 2)",
      "text": "Row 1:\n1548/15917 (9.7%) •1515/15189 (10.0%) •98 98 (1. 1.07) •000 000 (7 7 more)",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (column column 2)",
      "text": "Row 1:\n375/15917 (2.4%)",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (column column 2)",
      "text": "Row 1:\n194/15917 (1.2%) • 276/15189 (1.8%) ♪ 67 67 (0. 0.80) • 000 000 (4 4 less)",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (column column 2)",
      "text": "Row 1:\nng cancer)",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (column column 2)",
      "text": "Row 1:\n224/7305 (3.1%) •74/6554 (1.1%) •57 57 (3. 3.74) •000 000 (31 31 plus)",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading Diagnostics. Diagnostics. 2024; 14:399. (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"ImportationRow 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"CRITICRow 7:\n\"Row 8:\n\" \"Row 9:\n\" CRITICRow 10:\n\" row 11: \" 'Row 12:\n\" CRITICRow 13:\n\" Route 14: \" - \"Row 15:\n\" CriticicRow 16:\n\"\"Row 17:\n\" Now 18: \"",
      "start_page": 203,
      "end_page": 203
    },
    {
      "heading": "heading heading Explanations",
      "text": "Row 1:\n... . . . ... . ..\" . .\" . . \" . .",
      "start_page": 204,
      "end_page": 204
    },
    {
      "heading": "heading heading Explanations (column 1)",
      "text": "Row 1:\n•Row 2:\nCertainty assessment •patients patients •Effect •CertoRow 3:\n•Row 4:\nstudies studies •study study •Disruption risk •Sustainability loss •Improvement •More considerations •LDCT screening •LDCT screening ■Related (95% CI) •Absolute (95% CI), •row 5: • Overdiagnosis - screening screening (follow up: 5 5 years; •screen-detected screen-detected cancers).",
      "start_page": 204,
      "end_page": 204
    },
    {
      "heading": "heading heading Explanations (column 2)",
      "text": "Row 1:\n Row 2:\nImportanceRow 3:\nRowRow 4:\n Row 5:\nCRITICRow 6:\n Row 7:\n Row 8:\nIMPORTANT",
      "start_page": 204,
      "end_page": 204
    },
    {
      "heading": "heading heading BACKGROUND:",
      "text": "Row 1:\nday. day.",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "heading heading BACKGROUND: (column 1)",
      "text": "Row 1:\nRowRow 3:\n\"annual\" to to non-screening?Row 4:\n\"Row 5:\n\"POPULATION\": \"Raw 6: \"ROW 7: \"INTERVENTION\":",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "heading heading BACKGROUND: (column 2)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "heading heading BACKGROUND: (column 3)",
      "text": "Row 1:\nday day ...Row 2:\nale ale ...Row 3:\n\"Row 4:\n\"",
      "start_page": 205,
      "end_page": 205
    },
    {
      "heading": "heading heading Problem",
      "text": "136, 136, - NS NS (13, 13, 14) 2021 2021 (15). Italy Italy (6, 10, 13) Netherlands Netherlands (14), Germany (11), and Denmark (8).",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n•Row 2:\n• ProblemRow 3:\n• RowRow 4:\n•",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRity?",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\nectsRow 3:\nRow",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\n\"EVIDENCE EVIDENCE TESTS\": \"Row 2:\nLung Cancer (LC) computing computing (LDCT) achieved a 20% Trial Trial (NLST), radiography radiography [1], trials trials (RCT) RCTs RCTs [1",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\nRowRow 2:\nReviews Reviews (CENTRAL), controlled controlled trials; population population (n.3) or intervention (n.2) CXR CXR (populating populating (n.3) or participation (interest interest & CxR CxR (3: population population (peer peer education) population population (no) (3. 3.",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading Problem (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 206,
      "end_page": 206
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "(CCI) trials trials (95% CI) (studies) (GRADE) 31106 31106 - no no (a a (6 RCT) 0. 0.992) follow up: years years (19 to 25) All-case mortality - 998 998 31106",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website* European European Union: http://europa.eu.int/comm/index_en.htm",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95% CI)",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRow confidence 2:Row 3:\n(GRADE)",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "== Demographic evolution =References==",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n•Row 2:\n•Certez tests (GRAD) • CertezRow 3:\npanti •TestRow 4:\n•GRAD",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nandRow 4:\nDE)",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n\"Row\" 2: \"Coco Row\" 3: \"Rown\" 4: \"Raw\"",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\nommen",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\nnti",
      "start_page": 207,
      "end_page": 207
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n•Resectability rate - 13859 13859 • screening screening (a a (4 RCT) MODERATAb evaluated with: surgery 3.74) 000 000 follow-up: interval 3 (20 to 42) performance performance and/specific specific survival",
      "start_page": 208,
      "end_page": 208
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nResectability rate - evaluated evaluated with: cancer cancer follow-up: 35 35 years",
      "start_page": 208,
      "end_page": 208
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(20 to 42)",
      "start_page": 208,
      "end_page": 208
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\nResectability rate - evaluated evaluated with: follow follow up: 57 57 (3. 3.74)",
      "start_page": 208,
      "end_page": 208
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"Early Early detection\"",
      "start_page": 209,
      "end_page": 209
    },
    {
      "heading": "heading heading Undesirable effects",
      "text": "Row 1:\n\"Resectability Resectability rate\"Row 2:\n\"Row\" 3: \"Undesirable effects\"Row 4:\n\"anticipated anticipated effects?",
      "start_page": 210,
      "end_page": 210
    },
    {
      "heading": "heading heading Undesirable effects (column 1)",
      "text": "Row 1:\n•Row 2:\n• RowRow 3:\n• RowRow 4:\n•",
      "start_page": 210,
      "end_page": 210
    },
    {
      "heading": "heading heading Undesirable effects (column 2)",
      "text": "Row 1:\n\"Row 2:\ns\"Row 3:\nrable anticipated effects?",
      "start_page": 210,
      "end_page": 210
    },
    {
      "heading": "heading heading Undesirable effects (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 210,
      "end_page": 210
    },
    {
      "heading": "heading heading Undesirable effects (column 10)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"",
      "start_page": 210,
      "end_page": 210
    },
    {
      "heading": "heading heading Undesirable effects (from previous page)",
      "text": "Row 1:\nFALLOWING FALLOWING (FULLY FALSEING) FOLZING FON'FALKING FALKING - FALCING FILES) FUR, F/F. F.",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading Undesirable effects (from previous page)",
      "text": "Row 1:\n\"Row 2:\nEsiti\" Precipitated absolute effect* (95%) = relative effect (95% CI) = participants participants (studies) = [tests tests (GRADE) ] = [CommentsRow 3:\n\"CI\") =Row 4:\n\"Row 5:\n\"Row 6:\n\"LDCT LDCT screening\" = \"Richness with \"Row 7:\n\"LDCT\" = row 8: \"Screening Row\" = 9: \"Row 10:\nOverdiagnosis - evaluated evaluated by: number number of",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading Undesirable effects (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95% CI)",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading Undesirable effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading Undesirable effects (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n(GRADE)",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading Undesirable effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\nLDCT screening",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading Undesirable effects (from previous page)",
      "text": "Row 1:\nAverageRow 2:\noverdiagnosis -Row 3:\nRowRow 4:\nscreening was 0",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading Undesirable effects (from previous page)",
      "text": "Row 1:\noverdiagnosisRow 2:\nRowRow 3:\n(RowRow 4:\nRowRow 5:\nRowRow 6:\ngreater)",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading Undesirable effects (column column 4)",
      "text": "Row 1:\n\"Row 2:\nEsiti\" Precipitated absolute effect* (95%-) = relative effect (95% CI) = participants participants (studies) = [tests tests (GRADE) ] = [Comments]:Row 3:\n\"Ci\") =Row 4:\n\"Row 5:\n\"Row 6:\n\"LDCT LDCT screening\" = \"Richness with \"Raw 7\": \"LDCT\" = 8: \"Screening\" = 9: \"Row 10:\nOverdiagnosis - \"LDCT\" vs \"no screening\" evaluated by: of of \"-\"28656 (5 RCT) = \"BASSAa,b\" = 11: \"overdiagnoses overdiagnoses - major major (12. 12.63).",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading Undesirable effects (column column 5)",
      "text": "Row 1:\n Row 2:\ni",
      "start_page": 211,
      "end_page": 211
    },
    {
      "heading": "heading heading Undesirable effects (from previous page)",
      "text": "Row 1:\n\"follow follow up: rate rate - positive positive - 8635 = rate rate - 53 53 (2 RCT) is followed up: 0 0 (09 09 greater) performance performance and/studies studies (I-squared=65%) studies. studies.",
      "start_page": 212,
      "end_page": 212
    },
    {
      "heading": "heading heading Undesirable effects (from previous page)",
      "text": "Row 1:\nfollow follow up: 5 5 years",
      "start_page": 212,
      "end_page": 212
    },
    {
      "heading": "heading heading Undesirable effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\npositive rate -Row 3:\nRowRow 4:\nscreening was 0",
      "start_page": 212,
      "end_page": 212
    },
    {
      "heading": "heading heading Undesirable effects (column column 1)",
      "text": "Row 1:\nfollow follow up: 5 5 years",
      "start_page": 212,
      "end_page": 212
    },
    {
      "heading": "heading heading Values",
      "text": "Row 1:\n\"False positive\" = \"Row 3\": \"Certainty of evidence\" = . \"of of effects?\" = .",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "heading heading Values (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Certainty of evidence\"Row 4:\n\"of of effects? \"Row 5:\n\"Row 6:\n\"JUDIZI\"Row 7:\n\"Very low \" Low ● \"Moderate \"High \" No included studies\"Row 8:\n\"Raw 9: \"Values\"Row 10:\n\"people people value\"Row 11:\n\"",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "heading heading Values (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "heading heading Values (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nmain main outcomes?",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "heading heading Values (column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 213,
      "end_page": 213
    },
    {
      "heading": "heading heading Equity",
      "text": "Row 8:\nthe the appearance?",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\nhealth health capital:Row 2:\n\"or or variableity\" = \"or or variability\" = ● variable, \"or or variables\" = row 3: \"Row 4:\n\"Balance of effects\" =Row 5:\n\"the the interv\" = rule 6: \"Row 7:\nJUIDIZI\" = Rule 8: \" Favors the comparison\" = * \"the the compare\" = comparison comparison \"the the intervention\" ==References===External links==* Official website",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading Equity (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading Equity (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nmparison?",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading Equity (column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 214,
      "end_page": 214
    },
    {
      "heading": "heading heading Feasibility",
      "text": "Row 1:\n\"Reduced \" Probably reduced \" ● impact impact \" Probably increased \" Varies \" Don't know \"found found \"Row 2:\n\"Row 3:\n\"Acceptability \"Row 4:\n\"key key stakeholders? \"Row 5:\n\" Yes \" Diverses \" know know \" No evidence found\"Row 8:\n\"Row 9:\n\"Feasibility\" No ● \"Row 10:\n\"to to implementation\"?",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading Feasibility (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"AcceptabilityRow 3:\n\"RowRow 4:\n\"",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading Feasibility (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"FeasibilityRow 3:\n\"RowRow 4:\n\"",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading Feasibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading Feasibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading Feasibility (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nstakeholders stakeholders \"Row 4:\n\"",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading Feasibility (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nimplementation? \"Row 4:\n\"",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading Feasibility (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\ns?",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading Feasibility (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading Feasibility (column 16)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 215,
      "end_page": 215
    },
    {
      "heading": "heading heading TIP OF RECOMMENDATION",
      "text": "Row 1; Row 2; GIUDIZI 5; Row 4; No 5; Probably: Proba bly; ProBably; Vols. Vols.",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "heading heading TIP OF RECOMMENDATION",
      "text": "Row 1:\nthe the intervention",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "heading heading TIP OF RECOMMENDATION (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "heading heading TIP OF RECOMMENDATION (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\nDon't know\"Row 5:\n\"Don't knowing\"Row 6:\n\"Don't known\"Row 7:\n\"No included studies\"Row 8:\n\"Raw 9: \"Row\" 10: \"Wow\" 11: \"T\" Know\"Row 12:\n\"N't knows\"Row 13:\n\"Not know\" row 14: \"don't really know\"",
      "start_page": 216,
      "end_page": 216
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 217,
      "end_page": 217
    },
    {
      "heading": "heading heading harvested harvested lymphonodes",
      "text": "== Demographic evolution =References==",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "heading heading Harvested Harvested Lymphhonodes (column 1)",
      "text": "Row 1:\n... -Row 1:\n: -10:study study (s) \"of of distortion\"Disruption risk (iflow up: median 7 years) \"Row 8:\n•Row 9:\n21,2'Studies randomizability\" \"Impered\"No important\" (not important) \"no important\" \"non important\" Not important\"Row 10:\nOverall Survival RCT: Follow up up: years years old) \"Row 8:\n\"Raw 9: 2,2\" studs randomized \"non-important\" (non important) ] \"Row 10:\nRCT RCT (follow 9:21,2: Ooverall Survival RCT): \"Overall survival RCT\" (no important): \"Nor not important\": Ow 12: 1 1 - major observational: - major: 2 2 - 5 - 13 - 6 - not important - not significant - 12 - not major - non - not so - major - not huge - not relevant - major [ major - including important - 15 - 15, - 14 - 15; - 25 - 16 - 12, 12 - major",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "heading heading Harvested Harvested Lymphhonodes (column 2)",
      "text": "Row 1:\n... .. . . . ... . ..\" . . .\" . .\" . . \" . .",
      "start_page": 218,
      "end_page": 218
    },
    {
      "heading": "heading heading Postoperative air leaks",
      "text": "== Demographic evolution =References==",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading Postoperative air leaks (column 1)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRow",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading Postoperative air leaks (column 1)",
      "text": "Row 1:\nRow",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading Postoperative air leaks (column 1)",
      "text": "Row 1:\nRCT RCT (follow up:",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading Postoperative air leaks (column 1)",
      "text": "Row 1:\nRow",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading Postoperative air leaks (column 1)",
      "text": "Row 1:\nRow",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading Postoperative air leaks (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" RowRow 6:\n\"",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading Postoperative air leaks (column 2)",
      "text": "Row 1:",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading Postoperative air leaks (column 2)",
      "text": "Row 1:\n: median 7 years)",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading Postoperative air leaks (column 3)",
      "text": "Row 1:\n\"Row 2:\nCertainty assessment\"Row 3:\n\"Raw 4: \"Row 5:\nRisk of distortion\" results results \"Made of generalization\" precision precision \"More considerations\"Row 6:\n\"Row 7:\nnot not important\" non-important \"Not important\"Row 8:\n\"Rop 9: \"Row 10:\nserious\" non important \"No important\" row 11: \"row 12: \"Row 13:\nserious \"not important\" \"Seriog\"Row 14:\n\"Wow 15: \"How 16: serious or serious\" not important \"Way 17: \" Now 18: \"Now 19: serious not important\"\" Not important\"",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading Postoperative air leaks (column 4)",
      "text": "Row 1:\n•Row 2:\n•patients patients • row 3: •Row 4:\n•row 5: oniřla segmentectomy •lobectomy",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading Postoperative air leaves (column 5)",
      "text": "Row 1:\n\"Row\" (95% CI) \"Absolute (95% CI), \"Certo-Row 5:\n\"Rop\" 6: \"Middle\" (0. 0.74) \"Very low\" [Row 7:\n\"ROW 8: \"Row 9:\n\"‐Md\" less less (0. 0.46) ] \" Very low\" (Row 10:\n\"Rule 11: \"Row 12:\n\"RR 1.61\" (2. 2.31) \"100 100 (9 9 more) \"RowRow 13:\n\"Now 14: \"Row 15:\n\"Or 1.40\" (2. 2.08) \"100 100 (5 5 more) ...\" Very low \"Raw 16\": \"Short 17: \"row 18: \"Last\" (2. 2.08) \"2 + 100 (5 5 more).",
      "start_page": 219,
      "end_page": 219
    },
    {
      "heading": "heading heading Rehospitalization - not reported",
      "text": "==References===External links==* Official website",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "heading heading Rehospitalization - not reported (column 1)",
      "text": "Row 1:\n...",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "heading heading Rehospitalization - not reported (column 2)",
      "text": "Row 1:\n• \"Row\" 1: \"No\": \"No of patients\" \"ImportRow 3:\n•Row 4:\n\"Oni\" the segmentectomy\" \"Lobectomy\") \"Relative (95% CI) \"Absolute (95%CI) \"Certo\"Row 5:\n\"Ru\" 6: \"Wow\" 7: •Row 8:\n\"36/552 (6.5%) \"Ra\" 21/554 (3.8%) \"72 72 (2. 2.90) \"100 100 (7 7 more) \"Bassa\" CRITICORow 9:\n\"Row 10:\n♪Row 11:\n\"1/38\" (2.6%) \"R\"8/289 (2.8%) \"95 95 (7. 7.81) \"100 100 (15 15 more) ] \"Very low\" RW: \"CRITICoRow 12:\n\"Row 13:\n\"-Row 148/552 (26.8%) =142/554 (25.6%).\"",
      "start_page": 220,
      "end_page": 220
    },
    {
      "heading": "heading heading DOMANDA",
      "text": "Row 1:\nRecidental hospital stay; Local recurrence; Postoperative air leaks; Post-operative airleaks (Row)",
      "start_page": 222,
      "end_page": 222
    },
    {
      "heading": "heading heading Desirable effects",
      "text": "Row 1:\n\"Row 2:\nPERSPECTIVE: \"Row 3:\n\"Row 4:\nBACKGROUND: \" row 5: \"Row 6:\n\" CONFLICT OF INTERESTS: \"row 7: \"",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "heading heading Desirable effects",
      "text": "Row 1:\n= = ==Demographics==a a priority? ==References=_==External links==* Official website",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "heading heading Desirable effects (column 1)",
      "text": "Row 1:\n\"Row 2:\nPERSPECTIVE: \"Row 3:\n\"Row 4:\nBACKGROUND: \" row 5: \"Row 6:\n\" CONFLICT OF INTERESTS: \"row 7: \"",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "heading heading Desirable effects (column 1)",
      "text": "October October 2023: from from Don'October October 2023; records. records.",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "heading heading Desirable effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "heading heading Desirable effects (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 223,
      "end_page": 223
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipants (studies)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n(GRADE)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(14 to 20)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(-- a --)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(23 to 30)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(-- a --)",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (column column 1)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (column column 2)",
      "text": "Row 1:\n?Studies' NoRow 3:\n\"Row\" 4: \"Raw\" 5: \"Rown\" 6: \"Row\" 7: \"My Row\" 8: \"The Row\" 9: \"HR\" 0.82 (1. 1.02) \"Row 10:\n\"Wow\" 11: \"How\" 12: \" Row\" 13: \"Now\" 14: \"row\" 15: \" Row\" 16: \"hr\" 1.09 (1. 1.28) \"Row 17:\n\"Heavy\" 18: \"Dow\" 19: \"raw\" 20: \" Now\" 21: \" Roll\" 22: \"- Row\" 23: \"H\" 1.00 (1. 1.18) \"Rlow\" 24: \"Ow\" 25: \"Cow\" 26: \"===References==Further reading==",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (column column 7)",
      "text": "Row 1:\n\"Row\" 2: \"the the tests\" (GRADE) \"CreativeRow 3:\n\"The Row\" 4: \"Test Row\" 5: \"GRADE\"",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (column column 8)",
      "text": "Row 1:\n\"Row 2:\na\"CommentsRow 3:\n\"Row 4:\n\"Row 5:\n) \"Row 6:\n\"RowRow 7:\n\" RowRow 8:\n\"probably probably doesn'row row 9: \"cause cause any",
      "start_page": 224,
      "end_page": 224
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "07 07 - 792 • inferior inferior (5 observational studies) 58 58 - 1412 • 0 0 (0. 0.46) 0 0 (0. 0.66) H. H.",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "Row 1:\n\"RowRow 2:\n\"Row 3:\n\"Row 4:\nlife life - not reported\" - \"-\"-\"Row 5:\n\"-\"\"-\" row 6: \"Row 7:\nharvested harvested lymphonodes-\"\"792 (5 observational studies) 23, 23,24\" Very lowe,f\"RowRow 8:\n\"was was 0'lower lower (44 44 below)Row 9:\n\"Row 10:\nLenght hospital stay-\"1412 (9 observational trials)28 28 • and, and,f",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "Row 1:\nAverageRow 2:\nRowRow 3:\nHarvestedRow 4:\nLymphonodesRow 5:\nwas 0",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\nLowerRow 3:\n(RowRow 4:\n0.74 lower)",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "Row 1:\nAverageRow 2:\nRowRow 3:\nStay was 0",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\nLowerRow 3:\n(RowRow 4:\n0.46)",
      "start_page": 225,
      "end_page": 225
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "==References===External links==* Cardiovasc Cardiovasc Surg; J. J., P. P., A. A., Awais, O., J. J., Abbas, G., M. M., Weksler, B., Luketich, J",
      "start_page": 226,
      "end_page": 226
    },
    {
      "heading": "heading heading Desirable effects (from previous page)",
      "text": "==References===External links==* Thorac Thorac Cancer; T. T., M. M., D., F. F., G. G., J J Surg; X. X., Q. Q., Surg. Surg.",
      "start_page": 227,
      "end_page": 227
    },
    {
      "heading": "heading heading DFS (RCT)",
      "text": "Row 1:\nDFS DFS (RCT)",
      "start_page": 228,
      "end_page": 228
    },
    {
      "heading": "heading heading OS",
      "text": "Row 1:\n\"DFS\" OS RCT __MEDTERM0_=--",
      "start_page": 229,
      "end_page": 229
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\n\"Harvested Harvested Lymphonodes\"",
      "start_page": 230,
      "end_page": 230
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\n\"hospital hospital stay\"Row 2:\n\"Row 3:\n\"Undesirable effects\"Row 4:\n\"anticipated anticipated effects?\"Row 5:\n\"Raw 6: \"JUDICIAL EVIDENCE TESTS\"",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "heading heading OS_ (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"UndesirabRow 3:\n\"RowRow 4:\n\"",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "heading heading OS_ (column column 2)",
      "text": "Row 1:\n\"Row 2:\nble effects\"Row 3:\nanticipated anticipated effects?",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "heading heading OS_ (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "heading heading OS_ (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" ADDITIONAL CONSIDERATIONS \"",
      "start_page": 231,
      "end_page": 231
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "==Demographic evolution===References==*figures figures 2006<br>==External links==",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipants (studies)",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n(GRADE)",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(8 to 17)",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(5 to 10)",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading OS_ (column column 2)",
      "text": "Row 1:\n__MEDTERM0_ __MEDTERM0_ (T1aN0) Effect Effect Early* Certifications Certifications (95% CI) relative (studies) of the (95% Neiviral Neiviral disease) (GRADE) Lobctomy. Lobctomy.",
      "start_page": 232,
      "end_page": 232
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\n\"leads leads (RCT) (to to (1 RCT)2. 2.90) (4 to 11) OR OR 327",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 18)",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(22 to 33)",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(19 to 30)",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading OS_ (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"RR 1.72\" (2. 2.90)Row 5:\n\"Study population\" = 6: \" Row 7\": \"Raw 8: \"10\" = 9: \"4 to 11\") \"Row 10:\n\"Row 11:\n\"OR 0.95\" (7. 7.81) \"Row 12:\n\" Studio population\" *Row 13:\n\" row 14: \"Row 15:\n\"3 for 100\" = 100 (0 to 18) \"Row 16:\n\"ROW 17: \"04 04 (1. 1.27) \"Row 18:\n\"Population in study\" = 19: \" Now 20: \"",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading OS (column column 9)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nRowRow 4:\nRowRow 5:\ncomplications. complications.",
      "start_page": 233,
      "end_page": 233
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\n\"Rehospitalization - - -- - H. H., Okada, M., Tsuboi, M:, Nakajima, R., Suzuki, K., Aokage, K; Aokaki, T., Nakami, J., Yoshino, I., Ito, H ., Okaumura, N., I. I. , Asamura, H ... peripheral, non-ferill-cell cancer (JCOG0802/WJOG4607L): E. E., Nakas, A., E. E. , J. J., Cardiothorac Cardiothorac Surg; W. W., Yoshimura, M., Maniwa, Y., Kitamura, Y ., Tane, K ., Takenaka, D ., Adachi, S.. Thorac Thorac Surg; A A ... Schuchert, MJ., L. L., P. P., Daddi, N., Loizzi, D., Ampollini, L., Ardò, N ., Ventura, L ..., Carbognani, P. , Potenza, R., Ardissone, F., Sollitto, F ., Mattioli, S., M. M., Ragusa, M .. long long cancer: elderly elderly patients?. Surg Today; Dec 2016.",
      "start_page": 234,
      "end_page": 234
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\nRehospitalization - not reported",
      "start_page": 234,
      "end_page": 234
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Rowhang 1: R. R., J. J., Pennathur, A., O. O., Siegfried; J. M., D. D., J J == References = External links ==* J J Surg; K. K., Saji, H., I. I., Okada, M., Mizusawa, J., Nakajima, R., Tsuboi, M ., Nakamura, S",
      "start_page": 235,
      "end_page": 235
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\n\"Misumi,\" K., Hanaki, H., Hida, E., Okada, M.. J J Surg; rhythmic rhythmic (Y. Y., Miyata, Y",
      "start_page": 236,
      "end_page": 236
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\n\"Postoperative air leaks\"",
      "start_page": 237,
      "end_page": 237
    },
    {
      "heading": "heading heading OS (from previous page)",
      "text": "Row 1:\n\"Postoperative complications\"",
      "start_page": 238,
      "end_page": 238
    },
    {
      "heading": "heading heading Certainty of evidence",
      "text": "Row 1:\n'Row 2:\n'Row 3:\n'Certainty of evidence'Row 4:\n'of of effects? 'Row 5:\n'Row 6:\n'JUDICES' EVIDENCE EVIDENCE TESTS'.",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "heading heading Certainty of evidence (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Certainty of evidence\" \"Row 4:\n\"of of effects?\" \"Row 5:\n\"Row 6:\n\"JUDIZI\"Row 7:\n\"Very low \"Low ● Moderate \"High \" No included studies\"",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "heading heading Certainty of evidence (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "heading heading Certainty of evidence (column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 239,
      "end_page": 239
    },
    {
      "heading": "heading heading Values",
      "text": "Row 1:\n\"main main outcomes? \"Row 3:\n\"main main outcome?\" \"Row 4:\n\"Row 5:\n\"Judizi\"\" \"di di evidenza\" \"additional additional evidence\" \"Row 6:\n\"or or variable\" ● \"variability variability \"variables variables \"variation variation \"found. found.\" \"considerations considerations \"Row 7:\n\"Row 8:\n\"effects effects \"Row 9:\n\"the the companion\" \"Row 10:\n\"CompanyRow 11:\ninterventions interventions \"",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 1)",
      "text": "Row 1:\n'Row 2:\n'ValuesRow 3:\n'RowRow 4:\n'Row 5:\nJUDICES'Row 6:\n'or or variable'Row 7:\n'Raw 8: 'RowRow 9:\n'RowRow 10:\n'Row 11:\nJUDIZI'Row 12:\n'appearance appearance 'comparison comparison ' comparison comparison ● intervention intervention ' participation participation '",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nncertaint",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 2)",
      "text": "Row 1:\n Row 2:\nctsRow 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\ndesirable",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 8)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 8)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 9)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 9)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 10)",
      "text": "Row 1:\n Row 2:\n Row 3:\nmes?",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 10)",
      "text": "Row 1:\n Row 2:\n Row 3:\nmparison?",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 11)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 11)",
      "text": "Row 1:\n Row 2:\n Row 3:\n?",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Values (column 16)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 240,
      "end_page": 240
    },
    {
      "heading": "heading heading Feasibility",
      "text": "Rowlng 1: \"Rowlng: \"Raw\": \"Equity\": row 3: \"health health equity?\": \"Now 5: \"JUDITIONS\": ...\"TESTS, TESTS,\" \"ADDITIVE TESTING\":\"\"Row 6:\n\"Reduced \"Probably reduced \"impact impact ● Probably increased \"Varies \"Don't know\":found. found. \"Ruy 7: \"Row 8:\n\"Acceptability\"\" = 9: \"key key stakeholders?",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading Feasibility (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"EquityRow 3:\n\"RowRow 4:\n\"",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading Feasibility (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"AcceptabRow 3:\n\"RowRow 4:\n\"",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading Feasibility (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"FeasibilityRow 3:\n\"RowRow 4:\n\"",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading Feasibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nhealth health equity?",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading Feasibility (column 2)",
      "text": "Row 1:\n\"Row 2:\nbalance\"Row 3:\nkey key stakeho\"Row 4:\n\"Raw\"",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading Feasibility (column 2)",
      "text": "Row 1:\n\"Row 2:\ny\"Row 3:\n\"to to implementation?\" \"Rop 4: \"Raw\"",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading Feasibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading Feasibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nOlders?",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading Feasibility (column 15)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 241,
      "end_page": 241
    },
    {
      "heading": "heading heading JUDIZI",
      "text": "Row 1; Row 2; GIUDIZI 5; Row 4; No 5; Probably: Proba bly; ProBably; Vols. Vols.",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading JUDIZI (column 1)",
      "text": "Row 1:\n Row 2:\nPROBLEMRow 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:\n Row 11:\nRowRow 12:\n Row 13:\n Row 14:\nVALUESRow 15:\n Row 16:\n Row 17:\nRowRow 18:\n Row 19:\n Row 20:\nEQUITYRow 21:\n Row 22:\n Row 23:\nACCEPTABILITYRow 24:\n Row 25:\n Row 26:\nFEASIBILITY",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" row 7: \" \"Row 8:\n\" TS \"Row 9:\n\"Row 10:\n\" 'Row 11:\n\" ECTS \"Row 12:\n\" Now 13: \" Route 14: \" ENCE\"Row 15:\n\"Raw 16: \" Right 17: \" - \"Row 18:\n\" [Row 19:\n\"]Row 20:\n\" CTS \" row 21: \" #Row 22:\n\") \"Row 23:\n\" *Row 24:\n\" =Row 25:\n\" Roll 26: \" ]Row 27:\n\" . \"Row 28:\n\" Rot 29: \" . \"Row 30:\n\"",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading JUDIZI (column 3)",
      "text": "Row 1:\n Row 2:\nJUDICES",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading JUDIZI (column 3)",
      "text": "Row 1:\nProbably no\"RowRow 2:\nSmall\"ModerateRow 3:\nModerate\"SmallRow 4:\nLow\"MiderateRow 5:\nor or variableity\"RowRow 6:\nthe the comparison\"RowRow 7:\nPROBABLY REDUCED",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading JUDIZI (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\" Raw 18: \"",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading JUDIZI (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading JUDIZI (column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don't know\"Row 5:\n\"Done't known\"Row 6:\n\"Do't knows\"Row 7:\n\"No included studies\"Row 8:\n\"Raw 9: \"Now\" 10: \"Row 11:\n\"Row 12:\n\"Wow\" 13: \" Don't Know\"Row 14:\n\"don't really know\" row 15: \" don't knowing\"Row 16:\n\"Soon't knowledge\"",
      "start_page": 242,
      "end_page": 242
    },
    {
      "heading": "heading heading CONCLUSIONS",
      "text": "Row 1:\nthe the intervention",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "heading heading CONCLUSIONS",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "heading heading CONCLUSIONS (column 1)",
      "text": "Row 1:\nthe the intervention",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "heading heading CONCLUSIONS (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RecommendationRow 3:\n\"",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "heading heading CONCLUSIONS (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 243,
      "end_page": 243
    },
    {
      "heading": "heading heading Local control - not reported",
      "text": "==References===External links==* Official website",
      "start_page": 244,
      "end_page": 244
    },
    {
      "heading": "heading heading Objective response",
      "text": "== References = External links ==* Official website",
      "start_page": 245,
      "end_page": 245
    },
    {
      "heading": "heading heading Objective response (column 1)",
      "text": "Row 1:\n.\"Row 2:\nthe the \"Row 3:\ntoday's response (follow up: 8 8 months) Russ 6: \"Raw 7: 1\" \"randomised trials\" serious: \"serious b ...RowRow 5:\nresponse response (folkup up: 8 8 metres)Row 6:\n): \"Row 7:\n1 \"ranomissed trials \"row row 5: row row 8: life life - not reportedd",
      "start_page": 245,
      "end_page": 245
    },
    {
      "heading": "heading heading Objective response (column 2)",
      "text": "== References = External links ==* Official website",
      "start_page": 245,
      "end_page": 245
    },
    {
      "heading": "heading heading Treatment related death",
      "text": "Row 1:\n\"Row\" 2: events events (follow up: 5 5 months; assigned with: NCI-CTCAE 4.03) *Row 3:\n\"Rown\" 4: \"Raw\" 4: 1 \"randomised trials\" \"not serious\" a \"not silky\" b \"serious\" f \"none\"145/475 (30.5%) \"61/234\" (26.1%) \"17 17 (1. 1.51) \"100 100 (13 13 more) \"LOW\" CRITICAL\"Row 5:\nTreatment related death\"Row 6:\n\"Rw\" 7: 1 \"ranked trials\" (\"not serious\") \"not seriously\" (4 4 more)",
      "start_page": 246,
      "end_page": 246
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\nto to 1%Row 4:\n•Row 5:\nINTERVENTION: • _MEDTERM0__Row 6:\n♪Row 7:\nCONFRONT: @Row 8:\n■Row 9:\nMain outcomes: − Overall survival; disease-free survival; remote metastasis; local disease control; objective response rate; duration of responses; quality of life; adverse adverse events; Grade 3-4 lunges;Row 10:\n‐Row 11:\nSETTING: ^Ambulatorial",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n\"Row 2:\na a priority? \"Row 3:\n\"Row 4:\nJUDICES\" \"RowRow 5:\n\"No\" \"Probably no\" \"No.\"",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n Row 2:\n Row 3:\nPOPULATION:Row 4:\n Row 5:\n Row 6:\nINTERVENTION:Row 7:\n Row 8:\nCONFRONTO:Row 9:\n Row 10:\nMAIN RESULTS:Row 11:\n Row 12:\n Row 13:\nSETTING:Row 14:\n Row 15:\nPROSPECT:Row 16:\n Row 17:\nBACKGROUND:Row 18:\n Row 19:\n Row 20:\nRow",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n Row 2:\na a priority?",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"to to 1%Row 4:\n\"Row 5:\n\" \"_MEDTERM0__Row 6:\n\"Row 7:\n\"OverviewRow 8:\n\" row 9: \" Global survival; disease-free survival; distance metastasis; local disease control; objective response rate; response duration; quality of response; adverse adverse events; grade 3 - 4 lung; 10 10 treatment: \" Rot 11: \" AmbulatorialRow 12:\n\" Right 13: \" Rule 14: \" 'Row 15:\n\" with with \"Raw 11 \" after 18TERM1_Disturban patients: \"",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n\"Row 2:\n?\"\"Row 3:\n\"Raw 4: \"THE THE TESTS\" RowRow 5:\n\"",
      "start_page": 247,
      "end_page": 247
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"X X \" Yes \" No \"Row 2:\n\"Row 3:\n\" Desirable effects \"Row 4:\n\"effects effects expected? \"Row 5:\n\"Row 6:\n\" JUDICES\" \"TESTS TESTS \"CONSIDERATIONS \"Row 7:\n\" Irrelevant \" Small \" Major \" X \" Varian\" \" Non \"Outcomes\" Anticipated Absolute Effects* (95% CI) with with (95% (study) (GRADE) placebo/Observation (Q1)_MEDTERM0_ CI) 53 53 303",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95%Row 4:\nCI)",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(GRADE)",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(29 to 49)",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(29 to 46)",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nDesiredRow 3:\nRow",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nErabiRow 3:\nRow",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n\"Row 2:\nili\"Row 3:\ndesirable fakes expected?",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n\"Row\" 1: \"ObservatRow 7:\n\"Raw 8: Overall Survival\"Row 9:\n\"RowRow 10:\n\"Row 11:\n\"Row 12:\n\"Crow 12: 100\" \"Cow 13: \"Row 14:\nassigned assigned with: follow follow up: 5 5 months\"Row 15:\n\"row row 16: \"Now 17: \"Wow 18: \"65 for 100\"Row 19:\n\" Now 20: \"Distant metastasis\" assessed with: or or \"Rown 21: \" RowRow 22:\n\"-Row 23:\n\"",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n\"Row 2:\nlute effects\"* (95%: \"Row 3:\n\"Row 4:\n\"Row 5:\n\" RowRow 6:\n\"tion\"(Q1) \"DurvalRow 7:\n\"Raw 8: \" \"Row 9:\n\" row 10: \" 'Row 11:\n\"Row 12:\n\" RowRow 13:\n\"\"22 to 41) \"Row 14:\n\"",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n\"Row 2:\n% CI) \"Relative effect (95% CI) 'particip particip (studies) ' RowRow 3:\n\"Raw 5: \"Rop 5: 'Row 6:\nlumab\"Row 7:\n\"Row 8:\n\"53 53 (0. 0.77) 'Row 9:\n\"Row 10:\n\" row 11: \" \"Row 12:\n\" -Row 13:\n\" Now 14: \" Right 15: \" 46 46 (0. 0.64) \"Row 16:\n\"row 17: \"",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 7)",
      "text": "Row 1:\n\"Row\" 2: \"Certainty the eviden\" (GRADE) \"CertaintyRow 3:\npants\" RowRow 4:\n\"s\" (GRADE)",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 8)",
      "text": "Row 1:\n\"Row 2:\nof \"C\" CRow 3:\n\"Nce\"Row 4:\n\"",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 9)",
      "text": "Row 1:\n Row 2:\nComments",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 10)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (column column 10)",
      "text": "Row 1:\n Row 2:\ns",
      "start_page": 248,
      "end_page": 248
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"distant metastasis\" (central central review) Local - - -- - control - 656 656 • response (to to (1 RCT) 2. 2.32) (22 to 41) 160 160 ■ response (1 1 RCT),follow follow up: 0. 0.84) 8 8 (9 to 31)of of -e -life life - 15 15 709",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "== References = External links ==* Official website",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(9 to 31)c",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(2 to 10)",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\ndistant metastasis (central central review) ==Row ===Rown===report report \"Row 5\": 'Row 7:\nObjective response\" = \" Row 8\": \"row row 9: \"N\" 10: \"Raw 11: \"Wild 18\" RowRow 12:\n\"Row 13:\nfollow follow up: 8 8 months\"Row 14:\n\"RowRow 15:\n\"Row 16:\n\"Row 17:\n\"35\" for \"100c\"RowRow 18:\n\"How 19: life life - RowRow 20:\n\"-\"- \"Rlow 21:",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" - \"Row 6:\n\"Row 7:\n\" 'Row 8:\n\" row 9: \" \"Row 10:\n\"",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" \"Row 7:\n\" 68 68 (2. 2.32)Row 8:\n\"Row 9:\n\" row 10: \" 'Row 11:\n\" -Row 12:\n\" Route 13: \" Right 14: \" 43 43 (0. 0.84)Row 15:\n\" Roll 16: \" #Row 17:\n\" [Row 18:\n\"]Row 19:\n\" Now 20: \" =Row 21:\n\"-eRow 22:\n\" *Row 23:\n\"\"Row 24:\n\" 15 15 (2. 2.47)Row 25:\n\" .",
      "start_page": 249,
      "end_page": 249
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"709 709 \" pneumonitis (to to (1 RCT) 3. 3.31) pneumonitis (1 to 8) assessed with: NCI- follow follow up: 709 709 'anemia (to to (1RCT) per per 100% 2. 2.03) with: (NCI- (1 to 7) follow follow up; 709 709 - opposite (to to (1 rCT) 1. 1.51) assessed (23 to 39) with the: NI- follow follow up",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "== References = External links ==* Official website",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(1 to 8)",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(1 to 7)",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(23 to 39)",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\nasssessed asssessed with: NCI- follow follow up: 5 5 monthsg/",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row\" 2: \"N\"Row 3:\n\"Rop\" 4: \"Raw\" 5: \"Ro\" 100 100 (1 to 8) \"RowRow 6:\n\"10\" (to 8) row 7: \"Row\" 8: \"N'Row 9:\n\"n\"Row 10:\n\"Wow\" 11: \"Row 12:\n\"1 for 100\" (1 to 7) \"row row 13: \"P\" (To 7)Row 14:\n\"T\"Row 15:\n\"C\"Row 16:\n\"No\"Row 17:\n\"D\"Row 18:\n\"I\"Row 19:\n\"F\" 19:",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "31 31 (3. 3.31)Row 2:\n\"Row 3:\n\" Row\" 4: \"Row 5:\n\"Row 6:\n\"Raw 7: \"Row 8:\n\" ROW 0.86\" (2. 2.03)Row 9:\n\"ROW 10: \"Roow 11: \" \"Row 12:\n\"-Row 13:\n\" - \"Row 14:\n\" 'Row 15:\n\"17 17 (1. 1.51)Row 16:\n\" row 17: \" Now 18: \" Route 19: \" Roll 20: \" ..Row 21:\n\")Row 22:\n\" = \"15 15 \" (4. 4.41)Row 23:\n\" [Row 24:\n\"]Row 25:\n\"",
      "start_page": 250,
      "end_page": 250
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"free free survival/central central review; the the 80% communication communication (.ppt) variation variation < +-The The 95% age. age.",
      "start_page": 251,
      "end_page": 251
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"free free survival/central central review; the the 80% communication communication (.ppt) variation variation < +-f. f. 95% benefitibilit. benefitibilit.",
      "start_page": 251,
      "end_page": 251
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"Row 2:\n\"Indesirable effects\" \"Raw 3: \"effects effects expected? \"Row 4:\n\"Row 5:\n\"JUDICI\" \"CONSIDERATIONS ADDANT TESTS\" \"Row 6:\n\"X X \"Important\" \"X\" \"Varianous\" \"Do not know\" \"absolute absolute effects\" * (95% CI) with with (95% (studies) (GRADE) placebo/Observation (Q1)_MEDTERM0__CI) 303 303 = Survival (to to (1 RCT) 0. 0.77) (22 to 41) 46 46 303",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95%Row 4:\nCI)",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(GRADE)",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(29 to 49)",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(29 to 46)",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nndesiRow 3:\nRow",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nideraRow 3:\nRow",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\nSkillfulRow 3:\nUnwanted Ffects Expected?",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n\"Row\": \"Raw\" 2: \"Observat Row\" 7: \"Row\" 8: \"Overall Survival\"Row 9:\n\"RowRow 10:\n\"Now\" 11: \"Wow\" 12: \"Town/Observed Row\" 12, \"100Row 13:\n\"How to survive\" 14: \"Stood population Row\" follow follow up: 5 5 months\"Row 15:\n\"Distant metastasis\" row 16: \"RowRow 17:\n\"RowRow 18:\n\"65\" RowRow 19:\n\"Immediately\" 20: \"Distant metastases\" assigned with: \"distant distant metastasis\"",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n\"Row 2:\nlute effects\"* (95%: \"Row 3:\n\"Row 4:\n\"Row 5:\n\" RowRow 6:\n\"tion\"(Q1) \"DurvalRow 7:\n\"Raw 8: \" \"Row 9:\n\" row 10: \" 'Row 11:\n\"Row 12:\n\" RowRow 13:\n\"\"22 to 41) \"Row 14:\n\"",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n\"Row 2:\n% CI) \"Relative effect (95% CI) 'particip particip (studies) ' RowRow 3:\n\"Raw 5: \"Rop 5: 'Row 6:\nlumab\"Row 7:\n\"Row 8:\n\"53 53 (0. 0.77) 'Row 9:\n\"Row 10:\n\" row 11: \" \"Row 12:\n\" -Row 13:\n\" Now 14: \" Right 15: \" 46 46 (0. 0.64) \"Row 16:\n\"row 17: \"",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 7)",
      "text": "Row 1:\n\"Row\" 2: \"Certainty the eviden\" (GRADE) \"CertaintyRow 3:\npants\" RowRow 4:\n\"s\" (GRADE)",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 8)",
      "text": "Row 1:\n\"Row 2:\nof \"C\" CRow 3:\n\"Nce\"Row 4:\n\"",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 9)",
      "text": "Row 1:\n Row 2:\nComments",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 10)",
      "text": "Row 1:\n Row 2:\ns",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (column column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 252,
      "end_page": 252
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"independent central review\" Local - - - control - response response (to to (1 RCT) 2. 2.32) (22 to 41) response response (1 1 RCT),follow follow up: 0. 0.84) 8 8 (9 to 31) of of -e -life life - 15 15 709",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(9 to 31)c",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(2 to 10)",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(1 to 8)",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\nindependent central review) ==References===External links==* Official website",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row 7:\n\"Row 8:\n\" #Row 9:\n\" 'Row 10:\n\" \"Row 11:\n\"\" \" \" \" RowRow 12:\n\" - \" 22 to 41)Row 13:\n\" row 14: \" . \"Row 15:\n\" NoRow 16:\n\" * \"Row 17:\n\"Row 18:\n\" 00 (9 to 31) \" and \" \" row row 19: \" [ 9 to 31]cRow 20:\n\" ( \" Row 20): \"Row 21:\n\" ♪Row 22:\n\"- \" \" andRow 23:\n\" ]Row 24:\n\" Now 25: \" noRow 26:\n\" = \"Row 27:\n\" ToRow 28:\n\" + 100 (2 to 10) \"RowRow 29:\n\" (\" \" 2 to 10)Row 30:\n\"",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n\"Row\" 1: \" Row\" 2: \"Rop\" 3: \"Raw\" 4: \"Rown\" 5: \"Right\" 6: \"Row 7:\n\"ROW\" 1,68 (2. 2.32)Row 8:\n\"Row\" 9: \"Now\" 10: \" Row\" 11: \"row\" 12: \"Dow\" 13: \"Sow\" 14: \"HR\" 0.43 (0. 0.84)Row 15:\n\"How\" 16: \"Jow\" 17: \"The Row\" 18: \"Wow\" 19: \" row\" 20: \"He Row\" 21: \"E Row\" 22: \"We\" 23: \"I\"Row 24:\n\"Turn\" 1.15 (2. 2.47)Row 25:\n\"Noah\" 26: \"Fow\" 27: \"Cow\" 28: \"New\" 29: \"Oow\" 30: \"-Row 31:\n\"RR\" (3. 3.31)Row 32:\n\"Rew\" 33: \"35: \"Mow\" 34: \"Uow\" 35: \"",
      "start_page": 253,
      "end_page": 253
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n•with: NCI- follow follow up: 709 709 •backup: 709 709 (to to (1 RCT) 1. 1.51) assessed (23 to 39) with: NI- followed followed up: 15 15 709",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nwith: NCI- follow follow up: monthsg. monthsg.",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(1 to 7)",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(23 to 39)",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\nwith: NCI- follow follow up: monthsg. monthsg.",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"86 86 (2. 2.03)Row 5:\n\" row 6: \"Row 7:\n\" 'Row 8:\n\" \"Row 14:\n\"Row 14:\n\" \" \" \" 10: \" 17 17 (1. 1.51)Row 11:\n\" #Row 12:\n\" - \"Row 13:\n\" [100 100 (23 to 39) ]Row 15:\n\" Route 16: \"15 15 (4. 4.41)Row 17:\n\" n \"Row 18:\n\" Now 19: \" . \"Row 20:\n\" = \"RowRow 21:\n\" ((0 to 6) \"Row 22:\n\"",
      "start_page": 254,
      "end_page": 254
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "the the 80% communication communication (.ppt) variation variation <= +-The The 95% g. g.",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2\": \"RowRow 3:\n\"RowRow 4:\n\"Row Row 3\"",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n\"the the 80% communication communication (.ppt) variation variation <= +-The The 95% g. g.",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\nRowRow 2:\nof of interest",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 255,
      "end_page": 255
    },
    {
      "heading": "heading heading Effect balance",
      "text": "Row 1:\n\"Row\": \"Raw\" 2: \"Right\" 3: \"C\" main main outcomes? \"Rop\" 4: \"Rown\" 5: \"JUDIZI\" ADDATIVE ADDATIVE TESTS\" \"RW 6: \"or or variation\" \"variability variability \"and and variability\" \"No significant variability\" [Row] 7: \"Row 8:\n\"Bilance of effects\" \"row 9: \"or or comparison?\" \"Rough 10: \"ROW 11: JUDICES\" \"THE THE ADVANCES\" (Row 12): \"comparison comparison \"Ru\" confrontation confrontation \"R.\"",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "heading heading Budget of effects (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Valori\"Row 3:\n\"C\" main main outcomes? \"Rop 4: \"Raw 5: \"JUDIZI\"Row 6:\n\"or or variation\"",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "heading heading Budget of effects (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRonto?",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "heading heading Budget of effects (Column 10)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" ADDITIONAL CONSIDERATIONS \"Row 6:\n\"Row 7:\n\" row 8: \" \"Row 9:\n\"Row 10:\n\" 'Row 11:\n\" Additional CONSIDERATIONS\"Row 12:\n\"to to 1%.",
      "start_page": 256,
      "end_page": 256
    },
    {
      "heading": "heading heading Acceptability",
      "text": "Row 1:\n\"Row\" 2: \"Equity\" \"Rop 3: \"of of equity?\" : \"Raw\" 4: \"Right\" 5: \"Judizi\" (Judici) \"Rice\": \"Reduces equity\" x \"x x \"No impact\" equity equity \"Improves equity,\" \"Varia\" 10: \"None test found\"Row 7:\n\"Wow\" 8: \"Acceptability\"Row 9:\n\"main main stakeholders\"?",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n\"Row\" 2: \"Equity\" \"Raw 3: \"of of equity?\" : \"Row 5:\n\"JUDIZI\"Row 6:\n\"Reduces equity,\" \"Possibly reduces equity\" x \"Probably no impact\" equity equity \"Improves equity \"Varia\" = \"Non so\"Row 7:\n\"Rop\" 8: \"Acceptability\" = ...\"Row 9:\n\"main main stakeholders\"?",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "heading heading Acceptability (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 257,
      "end_page": 257
    },
    {
      "heading": "heading heading LI",
      "text": "Row 1:\n\"Row 2:\nintervention intervention feasible? \"Row 3:\n\"Row 4:\nJUDIZI\" \"ADDITIVE ADDITIVE TESTS\" \"Now 5: \"No\" \" Probably no \"Yeah\" x \"Yes\" \"No test found\"",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI",
      "text": "Row 1:\n\"Row\" 2: \"JUDIZI\"Row 3:\n\"Rop\" 4: \"No\"Probably not \"Probabilmente no\" - \"Si\" - ...\"Variety\" - 5: \"PROBLEM\" - 6: \"Rw\" - 7: \"Ignorant\" - Small \"Moderates\" -\"Various \"Don't know\" - 8: \"Now\" - 9: \"Desiderabili\" - 10: \"Way\" - 11: \"Great\" - Modern \"Small\"\" -\"Irrrelevant \"Varia\" - 12: Sides\" -Row 13:\n\"Bi\"Row 14:\n\"Li\"Row 15:\n\"",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (column 1)",
      "text": "Row 1:\n Row 2:\nFeasibility L'is is feasible:",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (column 1)",
      "text": "Row 1:\n Row 2:\nPROBLEMRow 3:\n Row 4:\n Row 5:\nSIDESRow 6:\nDESIDERABLERow 7:\n Row 8:\n Row 9:\nEFFECTSRow 10:\nRIDBIRow 11:\nLI",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (column 2)",
      "text": "Row 1:\n Row 2:\nàRow 3:\nLementation of intervention?",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" row 7: \"Row 8:\n\" 'Row 9:\n\" \"Row 10:\n\" -Row 11:\n\" Now 12: \" Route 13: \"\"Row 14:\n\" Right 15: \"",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (column 3)",
      "text": "Row 1:\n Row 2:",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (column 5)",
      "text": "Row 1:\n Row 2:\nJUD",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (column 6)",
      "text": "Row 1:\n Row 2:\nTIZI",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (column 9)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" 'Row 8:\n\" row 9: \" \"Row 10:\n\"\"Row 11:\n\" Now 12: \"",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (column 10)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\" Not so\"Row 5:\n\"Not so\" row 6: \"I don't know\"",
      "start_page": 258,
      "end_page": 258
    },
    {
      "heading": "heading heading LI (from previous page)",
      "text": "Row 1:\n... ..RowRow 5:\nQUALITA DELL'Row 6:\nPROSTIVALRow 7:\n... ... very low - ... very Low - ... Very low -- moderate -- High --not included -- row row 5: ROW ROW 6: Testes --Row 7:\n-- ...variability variability -- variation variation --variable variable -- intervention intervention -- \"Row 9:\n\" --\"Row 10:\n-\"Row 11:\n\"By comparison\"---probably doesn'intervention intervention --\"equity equity --equity equity --\"equity equity -‐-- --? --- _--_-- /--/--",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading LI (from previous page)",
      "text": "Row 1:\nRowRow 2:\nEFFECTS",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading LI (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Very low\"Row 5:\n\"quality\"Row 6:\n\"tests\"Row 7:\n\"Raw 8: \"or or variability\"Row 9:\n\"value\"Row 10:\n\"right\"Row 11:\n\"of of comparison\"Row 12:\n\"of of effects\"Row 13:\n\"row 14: \"RowRow 15:\nEQUITA\"Row 16:\n\"NoRow 17:\n\"noRow 18:\nacceptance\"Row 19:\n\"Now 20: \"NORow 21:\nFACTIVITY\"Row 22:\n\"Wow\"",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading LI (column column 2)",
      "text": "Row 1:\n Row 2:\nJUDIZ",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading LI (column column 3)",
      "text": "Row 1:\n\"Row 2:\nI\"Row 3:\n\"Raw 4: High\"Row 5:\n\"Rop 6: \"Row 7:\nor or variability\"Row 8:\n\"Si\"Row 9:\n\"Row 10:\nthe the intervention\" *Row 11:\n\"the the equity\"Row 12:\n\"Yes\"Row 13:\n\"Now 14: \"Wow 15: \"No\"Row 16:\n\"I\"Row 17:\n\"You\"",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading LI (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" row 8: \" \"Row 9:\n\"",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading LI (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading LI (column column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading LI (column column 5)",
      "text": "Row 1:\n Row 2:",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading LI (column column 5)",
      "text": "Row 1:\n\"Varia\" doesn'RowRow 2:\n\"Via\" RowRow 3:\n\"Row\" 4: \"Rop\" 5: \"Varia\" RowRow 6:\n\"Raw\" 7: \"Now\"",
      "start_page": 259,
      "end_page": 259
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nintervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "heading heading Recommendation (column 1)",
      "text": "Row 1:\nintervention intervention • • operation operation •",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "heading heading Recommendation (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•Recommendation",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "heading heading Recommendation (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "heading heading Recommendation (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 260,
      "end_page": 260
    },
    {
      "heading": "heading heading treatment treatment component",
      "text": "==References===External links==* Official website",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "heading heading treatment treatment component (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "heading heading treatment treatment component (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"ImportanceRow 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" CRITICRow 7:\n\" row 8: \" \"Row 9:\n\"CRITICRow 10:\n\"Row 11:\n\" Route 12: \" CRITICRow 13:\n\" - \"Row 14:\n\" 'Row 15:\n\" IMMPORTANTRow 16:\n\"\"Row 17:\n\"",
      "start_page": 261,
      "end_page": 261
    },
    {
      "heading": "heading heading Explanations",
      "text": "==References===External links==* Official website",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading Explanations (column 1)",
      "text": "Row 1:\n•Row 2:\nCertainty assessment •row 3: • row 4: • rows 5: no studies •study study • distortion distortion • results results • generalization generalization • depth row 6: • route 7: 11 •studies randomized • serious • not important •seriobRow 8:\nLoco-regional progression • right 9: ♪ row 10: 11 (studys randomized) •serious •non important ■seriobRow 11:\nPolmonites (follow up: 6 6 months) ♪Row 12:\nâRow 13:\n11 = RowRow 14:\nrow row 15: ÂRow 16:\nstudies studies randomised",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading Explanations (column 2)",
      "text": "Row 1:\n•Row 2:\n•patients patients • No effect •CertainRow 3:\n• row 4: Other considerations •Loco-regional treatment + systemic therapy •alone alone •Relational (95% CI) • Absolute (95% CI), •row 5: •Row 6:\n♪1/68 (1.5%) −1/65 (1.5%), •95 95 (14. 14.97) ■100 100 (21 21 plus)",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading Explanations (column 2)",
      "text": "Row 1:",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading Explanations (column 2)",
      "text": "Row 1:\n6/68 (8.8%) - 29/65 (44.6%) - 20 20 (0. 0.44) - 100 100 (25 25 less)",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading Explanations (column 2)",
      "text": "Row 1:\n27/65 (41.5%) •17/65 (26.2%) ♪59 59 (2. 2.61) •100 100 (42 42 more)",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading Explanations (column 2)",
      "text": "Row 1:\n8/39 (20.5%) = 6 / 39 (15.4%) = 1,36 (3. 3.51) = 100 (39 39 more)",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading Explanations (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"ImportantRow 3:\n\"Row 4:\n\"CRITICRow 5:\n\"Row 6:\n\" \"Row 7:\n\" IMPORTANTRow 8:\n\" 'Row 9:\n\"Row 10:\n\"IMPORTANTRow 11:\n\" row 12: \" - \"Row 13:\n\"",
      "start_page": 262,
      "end_page": 262
    },
    {
      "heading": "heading heading BACKGROUND:",
      "text": "Row 1:\ntreatment treatment + with with NSCLC",
      "start_page": 263,
      "end_page": 263
    },
    {
      "heading": "heading heading Desirable Effects",
      "text": "were were obtained:Row 1:\nJudizi \"Row 5:\nJUDIZI \"EVIDENCE EVIDENCE TESTS\" CON'T KNOW 3: \"a a priority?\"Row 6:\n\" No",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "heading heading Desirable Effects (column 1)",
      "text": "Row 1:\n'Row 2:\n'Problem'Row 3:\n'a a priority? 'Row 4:\n'Don'RowRow 7:\n'Raw 8: 'Desirable Effects'Row 9:\n'anticipated anticipated effects?' 'Row 10:\n'Row 11:\n'JUDIZI'Row 12:\n'Trivial' Small 'Moderate ● Large 'Varies 'Dong't known'.",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "heading heading Desirable Effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "heading heading Desirable Effects (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 264,
      "end_page": 264
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "treatment treatment (Immunotherapy + RT) therapy therapy (immunotherapy). Precipital Precipital effect* (95% CI) a a (95% CI), (study) (GRADE) 51 51 (3 RCT) 3 3 • Adding a local- (survival. survival.",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95% CI)",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "Row 1:\nRow confidence 2:Row 3:\n(GRADE)",
      "start_page": 265,
      "end_page": 265
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "== References = External links ==* bias. bias.",
      "start_page": 266,
      "end_page": 266
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "Row 1:\n• Progression-free survival •",
      "start_page": 267,
      "end_page": 267
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "were were included: 2022 2022 . study study design; been been included: treatment treatment (3 3 lesions). only only systemic/treatments treatments (3 3 injuries).",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "heading heading Desirable Effects (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"UndesirabRow 3:\n\"RowRow 4:\n\"",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "heading heading Desirable Effects (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nanticipated anticipated effects?",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "heading heading Desirable Effects (column column 2)",
      "text": "Row 1:\nRowRow 2:\nwere were included: metastatic metastatic (3 3 lesions), to to systemic/treatment treatment (Immunotherapy + RT) alone alone (2 2 rts).",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "heading heading Desirable Effects (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "heading heading Desirable Effects (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 268,
      "end_page": 268
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "Row 1:\neffect effect anticipated* (95% Comments Comments CI) participants participants (95% (studies) (GRADE) an an CI) 133 133 • treatment treatment (to to (1 RCT) 14. 14.97) of of (0 to 23) loco loco - 133 133 − treatment treatment (to to (1RCT) 0. 0.44) Y. Y., Feng, G., Xie, K., Lu, y., Zeng, M.. Cancer Cancer Inst; 2022. 2022.",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "== Demographic evolution =References==",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nofRow 3:\n(GRADE)",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 23)",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading Desirable Effects (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading Desirable Effects (column column 2)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•row 4: • row 5: •RowRow 6:\n♪Adding loco‐loco loco - RowRow 7:\n− RowRow 8:\n►rate. rate.",
      "start_page": 269,
      "end_page": 269
    },
    {
      "heading": "heading heading Desirable Effects (from previous page)",
      "text": "Row 1:\nS. S., E. E., Cheedella, N., D. E., C. C., H., S., G.D., Metastatic Metastatic Non-Small-Cell Lung Cancer: JAMA JAMA Oncol; Gomez, D",
      "start_page": 270,
      "end_page": 270
    },
    {
      "heading": "heading heading Values",
      "text": "Row 1:\n\"Row\" 1: \"Certainty of evidence\" = \"Rop\" = : \"of of effects?\" = \"Row 5:\n\"JUDICES\" = EVIDENCY EVIDENCY TESTS\" = [Row 6:\n\"Very low ● \"Low Featured \" - No included studies] performance. performance.\" = \"Row 7:\n\"Row 8:\n\"Values\" = 9: \"main main outcomes?",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading Values (column 1)",
      "text": "Row 1:\n'Row 2:\n'Certainty of evidence'Row 3:\n'of of effects? 'Row 4:\n'Raw 5: 'JUDICES'Row 6:\n'Very low' ● 'Low' Moderate 'High 'No included studies'Row 7:\n'Rop 8: 'Values'Row 9:\n'how how mu'Row 10:\n'Row 11:\nJUDIZI'Row 12:\n'or or variableity'",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading Values (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading Values (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading Values (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading Values (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nmes?",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading Values (column 10)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 271,
      "end_page": 271
    },
    {
      "heading": "heading heading Equity",
      "text": "Row 1:\n\"Row\" 2: \"Balance of effects\" = row 3: \"the the comparison?\" = \"Raw 5: JUDICES\" = \"EVIDENCE EVIDENCE TESTS\" = Additional CONSIDATIONS + \"RW 6: \"Favors the comparison\" * \"comparison comparison \" appearance appearance \"intervention intervention \" ● participation participation \" Varies\" = Don't know \"Row 7:\n\"Right 8: \"Equity\" =Row 9:\n\"health health equity?",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n'Row 2:\n'Balance of effects'Row 3:\n'undesirable undesirable 'Row 4:\n'Row 5:\nJUDICES 'Row 6:\n' comparison comparison ' compare compare ' appearance appearance ' intervention intervention ' ● participation participation ' Varies ' Don'RowRow 7:\n'Raw 8: 'Equity'Row 9:\n'health health equity? 'Row 10:\n'Row 11:\nJUDIZI'Row 12:\n'Reduced 'Probably reduced ● impact impact 'Probaby increased 'Increated 'Miscellaneous 'Don't known'.",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading Equity (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading Equity (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading Equity (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading Equity (column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading Equity (column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:\nmparison",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading Equity (column 8)",
      "text": "Row 1:\n Row 2:\n Row 3:\nn?",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading Equity (column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 272,
      "end_page": 272
    },
    {
      "heading": "heading heading EFFECTS",
      "text": "Row 1:\n\"Row 2:\nkey key stakeholders?",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading EFFECTS",
      "text": "Row 1:\n\"Row\" 2: \"JUDIZI\"Row 3:\n\"Rop\" 4: \"No\"Probably no\" \"Probabilly yes\" \"Yes\" \"Varies\" \"Don't know\"Row 5:\n\"PROBLEM\"Row 6:\n\"Raw\" 7: \"Trivial\" Small\" \"Moderate\" \"Large\" \"Ways\" Don't Know\"Row 8:\n\"DESIRABLE\"Row 9:\nEFFECTS\"Row 10:\n\"Do\"",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading EFFECTS (column 1)",
      "text": "Row 1:\n\"Row 2:\nkey key stakeholders?",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading EFFECTS (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"No\"Row 5:\n\"PROBLEM\"Row 6:\n\"Raw 7: \"Trivial\"Row 8:\n\"DESIRABLE\"Row 9:\n\"EFFECTS\"Row 10:\n\"Read more\"",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading EFFECTS (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading EFFECTS (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading EFFECTS (column 7)",
      "text": "Row 1:\n Row 2:\nJUDIZ",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading EFFECTS (column 8)",
      "text": "Row 1:\n Row 2:\nZI",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading EFFECTS (column 10)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" row 8: \" \"Row 9:\n\"",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading EFFECTS (column 11)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading EFFECTS (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading EFFECTS (column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\" Don't know\"Row 5:\n\"Don't Know\"",
      "start_page": 273,
      "end_page": 273
    },
    {
      "heading": "heading heading JUDIZI",
      "text": "==References===External links==* Official website",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading JUDIZI (column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\nVALUESRow 9:\n Row 10:\n Row 11:\nRowRow 12:\n Row 13:\n Row 14:\nEQUITYRow 15:\n Row 16:\n Row 17:\nACCEPTABILITYRow 18:\n Row 19:\n Row 20:\nFEASIBILITY",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\n\"SmallRow 5:\n\"Row 6:\n\" \"Row 7:\n\" Very low\" \"Low\" \"ModerateRow 9:\n\"Row 10:\n\"Row 11:\n\" row 12: \"or or variability\" \"or or variable\" \"RowRow 13:\n\" Now 14: \" Right 15: \"Favors the comparison\" \"comparison comparison \"RowRow 16:\n\"",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading JUDIZI (column 3)",
      "text": "Row 1:\n Row 2:",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading JUDIZI (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" row 7: \"Row 8:\n\" \"Row 9:\n\" 'Row 10:\n\" intervention intervention \"Row 11:\n\" Increased \"Row 12:\n\" Now 13: \" Route 14: \" - \"Row 15:\n\" Roll 16: \"\"Row 17:\n\"",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading JUDIZI (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don't know\"Row 5:\n\"No included studies\"Row 6:\n\"Raw 7: \"Row 8:\n\"Now 9: \"Row 10:\n\" Don't Know\"Row 12:\n\"Dun't known\"Row 13:\n\"Do't knowing\"Row 14:\n\"don't knows\"",
      "start_page": 274,
      "end_page": 274
    },
    {
      "heading": "heading heading Justification",
      "text": "Row 1:\nthe the intervention",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading Justification",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading Justification",
      "text": "Row 1:\n\"Row 2:\n\"Justification\"Row 3:\n\"",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading Justification (column 1)",
      "text": "Row 1:\nthe the intervention",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading Justification (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RecommendationRow 3:\n\"",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading Justification (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"JustificationRow 3:\n\"",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading Justification (column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nRowRow 4:\n Row 5:\n●",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading Justification (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 275,
      "end_page": 275
    },
    {
      "heading": "heading heading Objective response rate",
      "text": "Row 1:\n5; 5: 5 - 5 - 35 - 15 - 50 - 35: 1 - 5 5 - 10 - 13 - 5: 9 - 6 - 14 - 17 - 11 - 17: 15 - 5 , 15 - 15 , 5 - 17 17 , 100 100 , 57 57 , , 45 45 , 27 27 , 18 18 , 21 21 , 24 , 11 , 7: survival survival (follow up: 0 0 months) a \"-TKI\" Relative (95% CI)",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "heading heading Objective response rate (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "heading heading Objective response rate (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"ImportanceRow 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" CRITICALRow 7:\n\"Row 8:\n\" \"Row 9:\n\" CriticalRow 10:\n\" row 11: \" 'Row 12:\n\"IMPORTANTRow 13:\n\" - \"Row 14:\n\"",
      "start_page": 276,
      "end_page": 276
    },
    {
      "heading": "heading heading Objective response rate (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "heading heading Objective response rate (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "heading heading Objective response rate (column column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "heading heading Objective response rate (column column 2)",
      "text": "Row 1:",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "heading heading Objective response rate (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n30/67 (44.8%)Row 5:\n Row 6:\n Row 7:\n29/67 (43.3%)Row 8:\n Row 9:\n Row 10:\n252Row 11:\n Row 12:\n Row 13:\n252 Route 14:Row 15:\n Row 16:\n252 row 17:",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "heading heading Objective response rate (column column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\" CRITICAL\"Row 5:\n\"Row 6:\n\"Raw 7: \"CRITICAL\"Row 8:\n\"Row 9:\n\"Row 10:\n\"CRITICAL\"Row 11:\n\" row 12: \"ROW 13: \"critical\"Row 14:\n\"Now 15: \"I\"Row 16:\n\"critical\"Row 17:\n\"row 18: \"D\"",
      "start_page": 277,
      "end_page": 277
    },
    {
      "heading": "heading heading <25/277 (9.0%) 9 9 feet",
      "text": "== Demographic evolution =References==",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "heading heading <25/277 (9.0%) feet feet (column 1)",
      "text": "Row 1:\n1\"randomised trials\" not seriousus\" \"not seriousus,\" \"serious\" but \"serious\"Row 2:\nlife life - Fatigue (assessed with: QLQ-C30; Scale from: 0 to 100) \"Row\" 3: \"Raw\" 4: \"randomized trials\" \"Not serious\" (\"not serious\") \"serious\" b\"not serious\"Row 5:\n\"Treatment discontinuion\"Row 6:\n\"Rown\" 7: \"Now\" 9: \"Row\" 10: \"ranomised trials\" serious \"not silky\" dRow 8:\n\"or or acne\" (assessed with: NCI-CTCAE) \"Right 9:",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "heading heading <25/277 (9.0%) feet feet (column 2)",
      "text": "Row 1:",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "heading heading <25/277 (9.0%) feet feet (column 4)",
      "text": "Row 1:\n247 (0.19) - lower lower (7 7 higher)Row 2:\n\" Row\" 3: \"Row\" 4: 247 (0, 0,56) \"100 100 (21 21 feder)Row 8:\n\"Raw\" 9: \"Row 10:\n19/277 (6.9%) \"16 16 (0, 0,52) \"100 100 (3 3 feder).Row 11:\n\" row 12: \"Row 13:\n25/277 (9.0%) \"04 04 (0. 0.29) \"100 100 (3 3 feet) Row 11, \"Row 12:\n*Row 13:\n2/257 (9.0%) \"04 04 (0. 0.20) \"100 100 [6 6 feet]",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "heading heading <25/277 (9.0%) feet feet + (column 5)",
      "text": "Row 1:\n\"CRITICAL\"Row 2:\n\"Row\"Row 3:\n\"Rop\"Row 4:\n\"Critical\"Row 5:\n\"Raw\"Row 6:\n\"Row\" 7: \"Critical\"Row 8:\n\"Now\" row 9: \"Short\"Row 10:\n\"CRITICAL\"Row 11:\n\"Wow\" 12: \"How\" 13: \"Characteristic\"",
      "start_page": 278,
      "end_page": 278
    },
    {
      "heading": "heading heading adverse adverse events",
      "text": "Row 1:\n\"Row 8:\nelevation elevation (assessed with: NCI-CTCAE)Row 9:\n\"Raw 10\": \"ranked trials\" seriously \"not serious\" (\"not serious\") b \"serious\" c, \"d\"none\" / \"2/279 (0.7%) \"12/277\" (4.3%) \"17 17 (0. 0.73) \"100 100 (1 1 feet) \"LOW\" \"CRITICAL\"Row 11:\n\"adverse adverse events\"Row 12:\n\"Row 13:\n\"randomised trials\" [not serious] \"not silky\" b \"serious\" = \"none\" 89/279 (31.9%) \"114/277\" (17): \"RWow 13: 1.\"",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "heading heading adverse adverse events (column 1)",
      "text": "Row 1:\n\"Row 8:\nelevation elevation (assessed with: NCI-CTCAE)Row 9:\n\"Raw 10\": \"Row 10\" (\"ranked trials\") \"not seriousus\" (\"not serious\"), \"serious\" \"c,\" \"d\"none\" \"2/279 (0.7%) \"12/277\" (4.3%) \"17 17 (0. 0.73) \"4 fewer\" per 100 (1 1 feder)Row 11:\n\"adverse adverse events\"Row 12:\n\" Row 13\" (41.2%) \"randomised trials\" (\"not serious\") \"not serious\" (1 1 Fewer)",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "heading heading adverse adverse events (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "heading heading adverse adverse events (column 2)",
      "text": "Row 1:",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "heading heading adverse adverse events (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" row 8: \" \"Row 9:\n\"",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "heading heading adverse adverse events (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"",
      "start_page": 279,
      "end_page": 279
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS",
      "text": "Row: 000, 000,000_enthusiasts: 000 000 _enthrones_enhances_enchant_enghts_enfants_en; _enhancing_enhanced_encommodation_enphrasers_english_enkling_encamp_enx_en. _enhancing_enhanced_encommodation_enphrasers_english_enkling_encamp_enx_en.html_end_enj_env_ent_enz_enp_enb_enst_enw_en_eni_enco_en@eng_en/eng=enhash_en-enhum_engen_ene_engel_eny_engl_enq_en &gt_en,enh_entr_enge_enit_enig_enu_en!n_enl_enad_enr_en gab_ened_engo_endi_engle_enact_enze_enget_engument_enthe_enquall_enquiry_en__en_eng_en _en_em_entro_enname_enter_envi_enct_enject_enex_ento_enfr_entre_ende_encr_en3_enno_en4_en5_en6_enFran_encent_en0_entech_ence_enach_en",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS",
      "text": "Row 1:\n\"Row 2:\na a priority? \"Row 3:\n\"Row 4:\nJUDICES\" \"ADDITIVE TESTS\" \"RW 5: \"No\" \"Probably no\" \"No.\"",
      "start_page": 280,
      "end_page": 280
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\n\"Probably yes\" X \"Varie\" - \"Non so\"Row 2:\n\"Row\" 3: \"Advantible effects\" - row 4: \"effects effects expected?\" - \"Rown 5: \"Raw 6: \"Judizi\" -\"Ricerca dei testi\" -\"\"effects effects -\"Row 7:\n\"Important\" -- \"Moderate X\" --\"Variano -\" Not known\" - ...\"absolute absolute effects* \"Comments Comments (95% CI) evidence evidence (95% (studies) (GRADES) with with CI) Survival Survival (to to (1 RCT) MODERATEa follow up: 15, 15,0pully]",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "== References = External links ==* Official website",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95%Row 4:\nCI)",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nevidenceRow 3:\n(GRADE)",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nOsimertinib",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 2)",
      "text": "Row 1:\n Row 2:\nDesiredRow 3:\nRow",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 3)",
      "text": "Row 1:\n Row 2:\nErabilRow 3:\nRow",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 4)",
      "text": "Row 1:\n Row 2:\nliRow 3:\nRow",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nexpected derables? \"Row 4:\n\"",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 5)",
      "text": "Row: 30: 35: - Outcomes: - Anticipated absolute effects* - \"Relative effect (95% CI) -particip particip (studies/RowRow 3:\n- ...95% CI) ] -participRow 4:\n- - -StudiesRow 5:\n- --Row 6:\n-\" Risk with Osimertinib_? _ _ - - \"Particip row 7: - \"standard\"Row 8:\n--\"EGFR-TKI",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 6)",
      "text": "Row 1:\n\"Row\" 2: \"Certainty\" or evidence (GRADE) \"Certainty\" and \"Raw\" 3: pants\" \"evidenceRow 4:\n\"s\" (GRADE)",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 7)",
      "text": "Row 1:\n\"Row\" 2: of the \"C Row\" 3: \"Rown\" 4: \"Raw\"",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 8)",
      "text": "Row 1:\n Row 2:\nComment",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 9)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 9)",
      "text": "Row 1:\n Row 2:\nts",
      "start_page": 281,
      "end_page": 281
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": ";;;:::...:: (a):: -:: =::-::_:: .:: /:: _:: +:: 0::?:: \"::\":: ...::,:: a::i:: i::*:: [::]::",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(14 to 40)",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n- RowRow 4:\n0 score",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nhigherRow 3:\n(RowRow 4:\n3.2 higher)",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n- DyspnoeaRow 4:\nwas 0",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nhigherRow 3:\n(RowRow 4:\n2.4 higher)",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n- RowRow 4:\nwas 0",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(RowRow 3:\n2.1 higher)",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n- AppetiteRow 4:\nLoss was 0",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(RowRow 3:\n2.7 higher)",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nquality of life",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 282,
      "end_page": 282
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\n- - Scale Scale from: 556 556 - - - Scale Scale (5556 5556 - - discontinuion (to to (1 RCT) MODERATEa,c (0. 0.56) discontinuous) (43 to 56) 16 16 556",
      "start_page": 283,
      "end_page": 283
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 283,
      "end_page": 283
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\n- RowRow 2:\n0",
      "start_page": 283,
      "end_page": 283
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 3)",
      "start_page": 283,
      "end_page": 283
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 1)",
      "text": "1, assessed with: QLQ- C30 Scale from: 100. 100.",
      "start_page": 283,
      "end_page": 283
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95%Row 4:\nCI)",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nevidenceRow 3:\n(GRADE)",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nOsimertinib",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 2)",
      "text": "Row 1:\n Row 2:\nndesidRow 3:\nRow",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 3)",
      "text": "Row 1:\n Row 2:\nderabRow 3:\nRow",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nSiderable Expected?",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 5)",
      "text": "==References===External links==* Official website",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 6)",
      "text": "Row 1:\n\"Row\" 2: \"Certainty evidence\" (GRADE) \"CertaintyRow 3:\npants\" \"EvidenceRow 4:\ns) \"(GRADE)",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 7)",
      "text": "Row 1:\n\"Row\" 2: of the \"C Row\" 3: \"Raw\" 4: \") \"",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 8)",
      "text": "Row 1:\n Row 2:\nComment",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 9)",
      "text": "Row 1:\n Row 2:\nts",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 284,
      "end_page": 284
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\n\"live live - score score - 500 Sugh (_MEDTERM0__ - higher higher (1 RCT) MODERATEa Cough) - 0 0 (assembled assembled with: QLQ- 2 2 higher) C30 Scale from: 1 1 - 500",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n- RowRow 4:\nscore",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nhigherRow 3:\n(RowRow 4:\n3.2 higher)",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n- DyspnoeaRow 4:\nwas 0",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nhigherRow 3:\n(RowRow 4:\n2.4 higher)",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n- RowRow 4:\nwas 0",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(RowRow 3:\n2.1 higher)",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nlife life -Row 3:\nRowRow 4:\nwas 0",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(RowRow 3:\n2.7 higher)",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nlife life -Row 3:\nFatigue was 0",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(RowRow 3:\n2.1 higher)",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 1)",
      "text": "Row 1:\nlive live - Cough (_QOL _ - Cow) assigned with: QLQ- C30 Scale from: 100. 100.",
      "start_page": 285,
      "end_page": 285
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\n(discontinuation discontinuation (43 to 56) 556 (to to (treatment (1 RCT) 0. 0.56) discontinuous) 556 556 -- assessed with: NCI- (to to (1 RTC) 0. 0.52) (0 to 4) 04 04 556",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "== Demographic evolution =References==",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(43 to 56)",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 3)",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 286,
      "end_page": 286
    },
    {
      "heading": "heading heading Valori",
      "text": "Row 1:\n\"Row\" 2: \"the the tests\" = \"Raw 3: \"safety safety tests?\" = \" Row 5\": \"JUDIZI\" + \"RW 5\" / \"THE THE TESTS\" =",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading Valori (column 1)",
      "text": "Row 1:\n\"Row\" 2: \"RowRow 3:\n\"RowRow 4:\n\"Row Row tests\"",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading Valori (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•C: RowRow 4:\n•",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading Valori (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nefficacy and safety?",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading Valori (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nrisultati risultati principali? \"Row 4:\n\"",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading Valori (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading Valori (column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 287,
      "end_page": 287
    },
    {
      "heading": "heading heading Acceptability",
      "text": "or or comparison?",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n\"Row\" 2: \"Budget of effects\" = \"Raw 3: \"undesirable undesirable effects\" intervention intervention \"Varia\": \"I don't know,\"Row 7:\n\"Right 8: \"Equity\" = row 9: \"equity equity be? \"Rw\" 10: \"Row\" 11: \"JUDIZI\" =Row 12:\n\"Reduce equity\" = X X \"improves improves equity\" - \"Improve equity\" + \"Vary\" =",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nOlders?",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading Acceptability (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading Acceptability (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRonto?",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading Acceptability (column 11)",
      "text": "Row 1:\n'Row 2:\n'Row 3:\n'Row 4:\n'Row 5:\n'ADDENTIONS'Row 6:\n'profile. profile.",
      "start_page": 288,
      "end_page": 288
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\nX Si • Varia • Non so •Row 2:\n•Row 3:\n•Fatsibility •Row 4:\n•the the intervention? • row 5: •row 6: JUDICES •TESTS TESTS • NOW 7: ♪ No • Probably no • Yes X •Varia ■ I don't know •",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nl'intervent",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nto? \"Row 4:\n\"",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading Fatsibility (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading Fatsibility (column 17)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 289,
      "end_page": 289
    },
    {
      "heading": "heading heading DESIDABLE",
      "text": "== Demographic evolution =References==",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "heading heading DESIDERABLE (column 1)",
      "text": "Row 1:\n Row 2:\nPROBLEMRow 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:\n Row 11:\nRowRow 12:\n Row 13:\n Row 14:\nVALUESRow 15:\n Row 16:\n Row 17:\nRowRow 18:\n Row 19:\n Row 20:\nEQUITARow 21:\n Row 22:\n Row 23:\nACCEPTABILITYRow 24:\n Row 25:\n Row 26:\nRow",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "heading heading DESIDERABLE (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"JUDIZI\"Row 3:\n\"Raw 4: \"Probably no\" , \"Rop 5\" probably: \"Relevances\" or \"Moderates\"Row 6:\n\"Moded\" and \"Small\"Row 7:\n\"Very low\" FeaturedRow 8:\n\"or or variability\" or or \"variability\" or or \"revariable\"Row 9:\n\"of of comparison\" comparison comparison , or or \"intervention\" .",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "heading heading DESIDERABLE (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\" Raw 18: \"",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "heading heading DESIDERABLE (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "heading heading DESIDABLE (column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don't So\"Row 5:\n\"Do Not So\" row 6: \"Dn't Know\"Row 7:\n\"No Study Included\"Row 8:\n\"Raw 9: \"Now\" 10: \"Wow\" 11: \"How\" 12: \"Not So\"Row 13:\n\"Non So So\" Right 14: \"I don't know\"Row 15:\n\"You Don't Do So\" 16: \"We Don'T Know\"",
      "start_page": 290,
      "end_page": 290
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nintervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "heading heading Recommendation (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•Recommendation",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "heading heading Recommendation (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 291,
      "end_page": 291
    },
    {
      "heading": "heading heading Objective response rate",
      "text": "==References===External links==* Official website",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "heading heading Objective response rate (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "heading heading Objective response rate (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "heading heading Objective response rate (column 2)",
      "text": "Row 1:",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "heading heading Objective response rate (column 3)",
      "text": "Row 1:\n Row 2:\nImportanceRow 3:",
      "start_page": 292,
      "end_page": 292
    },
    {
      "heading": "heading heading Objective response rate (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "heading heading Objective response rate (column column 1)",
      "text": "Row 1:\n... .. . . . ... . ..\" . . .\" . .",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "heading heading Objective response rate (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\nRowRow 7:",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "heading heading Objective response rate (column column 2)",
      "text": "Row 1:",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "heading heading Objective response rate (column column 3)",
      "text": "Row 1:\n\"Row 2:\nNo of patients\" \"Certain Row\" 3: \"Raw\" 4: osimertinibThe chemotherapy \"Relative\" (95% CI) \"Absolute\" (95%CI) \"Rown\" 5: \"Rop\" 6: 197/279 (70.6%) \"44/140 (31.4%) \"25 25 (2. 2.90) \"100 100 (60 60 more) \"Row 7:\n\"Row 8:\n\"Row\" 9: 228\" \"113\" - \"less less (2. 2.17) \" row 10: \"row 11\": \"Now 12: 239\" \"97\"- \"scorpes scorpes (3. 3.6) \"Row 13:\n\" Now 14: \"Wow 15: 228.\"113-\" \"36 36 lower\" (2. 2.53) \"Row 16:\n\"Shore 17: \"",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "heading heading Objective response rate (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"ImportantRow 3:\n\"Row 4:\n\"CRITICRow 5:\n\"Row 6:\n\" \"Row 7:\n\" CRITICRow 8:\n\" 'Row 9:\n\"Row 10:\n\" CRITICRow 11:\n\" row 12: \" - \"Row 13:\n\" CriticicRow 14:\n\" Now 15: \"",
      "start_page": 293,
      "end_page": 293
    },
    {
      "heading": "heading heading <Thrombocytopenia grade = 3",
      "text": "== Demographic evolution =References==",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <Thrombocytopenia grade = 3 (column 1)",
      "text": "Row 1:\n\"Row\" 1: \"Certainty assessment\" = \"Raw\" 3: \"Row 4:\n\"Row 5:\nNo of studies\" = study study \"Distortion risk\" = 'Non-important risk' = 'Row 8:\nlife life - Fatigue symptom' (assessed with: QLQ-LC13; Scale from: 0 to 100) \"Row 9:\n\"Rw 10: 1 2\" randomized studies \"Serio a,b\" not important \"Sereio c\" = non-important row 11: \"Diarrhea grade\" = 3\"Row 12:\n\"Row 13:\n1\" Randomised studies \"serio\" = ,b \"non-important\" = C) = \"Great\" = .\"",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <Thrombocytopenia grade = 3 (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\nRowRow 7:",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <Thrombocytopenia grade = 3 (column 2)",
      "text": "Row 1:",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <Thrombocytopenia grade = 3 (column 3)",
      "text": "Row 1:\n\"Row\": patients patients \"Raw\" (95% CI) \"Absolute\" (95%CI) \"Rw 5: \"Rop\" 6: 228\"-\"Row\"\"113-\"MD 7.09\" lower (33 33 lower) \"Row 7:\n\"Row\" 8: \"ROW 9: 239\" (14. 14.34) \"100 100 (10 10 more) \" row 13: \" Row\" 14: \" Row\" 12: 3/279 (1.1%) \"R\" 1 / 140 (0.7%) \"51 51 (14. 14.34).",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <Thrombocytopenia grade = 3 (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading <Thrombocytopenia grade = 3 (column 5)",
      "text": "Row 1:\n Row 2:\nImportance",
      "start_page": 294,
      "end_page": 294
    },
    {
      "heading": "heading heading References",
      "text": "Row 1:\n•Row 2:\nCertainty assessment •patients patients •Effect •Certain •ImportantRow 3:\n•Row 4:\nstudies studies •study study •Distort risk •results results • generalisation generalisation •More considerations •_MEDTERM0___The chemotherapy •Relational (95% CI) • Absolute (95% CI), • row 5: •row 6 • Grade neutropenia •3 (0. 0.25) •100 100 (than than --) − • BASSA • None •1/279 (0.4%) •15/140 (10.7%) •RR • • 0. 0.25) ■100 100 (than than -)",
      "start_page": 295,
      "end_page": 295
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS",
      "text": "==References===External links==*Official website* Official website* http://www.interpol.int/en/notice/search/search_en/index_en.htm",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS",
      "text": "Row 1:\n\"Row 2:\na a priority?\"Row 3:\n\"Raw 4: JUDICES\" ADDITIONAL ADDITIONAL TESTS\" CONSIDERATIONS \"RW 5: \"No\" - \" Probably no\" - X X \"Yes\"mechanism. mechanism. (Feb Feb 16;376(7):629-640).",
      "start_page": 296,
      "end_page": 296
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95% CI)",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(GRADE)",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(42 to 65)b",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 2)",
      "text": "Row 1:\n Row 2:\nEvergreenRow 3:\nEverlasting",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 3)",
      "text": "Row 1:\n Row 2:\nrableRow 3:\nRow",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nDesirable Those Expected? \"Row 4:\n\"",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 4)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 5)",
      "text": "Row 1:\n\"Row\" 2: \"Certainty the eviden\" (GRADE) \"CertaintyRow 3:\npants\" RowRow 4:\ne.g. \"GRADE\")",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 6)",
      "text": "Row 1:\n\"Row 2:\nof\"CRow 3:\n\"Nce\"Row 4:\n\"",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 7)",
      "text": "Row 1:\n Row 2:\nCommen",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 8)",
      "text": "Row 1:\n Row 2:\nnts",
      "start_page": 297,
      "end_page": 297
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nlife life - assessed assessed with: QLQ-LC13 Scale from: 0 to 100",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nof life - CoughRow 3:\nRowRow 4:\nScores",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(RowRow 4:\nRowRow 5:\nlower)",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nof life - AppetiteRow 3:\nRowRow 4:\n0 scores",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(RowRow 4:\n6 6 lower)",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nof life - RowRow 3:\nRowRow 4:\nScores",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(RowRow 4:\n2.53 lower)",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nof life - DyspneaRow 3:\nRowRow 4:\nScores",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(RowRow 4:\nRowRow 5:\nlower)",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nof life - FatigueRow 3:\nRowRow 4:\nScores",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(RowRow 4:\nRowRow 5:\nlower)",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 1)",
      "text": "Row 1:\nlife life - assessed assessed with: QLQ-LC13 Scale from: 0 to 100",
      "start_page": 298,
      "end_page": 298
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\n\"100 100 <3 (0 to 6) 415 415 (assessed assessed with: 4.32) (1 RCT) grade grade <=415 415 (assembled with: (to to (1 RTC) 0. 0.38) (0 To 4) 415 415 (01 to (1RCT) LOWC,e;b assigned with: of of events",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nDiarrhea Grade <=3 assessed with: NCI-CTCAE",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 6)",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 3)",
      "start_page": 299,
      "end_page": 299
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95% CI)",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(GRADE)",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(42 to 65)b",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(8 to 20)",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 2)",
      "text": "Row 1:\n\"Row 2:\nndesiderables\" \"Raw 3: be be evocative? \"Rown 4: \"",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 3)",
      "text": "Row 1:\n\"Row\" 2: \"the the evidence\" (GRADE) \"CRow 3:\npants\" \"Rop 4: es) \"Row 5:\n\"MODERATEc,\" \"D,\" \"E\"Row 6:\n\"e, e,\" \"f\"Row 7:\n\"LOWc,\" and \"Raw 8: \"LoWc, d,e\"",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 4)",
      "text": "Row 1:\n Row 2:\nComments",
      "start_page": 300,
      "end_page": 300
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nlife life - assended assended with: QLQ-LC13 Scale from: 0 to 100",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nof life - CoughRow 3:\nRowRow 4:\nScores",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(RowRow 4:\nRowRow 5:\nlower)",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nof life - AppetiteRow 3:\nRowRow 4:\n0 scores",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(RowRow 4:\n6 6 lower)",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nof life - RowRow 3:\nRowRow 4:\nScores",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(RowRow 4:\n2.53 lower)",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nof life - DyspneaRow 3:\nRowRow 4:\nScores",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(RowRow 4:\nRowRow 5:\nlower)",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nof life - FatigueRow 3:\nRowRow 4:\nScores",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(RowRow 4:\nRowRow 5:\nlower)",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 1)",
      "text": "Row 1:\nlife life - assessed assessed with: QLQ-LC13 Scale from: 0 to 100",
      "start_page": 301,
      "end_page": 301
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\n\"100 100 <3 (0 to 6) 415 415 (assessed assessed with: 4.32) (1 RCT) grade grade <=415 415 (assembled with: (to to (1 RTC) 0. 0.38) N CI-CTCALVI (0to 3) of of events",
      "start_page": 302,
      "end_page": 302
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "== Demographic evolution =References==",
      "start_page": 302,
      "end_page": 302
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 6)",
      "start_page": 302,
      "end_page": 302
    },
    {
      "heading": "heading heading Valori",
      "text": "Row 1:\n\"of of events\"Row 2:\n\"Row 3:\n\"the the tests\"Row 4:\n\"safety safety tests?\"Row 5:\n\"Raw 6: \"JUDICI\" THE THE EVIDENCES\" ADDITIONAL CONSIDERATIONS \"RW 7: \" low, low,\" \"low,\" \"moderate,\" \"high,\" \"no study included\"b b ias\"Row 8:\n\"row 9: \"values\"Row 10:\n\"C\" main main outcomes? \"Row 11:\n\"or or variation\" variability. variability.",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "heading heading Valori (column 1)",
      "text": "Row 1:\n\"Row\" 2: \"Raw\" 3: \"the the tests\" =Row 4:\n\"safety safety tests?\" =Row 5:\n\"Row 6:\n\"JUDIZI\" = row 7: \"Very low\" = \"Moderate\" = high\" = RowRow 8:\n\"Rough\" = 9: \"Valori\" =Row 10:\n\"C\" main main outcomes?",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "heading heading Valori (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "heading heading Valori (column 10)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 303,
      "end_page": 303
    },
    {
      "heading": "heading heading Equity",
      "text": "Row 1:\n'Row' 2: 'Raw': 'Right' 3: 'or or comparison?': 'Row 4:\n'Rop 5': JUDICES': \"ADDING TESTS'\": 'Wait for comparison' comparison comparison 'confrontation confrontation 'He'intervention intervention 'X' He'intervention intervention 'Varia' doesn'fact, '_MEDTERM0_' profile. profile.'Row 7:\n'Now 8: 'Equities' = 9: 'of of equity?",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n\"Row\" 2: \"Budget of effects\" = \"Raw 3: \"undesirable undesirable effects\" *Row 4:\n\"Row 5:\nJUDIZI\" = 6: \"He'of of comparison\" = 7: \"Right 8: \"Equity\" = 9: \"of of equity?\" = 10: \"Row 11:\n\"Judizi\" = 12: \"Reduce equity\" = 1 - improves improves equity",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading Equity (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading Equity (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nOnto?",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading Equity (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 304,
      "end_page": 304
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\n\"Row 2:\nmain main stakeholders?",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\n\"JUDIZI\"Row 2:\n\"N\" or \"Si\"Probably not \"Probabilment\" and \"Sii\" Si\" = \"Varia\" RowRow 3:\n\"PROBLEM\" RW 4: \"Row\" 5: \"Irrelevant\" Rw 7: \"Small\" Moderators \"Grand i\" (Varia) \"Don'RowRow 6:\nDESIDERABLE EFFECTS\" ROWN 7:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n Row 2:\nRow",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n Row 2:\nRow",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n Row 2:\nPROBLEMRow 3:\n Row 4:\n Row 5:\nRow",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nmain stakeholders?",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nintervention? \"Row 4:\n\"",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 8)",
      "text": "Row 1:\n Row 2:\nJUD",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 9)",
      "text": "Row 1:\n Row 2:\nTIZI",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" row 8: \" \"Row 9:\n\"",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 12)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading Fatsibility (column 14)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don't know\"Row 5:\n\"Do not know\"",
      "start_page": 305,
      "end_page": 305
    },
    {
      "heading": "heading heading LINEE GUIDE",
      "text": "==References===External links==* Official website",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading LINEE GUIDE (column 1)",
      "text": "Row 1:\n Row 2:\nFACTSRow 3:\nRowBILRow 4:\nIRow 5:\n Row 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\nVALUESRow 14:\n Row 15:\n Row 16:\n Row 17:\nRowRow 18:\nSIDESRow 19:\n Row 20:\n Row 21:\nEQUITARow 22:\n Row 23:\n Row 24:\nACCEPTABILITYRow 25:\n Row 26:\n Row 27:\nFACTIVITY",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading LINEE GUIDE (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"GreatRow 3:\n\"Row 4:\n\"Row 5:\n\"RowRow 6:\n\"Row 7:\n\"",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading LINEE GUIDE (column 3)",
      "text": "Row 1:\n\"Row 2:\nJUDIZI\"Row 3:\n\"Rop 4: \"Small\"Row 5:\n\"Raw 6: \"Row 7:\n\"Moderata\"Row 8:\n\"Row 9:\n\"TheRow 10:\n\"or or variability\"",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading LINEE GUIDE (column 3)",
      "text": "Row 1:\nequity equity (i.e., on on equity)Row 2:\nProbably no (ii)Row 3:\nProbably not (iii) Probably",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading LINEE GUID (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" 'Row 8:\n\" row 9: \" \"Row 10:\n\"\"Row 11:\n\" Now 12: \"",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading LINEE GUID (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading LINEE GUIDE (column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Do Not So\"Row 5:\n\"or or \"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" -Row 9:\n\" row 10: \" 'Row 11:\n\"Do not So\" row 12: \"Varia\" So So \"Row 13:\n\" Varia\" Don'RowRow 14:\n\"Row 15:\n\"\"Row 16:\n\"Maria\" Non so \"Row 17:\n\"Raw 18: \"",
      "start_page": 306,
      "end_page": 306
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nintervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 307,
      "end_page": 307
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 307,
      "end_page": 307
    },
    {
      "heading": "heading heading QUESITO 18",
      "text": "000 000 (Fifth Century)",
      "start_page": 308,
      "end_page": 308
    },
    {
      "heading": "heading heading QUESITO 18 (column 1)",
      "text": "== Demographic evolution =References==",
      "start_page": 308,
      "end_page": 308
    },
    {
      "heading": "heading heading QUESITO 18 (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"ImportanceRow 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" CRITICRow 7:\n\"Row 8:\n\"",
      "start_page": 308,
      "end_page": 308
    },
    {
      "heading": "heading heading References",
      "text": "== Demographic evolution =References==",
      "start_page": 309,
      "end_page": 309
    },
    {
      "heading": "heading heading Problem",
      "text": "== References = External links ==* European European Union: http://europa.eu.int/comm/index_en.htm",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n\"Row\" 2: \"Problem\"Row 3:\n\"a a priority?\"Row 4:\n\"Rop 5: \"JUDICIAL EVIDENCE TESTS\" \"CONSIDERATIONS\" AdditionalRow 6:\n\"No\" \"Probably no \"Probably yes\" ● \"Yes,\" \"Varies,\" \"Don't know\"",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\nor or meta-...Row 2:\n__medTERM2__. __medTERM2__...\"Row 3:\n\"Row 4:\n\"POPULATION:\"Row 5:\n\"Now 6: \"Raw 7: \"INTERVENTION: \"Row 8:\n\"Row 9:\n\"COMPARISON: \"\"Row 10:\n\"NOW 11: \"MAIN OUTCOMES: \"ROW 12: \" -\"Row 13:\n\"SETTING: \"Row 14:\n\"'Row 15:\n\"PERSPECIVES: \" Now 16: \" 'Row 17:\n\"BACKGROUND: \"",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Problem\"Row 3:\n\"a a priority? \"Row 4:\n\"Row 5:\n\"JUDICIAL EVIDENCE TESTS\"Row 6:\n\"No,\" \"Probably no \"Probably yes\" ● \"Yes,\" \"Varies,\" \"Don't know\"",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\nAstatic with ... ..Row 2:\n•Row 3:\n•",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 310,
      "end_page": 310
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Comments Comments anticipated* (95% CI) participants participants (95% (studies) (GRADE) Risk CI) 697 697 • follows follows up: (a a (3 RCT) 0. 0.46) 100 100 (37 to 50)",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"Row\" 2: \"Exit\" effect effect (95% CI) = participants participants (studies) = 6: \"Rischio\" = 7: \"with\" with\" row 8: \"_MEDTERM0\" = \"_medTERM1___\"Row 9:\n\"Row 10:\nPFS follow up: months months \"37 37 (0. 0.46) \"697\" (3 RCT) 3 3 \" c, c,d\"RowRow 11:\n\"Population in studio\" =Row 12:\n\"Now 13:",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nofRow 3:\n(GRADE)",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"DesirablRow 3:\n\"RowRow 4:\n\"",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nRow",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nectsRow 3:\nRow",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nble anticipated effects?",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n\"Row 2\": \"Raw 2\" effect effect (95% CI) \"participants participants (studies) \"tests tests (GRADE) \"Commentary\":Row 3:\n\"Anticipated\": (95% CI), \"Rown\" 4: \"Rough\" 5: \"Row 6:\n\" Rischio\" = 7: \"with\" with\" row 8: \"_MEDTERM0_\"_alectinib\"Row 9:\n\"Row 10:\n__MEDTERM2_ follow up: months months \"HR 0.37\" (0. 0.46) \"697 (3 RCT) 1,2 \" RowRow 11:\n\"Population in study\"",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (column column 7)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 311,
      "end_page": 311
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "follow follow up: (to to (2 RCT) 0. 0.79) survival. survival. (13 to 23) followed followed up: (to to (3 RCT), 1. 1.23) increase the __1⁄100 100 (81 to 94) 303 303 → progressive progressive - (to to (1 TCT) al. al., 0. 0.27) MEDTERM8__-positive MEDTERM8__-positive non-Lung Lung Cancer; T. T., R. R., M. M., Rosell, R.",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nfollow follow up: months months •56 56 (0. 0.79) •Row 510 (2 RCT) 3 3 • e e •that that •RowRow 2:\n•Row 8:\n•Row 9:\n♪ MEDTERM5__ followed up: months months - •15 15 (1. 1.23) •663 (3 RCT), • • row 13: −476 • Very much Row: â â .",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 4)",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "follow follow up: (to to (2 RCT) 0. 0.79) survival. survival. (13 to 23) followed followed up: (to to (3 RCT), 1. 1.23) increase the __1⁄100 100 (81 to 94) 303 303 → progressive progressive - (to to (1 TCT) al. al., 0. 0.27) MEDTERM8__-positive MEDTERM8__-positive non-Lung Lung Cancer; T. T., R. R., M. M., Rosell, R.",
      "start_page": 312,
      "end_page": 312
    },
    {
      "heading": "heading heading OS",
      "text": "et et al; et et al",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "heading heading OS (column 1)",
      "text": "===Row 1:\n, Ruf, T., Noé, J., Peters, S.. ALK__-positive ALK__-positive non-small- Ann Ann Oncol; et et al",
      "start_page": 313,
      "end_page": 313
    },
    {
      "heading": "heading heading ORR",
      "text": "found. found.",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "heading heading ORR (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"UndesiraRow 3:\n\"RowRow 4:\n\"",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "heading heading ORR (column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nRow",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "heading heading ORR (column 3)",
      "text": "Row 1:\n\"_MEDTERM0__\"Row 2:\n\"Row 3:\n\"S\"Row 4:\n\"irable anticipated effects\"?",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "heading heading ORR (column 3)",
      "text": "with with •phase. phase.",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "heading heading ORR (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 314,
      "end_page": 314
    },
    {
      "heading": "heading heading ORR (from previous page)",
      "text": "Row 1:\nCertainties Certainties Comments* (95% CI) Participants Participants (95% (Studies) (GRADE) Aminotrasferase Aminotrasferase (to to (3 RCT) increase increase 3- aminotrasphere aminotrasphere (to to (2 RCT), increase increase - grade 3- 0. 0.91) 4 4 (2 to 7)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading ORR (from previous page)",
      "text": "Row 1; Row 3; Row 2; Esiti 5; Effetto essolutivo (95% CI) participants participants (studies) Row 4;Row 5; Row 6; Rw 10: Alanine anotrasferase increase- 23 23 (0. 0.45) Row 8; Raw 4; RW 9: •Row 10:\n23 23 (0. 0.44)Row 11:\ngrade grade 3- 4.Row 11:\n-Population in study",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading ORR (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading ORR (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading ORR (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nofRow 3:\n(GRADE)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading ORR (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(1 to 6)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading ORR (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(2 to 7)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading ORR (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 2)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading ORR (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(1 to 5)",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading ORR_ (column column 1)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading ORR_ (column column 2)",
      "text": "Row 1:\n\"Row\" 2: \"the the tests\" (GRADE) \"Comments\"Row 3:\n\"Nti\"Row 4:\n\"Rop\" 5: \"VERY BASSAa,\" \"b,\" \"c,\" \"D\"Row 6:\n\"Very BASSaa,\" \"B,\" \"C\"d\"Row 7:\n\"MUCH BASSAA, \"b\"c, \"d\" \"RW\" 8: \"Many Bassaa, \"B\"c\"",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading ORR_ (column column 3)",
      "text": "Row 1:",
      "start_page": 315,
      "end_page": 315
    },
    {
      "heading": "heading heading ORR (from previous page)",
      "text": "Kow 1: kinase-positive kinase-positive non- small-cell cancer (ALESIA): Respir Respir Med; K. K., Hida, T., Nokihara, H., Kumagai, M., A., Watanabe, S., Goto, K ., Satouchi, m., Kozuki, t., stuyama, R., Mitsudomi, T",
      "start_page": 316,
      "end_page": 316
    },
    {
      "heading": "heading heading ORR_ (column column 1)",
      "text": "Kow 1: kinase-positive kinase-positive non- small-cell cancer (ALESIA): Respir Respir Med; K. K., Hida, T., Nokihara, H., Kumagai, M., A., Watanabe, S., Goto, K ., Satouchi, m., Kozuki, t., stuyama, R., Mitsudomi, T",
      "start_page": 316,
      "end_page": 316
    },
    {
      "heading": "heading heading ORR (from previous page)",
      "text": "Row 1:\n• ALT 3+ Nausea 3+ Toxic death •",
      "start_page": 317,
      "end_page": 317
    },
    {
      "heading": "heading heading Values",
      "text": "Row 1:\n\"Row\" 2: \"Certainty of evidence\" is equal to: \"of of effects? \" Row\" 4: \"Rown\" 5: \"JUDICIAL EVIDENCE TRIALS\" = \"CONSIDERATIONS ADDENTY\" = 6: ● \"Very low \"Low\" = Modern \"High \" No included studies\" = 9: \"main main outcome?\" = 7: \"Raw 8: \"Values\" = 10: \"I don't know\" = 11: \"It'main main factors?\"",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading Values (column 1)",
      "text": "Row 1:\n'Row 2:\n'Certainty of evidence'Row 3:\n'of of effects? 'Row 4:\n'Raw 5: 'JUDIZI'Row 6:\n'Very low 'Low' Moderate 'High 'No included studies'.'Row 7:\n'Rop 8: 'Values'Row 9:\n'value value 'Row 10:\n'Row 11:\nJUDIZIORow 12:\n'variable variable 'variability variability '",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading Values (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading Values (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading Values (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nmes?",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading Values (column 10)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 318,
      "end_page": 318
    },
    {
      "heading": "heading heading Acceptability",
      "text": "death. death.",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"EquityRow 3:\n\"RowRow 4:\n\"",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"AcceptabilityRow 3:\n\"RowRow 4:\n\"",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nhealth equity? \"Row 4:\n\"",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nto key stakeholders? \"Row 4:\n\"",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading Acceptability (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nn?",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading Acceptability (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading Acceptability (column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 319,
      "end_page": 319
    },
    {
      "heading": "heading heading Acceptability (from previous page)",
      "text": "Row 1:\n● Yes • Varies • Don't know •Row 2:\n• Right 3: • Feasibility • row 4: • implement implement ? •row 5: •Row 6:\nCOURTS • TESTS TESTS •ADDATIVE CONSIDERATIONS • NOW 7: ♪ No • Probably no •Probably yes ● Yes • Various • don't knows •found found • No evidence found",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (from previous page)",
      "text": "Row 1:\n\"Row 2:\n\"JUDIZI\"Row 3:\n\"Raw 4: \"No\"Probably no\" \"Probabilly yes\" \"Yes\" and \"Don't know\"Row 5:\n\"PROBLEM\"Row 6:\n\"Rw\" 7: \"Trivial\" Small\" \"Moderate\" Large and \"Don't Know\"Row 8:\n\"DESIRABLE\"Row 9:\n\"EFFECTS\"Row 10:\n\"White\"Row 11:\n\"Large\" Moderate\" Small (Small) Trivials and \"Smale\" = \"Done't known\"Row 12:\n\"UNDESIRABLE\"Row 13:\n\"EFFECTS\"Row 14:\n\"Donot know\"",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"FeasibilitRow 3:\n\"RowRow 4:\n\"",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 1)",
      "text": "Row 1:\n Row 2:\n Row 3:\nPROBLEMRow 4:\n Row 5:\n Row 6:\n Row 7:\nDESIGNABLERow 8:\nEFFECTSRow 9:\n Row 10:\n Row 11:\nUNDESIRABLERow 12:\nEFFEECTS",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 2)",
      "text": "Row 1:\n Row 2:\ntyRow 3:\nRow",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nMRow 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nble to implementation? \"Row 4:\n\"",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" row 7: \"Row 8:\n\" 'Row 9:\n\" \"Row 10:\n\" -Row 11:\n\" Now 12: \" Route 13: \"\"Row 14:\n\"",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 4)",
      "text": "Row 1:\n Row 2:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 8)",
      "text": "Row 1:\n Row 2:\nG",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 9)",
      "text": "Row 1:\n Row 2:\nJUDGES",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 10)",
      "text": "Row 1:\n Row 2:\nIZI",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 12)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (column column 14)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don't Know\"Row 5:\n\"Raw 6: \"Way 7: \"Do't know\"Row 8:\n\"Now 9: \"Row 10:\n\"Varie\" and \"Done't Well\"Row 11:\n\"Row 12:\n\"",
      "start_page": 320,
      "end_page": 320
    },
    {
      "heading": "heading heading Acceptability (from previous page)",
      "text": "== References = External links ==* Official website",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Acceptability (column column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\n Row 5:\nVALUESRow 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:\n Row 11:\nRowRow 12:\n Row 13:\n Row 14:\nEQUITYRow 15:\n Row 16:\n Row 17:\nRowRow 18:\n Row 19:\n Row 20:\nFEASIBILITY",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Acceptability (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\nSRow 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\n Row 26:\n Row 27:\n Row 28:\nIRow 29:\n Row 30:\n Row 31:\n Row 32:\n Row 33:\n Row 34:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Acceptability (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\" Right 12: \"",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Acceptability (column column 3)",
      "text": "Row 1:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Acceptability (column column 4)",
      "text": "Row 1:\n Row 2:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Acceptability (column column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"LowRow 5:\n\"RowRow 6:\n\"RowRow 7:\n\"RowRow 8:\n\" RowRow 9:\n\" RowRow 10:\n\"",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Acceptability (column column 6)",
      "text": "Row 1:\n Row 2:\nGI",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Acceptability (column column 7)",
      "text": "Row 1:\n Row 2:\nIUDIZI",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Acceptability (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" row 8: \" \"Row 9:\n\"",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Acceptability (column column 8)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Acceptability (column column 9)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Acceptability (column column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"studies studies \"Row 5:\n\"Row 6:\n\" row 7: \"Row 8:\n\" 'Row 9:\n\" \"Row 10:\n\" Do n'or or w\"Row 11:\n\"Do n' o o w\" \"Row 12:\n\"Don't know \"Row 13:\n\" Don't Know \"Row 14:\n\" don't knowing\"",
      "start_page": 321,
      "end_page": 321
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nthe the intervention",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "heading heading Recommendation (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RecommendationRow 3:\n\"",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "heading heading Recommendation (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "heading heading Recommendation (column 3)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nRowRow 4:\n Row 5:\n●",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "heading heading Recommendation (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 322,
      "end_page": 322
    },
    {
      "heading": "heading heading QUESITO 19",
      "text": "== Demographic evolution =References==",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "heading heading QUESITO 19 (column 1)",
      "text": "Row 1:\n^Row 2:\nCertainty assessment ^Row 3:\n■Row 4:\n•Row 5:\nstudies studies ■study study ■Distortion risk ■results results ■ generalization generalization ■ImmediacyRow 6:\n• row 7: survival survival (follow up: 9 9 months) a •row 8: ♪Row 9:\n1 • Randomized studies • c c •non important •e e •RowRow 10:\nOverall survival (pollow up: 9 9 mesi)a • rows 11: {Row 12:\n1 = randomised studios • 9 9 • RowRow 13:\nORR (followup: median24.9 mei)aRow 14:\n‐Row 15:\n1 - 9 9 - midday • midday .",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "heading heading QUESITO 19 (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\nRowRow 7:\n Row 8:\n Row 9:",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "heading heading QUESITO 19 (column 2)",
      "text": "Row 1:",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "heading heading QUESITO 19 (column 3)",
      "text": "Row 1:\n\"Row\" 1: \"No\": \"No of patients\" \"Effect\" \"Certainly\" \"ImportionRow 3:\n\"Rown\" 4: \"_MEDTERM0\"_ \"_ MEDTERM1\" _ \"Relational\" (95% CI) \"Absolute\" (95%CI) \"Row 5:\n\"Rout\" 6: \"Row\" 7: \"Now\" 8: \"63/137\" (46.0%) \"87/138 (63.0%) \"49 49 (0. 0.68) \"100 100 (14 14 less) \"BASSA\" = CRITICRow 9:\n\"Wow\" 10: \"ROW\" 11: \"3/137 (24.1%), \"Raw 13: \"10\" (26.8%) \"R\" 0.92 \"R.\"",
      "start_page": 323,
      "end_page": 323
    },
    {
      "heading": "heading heading bearing bearing inGHS/QoL",
      "text": "==References===External links==* Official website",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading bearing bearing inGHS/QoL (column 1)",
      "text": "== Demographic evolution =References==",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading bearing bearing inGHS/QoL (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\nRowRow 7:",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading bearing bearing inGHS/QoL (column 2)",
      "text": "Row 1:",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading bearing bearing inGHS/QoL (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading bearing bearing inGHS/QoL (column 3)",
      "text": "Row 1:\nminus 1; minus 1 - 10: less 1 - 13 - _ _ - 10 - 0 0 - - 3 3 - minus minus 2: No of patients' 'Effected' -CertoRow 3:\n\" OutRow 4:\n_ _ - - - _ - MEDTERM1___ MEDTERM1___ [Relativo (95% CI) - Absolute (95% CI (CI) - - TotalRow 5:\n•Row 6:\n31/47 (66.0%) - [66.0%) -8 (16.3%) - 9 (16.3%) - 04 04 (7. 7.87) - 50 / 47 (66.8%) - + 100 (100 100 + to 100 (to to 100) - 12 (to to 25) - Row:",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading bearing bearing inGHS/QoL (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"ImportationRow 3:\n\"Row 4:\n\"CRITICRow 5:\n\"Row 6:\n\" \"Row 7:\n\" CRITICRow 8:\n\" row 9: \" 'Row 10:\n\" CRITICRow 11:\n\"Row 12:\n\" - \"Row 13:\n\" CrititicRow 14:\n\" \"Row 15:\n\" Right 16: \"CriticalRow 17:\n\" Now 18: \" Route 19: \"",
      "start_page": 324,
      "end_page": 324
    },
    {
      "heading": "heading heading References",
      "text": "Row 1:\n\"Row 2:\nCertainty assessment\" Patient's No (s) of patients \"Effect\" (sure) \"ImportantRow 3:\n\"Raw\" 4: studies studies \"the the study\" \"Distortion risk\" (ies) \"Absolute\" (95% CI) \"Rout\" 5: \"Rown\" 6: 1 \"Studies randomized\" (164 164 plus) \"G\" series \"None\"17/136 (12.5%) \"12/137 (8.8%) \"43 43 (2. 2.87) \"000 000 (164 164 more) \"MUCH BASSA\" (ii) \"CRITIC",
      "start_page": 325,
      "end_page": 325
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\nadvanced advanced stage",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n\"Row 2:\na a priority? \"Row 3:\n\"Row 4:\n\" JUDICES\" \"EVIDENCE EVIDENCE TESTS\" \"CONSIDERATIONS\"Row 5:\n\"No\" \"Probably not \"Yes\" ● \"Varia\" \"I don'out. out.\"",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\nwith with NSLC/Row 2:\n•Row 3:\nPOPULATION: •Row 4:\n• row 5: INTERVENTION: â ¢Row 6:\nÂRow 7:\nCOMPARISON: ■Row 8:\n−Row 9:\nMAIN EXITS: ¶",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n\"Row 2:\nSETTING: \"Row 3:\n\"Row 4:\nPROSPECTIVE: \" row 5: \"Row 6:\n\" BACKGROUND: \"row 7: \"RW 8: CONFLICTS OF \"Row 9:\nINTEREST \"Row 10:\n\"",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n Row 2:\na a priority?Row 3:\n Row 4:\nJUDICES",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\nRow",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\nRow",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading Problem (column 4)",
      "text": "Row 1:",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading Problem (column 4)",
      "text": "Row 1:\n Row 2:",
      "start_page": 326,
      "end_page": 326
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nofRow 3:\n(GRADE)",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100Row 3:\n(29 to 49)",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nEsiderRow 3:\nRow",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nSiderable Expected?",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\nRowRow 2:\nstudy study (ALTA-1) age age > Early Early comments* (95% CI) trials trials (95% MEDTERMOPERM0_ vintage &amp; day. day.",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (column column 7)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 327,
      "end_page": 327
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "follow follow up: 4.04 (1 RCT.) of of (62 to 87) response. response.",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/en_en/index_en.htm",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100Row 3:\n(62 to 87)",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100Row 3:\n(17 to 45)",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100Row 3:\n(34 to 100)",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n1,000",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n1,000",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n•Row 2:\n• row 3: •row 4: •MEDTERM0_ follow up: months months •20 20 (1. 1.41)Row 5:\n• study population •Row 6:\n♪Row 7:\n■Row 8:\n@100 100 •100 100 (62 to 87) •Row 9:\n¶Row 10:\nIntracranial •_MEDTERM1_ follow-up: months months ‐25 25 (0. 0.45)Row 11:\n^â â ¢Row 12:\nRowRow 13:\n−Row 14:\nâ¬ Row 14; â€100 100 (17 to 45) RowRow 15:\n·Row 16:\n¢â â .",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nRowRow 4:\nrow row 5: not not having",
      "start_page": 328,
      "end_page": 328
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References==",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"life. life.\"Row 2:\n\"312 to 534) \"Row 3:\n\"Row 4:\nimprovements improvements inGHS/follow follow up: 9 9 months\"26 26 (0. 0.56) \"119 (1 RCT) \"1 \" d, d,e\" \"__medTERM1_ __medTERM1_ Q- C30Row 5:\n\"Population in study\"",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n(RowRow 2:\n534)",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n1,000",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(49 to 210)",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row\" 2: \"312 to 534) \"Row 3:\n\"Row 4:\nimprovements improvements inGHS/follow follow up: months months \"26 26 (0. 0.56) \"119 (1 RCT) \"1Row 5:\n\"Population in study\" \"Rw 6: \"Raw 7: \"Row 8:\n\"344\" 000 000 \"104\" 000 000 (49 to 210) \"Row 9:\n\"",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\nRowRow 2:\nMEDTERM1__ MEDTERM1__ Q-C30",
      "start_page": 329,
      "end_page": 329
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nndesidRow 3:\nRow",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nDerabiRow 3:\nRow",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\niiRow 3:\nRow",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n\"__medTERM2__ __medTERM2__ + cancer cancer (ALTA-1L). Lung Cancer; that that 27% indirectity indirectity (inappropriate inappropriate follow-up). default default (an an interim-analysis). bias bias (open label study). e. 3: d. d.",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\nRowRow 2:\nstudy study (ALTA-1) patients patients > treatment treatment arms: BID. BID.",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading Problem (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 330,
      "end_page": 330
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n(GRADE) Risk CI) grade grade < 273 273 • 19 19 (1 RCT)follow follow up: 100 100 (9 9 (61 to 86) 1,40) RR73 RR73 •_MEDTERM1,c follow-up: 0.91 (1 RTC) 100 100 (100 100 (97 to 100) 10.01) AST AST (< G3 Study population",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nofRow 3:\n(GRADE)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(61 to 86)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(97 to 100)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n1,000",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(12 to 107)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row: partecip partecip (studies) RowRow 3:\n\"anticipated\" (95% CI) -partecipRow 4:\n\"Studies\"Row 5:\n\" \"Row 6:\n\"Rischio\" Raw Raw 7: \"con\"",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row\" 2: \"Certe delle p\" (GRA) \"CerteRow 3:\npanti\" RowRow 4:\n\"GRA\"",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\nADE)",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n•Row 2:\n• CommentsRow 3:\n• row 4: •row 5: •RowRow 6:\n♪RowRow 7:\n■the the •ST ST < 3.Row 8:\n−",
      "start_page": 331,
      "end_page": 331
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "much much (13 to 99) RR RR <3 - follow follow up: (to to (1 RCT)grade grade <=RR RR 273",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nALT grade <3 follow-up: 9 9 months/36 36 (0. 0.97)",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n1,000",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(13 to 99)",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n1,000",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(62 to 251)",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\nALT grade <=3 follow-up: 36 36 (0. 0.97)",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\nRowRow 2:\ndiscontinuity. discontinuity.",
      "start_page": 332,
      "end_page": 332
    },
    {
      "heading": "heading heading Valori",
      "text": "bias bias (open label study). data data (sponsor bias). imprecision imprecision (an an interim-analysis).",
      "start_page": 333,
      "end_page": 333
    },
    {
      "heading": "heading heading Valori (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"the the tests\" [Row 4:\n\"safety safety tests?\"]Row 5:\n\"Raw 6: \"JUDIZI\"Row 7:\n\"Very low\" - \"Low\" - moderated - \"High\" - included included - \"Rw 8\": \"Row 9:\n\"Valori\" -Row 10:\n\"C\" main main outcomes? \"Row 11:\n\"Wow\" 12: \"GIUDIZI\"\"Row 13:\n\"or or variable\" - variation variation ● or or variability",
      "start_page": 333,
      "end_page": 333
    },
    {
      "heading": "heading heading Valori (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 333,
      "end_page": 333
    },
    {
      "heading": "heading heading Equity",
      "text": "==References===External links==* Official website",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nor or comparison?",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nuità? \"Row 4:\n\"",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading Equity (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading Equity (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 334,
      "end_page": 334
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\n\"Row\" 2: \"Acceptibility\" \"Rop 3: \"main main stakeholders?\" \"Raw 4: \"Roo 5: \"JUDICI\" \"EVIDENCE EVIDENCE TESTS\" \"ADDENTIONS\" \"ROW 6: \"No\" \"Probably no\" \"You\" ● \"Yes,\" \"Vary,\" \"I don't know,\" \"found. found. \"filled. filled.\" \"Ruh 7: \"Roh 8: \"Fatsibility\" \"Row 9:\n\"the the intervention\" \"Now 10: \"Needle\" \"Not known.\"",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•AcceptabilityRow 3:\n•RowRow 4:\n•",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•Now 4:",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nMain",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nell'interve",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nstakeholders?",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nento\"? \"Raw 4: \"",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading Fatsibility (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading Fatsibility (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 335,
      "end_page": 335
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading Fatsibility (column column 1)",
      "text": "Row 1:\n Row 2:\nPROBLEMRow 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:\n Row 11:\nRowRow 12:\n Row 13:\n Row 14:\nVALUESRow 15:\n Row 16:\n Row 17:\nRow",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading Fatsibility (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\nERABILIRow 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\nIBERABLERow 14:\n Row 15:\n Row 16:\n Row 17:\nELLERow 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\n Row 26:\n Row 27:\nORRow 28:\n Row 29:\n Row 30:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading Fatsibility (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\" Now 12: \" Roll 13: \" Route 14: \" Right 15: \" [Row 16:\n\"]Row 17:\n\" #Row 18:\n\"\"Row 19:\n\")Row 20:\n\" *Row 21:\n\" Rule 22: \"",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading Fatsibility (column column 3)",
      "text": "Row 1:\n Row 2:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading Fatsibility (column column 7)",
      "text": "Row 1:\n Row 2:\nJUDICES",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading Fatsibility (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\" Raw 18: \"",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading Fatsibility (column column 9)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading Fatsibility (column column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\" Don't know\"Row 5:\n\"Don't knowing\"Row 6:\n\"Do't known\"Row 7:\n\"No included studies\"Row 8:\n\"Raw 9: \"Row 10:\n\" row 11: \"Row 12:\n\"N\" 13: \"don't knows\"",
      "start_page": 336,
      "end_page": 336
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "Row 1:\n\"Row 2:\n\"JUDIZI\"Row 3:\n\"Raw 4: \"Reduce d\"reduce reduce d\" Probably no impact\" by by \"Increased by \"Varies\" or \"n\" or or \"w\"Row 5:\n\" EQUITA\"Row 6:\n\"N\"Row 7:\n\"No\" no no \"yes yes \"Yes\"",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading Fatsibility (column column 1)",
      "text": "Row 1:\n Row 2:\nEQUITA:Row 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\nFACTIVITY",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading Fatsibility (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" 'Row 8:\n\" row 9: \" \"Row 10:\n\"\"Row 11:\n\" Now 12: \"",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading Fatsibility (column column 2)",
      "text": "Row 1:",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading Fatsibility (column column 3)",
      "text": "Row 1:\n Row 2:",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading Fatsibility (column column 7)",
      "text": "Row 1:\n Row 2:\nJU",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading Fatsibility (column column 8)",
      "text": "Row 1:\n Row 2:\nUDIZI",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading Fatsibility (column column 9)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading Fatsibility (column column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"D o n' o o w\" \"Row 5:\n\"D or \"n' t \" n o \" \"Row 6:\n\" n n \" or or \" w\"",
      "start_page": 337,
      "end_page": 337
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nagainst against intervention",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 338,
      "end_page": 338
    },
    {
      "heading": "heading heading QUESITO 20",
      "text": "== Demographic evolution =References==",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "heading heading QUESITO 20 (column 1)",
      "text": "Row 1:\nCertainty assessment:Row 2:\n...Row 3:\n...\"Study\"Row 4:\n..Row 8:\nProgression free survival\"Row 9:\n2...\"randomised trials\" b. b..\"\"serious c\"not seriousus d\"not seriousness\"Row 10:\n\"Overall survival\" row 11: 2\"randomized trials\" b, b,e\"not graveus\"not silky d\"serious f ...Row 12:\nrate rate \"Row 13:\n2'randomisised trials\" B, B,g\"unsericious unsericious d\"serious h\")Row 14:\n\"Nausea responde rate\"Row 13:\n...",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "heading heading QUESITO 20 (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nsubscriptionRow 4:",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "heading heading QUESITO 20 (column 3)",
      "text": "Row 1, \"No of patients\" = \"Importance Row,\" \"No\" =\"\"ceritinib or\"_Relative\" = [Absolute] = \"Certainty\" =\"ImportantRow 3:\n\"ns\"_MEDTERM1_ _ or\"chemotherapy\" (95% CI) ] = \"Row 4:\n\"_MEDTHERM2___\"Row 5:\n\"\"Row 6:\n\"ModerateRow 7:\n\"111/187\" (59.4%) \"110/151 (72.8%) \"45 45 (0. 0.59) \"100 100 (37 37 feet) \" MODERATE\" = CRITICALRow 8:\n\"RW 9:",
      "start_page": 339,
      "end_page": 339
    },
    {
      "heading": "heading heading QUESITO 20 (from previous page)",
      "text": "Row 1:\nGGT increased - ceritinib",
      "start_page": 340,
      "end_page": 340
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS",
      "text": "Row 9:\n- 10: SETTING: \"RowRow 11:\n\"Row 12:\n• 28: 2nd diet: 2; 2nd metastatic: 2D_Mow: 1; Row",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS",
      "text": "Row 1:\n•Row 2:\na a priority? •row 3: • row 4: JUDICES •TESTS TESTS •Row 5:\n• no • probably no ♪ X X • Yes",
      "start_page": 341,
      "end_page": 341
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "desirable desirable effects?Row 5:\n\"Row 6:\n\"JUDICIS\"Row 7:\n\"Comments Comments CI) evidence evidence (95% CI) (studies) (GRAD) chemotherapy chemotherapy (Comments Comments CI) evidence evidence 95% CI (studies) (GRADE) chemotherapy chemotherapy (_168TERM _168TERM 1__] 59 59 (36) 338 338 ? Survival (to to (2 RCTs) 9 9 (36).",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95% CI)",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nevidenceRow 3:\n(GRADE)",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nchemotherapy",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 2)",
      "text": "Row 1:\n Row 2:\nEvergreenRow 3:\nEverlasting",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 3)",
      "text": "Row 1:\n Row 2:\nrableRow 3:\nRow",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nDesirable Those Expected? \"Row 4:\n\"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 4)",
      "text": "Row 1:\n\"Row 2:\nOutcomes\" \"Outcomes\"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 5)",
      "text": "Row 1:\n... \"Row 5:\n..RowRow 11:\n..\"Row 12:\n. ..Row 13:\n.\"RowRow 14:\n.\"\"Row 15:\n. ... row row 23: .",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 6)",
      "text": "Row 1:\n\"Row with Row\" 2: d absolute effects* (9thRow 3:\n\"Raw\" 4: \"Rop\" 5: \"Rown\" 6: \"RowRow 7:\n\"Apy\" (Q9): \"CeritiniRow 8:\n\"_MEDTERM0__\"Row 9:\n\"Wow\" 10: \"Row 11:\n\"ation\"Row 12:\n\"Now\" 13: \"Dow\" 14: \"4\" for \"100Row 15:\n\"8th Row\" to \"54)Row 16:\n\"How\" 17: \"How\" 18: \"athion\"Row 19:\n\"Sow\" 20: \"Row\" 21: \"7\" RowRow 22:\n\"28 to \"49\"Row 23:\n\"He\"Row 24:\n\"Fow\" 25: \"Jow\"Row 26:\n\"New\" 27: \"The Row\" 28: \"RowRow 29:\n\"20 to \"79\"Row 30:\n\"Imrow\" 31: \"10 \"Rlow\" 38: \"Eight\": \"3: ation Row\" Row: \"Bow\" 33: \"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 7)",
      "text": "Row 1:\n... .. . . . ... . ...\" . ..\" ..\"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 8)",
      "text": "Row 1:\n\"Row\" 2: \"Certainty\" or evidence (GRADE) \"Certainty\" and \"Raw\" 3: pants\" \"evidenceRow 4:\n\"s\" (GRADE)",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 9)",
      "text": "Row 1:\n Row 2:\nRowRow 3:",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 10)",
      "text": "Row 1:\n\"Row 2:\nCommen\"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS (column column 11)",
      "text": "Row 1:\n Row 2:\nnts",
      "start_page": 342,
      "end_page": 342
    },
    {
      "heading": "heading heading I2=89%",
      "text": "==References===External links==* Official website",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "heading heading I2=89%",
      "text": "Row 1:\nGGT increased - ceritinib",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "heading heading I2=89%",
      "text": "Row 1:\nRowRow 2:\n(0 to 0)",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "heading heading I2=89% (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 343,
      "end_page": 343
    },
    {
      "heading": "heading heading I2=89% (from previous page)",
      "text": "Row 1:\n\"Row 2:\n\"Indesirable effects\" [Row 3]: \"effects effects expected?\" (Row 4:\n\"Wow 5: \"ADDITIVE ADDITIVE TESTS\" (Raw 6): \"Great\" (Now 6: \") \"Moderate X\" (Studies) \" (GRADE) \" Chemotherapy Chemotherapy (Q9) \"338 338 \"Survival\" (to to (2 RCTs) 59 59 (36 to 54) \"HR HR .",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95% CI)",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (from previous page)",
      "text": "Row 1:\nRowRow 2:\nevidenceRow 3:\n(GRADE)",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (from previous page)",
      "text": "Row 1:\nRowRow 2:\nchemotherapy",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 2)",
      "text": "Row 1:\n Row 2:\nndesidRow 3:\nRow",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 3)",
      "text": "Row 1:\n Row 2:\nderabiRow 3:\nRow",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 4)",
      "text": "Row 1:\n Row 2:\niiRow 3:\nUnwanted Tits Expected?",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 4)",
      "text": "Row:Row 4:\n Row 5:\n Row 6:\n- \"Row 6:\n\"Raw 5: \"Row 7:\n\"RowRow 11:\n\" RowRow 12:\n\"\"Row 13:\n\"ChemotheraRow 8:\n\" \" RW 9: RowRow 10:\n\" row row 11:",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 5)",
      "text": "Row 1:\n\"Row with Row\" 2: d absolute effects* (9thRow 3:\n\"Raw\" 4: \"Rop\" 5: \"Rown\" 6: \"RowRow 7:\n\"Apy\" (Q9): \"CeritiniRow 8:\n\"_MEDTERM0__\"Row 9:\n\"Wow\" 10: \" Row\" 11: \"ation\"Row 12:\n\"Now\" 13: \"Dow\" 14: \"4\" for \"100Row 15:\n\"28 to \"54)Row 16:\n\"How\" 17: \"Row\" 18: \"Otion\" [Row] 19: \"==Row 20:\n\"Sow\" 21: \"7\" RowRow 22:\n\"20 to \"79\"Row 23:\n\" Row\" 24: \"5\"Row 25:\n\"Action\"Row 26:\n\"Fow\" 33: \"10\"Row 28:\n\"RowRow 29:\n\"+20 to 79\"Row 30:\n\"- Row\"Row 31:\n\"ROW\": \"3: \"50: \"35\" Row\" - 35: \"Bight to \" Row.\"",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 6)",
      "text": "==References===External links==* Official website",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 7)",
      "text": "Row 1:\n\"Row\" 2: \"Certainty\" or evidence (GRADE) \"Certainty\" and \"Raw\" 3: pants\" \"evidenceRow 4:\n\"s\" (GRADE)",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 8)",
      "text": "Row 1:\n Row 2:\nRowRow 3:",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 9)",
      "text": "Row 1:\n\"Row 2:\nCommen\"",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 10)",
      "text": "Row 1:\n Row 2:\nnts",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (column column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 344,
      "end_page": 344
    },
    {
      "heading": "heading heading I2=89% (from previous page)",
      "text": "Rowter 1: • 291 291 • treatment (3 to 15) (to to (2 RCTs) 1. 1.94) I2=31% patients patients was: 26% and and 33% MEDTERM7_ MEDTERM7_ 0/1 (91.7% vs 85.7% metastasis metastasis (34.7% vs 25.7%).",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "heading heading I2=89% (from previous page)",
      "text": "Row 1:\n85 85 (1. 1.94)",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "heading heading I2=89% (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(3 to 15)",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "heading heading I2=89% (column column 1)",
      "text": "Rowter 1: • 291 291 • treatment (3 to 15) (to to (2 RCTs) 1. 1.94) I2=31% patients patients was: 26% and and 33% MEDTERM7_ MEDTERM7_ 0/1 (91.7% vs 85.7% metastasis metastasis (34.7% vs 25.7%).",
      "start_page": 345,
      "end_page": 345
    },
    {
      "heading": "heading heading Valori",
      "text": "Row 1:\n\"Row\" 2: \"the the tests\" •Row 3:\n\"safety safety tests?\" • row 4: •row 5: \"JUDIZI\" ♪tests tests •now 6: • X X • moderated • high • included included • •biases biases • estimates estimates • Now 7: −Row 8:\n\"Valori\" ¶Row 9:\n\"C\" main main outcomes? •Row 10:\n\"Raw 11: JUDITIONS •EVENTS EVENTS • NOW 12: \"variability variability • variation variation • or or variability\"",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "heading heading Valori (column 1)",
      "text": "Row 1:\n\"Row\" 2: \"the the tests\" = \"Raw 3: \"safety safety tests?\" = \"Row 4:\n\"Row 5:\n\"JUDIZI\" = row 6: \"X X \"Moderated low\" = high 7: \"Row 8:\n\"Valori\" =Row 9:\n\"C\" main main outcomes\" = .Row 10:\n\"Rown 11: \"Giudizi\" = rows 12: \"or or variation\" = whatsoever. whatsoever.",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "heading heading Valori (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n?",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "heading heading Valori (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nwings?",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "heading heading Valori (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "heading heading Valori (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 346,
      "end_page": 346
    },
    {
      "heading": "heading heading Acceptability",
      "text": "or or comparison?",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n\"Row\" 2: \"Budget of effects\" = \"Raw 3: \"undesirable undesirable effects\" favour favour , \"Varia\" = , row row 7: \"Right 8: \"Equity\" = 9: \"of of equity?\" = 10: \"Wait\" = 11: \"Judizi\" = 12: \"Reduce equity\" = 15: \"stakeh stakeh = 10\" - \"Improve equity\" - 5: \"Vay\" - 1: \"Don't know\" - 13: \"Now\" - 14: \"Acceptability\" -15: \"Possibly no impact\" - equity equity -- \"Improved equity\"",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nKeepers?",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading Acceptability (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading Acceptability (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nFront?",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading Acceptability (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 347,
      "end_page": 347
    },
    {
      "heading": "heading heading BILI",
      "text": "Row 1:\n\"Varia\" doesn'RowRow 2:\n\"Row\" 3: the the intervention? \"Rop\" 4: \"Rw\" 5: \"JUDICI\" = \"ADDITIONAL ADDITIONAL TESTS\" = row 6: \"No\" no no \"Probably yes\" x \"Varia\" known. known.",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading BILI",
      "text": "Row 1:\n'Row 2:\n'JUDIZI'Row 3:\n'Rop 4: 'No'Probabilm ente no'Probilm entre si' \"Si\": 'Varia' not so 'Raw 5': 'PROBLEM'Row 6:\n'Rout' 7: 'Relevances' 'Small' 'Moderates' 'Various' 'Do not so'Row 8:\nDESIDERABLE SIDES'Row 9:\n'Row 10:\n'Great' 'Moderati' 'Piccoli' (Smells) 'Models'\" 'Vary 'Not so 'Wow 11: Sides'Row 12:\n'Now 13: BILIS'Row 14:\n'row 15: 'bas bas sa'Bassa'Moderated 'Alta'or or 'Right 16: QUITARow 17:\n'DELLERow 18:\nWATCHES'Row 19:\n'",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading BILI (column 1)",
      "text": "Row 1:\n Row 2:\nRow",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading BILI (column 1)",
      "text": "Row 1:\n Row 2:\n Row 3:\nPROBLEMRow 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:\n Row 11:\n Row 12:\nSIDESRow 13:\nRIGHTRow 14:\nBIBILIRow 15:\n Row 16:\n Row 17:\nQUALITYRow 18:\nDELLERow 19:\nTESTS",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under headingbile (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nthe the surgery?",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under headingbile (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\" Now 12: \" Roll 13: \" Route 14: \"\"Row 15:\n\" Right 16: \")Row 17:\n\" [ \"Row 18:\n\"]Row 19:\n\"",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading BILI (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading BILI (column 3)",
      "text": "Row 1:\n Row 2:",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading BILI (column 7)",
      "text": "Row 1:\n Row 2:\nG",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading> (column 8)",
      "text": "Row 1:\n Row 2:\nJUDIZ",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading> (column 9)",
      "text": "Row 1:\n Row 2:\nZI",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading> (column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" row 7: \"Row 8:\n\" 'Row 9:\n\" \"Row 10:\n\" -Row 11:\n\" Now 12: \" Route 13: \"\"Row 14:\n\" Right 15: \"",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading> (column 12)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading> (column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "table under heading> (column 14)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don'RowRow 5:\n\"RowRow 6:\n\"D\"Row 7:\n\"o o \"Row 8:\n\"Row 9:\n\"",
      "start_page": 348,
      "end_page": 348
    },
    {
      "heading": "heading heading JUDIZI",
      "text": "Row 1:\n... \"Row 7\": \"or or variability\" variation. variation...\"or or variable\" comparison. comparison..\"\"or or variability\" = \"Raw 8\" is important: \"Row 9\": ...\"Row 10:\n\"of of comparison\" and and \"interven to\" isn'comparison, \"comparison, comparison,\" \"Probabably reduces equity\" (on on equity) \"Probiably increase equity\" to to \"Ru\" 12: \"RWow 13: \"Reduces equity\")...",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading JUDIZI (column 1)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\nEQUITARow 12:\n Row 13:\n Row 14:\nACCEPTABILITYRow 15:\n Row 16:\n Row 17:\nFACTIVITY",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\n\"Row\" 2: \"JUDIZI\"Row 3:\n\"Raw\" 4: \" Row\" 5: \"Row 6:\n\"Rop\" 7: \"or or variability\" = \"or or variation\" - \"or or variability\" - ...\"Row 8:\n\"Row\" 9: \"-Row 10:\n\"of of comparison\" -\"\"comparison comparison - \"intervention intervention \"nto\"Row 11:\n\"Now\" 12: \"Wow\" 13: \"Reduce equity\" - equity equity - \"on on equity\"",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading JUDIZI (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" row 8: \" \"Row 9:\n\"",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading JUDIZI (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading JUDIZI (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Nor so\"Row 5:\n\"Raw 6: \"Row 7:\n\"Row 8:\n\" row 9: \" \"Row 10:\n\"Don't know\"Row 11:\n\"Varia\" know know \"Row 12:\n\"Miscellaneous\"Row 13:\n\"Row 14:\n\"Way\" 15: \"Save\"Row 16:\n\"Now 17: \"I don't care\"",
      "start_page": 349,
      "end_page": 349
    },
    {
      "heading": "heading heading Strong recommendation",
      "text": "Row 1:\nintervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "heading heading Strong recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "heading heading Strong recommendation (column 1)",
      "text": "Row 1:\nintervention intervention • • operation operation •",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "heading heading Strong recommendation (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•Recommendation",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "heading heading Strong recommendation (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 350,
      "end_page": 350
    },
    {
      "heading": "heading heading QUESITO 21",
      "text": "==References===External links==* Official website",
      "start_page": 351,
      "end_page": 351
    },
    {
      "heading": "heading heading Ipertridemia grade 3-4",
      "text": "Row 1:\n\"Row\": \"Raw\": 5 hours \"Rown 3: \"Right\": studies studies \"Rough\": 15 years \"Different\": 4 years \"Worthful\": 3 years \"Few months\": 10 years \"Serious\": 2 years \"Very serious\": very serious (very serious) = \"Current\": 7 years \"Harthly\": 6 years \"Great\": 1 years \"Garly\"; 5 years \"Life\": 9 years \"al. al. 10/baseline. baseline.\" 47/patients. patients.",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "heading heading  Hypertridemia grade 3-4 (column 1)",
      "text": "Row 1:\n\"Distorting risk\": Certainty assessment: \"Row\" 3: \"Raw 4: \" Row\" 5: \"No studies\": \"the the study\": very serious: \"Very serious\": c\" very serious; \"Rw\" 8: \"grade grade 3-4\"Row 9:\n\"Row 10:\n2 1,2\" observational studies: very seriously: \"very serious\" = \"Verily serious\"; \"C\": Very serious: C\": Highly serious: high: \"High\": Low: low: 2 1.2\" observationally studied: very Serious: very severe: very bad: low to high: high to low: high level: high-grade: low-level: low 16: 2,2\" serious. serious.",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "heading heading  Hypertridemia grade 3-4 (column 2)",
      "text": "Row 1:\nFew-to-five-century patients: al. al. 10/al al 1/patient patient (Row).",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "heading heading  Hypertridemia grade 3-4 (column 3)",
      "text": "Row 1:\n Row 2:\nImportance",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "heading heading  Hypertridemia grade 3-4 (column 3)",
      "text": "Row 1:",
      "start_page": 352,
      "end_page": 352
    },
    {
      "heading": "heading heading References",
      "text": "Row 1:\n•Row 2:\nCertainty assessment •row 3: • row 4: design design •distortion distortion • results results •now 8: 1 • observational studies •not important • very serious • no one •study study •15/4. 4. • molto bassa •",
      "start_page": 353,
      "end_page": 353
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\nor or __DETERM2__",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n\"Row 2:\na a priority? \"Row 3:\n\"Row 4:\n\" JUDICES\" \"EVIDENCE EVIDENCE TESTS\" \"CONSIDERATIONS\"Row 5:\n\"No\" \"Probably not \"Yes\" ● \"Varia\" \"I don'out. out.\"",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\nShouldRow 2:\nRowRow 3:\n Row 4:\nPOPULATION:Row 5:\n Row 6:\nINTERVENTION:Row 7:\n Row 8:\nCOMPARISON:Row 9:\n Row 10:\nMAIN EXITS:Row 11:\n Row 12:\n Row 13:\nSETTING:Row 14:\n Row 15:\nPROSPECTIVE:Row 16:\n Row 17:\nBACKGROUND:Row 18:\n Row 19:\nRow",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\npriority:",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\nre-arrangem re-arrangem +Row 2:\nor or __medTERM2___",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" row 7: \"Row 8:\n\" E \"Row 9:\n\"",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nTà?",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\nRowRow 2:\ncompleted. completed.",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\nRow",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\n Row 2:",
      "start_page": 354,
      "end_page": 354
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "=Effects Effects (Row 3:\n\"desirable desirable effects?==:::;;;::.:: .::]:: Row:: , , 5: CONSIDERATIONS CONSIDERATIONS ,Row 6:\n• Irrelevant , Little ● Varian Varian , _ _ &amp; had had before; treated, and",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"Row\" 2: \"Impact\": \"No\" of the \"the the Rows\" 3: \"Participants\" \"Tests\" \"Raw 4: \"Studies\" \"GRADE) \"Row 5:\n\"follow follow up\": months months \"(1 observational study\") 1 \" MANY BASSAA, \"b\" \"Row 7:\n\"months months (95%1-30. 1-30.3). \"Row 8:\n\"Row 9:\nResponse duration\" = 12: \"_MEDTERM0__ rearranged\" months months \"Rown 13: \"95%IC 6.8-NR\"). \"Rop 14: \"Now\" with with \"Right 12: •ranged. ranged.\"",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nmonths (95%1-30. 1-30.3).",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nEsiderRow 3:\nRow",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nSiderable Expected?",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "between between 10- 35 35 - of of −the the follow_MERALM1_=Festes Festes (GR duration) of of , one one line- 1 line; iron, iron, and",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading Problem (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 355,
      "end_page": 355
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row. , Fl. Fl., months months (95%4-7. 4-7.4). al. al. 10/32 patients (disease. disease.",
      "start_page": 356,
      "end_page": 356
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 356,
      "end_page": 356
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "et et al'TKI. TKI. 1/patient. patient.",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n'Row 2:\nOutcomes'\"Impact\"the the \"Certainness\" \"Row 3:\n\"Participants\" of the tests\" \"Row 4:\n\"Studies\" \"GRADE) \"Row 5:\n\"Raw 6: \"3-4 3-4 \"(2 observational studies) 1,2 \" MANY BASSAA, b\"Row 7:\n\"54 54 \"Row 8:\n\"Total patients\" RowRow 9:\n\"3 3 \"Row 10:\n\"al. al.\" 1/295 \"Row 11:\n\"Persons\" RowRow 12:\n\"AST\" RowRow 13:\n\"Grade 4 \"Row 14:\n\"",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nndesidRow 3:\nRow",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nDerabiRow 3:\nRow",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\niiRow 3:\nRow",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n\"TKI. TKI.",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\nRowRow 2:\nal. al.'et et al'by by −of of − MEDTERM2_ patient.",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading Problem (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 357,
      "end_page": 357
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nal. al. 2/54 (on on observationals) b b (verbal verbal expression), al al . of 54 (developed developed observationals).patients patients (have have observed).",
      "start_page": 358,
      "end_page": 358
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "== Demographic evolution =References==",
      "start_page": 358,
      "end_page": 358
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nal. al. 15/295Row 2:\nRowRow 3:\ngain. gain.",
      "start_page": 358,
      "end_page": 358
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "== Demographic evolution =References==*density density ==External links==",
      "start_page": 358,
      "end_page": 358
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/en_en/index_en.htm",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nveRow 3:\nof",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n\"J. S., Chen, J., F. F., Abbattista, A., J. J.. Lorlatinib in non-__medTERM2__ __medTERM2__ rearrangement: single-arm single-arm first-Lancet Lancet Oncol; or or several?",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\nRowRow 2:\nfollowing following reasons: - distortion distortion (uncontrolled observational studies) - non-consistency non-consistency - indirectness indirectness - inaccuracy. inaccuracy.",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading Problem (column column 7)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 359,
      "end_page": 359
    },
    {
      "heading": "heading heading Effect balance",
      "text": "==References===External links==* gain. gain.",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading Budget of effects (column 1)",
      "text": "gain. gain.",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading Budget of effects (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 360,
      "end_page": 360
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\n\"Row\": \"Raw\" 2: \"Right\" = \"Rown\" 3: \"of of equity? \"Rop\" 4: \"Rough\" 5: \"JUDIZI\" 5 - \"EVIDENCE EVIDENCE TESTS\" ): \"Reduces equity\" equity equity ● \"No impact\" equity equity \"Improves equity,\" \"Vary\" 10: \"found. found.\" \"filled. filled.\" \"Rw 7: \"Row 8:\n\"Acceptibility\"",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•AcceptabilityRow 3:\n•RowRow 4:\n•",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•The",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nUità?",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nstakeholders? \"Row 4:\n\"",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nento\"? \"Raw 4: \"",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading Fatsibility (column 9)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 361,
      "end_page": 361
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "Row 1:\n• Vary • Not known",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "== Demographic evolution =References==",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading Fatsibility (column column 1)",
      "text": "Row 1:\n Row 2:\nPROBLEMRow 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:\n Row 11:\nRowRow 12:\n Row 13:\n Row 14:\nVALUESRow 15:\n Row 16:\n Row 17:\nRowRow 18:\n Row 19:\n Row 20:\nEQUITA",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading Fatsibility (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\" IRow 12:\n\" Now 13: \" Route 14: \" Right 15: \"",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading Fatsibility (column column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading Fatsibility (column column 3)",
      "text": "Row 1:\n Row 2:\nJUDICES",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading Fatsibility (column column 3)",
      "text": "Row 1:\nProbably no\"RowRow 2:\nSmall\"ModerateRow 3:\nModerat e\"SmallRow 4:\nLow\"Moderat e \"Row 5:\nor or variable\"\"RowRow 6:\non on \"RowRow 7:\nProBably reduced [Probabilly no impact]",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading Fatsibility (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\" Raw 18: \"",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading Fatsibility (column column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don't know\"Row 5:\n\"Dun't knows\"Row 6:\n\"Do't known\"Row 7:\n\"No included studies\"Row 8:\n\"Raw 9: \"Row 10:\n\"Row 11:\n\"Row 12:\n\"Now 13: \" Don't Know\"Row 14:\n\"don't really know\"",
      "start_page": 362,
      "end_page": 362
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n\"Row 2:\n\"JUDIZI\"Row 3:\n\"Rown 4: \"No\"Probably no\" \"Probabilly yes\" \"Yes\" \"Varies D\"on'RowRow 5:\nACCEPTABLE TY\"Row 6:\n\"Raw 7: \"No\"\"Probably no \"Probably yes \"Yes\" \"Warries\" Don'RowRow 8:\nFACTABILITY\"Row 9:\n\"",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nagainst against intervention",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n Row 2:\nrecommendation",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading Recommendation (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"JUDIZI\"Row 3:\n\"Rown 4: \"No\"Probably no\" \"Probabilly yes\" \"Yes\"Row 5:\nACCEPTABLE \"TY\"Row 6:\n\"Now 7: \"No\"\"Probable no\"Probably yes \"Yes\")Row 8:\nFACTIVITY \"Raw 9: \"",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading Recommendation (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\" On'RowRow 5:\n\"Don't know",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading Recommendation (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 363,
      "end_page": 363
    },
    {
      "heading": "heading heading QUESITO 22",
      "text": "== Demographic evolution =References==",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading QUESITO 22 (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading QUESITO 22 (column 2)",
      "text": "Row 1:\n\"RowRow 2:\n\"RowRow 3:\n\"RowRow 4:\n\"ions\" withRow 5:\n\"_MEDTERM0__Row 6:\n\"Row 7:\n\"",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading QUESITO 22 (column 2)",
      "text": "Row 1:",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading QUESITO 22 (column 3)",
      "text": "Row 1:\ntients...Row 2:\nst...\"chemotheraRow 3:\napy\"Row 4:\n\"Row 5:\nb\"Row 6:\n\"Raw 7: \"",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading QUESITO 22 (column 4)",
      "text": "Row 1:\n\"Effect\"Row 2:\n\"Row\" 3: \"Certainty\"ImportanceRow 4:\n\"Relational\"Row 5:\n\"Apy\"Row 6:\n\"95% CI\") \"Rop 7: \"Raw 8: \"Row\" 9: \"Now\" 10: \"Wow\" 11: \"-\"",
      "start_page": 364,
      "end_page": 364
    },
    {
      "heading": "heading heading QUESITO 22 (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 365,
      "end_page": 365
    },
    {
      "heading": "heading heading QUESITO 22 (column column 1)",
      "text": "==Filmography===References==",
      "start_page": 365,
      "end_page": 365
    },
    {
      "heading": "heading heading QUESITO 22 (column column 2)",
      "text": "Row 1:",
      "start_page": 365,
      "end_page": 365
    },
    {
      "heading": "heading heading QUESITO 22 (column column 4)",
      "text": "Row 1:\n-...",
      "start_page": 365,
      "end_page": 365
    },
    {
      "heading": "heading heading QUESITO 22 (column column 5)",
      "text": "Row 1:\n\"Row\" 2: \"Rop\" 3: \"Critical\"Row 4:\n\"Rown\"Row 5:\n\"Raw\" 6: \"Critical\"Row 7:\n\"Row\" 8: \"Now\" 9: \"CRITAL\"Row 10:\n\"Wow\"Row 11:\n\"How\" 12: \"Gritical\"Row 13:\n\"Heavy\"Row 14:\n\"Short\"Row 15:\n\"Clitical\" row 16: \"The Row\" 17: \"Weapon\" 18: \"Free\"Row 19:\n\"Down\" 20: \"No\"Row 21:\n\"Christical\" row 22: \"News\" 23: \"Il\"Row 24:\n\"Charcoal\"Row 25:\n\"Oh, no.\"",
      "start_page": 365,
      "end_page": 365
    },
    {
      "heading": "heading heading Explanations",
      "text": "== Demographic evolution =References==",
      "start_page": 366,
      "end_page": 366
    },
    {
      "heading": "heading heading CONFLICTS OF INTEREST",
      "text": "Row_Low_Med_Material_Impairment: __Mad_Matt_Maw_Mut_Map_Patient: __MEDTERS2_Row __MEDTERS2_Row 3:\n\"Row 4:\n\"INTERVENTION: \"RowRow 5:\n\"RW\" 6: \"CONFRONT: \"ChemotherapyRow 7:\n\"Row 8:\nMain outcomes: \"Global survival; objective response rate; quality of life; diarrhea/to to 3; to to three; RowRow 9:\n\"ROW\"",
      "start_page": 367,
      "end_page": 367
    },
    {
      "heading": "heading heading X Si",
      "text": "Row 1:\n\"Row 2:\n\"Problem\" = \"Raw 3: \"a a priority?\" = \"Row 5:\n\"JUDIZI\" = ADDITIVE ADDITIVE TESTS\" = 6: \"No,\" \" Probably no\" = 10, \"Wouldn't\" = 7: \"Right 8: \"Wishable effects\" = 9: \"desirable desirable effects?\" = 10: \"Now 11: \"absolute absolute effects\"==References===External links==",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si",
      "text": "Row 1:\n\"Row\": \"Raw\" 2: \"Advanced absolute effects\"* \"Rolative effect (95% CI) \"participants participants (studies) \"evidence evidence (GRADE) \"CommentsRow 3:\n\"95% CI\") \"Row 4:\n\"Rown 5: \"With chemotherapy\" \"clue clue 7: \"Q6a first\"Row 8:\n\"Li\" and \"therapy\"Row 9:\n\"with\"Row 10:\n\"Medterm0\"_ \"Rw\" 11: \"Now 12: survival survival - al al (METROS) \" Freenot estimated\" [26] (1 observational study) \"VERY LOWa,b\"Row 13:\n\"Study population\" [Row] 14: \"Row 15:\n\"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95%Row 4:\nCI)",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(GRADE)",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si",
      "text": "Row 1:\nRowRow 2:\nchemotherapy",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 1)",
      "text": "Row 1:\n•Row 2:\n• TheRow 3:\n• RowRow 4:\n•",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 1)",
      "text": "Row 1:\n•Row 2:\n• RowRow 3:\n• RowRow 4:\n•",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nà?",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 2)",
      "text": "Row 1:\n Row 2:\nrableRow 3:\nRow",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nDesirable Those Expected? \"Row 4:\n\"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 3)",
      "text": "Row 1:\n\"Row 2:\nOutcomes\" AnticipatedRow 3:\n\"95% CI\"Row 4:\n\"Rop 5: \"Raw 6: \" Risk with chemotherapy\" RowRow 7:\n\"chemotheraRow 8:\n\"Row 9:\nsurvival survival - al al (METROS) \"Row 10:\n\"RowRow 11:\n\"Row 12:\n\" row 13: \"0\" RowRow 14:\n\"How 15: Progressions-free survival - at at - not reported\"Row 16:\n\"-\"-Row 17:\n\"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 4)",
      "text": "Row 1:\n\"Row 2:\nd absolute effects*\"Relat effect (95% CI) \"RelatRow 3:\n\"EffectRow 4:\n\"95%Row 5:\n\" \"Raw 6: \" Risk with\" \"CI\") \"Row 7:\n\"apy\" \"Q6)\" firstRow 8:\n\"I\" and \"therapy\"Row 9:\n\"With\"Row 10:\n\"_MEDTERM0__\"Row 11:\n\"Row 12:\n\"Rop 13: \"Lation\"Row 14:\n\"Row 15:\n\"Now 16: \"0\" for \"1,000\"Row 17:\n\" (0 to \") \"Row 18:\n\"-Row 19:\n\"\"Row 20:\n\" - \"Row 21:\n\"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 5)",
      "text": "Row 1:\n\"Row 2:\ntive\" participants participants (studies) \"evid evid (GRAD) \" CertainRow 3:\nt\"RowRow 4:\n% \"GRADRow 5:\n\"Raw 6: \"26\" (1 observational study) \"Row 7:\n\"-\"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 6)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\ndenceRow 4:\nDE)",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 7)",
      "text": "Row 1:\n\"Row 2:\nCommen\"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (column 8)",
      "text": "Row 1:\n Row 2:\nnts",
      "start_page": 368,
      "end_page": 368
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "===Progression-free survival - 30 30 \" estimated estimated (observational observational (to 0) study) Overall survival - 26 26 \" al (METROS) estimated (observational observational (0 to 0] study) Overall survival - not not 53",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "== Demographic evolution =References==",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading X Si (column column 2)",
      "text": "Row 1:\n... ..Row 6:\n..Row 7:\n. . ..\"Row 8:\n..\"RowRow 9:\n. \"Row 10:\n.\"Row 11:\n.",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading X Si (column column 3)",
      "text": "Row 5:\n00-RowRow 6:\n.RowRow 7:\n.0Row 8:\n.9Row 9:\n.10: .00Row 11:\n.000Row 12:\n00 -RowRow 13:\n.02 to 0)Row 14:\n.09Row 15:\n.06Row 16:\n.17: .18:",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading X Si (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n00 \"Row 6:\n\"Row 7:\n\"Row 8:\n\" \"Row 9:\n\" 'Row 10:\n\" row 11: \" Right 12: \"",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading X Si (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" 00 \"Row 7:\n\"Row 8:\n\" \"Row 9:\n\" row 10: \"",
      "start_page": 369,
      "end_page": 369
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "== References = External links ==* Official website",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading X Si (column column 1)",
      "text": "== Demographic evolution =References==",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading X Si (column column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading X Si (column column 3)",
      "text": "Row 1:",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading X Si (column column 3)",
      "text": "Row 1:\n Row 2:",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading X Si (column column 3)",
      "text": "Row 1:\n\"Row\" 2: \"Rop\" 3: \"Raw\" 4: \"Rown\" 5: \"Rw\" 6: \"00\"Row 7:\n\"Row\" 8: \"Wow\" 9: \"Now\" 10: \"The Row\" 11: \"Dow\" 12: \"Sow\" 13: \" 00\"Row 14:\n\"How\" 15: \"UsingRow 16:\n\"Cow\" 17: \"ImagesRow 18:\n\"Weeping Row\" 19: \"TurningRow 20:\n\"No\" 21: \"HeartingRow 22:\n\"A\"Row 23:\n\"EmployingRow 24:\n\"YoungRow 25:\n\"It'sRow 26:\n\"DoubleRow 27:\n00\" row 28: \"OneRow 29:\n\"===References==",
      "start_page": 370,
      "end_page": 370
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\n\"Toxicity grade <=3 - of of - (to to study) reduction. reduction.\" of of 8/from from 7/nature. nature.",
      "start_page": 371,
      "end_page": 371
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\nToxicity grade <=3 - al al ... ((1 observational study) \" VERY LOWa,c\"Row 2:\n\"of. of...'Row 3:\n\"of of our\"Row 4:\n\"able able to\"Row 5:\n\"or or \"Row 6:\n\"5 toxicity.\" series, no\"Row 7:\n\"grade grade 4\" or \"Row 8:\n\"One One patient\"Row 9:\n\"3 3 \"row\"Row 10:\n\"Toxicity,\" RowRow 11:\n\"and and dose\"Row 12:\n\"Reduction\" 13: \"Toxity grade.\"",
      "start_page": 371,
      "end_page": 371
    },
    {
      "heading": "heading heading X Si (column column 1)",
      "text": "Row 1:\nToxicity grade <=3 - al al ... ((1 observational study) \" RowRow 2:\n\"2Because 2Because of\"Row 3:\n\"of of our\"Row 4:\n\"able able to\"Row 5:\n\"or or \"Row 6:\n\"5 toxicity.\" series, no\"Row 7:\n\"4or 4or \"Row 8:\n\"One One patient\"Row 9:\n\"3 3 Liver\"Row 10:\n\"Toxity,\" RowRow 11:\n\"and and dose\"Row 12:\n\"Reduction.\"",
      "start_page": 371,
      "end_page": 371
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\n\"Row 2:\n\"Indesirable effects\" \"Raw 3: \"to to be? \"Row 4:\n\"Row 5:\n\"JUDIZI\" \"ADDITIVE ADDITIVE TESTS\" \"ROW 6: \"Great\" \"Moderate\" \"Small X Irrelevant\" \"Varianous\" \"Not known\" \"Absolute Absolute Effects\" \"Comments Comments (95% CI) evidence evidence \" (95% (study) \" (GRADE) with with CI\") chemotherapy \" (Q6)line line therapy\" survival survival (0, \"tudy population\" not 26 \"al al (METROS) estimated (observational observational (to 0, stuvedy) on non-survival - not.",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95%Row 4:\nCI)",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(GRADE)",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\nRowRow 2:\nchemotherapy",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (column column 2)",
      "text": "Row 1:\n Row 2:\nndesidRow 3:\nRow",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (column column 3)",
      "text": "Row 1:\n Row 2:\nderabiRow 3:\nRow",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (column column 4)",
      "text": "Row 1:\n Row 2:\niiRow 3:\nUnwanted Tits Expected?",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (column column 4)",
      "text": "Row 1:\n\"Row 1:\n\"Raw 5: \"Row 5:\n'Row 6:\n\" chemothera. chemothera.' RowRow 7:\n\"chemothera row 8: \"\"Row 9:\nsurvival survival - al al (METROS)Row 10:\n\"row row 11: \" \" RW 12: \"-",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (column column 5)",
      "text": "==References===External links==* Official website",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (column column 6)",
      "text": "Row 1:\n\"Row 2:\ntive\" participants participants (studies) \"evidence evidence (GRADE)Row 3:\nt\"Row 4:\n%\"Row 5:\n\"Rown 6: \"M\"26 (1 observational study) \"RowRow 7:\n\"VERY Lowa,\"bRow 8:\n\"10\" (1 observational study), \"VLY Lowa\"cRow 9:\n\"12\" (1 observed study) ...\"",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (column column 7)",
      "text": "Row 1:\n\"Row 2:\nCommen\"",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (column column 8)",
      "text": "Row 1:\n Row 2:\nnts",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (column column 10)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 372,
      "end_page": 372
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1, \"Overall survival - Mazières J. - - - et al. - Objective Objective - 2019 2019 (_MEDTERM0_) estimated (rated rated with: observational observational (0 to 0) study) rate rate - not not 30",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\nOverall survival - al. al. - not reported-",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading X Si (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading X Si (column column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading X Si (column column 3)",
      "text": "Row 1:",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading X Si (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n0 \"Row 7:\n\" row 8: \" \"Row 9:\n\" 'Row 10:\n\"Row 11:\n\" Right 12: \" -Row 13:\n00 \"Row 14:\n\" Route 15: \" Roll 16: \"\"Row 17:\n\")Row 18:\n\" #Row 19:\n\" Now 20: \" = \"Row 21:\n\" [Row 22:\n\"]Row 23:\n\" *Row 24:\n\"",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading X Si (column column 3)",
      "text": "Row 1:\n Row 2:",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading X Si (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" 0 \"Row 7:\n\"Row 8:\n\" 'Row 9:\n\" row 10: \" \"Row 11:\n\" -Row 12:\n\" Now 13: \" Route 14: \" Right 15: \" [Row 16:\n\"]Row 17:\n\"\"Row 18:\n\"",
      "start_page": 373,
      "end_page": 373
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "grade grade <3 - (0 to 0) not (1, , al. al. (METROS) b b study) Neutropenias grade <=3 - 53 53 , estimated estimated (0, 0, study).",
      "start_page": 374,
      "end_page": 374
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 374,
      "end_page": 374
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 0)",
      "start_page": 374,
      "end_page": 374
    },
    {
      "heading": "heading heading X Si (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 374,
      "end_page": 374
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\n\"76% patients patients (89%) and and 42% sufferers sufferers (80.7% line line ...",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading X Si (column column 1)",
      "text": "Row 1:\n\"Row 2\": \"RowRow 3:\n\"RowRow 4:\n\"Row Row 3\"",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading X Si (column column 2)",
      "text": "Row 1:\n\"76% patients patients (89%) and and 42% sufferers sufferers (80.7%) chemotherapy chemotherapy line\"Row 2:\n\"Row 3:\nrove",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading X Si (column column 2)",
      "text": "Row 1:\nRowRow 2:\nand and indirectness",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading X Si (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 375,
      "end_page": 375
    },
    {
      "heading": "heading heading Effect balance",
      "text": "Row 1:\n\"Row\" 2: \"Raw values\" 3: \"C\" main main outcomes? \"Row 4:\n\" Row 5\": \"Right\" 5: \"Wait\" 7: \"Row 8:\n\"Budget of effects\"Row 9:\n\"or or comparison?\" \"Rown 10: \"row 11: \"Judizios\" RICERCA OF TESTS\" X \"Ready\" 12: \"It'comparison, comparison,\" \"Probably it'comparison. comparison.\"",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading Budget of effects (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Valori\"Row 3:\n\"C\" main main outcomes? \"Rop 4: \"Raw 5: \"JUDIZI\"Row 6:\n\"variation, variation,\" \"volatility, volatility,\" \"major major variability\" or or variability\"Row 7:\n\"Rw 8: \"Budget of effects\"",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading Budget of effects (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nFront?",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading Budget of effects (column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 376,
      "end_page": 376
    },
    {
      "heading": "heading heading Acceptability",
      "text": "Row 1:\n\"Row\" 2: \"Equity\" =Row 3:\n\"of of equity?\" = \"Right\" = 5: \"Judizi\" = 7: \"Reduce equity\" = 6: \"Freeness\" = 9: \"Probably no impact\" = 10: \"Improve equity\" / \"Vary\" = 11: \"Raw\" = 8: \"Acceptability\" = row = 9, \"No intervention\" main main stakeholders?",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•of of equity?",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n•Row 2:\n•AcceptabilityRow 3:\n•RowRow 4:\n•",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n?",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nkeepers? \"Row 4:\n\"",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading Acceptability (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading Acceptability (column 15)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 377,
      "end_page": 377
    },
    {
      "heading": "heading heading DESIDABLE",
      "text": "Row 1:\n\"Row 2:\nintervention intervention feasible? \"Row 3:\n\"Row 4:\n\"JUDIZI\" TESTS TESTS \"RW 5: \"No\" \"Probably no \"Yeah\" X \"Varia\"",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading DESIDABLE",
      "text": "Row 1:\n\"Row\" 2: \"JUDIZI\"Row 3:\n\"Rop\" 4: \"No\"Probably not \"Probabilmente no\" - \"Si\" - (\"Various\") - \"Non so\"Row 5:\n\"PROBLEM\" - row 6: \"Rw\" 7: \"Great\" - ...\"Moderate\" --\"Small\" -\"\"Smelling\" -\"Varities\" -- \"Do not know\" -‐Row 8:\nDESIDERABLE EFFECTS --Row 9:\n\"Very low --\"Row 10:\n\"Moderated --\"\"included included -- row 14: THE THE TESTS\" -'Row 15:\n\"Wow 16: \"or or variability\" - variable variable -- significant. significant.",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading DESIDERABLE (column 1)",
      "text": "Row 1:\n Row 2:\nthe the intervention?Row 3:\n Row 4:\nJUDICES",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading DESIDERABLE (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" PROBLEM \"Row 6:\n\"Row 7:\n\"Row 8:\n\" DESIDABLE EFFECTS \"Row 9:\n\" row 10: \" Route 11: \" SIDES \"Row 12:\n\" -Row 13:\n\" Roll 14: \" TESTS TESTS \"Row 15:\n\" Now 16: \" 'Row 17:\n\" \"Row 18:\n\"",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading DESIDERABLE (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading DESIDERABLE (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading DESIDERABLE (column 4)",
      "text": "Row 1:\n Row 2:\nJUD",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading DESIDABLE (column 5)",
      "text": "Row 1:\n Row 2:\nTIZI",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading DESIDERABLE (column 7)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\" Raw 18: \"",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading DESIDABLE (column 9)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading DESIDABLE (column 9)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\" Non so\"Row 5:\n\"Non so\" row 6: \"Do not know\"Row 7:\n\"No study included\"Row 8:\n\"Row 9:\n\"Raw 10: \"Row 11:\n\"row 12: \"",
      "start_page": 378,
      "end_page": 378
    },
    {
      "heading": "heading heading JUDIZI",
      "text": "Row 1:\n\"Row 2:\n\"JUDIZI\"Row 3:\n\"Rop 4: \"of of comparison\" : \"Raw 5\": \"Budget\"Row 6:\n\"Face\"Row 7:\n\"Reduces equity\" 9: \"Freeness\" on on equity\" increased. increased.",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading JUDIZI",
      "text": "Row 1:\nintervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading JUDIZI (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"of of comparison\"Row 5:\n\"Budget\"Row 6:\n\"Raw 7\": \"Reflectivity\"Row 8:\n\"Row 9:\n\" Reduces equity\"Row 10:\n\" EQUITA\"Row 11:\n\"row 12: \"NoRow 13:\nACCEPTABILITY\"Row 14:\n\"Row 15:\n\"Now 16: FACTIVITY\"Row 17:\n\"",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\n Row 2:\nJUDICES",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\nintervention. intervention.",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\nequity. equity.",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\nintervention intervention X",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading JUDIZI (column 3)",
      "text": "Row 1:\n Row 2:",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading JUDIZI (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading JUDIZI (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don't know\"Row 5:\n\"Varia\" Doesn'RowRow 6:\n\"Miscellaneous\"Row 7:\n\"Raw 8: \"Next\"Row 9:\n\"White\"Row 10:\n\"I don't care\"Row 11:\n\"no. no.\"",
      "start_page": 379,
      "end_page": 379
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 380,
      "end_page": 380
    },
    {
      "heading": "heading heading Recommendation (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•Recommendation",
      "start_page": 380,
      "end_page": 380
    },
    {
      "heading": "heading heading Recommendation (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 380,
      "end_page": 380
    },
    {
      "heading": "heading heading QUESITO 23",
      "text": "==References===External links==* Official website",
      "start_page": 381,
      "end_page": 381
    },
    {
      "heading": "heading heading References",
      "text": "Row 1:\n•Row 2:\nCertainty assessment •row 3: • row 4: studies studies •study study • distortion distortion • results results • generalization generalization •immediation • additional considerations • impact • sure • rows 5: • low 6: 1 • observational studies ■ very serious • not important • a a • none • months months (IC95% 13.9-28.6) • VERY LOW • CRITIC",
      "start_page": 382,
      "end_page": 382
    },
    {
      "heading": "heading heading References (column 1)",
      "text": "Row 1:\n•Row 2:\nCertainty assessment •row 3: • row 4: No studies • study study • distortion risk • results results • generalization generalization •immediation • additional considerations • impact • sure row 5: • rows 6: 1 • observational studies ♪ very serious • not important • at at • no major • months months (IC95% 13.9-28.6) •",
      "start_page": 382,
      "end_page": 382
    },
    {
      "heading": "heading heading References (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"ImportantRow 3:\n\"Row 4:\n\"CRITIC\"",
      "start_page": 382,
      "end_page": 382
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\nof of __medTERM2__",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n\"Row 2:\na a priority? \"Row 3:\n\"Row 4:\n\" JUDICES\" \"EVIDENCE EVIDENCE TESTS\" \"CONSIDERATIONS\"Row 5:\n\"No\" \"Probably not \"Yes\" ● \"Varia\" \"I don'out. out.\"",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\nRow",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n Row 2:\na a priority?Row 3:\n Row 4:\nJUDICES",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\nRow",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\nrow row 2:",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading Problem (column 4)",
      "text": "Row 1:\nRow",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading Problem (column 5)",
      "text": "Row 1:\nrangiam",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading Problem (column 6)",
      "text": "Row 1:\nRow",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading Problem (column 6)",
      "text": "Row 1:\n Row 2:",
      "start_page": 383,
      "end_page": 383
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "al. al. (202) al. al. (2021) __ __ [__MEDTERM2_ __MEDTERM2_ =trials trials (l MEDTERM0__ < < trial trial (study of study) the the patient'trial trial (ested before) a a clinical; 48; met met , cerebral cerebral (1 cerebral/ cerebral (with cerebral) with Behatatal) since since , 15 15 - evaluation evaluation (see) a a medicalal) response response (a) least least (and and 2;;; two two months;; the the response;;",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"Row 2:\nImpact\" (Impact) the the \"the the Rows\" 3: \"Participants\" (observational study) \"VERY BASSAa,\" \"b\"Row 7:\n\"Obiective response\" obtained from 108/161 patients\"Row 8:\n\"Raw 9: follow follow up: 8 8 months\" (\"1 observational study\") \"AA, \"B\"Row 10:\n\"of of __MEDTERM0_\" months months (11-21.1), 48/event. event. \"Rough 11: \"Now 12: cephalic cephalic disease: 8 8 months\" (1 observational trial) \"MOST metastases\" (Bassa, b) \"Rown\": \"Wow\" (non-targeted non-targeted patients): \"No\" (8 8 month\" (1st).",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nfrom from 108/161Row 2:\npatients",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nmonths (11-21.1), 48/RowRow 3:\nevent. event.",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n52.5% RowRow 3:\nbaseline baseline (RowRow 4:\nmeasurable and non-measurable).",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nEsiderRow 3:\nRow",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nSiderable Expected?",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\nRowRow 2:\nal. al. (2021) patient patient observational) MEDTERM3__ MEDTERM3__ (1 study",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 384,
      "end_page": 384
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==response response (months months (IC95% 13.9-28.6) observational) VERY follow-up up: months months (1 study",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nfollow-up follow-up response: months months ((1 observational study) • RowRow 2:\n• months months (IC95% 13.9-28.6) •Row 3:\n• follow follow up: months months • 1 observational trial) ♪ RowRow 5:\n• months months 81%, follow-ups. follow-ups. • row 6: −",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nmonths months (IC95% 13.9-28.6)",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n81%, RowRow 3:\nduring follow-up.",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nndesidRow 3:\nRow",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nDerabiRow 3:\nRow",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\niiRow 3:\nRow",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n\"response response (1 study - months months (IC95% 13.9-28.6) observational) VERY follow-up: months months (1 trial - follow up: median 81%, observational observational patients) arm. arm.",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\nRowRow 2:\nal. al. (2021) __Entrectinib __Entrectinib < effects. effects.",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading Problem (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 385,
      "end_page": 385
    },
    {
      "heading": "heading heading Valori",
      "text": "Row 1:\n\"To be completed\": \"Row 3:\n\"safety safety tests?\"Row 4:\n\"Rop 5: \"Judizi\" •di di evidenza\" ■ADDATIVE CONSIDERATIONS •Row 6:\n● Very low • Moderate • • High • imprecision. imprecision. • row 7: ♪Row 8:\n\"Valori\" −Row 9:\n\"C\" main main outcomes? •",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading Valori (column 1)",
      "text": "Row 1:\n\"Row\" 2: \"the the tests\" \"Raw 3: \"safety safety tests?\" \"Row 4:\n\"Row 5:\n\"JUDIZI\"Row 6:\n\"Very low\" \"Moderate Low\" \"High\" \"included included \"Rough\" 7: \"Rop 8: \"Valori\"Row 9:\n\"C\" main main outcomes? \"Rown 10: \"Row 11:\n\"JUSTICES\"Row 12:\n\"or or variation\" ● volatility volatility ● or or variability",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading Valori (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading Valori (column 7)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 386,
      "end_page": 386
    },
    {
      "heading": "heading heading Equity",
      "text": "months months (IC95% 13.9-28.6).52. 52.5% baseline baseline (and and non-measurable).",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nor or comparison?",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nuità? \"Row 4:\n\"",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading Equity (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n?",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading Equity (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading Equity (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 387,
      "end_page": 387
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\n\"Row\" 2: \"Acceptibility\" \"Raw 3: \"main main stakeholders?\" \"Rop 4: \"Rown 5: \"Judizi\"\" \"found. found.\"\"Row 7:\n\"Right 8: \"Fatsibility\" \"Now 9: \"the the intervention?\" \"Wait 10: \"Need 11: \"Don't know\" \"in. in.\" \"Rw 7:",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•AcceptabilityRow 3:\n•RowRow 4:\n•",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•Now 4:",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nMain",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nell'interve",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nstakeholders?",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nento\"? \"Raw 4: \"",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading Fatsibility (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading Fatsibility (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 388,
      "end_page": 388
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "Row 1:\n\"Row\" = \"Don't kno\" = [Row] = \"Now\": \"Proba bly no\" = (Probab) * \"Small\" = (\"Very low\") = \"Moderate\" =\"\"Wow 5: \"PROBLEM\" = ,\"Row 6:\n\"Raw 7: \"Trivial\" = ...\"Moder ate\" (Smell) = \"ie ie s\" =\"Don 't kn \" w\"Row 8:\nDESIDERABLE SIDES\" + \"Rw 12: \"Row 13:\n\"Very very low\" / \"Moder ate\" - \"High\" No incl.",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "Row 1:\nRIGHT SIDES 2: WISHABLE",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "Row 1:\nRow 2 EFFECTS:BECAUSE",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "Row 1:\nQUALITY:Row 2:\nOFRow 3:\nTESTS",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading Fatsibility (column column 1)",
      "text": "Row 1:\n Row 2:\n Row 3:\nPROBLEMRow 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\nSIDESRow 9:\nDESIDERABLERow 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\nEFFECTSRow 15:\nRowRow 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\nQUALITYRow 21:\nDELLERow 22:\nTESTSRow 23:\n Row 24:\n Row 25:\n Row 26:\n Row 27:\nVALUESRow 28:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading Fatsibility (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\nBIBILIRow 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\n Row 26:\n Row 27:\n Row 28:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading Fatsibility (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\" Raw 18: \"",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading Fatsibility (column column 4)",
      "text": "Row 1:\n Row 2:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading Fatsibility (column column 6)",
      "text": "Row 1:\n Row 2:\nJUDICES",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading Fatsibility (column column 6)",
      "text": "Row 1:\nRowRow 2:\nModerateRow 3:\nSmallRow 4:\nRowRow 5:\nor or variability",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading Fatsibility (column column 7)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\" Raw 18: \"",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading Fatsibility (column column 8)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading Fatsibility (column column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don't kno w\"Row 5:\n\"Don't know w\" row 6: \" Don't Kno W\"Row 7:\n\"stud stud ies\"Row 8:\n\"Raw 9: \"Row 10:\n\"Row 11:\n\" Now 12: \"",
      "start_page": 389,
      "end_page": 389
    },
    {
      "heading": "heading heading JUDIZI",
      "text": "Row 1:\n\"Row\" 1: \"JUDIZI\": \"Raw\" 3: \"Rop\" 4: \"compa compa rison\" •rison rison •rison rison . •Row 7:\n\"intervention intervention •ntion ntion •s. s. •Don 't kno •Row 8:\nSIDES SIDES •Row 9:\n\"Reduc ed ♪d d • impact impact •sed sed •Increas ed • e e s\"Don't know 11: EQUITA row 12: \"10\"",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading JUDIZI (column 1)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\nEQUITARow 9:\n Row 10:\n Row 11:\nRowRow 12:\n Row 13:\n Row 14:\nRow",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\" Raw 18: \"",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading JUDIZI (column 7)",
      "text": "Row 1:\n Row 2:\nJUDICES",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading JUDIZI (column 9)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading JUDIZI (column 9)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading JUDIZI (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" Don 't kno w\"Row 8:\n\"Don 't know w\" row 9: \"Do 't Kno w\")",
      "start_page": 390,
      "end_page": 390
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nagainst against intervention",
      "start_page": 391,
      "end_page": 391
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 391,
      "end_page": 391
    },
    {
      "heading": "heading heading QUESITO 24",
      "text": "000, 000,000;000, 000,000;this this year;Four Four (11%) 27 27 (75%, 95% CI 58/88) control. control. • Very low (CRITIC Row 12): life life - not measured •Row 13:\n- • • studies studies • not important • cases cases • none • 25 (69%) events events (8 [22%)), disease progression (14 [39%)), investigator decision (2 [6%) decision decision (1 [3%) nine nine (36%) one one (4%) two two (8%) nine nine (136%) one one (4%), follow. follow.",
      "start_page": 392,
      "end_page": 392
    },
    {
      "heading": "heading heading References",
      "text": "Row 1:\n\"Row 2:\nCertainty assessment\" = \"Impact\" = ...\"Certainty\" =\"ImportionRow 3:\n\"Rop 4: No study design\": \"Distortion risk\" =\"\"study, study,\" \"episodes episodes (four [11%), aminotransferase aminotransferase (four [1%]), hypertension (four (11%)) and vomiting (three [8%). \" MOLTO BASSA\" = CRITICRow 7:\nTreatment-related deaths (follow up: 9 9 months) \"Row 8:\n1\" observational studies \"very serious\" = not important b\" = treatment treatment (follow up: 9 9 month) \"Raw 8:1\" studies studies \"not important\" = and and \"no death\" ===References===External links==",
      "start_page": 393,
      "end_page": 393
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\nRowRow 18:\n88:Dr.Row 2:\nPOPULATION: ...3 3 mutation: \"Row 4:\nINTERVENTION\": \"RowRow 5:\n\"Row 6:\nCONFRONTO: \"RowRow 7:\n\"Row 8:\nMain outcomes: \"Overall Survival; Progression free survival\"; Response rate; Quality of life; Any interruption; grade grade 3-4; RowRow 9:\n\"Row 10:\n\"InpatientsRow 11:\n\"Now 12: Prospectiva: \"NoveRow 13:\n\" -Row 14:\nBACKGROUND: \" Now 15: \" ROW 16: THE THE Votes: Dr.",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n\"Row\" 2: a a priority? •Row 3:\n•Row 4:\nJUDICES • TESTS TESTS •Row 5:\n• No • Probably no • X Yes • Varia • I don't know • cancer cancer (_MEDTERM4_) in in 4% with with non-cancers cancers (_medterm4_). 50% and and Mediterm_",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n\"Row 2:\nPOPULATION: \"Row 3:\n\"Row 4:\nINTERVENTION: \" row 5: \" 'Row 6:\nCOMPARISON: \"Row 7:\n\" -Row 8:\nMAIN EXITS: \" ROW 9: \" \"Row 10:\nSETTING: \"row 11: \" NOW 12: PROSPITIVE: \" Route 13: \" Now 14: \" BACKGROUND: \" Rome 15: \" . \"Row 16:\nCONFLICTS OF \"Row 17:\nINTEREST \"Row 18:\n\"",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "a a priority?",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 394,
      "end_page": 394
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* dabrafenib dabrafenib (twice twice daily) __trametinib __trametinib (once once daily) patient. patient.",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nEsiderRow 3:\nRow",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\nmonotherapy monotherapy (2) Row8_MEDTERMI8_min. Row8_MEDTERMI8_min.",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\nRowRow 2:\ncentral, PubMed/gov gov (www.clinicaltrials .gov). included included (1) oral oral (twice twice daily) oral oral (once once daily) patient. patient.",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading Problem (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 395,
      "end_page": 395
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "36 36 (67%) patients went (Survival Survival (PFS) or or observational) evaluated evaluated with: cause cause follow-up: 36 36 67%) gone gone (survival survival (_ _MEDTERMM1___) or or observational) measured measured with: b b ,months months (95% of of 7·0",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n36 36 (67%) RowRow 2:\nRowRow 3:\nRowRow 4:\nRowRow 5:\nmonths months (95% CIRow 6:\n7·0",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "==Filmography===References==",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"No\" ofRow 3:\n\"PartecipateRow 4:\n\"Studies\")Row 5:\n\"Rop 6: \"Now 7: \"",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\naRow 6:\n Row 7:\n Row 8:",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\"",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n\"Row\" 2: \"Cer Row\" 3: \"anti-the Row\" 4: \"GRRow 5:\n\"",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\ndifficultyRow 3:\nRowRow 4:\nRADE",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n\"Row 2:\ny of\"Row 3:\n\"Nce\"Row 4:\n\"Raw 5: \"",
      "start_page": 396,
      "end_page": 396
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n• Any 25 (69%) discontinued treatment (1 study • events events (8 [22%], observational) 1 - MANY follow-up: progression progression (14 [39%)), decision decision (2 [6%)) decision decision (1 [3%) nine nine (36%) one one (4%) two two (8%) three three (12%) ten ten (40%) therapy. therapy.",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\ntreatment",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "==References===External links==*Official website* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" row 6: \"Row 7:\n\" \"Row 8:\n\" or \"Row 9:\n\" a \"Row 10:\n\" 'Row 11:\n\" - \"Row 12:\n\" Route 13: \" O \"Row 14:\n\" Right 15: \" *Row 16:\n\" Roll 17: \" Now 18: \"\"Row 19:\n\" [ \"Row 20:\n\"]Row 21:\n\" = \"Row 22:\n\" #Row 23:\n\" Rule 24: \" ]Row 25:\n\" .",
      "start_page": 397,
      "end_page": 397
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nLancet Lancet Oncol; are are expected?",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nndesidRow 3:\nRow",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nDerabiRow 3:\nRow",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\niiRow 3:\nRow",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n\"BRAFV600E-mutant metastatic non-small-cell lung cancer: Lancet Lancet Oncol; It It 'for for imprecision: RowRow 2:\n\"Row 3:\n\"Row 4:\ndesirable\"?",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\nRowRow 2:\ncentral, PubMed/gov gov (www.clinicaltrials .gov). included included (1) oral oral (twice twice daily) oral oral (once once daily) patient. patient.",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading Problem (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 398,
      "end_page": 398
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "36 36 (67%) patients went (Survival Survival (PFS) or or observational) evaluated evaluated with: cause cause follow-up: 36 36 67%) gone gone (survival survival (_ _MEDTERMM1___) or or observational) measured measured with: b b ,months months (95% of of 7·0",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n36 36 (67%) RowRow 2:\nRowRow 3:\nRowRow 4:\nRowRow 5:\nmonths months (95% CIRow 6:\n7·0",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "==Filmography===References==",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"No\" ofRow 3:\n\"PartecipateRow 4:\n\"Studies\")Row 5:\n\"Rop 6: \"Now 7: \"",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\naRow 6:\n Row 7:\n Row 8:",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\"",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n\"Row\" 2: \"Cer Row\" 3: \"anti-the Row\" 4: \"GRRow 5:\n\"",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\ndifficultyRow 3:\nRowRow 4:\nRADE",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n\"Row 2:\ny of\"Row 3:\n\"Nce\"Row 4:\n\"Raw 5: \"",
      "start_page": 399,
      "end_page": 399
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "25 25 (69%) discontinued treatment (1 study →events events (8 [22%], observational) follow follow up: progression progression (14 [39%)), decision decision (2 [6%)) decision decision (1 [3%) nine nine (12%) one one (4%) two two (8%) three three (12%) ten ten (40%) therapy. therapy.",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\ntreatment",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" row 6: \"Row 7:\n\" \"Row 8:\n\" or \"Row 9:\n\" a \"Row 10:\n\" 'Row 11:\n\" - \"Row 12:\n\" Route 13: \" O \"Row 14:\n\" Right 15: \" *Row 16:\n\" Roll 17: \" Now 18: \"\"Row 19:\n\" [ \"Row 20:\n\"]Row 21:\n\" = \"Row 22:\n\" #Row 23:\n\" Rule 24: \" ]Row 25:\n\" .",
      "start_page": 400,
      "end_page": 400
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL TESTS",
      "text": "Row",
      "start_page": 401,
      "end_page": 401
    },
    {
      "heading": "heading heading Equity",
      "text": "Row 1:\n\"Row 2:\n\"Budget of effects\" = \"Raw 3: \"or or comparison?\" = \"Row 4:\n\"Row 5:\n\"JUDICES\" = ADJUSTABLE TESTS + \"RW 6: \"He'comparison, comparison,\" \"comparison, \"He doesn'confrontation, confrontation,\" \"X\" intervention, \"favour, favour,\" \"Varia\" - \"I don't know\" - row 7: \"Right 8: \"Equity\" -Row 9:\n\"of of equity?\" - \"Ru 10: \"ROW 11: JUDIZI\" - THE THE EVENTS\" - Additional CONSIDERATIONS - \"Nequità\" - 12: \"Reduce equity\" - X X \"No impact\" - equity equity --improves equity.",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nsiderabili",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nuità? \"Row 4:\n\"",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading Equity (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nfavor",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading Equity (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading Equity (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading Equity (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nOnfront?",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading Equity (column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\n?",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading Equity (column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 402,
      "end_page": 402
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\n\"Row\" 2: \"Acceptability\" \"Raw 3: \"main main stakeholders?\" \"Rop 4: \"Rw 5: \"JUDIZI\" \"ADDITIONAL ADDITIONAL TESTS\" \"ROW 6: \"No\" \"Probably no\" \" Probably no\" - \"Yes\" - X \"Varia\" \"No test found\" \"None found\" [Row 7:\n\"Roo 8: \"Fatsibility\" \"Row 9:\n\"intervention intervention \"Ru\" 10: \"So\"Row 11:\n\"Giudizi\" \"RICERCA\" TESTS TESTS \"RW\" 12: \" No\" \"Perhaps not\" \"It'X X \"Ye\" \"Vary\" \"Not so\"found. found.\"",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•AcceptabilityRow 3:\n•RowRow 4:\n•",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•Now 4:",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nMain",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nell'interve",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nstakeholders?",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nento\"? \"Raw 4: \"",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading Fatsibility (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading Fatsibility (column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 403,
      "end_page": 403
    },
    {
      "heading": "heading heading DESIDABLE",
      "text": "==References===External links==* Official website",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading DESIDERABLE (column 1)",
      "text": "Row 1:\n Row 2:\nPROBLEMRow 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:\n Row 11:\nRowRow 12:\n Row 13:\n Row 14:\nVALUESRow 15:\n Row 16:\n Row 17:\nRowRow 18:\n Row 19:\n Row 20:\nEQUITARow 21:\n Row 22:\n Row 23:\nACCEPTABILITY",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading DESIDERABLE (column 2)",
      "text": "Row 1, \"Row 10,\" \"Raw 6\": \"Rw 7\": ...\"Row 4:\n\"No\"Probably no\" is \"Probabilmente no\" = \"Rown 5\": - \"Rop 6\" = *\"Row 7:\n\"Immportant\" = ...\"Row 11:\n\"Row 12:\n\"Very low\" =\"\"Row 9:\n\"Moderate\" =",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading DESIDERABLE (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\" Raw 18: \"",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading DESIDERABLE (column 3)",
      "text": "Row 1:\n Row 2:",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading DESIDERABLE (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Do Not So\"Row 5:\n\"Do not So\" row 6: \"Don't Know\"Row 7:\n\"No Study Included\"Row 8:\n\"Now 9: \"Raw 10: \"Row 11:\n\"Row 12:\n\"I don't So\" 13: \"Not So\"",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading DESIDERABLE (column 4)",
      "text": "Row 1:\n\"Varia\" doesn'RowRow 2:\n\"Via\" RowRow 3:\n\"Row\" 4: \"Vay\"",
      "start_page": 404,
      "end_page": 404
    },
    {
      "heading": "heading heading Strong recommendation",
      "text": "Row 1:\n\"No\" - Probably not \"Probably \"Yes\" - \"Varia\" - I don'RowRow 2:\nFACTIBILITY\" -Row 3:\n\"",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading Strong recommendation",
      "text": "Row 1:\nagainst against intervention",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading Strong recommendation",
      "text": "Row 1:\n Row 2:\nrecommendation",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading Strong recommendation (column 1)",
      "text": "Row 1:\n\"No\"RowRow 2:\nFACTIVITY\" \"Row 3:\n\"No,\" \"No.\"",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading Strong recommendation (column 1)",
      "text": "Row 1:\nintervention intervention • • operation operation •",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading Strong recommendation (column 2)",
      "text": "Row 1:\nYes...Row 2:\n..Row 3:\n..",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading Strong recommendation (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading Strong recommendation (column 3)",
      "text": "Row 1:\n\"Varia\" doesn'RowRow 2:\n\"Row\" 3: \"Mary\"",
      "start_page": 405,
      "end_page": 405
    },
    {
      "heading": "heading heading QUESITO 30",
      "text": "Row 1; row 1; = 5; = 2; = 3; = 4; = 6; = 8; = 7; = 10; = 9; = 11; = 12; = 13; = 15; = 14; = 17; = 16; = 20; = 30; = 25; = 45; = 40; = 50; = 100; = 35; = 38; = 22; = 21; = 29; = 23; = 28; = 18; = 24; = 36; = 37; = 44; = 41; = 43; = 42; = 34; = 52; = 39; = 33; = 49; = 56; = 54; = 57; = 61; = 60; = 55; = 48; = 58; = 59; = 51; = 53; = 95; = 66; = 105; = 65; = 97; = 0; = 106; = 75; = 85; = 103; = 74; = 96; = 90; = 80; = 102; = 101; = 107; = 68; = 104; = 98; = 47; = .",
      "start_page": 406,
      "end_page": 406
    },
    {
      "heading": "heading heading QUESITO 30 (column 1)",
      "text": "Row 1:\n\"Row\" 1: \"Study design\" - Risk of bias\" - Inconsistency - Imprecision - Other considerations - RowRow 6:\n\"Raw 7: Overall survival\" (follow up: 2 2 months) -Row 8:\n\"Row 9:\n1\"randomised trials\" - a, a,b\" not serious -not serious - Not serious -None 73/154 (47.4%) -Row 10:\nsurvival survival (follow up: 2 2 months)",
      "start_page": 406,
      "end_page": 406
    },
    {
      "heading": "heading heading QUESITO 30 (column 2)",
      "text": "Row 1:\n\"Row\" 2: \"Effect\" = \"Certainty\" = ImportanceRow 3:\n\"Raw\" = : \"Rop\" = 5: pia\" = 95% CI) \"Absolute\" = (95% CI) = 6: \" Row\" = 7: \" Row\" = 8: \" row\" = 9: \"HR\" = 0.49 (0. 0.69) = 25 Fewer = 100 (13 13 feder) = 10: \"CRITAL Row \" = 11: \"row\" = 12: \"TR 0.50\" (0. 0.68) = 100 100 (13 13 fewer) = 15: \"ROW\" = 14: \"Row\" = 15, \"61 61 (2. 2.20) = per per 100",
      "start_page": 406,
      "end_page": 406
    },
    {
      "heading": "heading heading QUESITO 30 (from previous page)",
      "text": "Row 1:\n\"33 33 more) \"Row 2:\nAEs AEs (follow up: 2 2 months)Row 3:\n\"Row\" 4: \"1\" randomised trials\" \"serious\" a, \"d\"not serious\" \"not serious,\" \"not silky\" \"none\" \"48/154\" (31.2%) \"80/150 (53.3%) \"58 58 (0. 0.77) \"100 100 (12 12 feet) \"MODERATE\" \"CRITICAL\" \"Raw 5: treatment treatment component\"Row 6:\n\"Rown 7: 1\"randomised trials\"\"s\"\"serius a,d\" not serious\" (\"not serious\") \"not seriously\" [80/154 (51.9%) and \"106/151 (70.2%) \"74 74 (0. 0.89) \"18 feder\" for 100 (femere) 2788 (femur) ]",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading QUESITO 30 (column column 1)",
      "text": "Row 1:\n\"33 33 more)Row 2:\nAEs AEs (follow up: 2 2 months)Row 3:\n\"Row\" 4: \"1\" randomized trials\" \"serious\" a, \"d\"not serious\" \"not serious,\" \"not silky\" \"none\" \"48/154\" (31.2%) \"80/150\" (53.3%) \"58 58 (0. 0.77) \"100 100 (12 12 feet)Row 5:\ntreatment treatment component\"Row 6:\n\"Raw 7: \"1\"\"randomised trials\" (\"serious\") \"a,\" \"D\" not serious\" (\"not serious\") \"not seriously\"\"80/154 (51.9%) and \"106/151\" (70.2%) f\"74 74 (0. 0.88) \"100 100 (to to 8wer)",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading QUESITO 30 (column column 2)",
      "text": "Row 1:",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading QUESITO 30 (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\" CRITICAL\"Row 5:\n\"Row 6:\n\"Raw 7: \" CRITICAL\"",
      "start_page": 407,
      "end_page": 407
    },
    {
      "heading": "heading heading CONFLICTS OF INTEREST",
      "text": "Row: 000, 000,000; 000, 000,000; of of 1995; years years ago; years years old; year year olds; of of age; months months old; years years later; years years older; years years earlier; old. old.",
      "start_page": 408,
      "end_page": 408
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n\"Row\" 2: \"Problem\" •Row 3:\n\"a a priority?\" • row 4: •row 5: \"JUDIZI\" ♪Row 7:\n\"Raw 8: \"Wishful effects\" −Row 9:\n\"desirable desirable effects? • now 10: \"Now 11: \"Giudizi\" ■teste teste •\"a a (95% (GRADES) • as as \"absolute absolute effects\") • (95% CI) Commentary Commentary • Minor • Moderate X • Varian • Non-Solute Effects\" (FRADE)",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n\"Row 2:\nOutcomes\" * Anticipated absolute effects* (95% CI) - Relative effect (95% CI), \"participants participants (studies) \"evidence evidence (GRADE) \"CommentsRow 3:\n\"Row 4:\n\"Row 5:\n\" Risk with chemotherapy\" \" with with pembrolizumab\"Row 6:\n\"Row 7:\nfollow follow up: 2 2 months/49 49 (0. 0.69).",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n•Row 2:\n• TheRow 3:\n• RowRow 4:\n•",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n•Row 2:\n• RowRow 3:\n• RowRow 4:\n•",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nita?",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\nRabiliRow 3:\nRow",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nEratable Expected? \"Row 4:\n\"",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 4)",
      "text": "Row 1:\n Row 2:\nOutcomes",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 5)",
      "text": "Row 1:\n\"Row 2:\n\"AnticipatedRow 3:\n\"Row 4:\n\"Row 5:\n\" RowRow 6:\n\"chemioteraRow 7:\n\"Row 8:\n\" \"Row 9:\n\" 'Row 10:\n\" RowRow 11:\n\"Row 12:\n\" row 13: \" - RowRow 14:\n\" Now 15: \" Route 16: \"\"Row 17:\n\"RowRow 18:\n\"",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 6)",
      "text": "Row 1:\n\"Row 2:\nd absolute effects* (95% CI) = Related effect (95% CI),Row 3:\n\"Row 4:\n\"Row 5:\napia\" with with pembrolizumab",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 7)",
      "text": "Row 1:\n\"Row 2:\nive\" \"participants participants (studies) \"Certaint evidence (Grade): \"CertaintRow 3:\n\"EvidenceRow 4:\n\"GRADERow 5:\n\"Raw 6: \"Row 7:\n\" - 305 (1 RCT) \"Row 8:\n\"",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 8)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nandRow 4:\nE)",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 9)",
      "text": "Row 1:\n Row 2:\nCommen",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 10)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (column 10)",
      "text": "Row 1:\n Row 2:\nnts",
      "start_page": 409,
      "end_page": 409
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n•survival survival (49 to 71) 305 • (follow follow up: median (1 RCT) 0. 0.68) 305 305 ■ rate (to to (1 RTC) HICHA,c follow-up: 2. 2.20) 0. 0.77) (23 to 41) 305 305 › treatment treatment (1 1 RCT),0. 0.89) (43 to 62)",
      "start_page": 410,
      "end_page": 410
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 410,
      "end_page": 410
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\nfollow follow up: 2 2 months",
      "start_page": 410,
      "end_page": 410
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"50 50 (0. 0.68) = .305 (1 RCT)Row 2:\n\"Row 3:\n\" Row\" 4: \"Row 5:\n\"Row 6:\n\"R 1.61\" (2. 2.20) \"Row 7:\n\" row 8: \" \"Row 9:\n\" 'Row 10:\n\" - \"Row 11:\n\" Right 12: \"Row 13:\n\"58 58 (0. 0.77) \"304 (1 RTC) \"Row 14:\n\" [Row 15:\n\"]Row 16:\n\"",
      "start_page": 410,
      "end_page": 410
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n•Row 2:\n• IndRow 3:\n• RowRow 4:\n•",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nDesiredRow 3:\nRow",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nerableRow 3:\nRow",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nUnwanted Tits Expected?",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "==References===External links==* Official website",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "==References===External links==* Official website",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\nthe the e)",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (column column 7)",
      "text": "Row 1:\n Row 2:\nCommen",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (column column 8)",
      "text": "Row 1:\n Row 2:\nnts",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (column column 10)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 411,
      "end_page": 411
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"Continuation Continuation reasons: treatment. treatment.",
      "start_page": 412,
      "end_page": 412
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2\": \"RowRow 3:\n\"RowRow 4:\n\"Row Row 3\"",
      "start_page": 412,
      "end_page": 412
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"bias. bias.",
      "start_page": 412,
      "end_page": 412
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\nRowRow 2:\ndetection detection bias",
      "start_page": 412,
      "end_page": 412
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 412,
      "end_page": 412
    },
    {
      "heading": "heading heading Effect balance",
      "text": "Row 1:\n\"Row\" 2: \"Raw value\" 3: \"C\" main main outcomes? \"Row 4:\n\" Row 5\": \"Right\" 5: \"Wait\" 8: \"Budget of effects\"Row 9:\n\"or or comparison?\" \"Rw 10: \"Row 11:\n\"Judizios\" RICERCA OF TESTS\" X \"Ready\" 12: \"It'comparison, comparison,\" \"Probably it'comparison. comparison.\"",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "heading heading Budget of effects (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Valori\"Row 3:\n\"C\" main main outcomes? \"Rop 4: \"Raw 5: \"JUDIZI\"Row 6:\n\"or or variation\"",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "heading heading Budget of effects (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nFront?",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "heading heading Budget of effects (column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 413,
      "end_page": 413
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\n\"Row\" 2: \"Right\": \"Raw\" 3: \"of of equity? \"Rop\" 4: \"Rough\" 5: \"Judizi\" 5, \"Ricerca\" of \"ADDING\" TESTS\"Row 6:\n\"Reduces equity\" = \"equity equity X\" equity equity \"Improves equity,\" \"Improved equity,\" and \"Improving equity\" (not not known)Row 7:\n\"Row 8:\n\"Acceptibility\" ^Row 9:\n\"No\" main main stakeholders?",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"EquityRow 3:\n\"RowRow 4:\n\"",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•AcceptabilityRow 3:\n•RowRow 4:\n•",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•The",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\ni of equity?",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n?",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nkeepers? \"Row 4:\n\"",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\" or \"Row 4:\n\"",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading Fatsibility (column 16)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 414,
      "end_page": 414
    },
    {
      "heading": "heading heading DESIDABLE",
      "text": "Row 1:\n\"Probabilment and no\"Probability and si\": \"Si\" = \"Variety\" = 5: \"PROBLEM\" = 6: \"Row\" = 7: \"Irish nti\" = 10: \"Moderate\" = 9: \"White\" = 8: \"Great\" = 11: \"Bold\" = 12: \"Very low\" = 1: \"High\" = 0: \"Moded\" = 14: \"or or \"Raw\" = 15: \"Row\" = 16: \"Non-uncertainty\" or \"variable\" = 13: \"Popularity\" = 30: \"Alta\" = 25: \"in in favour\" = 20: \"Dowperfection\" = 17: \"Not known\" = 35: \"Further\" = 36: \"Earred\" = 4\" = 2: \"Ready\" = 3: \"Gold\"===References==External links==* Official website",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading DESIDERABLE (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" PROBLEM\"Row 6:\n\"Row 7:\n\"Row 8:\n\"Desiderable Effects\"Row 9:\n\"Raw 10: \" row 11: \"Residency\"Row 12:\n\"Row 13:\n\"ROW 14: THE THE TESTS\"Row 15:\n\"Now 16: \"row 17: \"Times\"Row 18:\n\" Now 19: \" NOW 20: THE THE EFFECTS\"Row 21:\n\"",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading DESIDERABLE (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading DESIDERABLE (column 3)",
      "text": "Row 1:\n Row 2:\nJUD",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading DESIDERABLE (column 4)",
      "text": "Row 1:\n Row 2:\nTIZI",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading DESIDABLE (column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" row 7: \"Row 8:\n\"",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading DESIDERABLE (column 7)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\" Not so\"Row 5:\n\"Not so\" row 6: \"Do not know\"Row 7:\n\"inclus inclus o\"Row 8:\n\"Raw 9: \"Row 10:\n\"Row 11:\n\"Don't know\"",
      "start_page": 415,
      "end_page": 415
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n\"Row 2:\n\"JUDIZI\"Row 3:\n\"Raw 4: \"equity equity a\"equity equity \"equity equity \"equity equity \"Increases equity \"Varia\" = \"RowRow 5:\nEQUITA\" = row 6: \"Rop 7: \"No\" =",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nintervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n Row 2:\nrecommendation",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "heading heading Recommendation (column 1)",
      "text": "Row 1:\n\"Row\" 2: \"JUDIZI\"Row 3:\n\"Raw\" 4: \"the the entity\" \"Probabilm\" reduces equity\" \"equity equity \"Probabilm\" increases equity \"Rop\" 5: EQUITA\"Row 6:\n\"Rown\" 7: \"No\"Probably not \"Probbabilm,\" \"Si\"Row 8:\nACCEPTABILITY\"Row 9:\n\"Now 10: \"Not\"Probedibly no\" \"Yes\"Row 11:\nFACTIBI LITY\"Row 12:\n\"Wow\"",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "heading heading Recommendation (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Varia\" \"Don'RowRow 5:\n\"Via\" \"RowRow 6:\n\"Raw 7: \"Wow 8: \"Maria\" row row 9: \"Now 10: \"",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "heading heading Recommendation (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 416,
      "end_page": 416
    },
    {
      "heading": "heading heading patients patients Effect",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 417,
      "end_page": 417
    },
    {
      "heading": "heading heading any any AEs",
      "text": "== Demographic evolution =References==",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "heading heading any any AEs (column 1)",
      "text": "Row 1:\n\"Row 2:\nCertainty assessment\" =Row 3:\n\"Row 4:\n\"Row 5:\nNo of studies\" = \"Study design\" + \"Inconsistency\" = Inconsistentness = \"InaccesiRow 6:\n\"Row 7:\nProgression free survival\" = row 8: \"Raw 9: 2\" / \"randomised trials\" = and and \"not serious\" = ,d \"Row 10:\nObjective response rate\" = [Row 11:\n\"]Row 12:\n\"2\" /\"randomized trials \"not seriously\" a,e \"not seriousness\" = d d ]Row 13:\nAEs AEs \"Row 14:\n\"",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "heading heading any any AEs (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" RowRow 6:\n\"Row 7:\n\"Row 8:\n\" row 9: \"",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "heading heading any any AEs (column 2)",
      "text": "Row 1:",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "heading heading any any AEs (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"No of patients\"Row 3:\n\"Row 4:\n\"Row 5:\nons\" RowRow 6:\n\"Row 7:\n\"Row 8:\n\"Row 9:\n\"",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "heading heading any any AEs (column 4)",
      "text": "Row 1:\n\"Row\" 2: \"Effect\" = \"Certainty\" = ImportanceRow 3:\n\"Rop\" 4: \"Apia\" = 5: \"Rolative\" = (95% CI) \"Absolute\" = 6: \"Row\" = 7: \" Row\" = 8: \" Row\" = 9: \"HR \" 0.63\" (0. 0.80) \"16 fewer\" = 100 (7 7 feet) \" MODERATE\" = 10: \"CRITAL Row\" + 11: \"ROW\" = 12: \"RR 2.16\" (.2. 2.95) \"100 100 (41 41 more) \" MODERATE\" - CRITICALRow 13:\n\"Now 14: \"",
      "start_page": 418,
      "end_page": 418
    },
    {
      "heading": "heading heading any any AEs (from previous page)",
      "text": "== Demographic evolution =References==",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "heading heading any any AEs (column column 1)",
      "text": "Row 1:\n•Row 2:\nCertainty assessment • row 3: •row 4: •now 5: studies studies •study design •bias bias •inconsistentness •impreciseRow 6:\n•bow 7: 2 •randomised trials •f f •serious g •h h •Row 8:\ncomponentj componentj •low 9: ♪ row 10: 2",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "heading heading any any AEs (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" RowRow 6:\n\"",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "heading heading any any AEs (column column 2)",
      "text": "Row 1:",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "heading heading any any AEs (column column 3)",
      "text": "Row 1:\n'Row 2:\n'No of patients'Row 3:\n'Row 4:\n' Row 5': 'ons' RowRow 6:\n'first line'Row 7:\n'platin base'Row 8:\n'Pemetrexed and 'row'Row 9:\n'_MEDTERM0', 'Rop 10: 'followed'Row 11:\n'maintaining'Row 12:\n'con'Row 13:\n'pemetrexed' and 'raw'Row 14:\n'Medterm0' _ 'Raw 15: 'of of 'row 16: 'turning' or 'row 17: 'stability of 'rows'Row 18:\n'after 4'Row 19:\n'wheel cycles'Row 20:\n'treatingRow 21:\n'row 22: '- 295/464' (63.6%)",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "heading heading any any AEs (column column 4)",
      "text": "Row 1:\n\"Row\" 2: \"Effect\" = \"Certainty\" = ImportanceRow 3:\n\"Raw\" = : \"Rop 5\": apia\" = (95% CI) = \"Absolute\" = (CI) = 6: \" Row\" = 7: \"RR\" = 1.06 (1. 1.19) = 100 100 (11 11 more) = VERY LOW\" = CRITICALRow 8:\n\" Row\" = 9: \"row\" = 10: \"ROW\" = 0. 0.88) = 16 Fewer = 100 (9 9 feet) = VERY LOW CRITICAL",
      "start_page": 419,
      "end_page": 419
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS",
      "text": "Row 1:\nstatus status (0-1)?Row 2:\n•Row 3:\n•expression expression <50% mutation mutation l",
      "start_page": 421,
      "end_page": 421
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS",
      "text": "Row 1:\n\"Row 2:\na a priority? \"Row 3:\n\"Row 4:\nJUDGEMENT\" RESEARCH EVIDENCE\" RowRow 5:\n\"No,\" \"Probably no\" \"Probably yes\" \"1 1 (PD-1) metastatic metastatic non-cancer cancer (NSCLC) MEDTERM0_ MEDTERM0_ (Keytruda, Merck), __medTERM1_ (Opdivo, Bristol-Myers Squibb), and __AMTERM2_ (Tecentriq, Genentech) therapy. therapy.",
      "start_page": 421,
      "end_page": 421
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (from previous page)",
      "text": "Yes Yes - Varies - Don't know (Med Med 2018;378:2078-92.",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95%Row 4:\nCI)",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nevidenceRow 3:\n(GRADE)",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nchemotherapy",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"DesirableRow 3:\n\"RowRow 4:\n\"",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nRow",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (column column 3)",
      "text": "Row 1:\n Row 2:\nctsRow 3:\nRow",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (column column 4)",
      "text": "Row 1:\n\"Med Med 2018;378:2078-92.",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (column column 4)",
      "text": "==References===;;; - . - . . .;; _ - .; - , , .; , - . , 15 15 , 35 35 , 17 17 , 29 29 , 28 28 , 31 31 , 24 24 , 65 65 , 12 12 , 77 77 , 7 7 , by by maintenance: , 1 1 , 34 34 , at at , case case ,Row 9:\n• after after 4",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (column column 5)",
      "text": "Row 1:\n Row 2:\nComment",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (column column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" ADDITIONAL CONSIDERATIONS \"Row 6:\n\"",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (column column 6)",
      "text": "Row 1:\n Row 2:\nts",
      "start_page": 422,
      "end_page": 422
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (from previous page)",
      "text": "Row one: 728 728 (to to (2 RCTs) 1. 1.19) i i (53 to 67) following following reasons: 189 189 study: following following reasons: 78 78 AEs; clinical clinical progression; Following Following reason: monitoring monitoring reasons: 21 21 AEs",
      "start_page": 423,
      "end_page": 423
    },
    {
      "heading": "heading heading ADDITIONAL ADDITIONAL CONSIDERATIONS (from previous page)",
      "text": "Row 1:\n06 06 (1. 1.19) = 728 (2 RCTs) = h, h,i",
      "start_page": 423,
      "end_page": 423
    },
    {
      "heading": "heading heading PFS:",
      "text": "Row 1:\n\"Plot Plot OS: PFS: Objective response rate: ...",
      "start_page": 424,
      "end_page": 424
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\n\"grade grade 3-5: Continuation rate: ...",
      "start_page": 425,
      "end_page": 425
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\n\"Row 2:\n\"Undesirable effects\"Row 3:\n\"anticipated anticipated effects? \"Row 5:\n\"JUDGEMENT RESEARCH EVIDENCE\" \"ADDITIONAL CONSIDERATION\" * (95% CI) at at (95% (studies) (GRADE) and and CI) HR. HR.",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95%Row 4:\nCI)",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\nRowRow 2:\nevidenceRow 3:\n(GRADE)",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\nRowRow 2:\nchemotherapy",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"UndesiraRow 3:\n\"RowRow 4:\n\"",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nRow",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nthe anticipated effects?",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (column column 3)",
      "text": "==References===External links==* Official website",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (column column 4)",
      "text": "Row 1:\n Row 2:\nComment",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (column column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" ADDITIONAL CONSIDERATIONS \"Row 6:\n\"",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (column column 5)",
      "text": "Row 1:\n Row 2:\nts",
      "start_page": 426,
      "end_page": 426
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row of 1: an...any any (to to (2 RCTs) 0. 0.88) (57 to 68) 189 189 study: following following reasons: clinical clinical progression; following following reasons: monitoring monitoring reasons: clinical clinical progression; proportion proportion score",
      "start_page": 427,
      "end_page": 427
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\n80 80 (0. 0.88) • 739 (2 RCTs) • • k k •Row 2:\n• Study population • row 3: •row 4: • rows 5: •100 100 •100 100 (57 to 68) ♪Row 6:\n♪",
      "start_page": 427,
      "end_page": 427
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(57 to 68)",
      "start_page": 427,
      "end_page": 427
    },
    {
      "heading": "heading heading PFS:",
      "text": "Row 1:\n\"Forest Plot OS: __ MEDTERM1__: Objective response rate:\"",
      "start_page": 428,
      "end_page": 428
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\n\"grade grade 3-5: Continuation rate: ...",
      "start_page": 429,
      "end_page": 429
    },
    {
      "heading": "heading heading Values",
      "text": "Row 1:\n\"Row\": \"Certainty of evidence\" = \"Raw\" of of effects?",
      "start_page": 430,
      "end_page": 430
    },
    {
      "heading": "heading heading Values (column 1)",
      "text": "Row 1:\n'Row 2:\n'Certainty of evidence'Row 3:\n'of of effects? 'Row 4:\n'Raw 5: 'JUDGEMENT'Row 6:\n'Very low 'Moderate Moderate 'High ' No included studies'Row 7:\n'Row 8:\n'Words'Row 9:\n'main main outcomes?'Row 10:\n'Rop 11: JUDGEment'Row 12:\n'variable variable 'variability variability 'variable variable '",
      "start_page": 430,
      "end_page": 430
    },
    {
      "heading": "heading heading Values (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 430,
      "end_page": 430
    },
    {
      "heading": "heading heading Values (column 7)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 430,
      "end_page": 430
    },
    {
      "heading": "heading heading Acceptability",
      "text": "==References===External links==* Official website",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n\"Row\" and \"undesira\"Row 4:\n\"Raw\" 5: \"JUDGEMENT\"Row 6:\n\"Favors the comparison\" comparison comparison \"appearance appearance \"participation participation \"Don't know\"Row 7:\n\"Right 8: \"Equity\"Row 9:\n\"health health equity\"Row 10:\n\"Row 11:\n\" JUDGEment\"Row 12:\n\"Reduced \"Probabally reduced\" x \"Probbable\" no impact \"ProBably increased\"",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\ns?",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading Acceptability (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading Acceptability (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading Acceptability (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading Acceptability (column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:\nmparison?",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading Acceptability (column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 431,
      "end_page": 431
    },
    {
      "heading": "heading heading Feasibility",
      "text": "Row 1:\nx Yes ... Varieties Don't know...\"Row 2:\n\"Row 3:\nto to implementation?\"Row 4:\n\"Raw 5: \"JUDGEMENT\"RESEARCH EVIDENCE\" \"ADDITIONAL CONSIDERATIONS\"Row 6:\n\"No\" \"Probably no \"Probably yes\" x \"Yes\" Varies \"Don't Know\"No evidence found\"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility",
      "text": "Row 1:\n\"Row\" 2: \"JUDGEMENT\"Row 3:\n\"Rop\" 4: \"No\"Probab ly no\" \"Probabl y yes\" \"Yes\" \"Varies\" \"Don't know\"Row 5:\n\"PROBLEM\"Row 6:\n\"Rw\" 7: \"Trivial\" \"Small\" \"Modera te\" \"Large\" \"Very Small\" \"Don't Know\"Row 8:\n\"DESIRABLE EFFECTS\"Row 9:\n\"Row 10:\n\"Large\"Moder ate\" \"Little\" \"Trivial\" \"Vories\" Don't known\"Row 11:\n\"UNDESIRABLE EFFECTS\"Row 12:\n\"Now\"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (column 1)",
      "text": "Row 1:\n Row 2:\nRow",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (column 1)",
      "text": "Row 1:\n Row 2:\nPROBLEMRow 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\nRow",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nand to implement? \"Row 4:\n\"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" row 7: \"Row 8:\n\" 'Row 9:\n\" \"Row 10:\n\" -Row 11:\n\" Now 12: \" Route 13: \"\"Row 14:\n\"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (column 3)",
      "text": "Row 1:\n Row 2:",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (column 6)",
      "text": "Row 1:\n Row 2:\nJUDG",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (column 7)",
      "text": "Row 1:\n Row 2:\nGEMENT",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" 'Row 8:\n\" row 9: \" \"Row 10:\n\"\"Row 11:\n\" Now 12: \"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (column 9)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\" Don't know\"Row 5:\n\"Don't knows\"Row 6:\n\"Do't Know\"",
      "start_page": 432,
      "end_page": 432
    },
    {
      "heading": "heading heading Feasibility (from previous page)",
      "text": "Row 1:\n\"Row\" 2: \"JUDGEMENT\"Row 3:\n\"Raw\" 4: \"Very low\" \"Low\" \"Moderate\" \"High\" \"No included studies\" \"Rown\" 5: \"CERTAINTY OF\"Row 6:\n\"IVIDENCE\"Row 7:\n\"Right\" 8: \"variabil variabil ity\" \"ity ity \"variable variable \"ty\" \"o o variablety\"Row 9:\nVALUES \"RW\" 10: \"Row\" 11: \"compare compare ison\" \"ison ison \"N\" \"ison. ison.\"",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading Feasibility (from previous page)",
      "text": "Row 1:\nBALANCERow 2:\nOFRow 3:\nEFFECTS",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading Feasibility (column column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nEVIDENCERow 4:\n Row 5:\n Row 6:\n Row 7:\nVALUESRow 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\nBALANCERow 13:\nOFRow 14:\nEFFECTSRow 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\nEQUITYRow 20:",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading Feasibility (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading Feasibility (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" row 7: \"Row 8:\n\" 'Row 9:\n\" \"Row 10:\n\" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Roll 15: \"\"Row 16:\n\"",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading Feasibility (column column 3)",
      "text": "Row 1:\n Row 2:",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading Feasibility (column column 7)",
      "text": "Row 1:\n Row 2:\nJUDG",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading Feasibility (column column 8)",
      "text": "Row 1:\n Row 2:\nGEMENT",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading Feasibility (column column 9)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" row 8: \" \"Row 9:\n\"",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading Feasibility (column column 10)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading Feasibility (column column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"studies studies \"Row 5:\n\"Row 6:\n\"Row 7:\n\" row 8: \" \"Row 9:\n\" 'Row 10:\n\" D or n' o o w\"Row 11:\n\"n n \" t \" or or w\" \"",
      "start_page": 433,
      "end_page": 433
    },
    {
      "heading": "heading heading Feasibility (from previous page)",
      "text": "Row 1:\n\"Row\" 2: \"JUDGEMENT\"Row 3:\n\"Rop\" 4: \"No\"Probab ly no\" \"Probabl y yes\" \"Yes\" \"Va rie s\" \"D\" or \"n\" \"W\"Row 5:\n\"ACCEPTAB ILITY\"Row 6:\n\"Raw 7: \"No\"\"no no \"yes yes \"Yes\") \"Vaa río s\" or n' or or \"w\"Row 8:\nFEASIBILIT Y\"Row 9:\n\"",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading Feasibility (from previous page)",
      "text": "Row 1:\nthe the intervention",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading Feasibility (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" ACCEPTAB ILITY \"Row 6:\n\"Row 7:\n\"Row 8:\n\" FEASIBILITY Y \"Row 9:\n\"",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading Feasibility (column column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading Feasibility (column column 3)",
      "text": "Row 1:\n Row 2:\nJUDG",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading Feasibility (column column 3)",
      "text": "Row 1:\nRowRow 2:\nProbabl y yes",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading Feasibility (column column 4)",
      "text": "Row 1:\n\"Row 2:\nGEMENT\"Row 3:\n\"Rop 4: \"Rown 5: \"Raw 6: \"Row 7:\n\"Row 8:\n\"Row 9:\n\"",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading Feasibility (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading Feasibility (column column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"D o n' o o w\" \"Row 5:\n\"D or \"n\" \"k\" or \"w\"",
      "start_page": 434,
      "end_page": 434
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 435,
      "end_page": 435
    },
    {
      "heading": "heading heading  Progression free survival",
      "text": "==References===External links==* Official website",
      "start_page": 436,
      "end_page": 436
    },
    {
      "heading": "heading heading  Progression free survival (column 1)",
      "text": "Row 1:\n•Row 2:\npatients patients •Row 3:\n• Row 4; •Row 5:\n: studies studies • Distortation risk • results results • generalization generalization • Imperfection • Other considerations • CBCCA + Paclitaxel or Nab- Paclitaxel • Non-important sage • None • 181/338 (53.6%) •row 10: survival survival • row 11: ♪Row 12:\nStuds Studs • Randomized stories • Serious stove • Not important •stoop stoop •None •240/338 (71.0%) • Fast rate (answers answers + partial answers) •Row 12:\n: 1 1 • High quality • schoke schoke •non significant •Non-important •no 240/338 (8.0%)",
      "start_page": 436,
      "end_page": 436
    },
    {
      "heading": "heading heading  Progression free survival (column 2)",
      "text": "Row 1:\n\"Row 2:\nSureRow 3:\n\"Row 4:\n\" Row 5\": Relative (95% CI) \"Absolute (95% CI): \" Row 6\": \" Row 7\": ♪Row 8:\n\"Raw 9\": 72 72 (0. 0.88) \"100 100 (5 5 less) \"Row 10:\n\" row 11: \"Row 12:\n\"57 57 (0. 0.68) \"100 100 (13 13 less) 'Row 13:\n\" Now 14: \"row 15: 66 66 (1. 1.96) \"100 100 (35 35 more) \" [Row 16:\n\"]Row 17:\n\" -\"Row 18:\n\"greater greater (7 7 greater) ] \"Row 19:\n\"-Row 20:\n\"",
      "start_page": 436,
      "end_page": 436
    },
    {
      "heading": "heading heading  Progression free survival (column 3)",
      "text": "Row 1:\n Row 2:\nImportanceRow 3:\n Row 4:\n Row 5:\nCRITICRow 6:\n Row 7:\n Row 8:\nIMPORTANTRow 9:\n Row 10:\n Row 11:\nCRITICALRow 12:\n Row 13:\n Row 14:\nCRISTICRow 15:",
      "start_page": 436,
      "end_page": 436
    },
    {
      "heading": "heading heading Immunotherapy-related adverse events",
      "text": "==References===External links==* Official website",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading Immunotherapy-related adverse events (column 1)",
      "text": "Row 1:\n•Row 2:\nCertainty assessment •Row 3:\n•row 4: • row 5: studies studies •study study •Distortion risk •results results • generalization generalization •Immediacy • Right 6: •Row 7:\n1 •Studies randomized •Very serious •No important •important important ■Row 8:\nAny discontinuation • Raw 9: ♪Row 10:\n2 •2 •studies randomised •Unimportant •Warly •Not important ‐Serium •Know 11: Toxic death (treatment-related deaths) • Rot 12: −Row 13:\n3 3 •studi randomised •non important â€important important ¢Row 17:\nâ â .",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading Immunotherapy-related adverse events (column 2)",
      "text": "Row 1:\n•Row 2:\n•patients patients •Effect •CertoRow 3:\n•Row 4:\n• row 5: Additional considerations •CBDCA + Paclitaxel or • Nab-Paclitaxel + •MEDTERM0__ •chemotherapy •Relation (95% CI) • Absolute (95% CI), •row 6: •Row 7:\n♪191 •162 • •greater greater (5 5 greater) −",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading Immunotherapy-related adverse events (column 2)",
      "text": "Row 1:",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading Immunotherapy-related adverse events (column 2)",
      "text": "Row 1:\n188/338 (55.6%) = 251/344 (73.0%) = 0.76 (0. 0.85) = 100 100 (11 11 less)",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading Immunotherapy-related adverse events (column 2)",
      "text": "Row 1:\n32/337 (9.5%) • 21/342 (6.1%) • 1,55 (2. 2.64) • 100 100 (10 10 plus)",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading Immunotherapy-related adverse events (column 2)",
      "text": "Row 1:\n51/337 (15.1%) = 67/342 (19.6%) = 77 77 (1. 1.07) = 100 100 (1 1 plus)",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading Immunotherapy-related adverse events (column 2)",
      "text": "Row 1:\n66/337 (19.6%) •70/342 (20.5%) •95 95 (1. 1.27) •100 100 (6 6 more)",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading Immunotherapy-related adverse events (column 2)",
      "text": "Row 1:\n25/337 (7.4%) • 21/342 (6.1%) • 1.20 (2. 2.11) •100 100 (7 7 plus)",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading Immunotherapy-related adverse events (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"ImportantRow 3:\n\"Row 4:\n\"CRITICRow 5:\n\"Row 6:\n\" \"Row 7:\n\" IMMPORTANTRow 8:\n\"Row 9:\n\" CRITICRow 11:\n\" row 12: \" 'Row 13:\n\"CriticRow 14:\n\" - \"Row 15:\n\"",
      "start_page": 437,
      "end_page": 437
    },
    {
      "heading": "heading heading References",
      "text": "Row 1:\n\"Row 2:\nCertainty assessment\" Patient's No (s): \"Effect\" (s) \"ImportantRow 3:\n\"Raw 4: \" Row 5\": \"No\" Study Design\" (Study Drawing) \"Distortion Risk\" (Middles) \"Made-of-Globalization Lack\" (i.e. \"CBDCA\" + \"Paclitaxel\" or \"Nab- Paclitaxel\") + \"_MEDTERM0\"_\"Relational (% CI) \"Absolute (95% CI) 'Row 6:\n\"Rough 7: 2 2,3\" Randomized studies\" (ii) \"non-important\" (iii) \"serious\" and \"none\" (32.9%) \"32/342 (9.4%) \"07 07 (5. 5.96) \"100 100 (5 plus 46+) \"BASSA BASE\"",
      "start_page": 438,
      "end_page": 438
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\nShould CBDCA + nab-paclitaxel nab-paclitaxel + status status (0-1)",
      "start_page": 439,
      "end_page": 439
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n\"Row 2:\na a priority? \"Row 3:\n\"Row 4:\nJUDICIAL EVIDENCE TESTS\" \"RowRow 5:\n\"no no \"Probably yes \" Yes ● Varies \"Don't know \"",
      "start_page": 439,
      "end_page": 439
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nPOPULATION:Row 5:\n Row 6:\nINTERVENTION:Row 7:\n Row 8:\nCOMPARISON:Row 9:\n Row 10:\nMAIN OUTCOMES:Row 11:\n Row 12:\n Row 13:\nSETTING:Row 14:\n Row 15:\nPERSPECTIVE:Row 16:\n Row 17:\nBACKGROUND:Row 18:\n Row 19:\nCONFLICT OF INTERESTS:",
      "start_page": 439,
      "end_page": 439
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n Row 2:\na a priority?",
      "start_page": 439,
      "end_page": 439
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\nVerified by: CBDCA + nab-paclitaxel nab-paclitaxel + status status (0-1)",
      "start_page": 439,
      "end_page": 439
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n\"Row\" 2: \"Rop\" 3: \"Raw\" 4: \"REARING EVIDENCE TESTS\"",
      "start_page": 439,
      "end_page": 439
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "status status (0-1), banks. banks.",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"DesirablRow 3:\n\"RowRow 4:\n\"",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nRow",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nectsRow 3:\nRow",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nthe anticipated effects?",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 440,
      "end_page": 440
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n(GRADE) Absolute early effect* (95% CI CI Comments) relative participants (95% (studies) with with CI) (GRADE) chemotherapy CBDCA + Nab-Paclitaxel Nab-Paclitaxel + HR HR 682",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n(GRADE)",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nChemotherapy",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(43 to 57)",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(56 to 70)",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(52 to 72)",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1, 2009-2011: 10, 2011-2015: 11, 2012-2016: 20, 2015-2010: 10 and 2010-2014: 12, 2012: 15, 2013-2015 (Row 16, 2015: 10) - 10, 2014: 10 (Raw 13, 2011: 10): 10, 2010-2018: 14 (Rw 25, 2016: 0, 2012) - 11, 2010: 23, 2012; 10, 2012 - 10: 10: \" 2015 2015 - 5, 2011 - 2011 2011 , 2006: 2007 2007 , 2005 2005 , 2001 2001 , 2015 2015 , 2017 2017 , 1995 1995 , 1998 1998 , 1996 , 1994 , 2012",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n•Row 2:\n•tests tests (GRAD) • CertezzRow 3:\nAnti-Row 4:\n•Row 5:\n•GRAD",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n...Row 2:\nza...\"CommentsRow 3:\n\"Row 4:\n\"Row 5:\nDE) \"Row 6:\n\"CBDCA CBDCA + Paclitaxel or Nab- Paclitaxel + RowRow 7:\n\"CBDCA CBDCA + Paclitaxel or Nab- Paclitaxel + RowRow 8:\n\"CBDCa CBDCa + Pacrotaxel or nab- Paclivastatin + response. response.",
      "start_page": 441,
      "end_page": 441
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nlife life (EORTC QLQ-C30) assessed with: Life Life Questionnaire- Core 30 (global health status/life life score) Scale from: 100 100 follow-up: 9 weeks",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nAverageRow 2:\nRowRow 3:\nLife was 0",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(RowRow 3:\n7.7 greater)",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nAverageRow 2:\nRowRow 3:\nLife was 0",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(RowRow 3:\n7.5 greater)",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\nlife life (EORTC QLQ-C30) evaluated with: Life Life Questionnaire- Core 30 (global health status/life life score) Scale from: 100 100 follow-up: 9 weeks",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"VERY LOW\"RowRow 2:\n\"Very LOW,\"c",
      "start_page": 442,
      "end_page": 442
    },
    {
      "heading": "heading heading OS",
      "text": "==References===External links==* data. data. OS_",
      "start_page": 443,
      "end_page": 443
    },
    {
      "heading": "heading heading OS (column 1)",
      "text": "==References===External links==* efficacy efficacy data). OS",
      "start_page": 443,
      "end_page": 443
    },
    {
      "heading": "heading heading PFS",
      "text": "Row 1:\n...rate rate ...Row 2:\n..Row 3:\n..with with .. . . . and . ..and . . with with . .",
      "start_page": 444,
      "end_page": 444
    },
    {
      "heading": "heading heading PFS (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"UndesiraRow 3:\n\"RowRow 4:\n\"",
      "start_page": 444,
      "end_page": 444
    },
    {
      "heading": "heading heading PFS (column 2)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\nRow",
      "start_page": 444,
      "end_page": 444
    },
    {
      "heading": "heading heading PFS (column 3)",
      "text": "Row 1:\n\"Row 2:\ns\"Row 3:\nrable anticipated effects?",
      "start_page": 444,
      "end_page": 444
    },
    {
      "heading": "heading heading PFS (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 444,
      "end_page": 444
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\n(GRADE) Absolute early effect* Comments Comments (95% CI) relative participants (95% (studies) with with CI) (GRADE) chemotherapy CBDCA + nab-paclitaxel nab-paclitaxel + RR RR 682",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n(GRADE)",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\nRowRow 2:\nChemotherapy",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(50 to 62)",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(6 to 16)",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(11 to 21)",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading PFS_ (column column 1)",
      "text": "Row 1:\n(0fm) = 100 m3 = 10 m3 + 10 m2 = 20 m3 / 10 m4 = 10 cm3 = m5 m5 = m7 m7 = 2 m3 - 3 m3",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading PFS_ (column column 2)",
      "text": "Row 1:\n\"Row\" 2: \"the the tests\" (GRADE) = \"CreativeRow 3:\n\"Nti\" RowRow 4:\n\"Tree Row 5\": \"GRADE\"",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading PFS_ (column column 3)",
      "text": "Row 1:\n\"Row 2\": a \"CommentsRow 3:\n\"Row 4:\n\"Row 5:\nE\" \" Row 6\": \"CBDCA\" + \"Paclitaxel\" or \"Nab- Paclitaxel\") + \"_MEDTERM0\" RowRow 7:\n\"CBDCA CBDCA + \"Paclitaxel\" and \"Nab- Paciltaxel\" + RowRow 8:\n\"CBCCA\"+ \"Paclitaxel,\" or \"Nabi- Pacrotaxel\" in in determining",
      "start_page": 445,
      "end_page": 445
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\n.95 (2 RCT) or or Nab- 100 100 (Paclitaxel Paclitaxel + (14 to 26) 1.27) 679 679 • CBDCA + Grade 3-4: 1.20 (2 RTC) 100 100 (Paciltaxel Paciltaxel + (4 to 13) 2.11) 679 679 - 07 07 (2 Rct) 100 100 (deed deed + the the CBA+Padc)",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(14 to 26)",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(4 to 13)",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(15 to 56)",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading PFS_ (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" PeopleRow 6:\n\"Row 7:\n\" \"Row 8:\n\" 20 for \" 100Row 9:\n\" row 10: \" 'Row 11:\n\" PopularityRow 12:\n\" Route 13: \"Row 14:\n\" 6 for \"100Row 15:\n\" - \"Row 16:\n\"\"Row 17:\n\"PopulationRow 18:\n\" Now 19: \" Roll 20: \" 9 for \"10Row 21:\n\"",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading PFS_ (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\nne in studio\" \"Row 6:\n\"Row 7:\n\"Row 8:\n\"0\" 100 100 (14 to 26) \"RowRow 9:\n\"14 to 26\"Row 10:\n\"Raw 11: \" row 12: \"studio studio \"Row 13:\n\"row 14: \" Route 15: \"100 100 (4 to 13) \"RowRow 16:\n\"4 to 13\"Row 17:\n\" Now 18: \" Roll 19: \"Ne in studio\"\"Row 20:\n\" Right 21: \" - \"Row 22:\n\" 100 100 (15 to 56) \"row row 23: \"15 to 56\"Row 24:\n\"",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading PFS (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\" 95 95 (1. 1.27) \"Row 5:\n\"Row 6:\n\"Row 7:\n\" row 8: \" 'Row 9:\n\" \"Row 10:\n\" -Row 11:\n\" 20 20 (2. 2.11) \"Row 12:\n\" Roll 13: \" Route 14: \"\"Row 15:\n\" Now 16: \" Right 17: \" .Row 18:\n\"07 07 (5. 5.96)Row 19:\n\" Rule 20: \"",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading PFS_ (column column 7)",
      "text": "Row 1:\nGrade 3- 4.Row 2:\nCBDCA + Paclitaxel or Nab- Paclitaxel + RowRow 3:\nCBDC A + Paclitaxel or Nab- Paclitaxel + RowRow 4:\nCBDCAs CBDCAs + Pacrotaxel or nab- Pacilitaxel+ adverse adverse events",
      "start_page": 446,
      "end_page": 446
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\n-- J. J., M. M., Borghaei, H., A. A., F. F., D. D., population population (Langer Langer 2016: or or IV; RTC RTC KEYNOTE-407: stage stage IV). for for imprecision: confidence. confidence.",
      "start_page": 447,
      "end_page": 447
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\nRowRow 2:\n•Row 3:\n•",
      "start_page": 447,
      "end_page": 447
    },
    {
      "heading": "heading heading PFS_ (column column 1)",
      "text": "Row 1:\n-- J. J., M. M., Borghaei, H., A. A., F. F., D. D., population population (Langer Langer 2016: or or IV; RTC RTC KEYNOTE-407: stage stage IV). for for imprecision: confidence. confidence.",
      "start_page": 447,
      "end_page": 447
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\n\"D\" for for inaccuracy: heterogeneity heterogeneity (I2= 55%) death death Anaemia",
      "start_page": 448,
      "end_page": 448
    },
    {
      "heading": "heading heading PFS (from previous page)",
      "text": "Row 1:\n...to to imunotherapy",
      "start_page": 449,
      "end_page": 449
    },
    {
      "heading": "heading heading Values",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search_en/index_en.htm",
      "start_page": 450,
      "end_page": 450
    },
    {
      "heading": "heading heading Values (column 1)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/en_en/index_en.htm",
      "start_page": 450,
      "end_page": 450
    },
    {
      "heading": "heading heading Values (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 450,
      "end_page": 450
    },
    {
      "heading": "heading heading Equity",
      "text": "Row 1500:\n... .. . . . ... . ..\" . . .\" . .\" . . \" . .\"; . .' . .; . .",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"EquityRow 3:\n\"RowRow 4:\n\"",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nthe the comparison?",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nealth equity? \"Row 4:\n\"",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading Equity (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading Equity (column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 451,
      "end_page": 451
    },
    {
      "heading": "heading heading Feasibility",
      "text": "Row 1:\n\"Row 2:\n\"Acceptability\"Row 3:\n\"key key stakeholders? \"Row 4:\n\"Row 5:\n\"Judizi\" \"di di evidenza\" \"found. found.\"Row 6:\n\"No probability\" no \"Probably yes ● \"Yes,\" \"Varies,\" \"Don't know\"RowRow 7:\n\"Raw 8: \"Feasibility\"Row 9:\n\"to to implementation\"Row 10:\n\"Row 11:\n\"JUSTICES\" EVIDENCE EVIDENCE TESTS\" ADDITIONAL CONSIDERATIONS \"RWay 12: \" No,\" \"Probably no,\" \" probably yes,\" \"Yes\" \"Various\" Don'whatsoever. whatsoever.",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading Feasibility (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"AcceptabilityRow 3:\n\"RowRow 4:\n\"",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading Feasibility (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"FeasibilityRow 3:\n\"RowRow 4:\n\"",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading Feasibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nkey key stakeholders?",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading Feasibility (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nsible to implementation? \"Row 4:\n\"",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading Feasibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading Feasibility (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 452,
      "end_page": 452
    },
    {
      "heading": "heading heading Feasibility (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading Feasibility (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" PROBLEM\"Row 6:\n\"Row 7:\n\"Row 8:\n\" DESIRABLE EFFECTS\"Row 9:\n\"Raw 10: \"ROW 11: \"UNDESIRABLE EffECTS\")Row 12:\n\"Row 13:\n\"Rule 14: \"CERTAINTY OF EVIDENCE\"Row 15:\n\" NOW 16: \"QUETY\"Row 17:\n\"VALUES\"Row 18:\n\"WOW 19: \"BALANCE OF EFFECTS\"Row 21:\n\"",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading Feasibility (column column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading Feasibility (column column 3)",
      "text": "Row 1:\n Row 2:\nJUDICES",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading Feasibility (column column 3)",
      "text": "Row 1:\nProbably no ...yes. yes...Row 2:\n\" Row\" 3: \"Row\" 4: \"Small\": \"Modera te\" & \"Larg\" 5: \"Raw\" 6: \"Row\" 7: \" Moderate\" = \"Small\" / \"Trivi al\" *Row 8:\n\"Wow\" 9: \"How\" 10: \"Low\" / ...\"Modera te \"High\"Row 11:\n\"Row 12:\n\"-Row 13:\n\"or or variable\" /\"\"or or variableity\" /\"or or variableness\" /\")Row 14:\n\"row 15: \"Now 16: on. on.\"",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading Feasibility (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading Feasibility (column column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don't know\"Row 5:\n\"Dun't knows\"Row 6:\n\"Do't Know\"Row 7:\n\"No included studies\"Row 8:\n\"Raw 9: \"Row 10:\n\"Now 11: \"Row 12:\n\"Wow 13: \" Don't known\"Row 14:\n\"don't knowing\"Row 15:\n\" don't really know\"",
      "start_page": 453,
      "end_page": 453
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n\"Row 2:\n\"JUDIZI\"Row 3:\n\"Rown 4: \"No\"Probably no\"Probably yes\" Yes\" = \"Vari es\" Don 'RowRow 5:\nFEASIBILITY\"Row 6:\n\"Don't know\"",
      "start_page": 454,
      "end_page": 454
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nthe the intervention",
      "start_page": 454,
      "end_page": 454
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n Row 2:\nRecommendation",
      "start_page": 454,
      "end_page": 454
    },
    {
      "heading": "heading heading QUESITO 37",
      "text": "==References===External links==* Official website",
      "start_page": 455,
      "end_page": 455
    },
    {
      "heading": "heading heading QUESITO 37 (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 455,
      "end_page": 455
    },
    {
      "heading": "heading heading QUESITO 37 (column 2)",
      "text": "Row 1:\n\"Row\" 2: \"Effect\"Row 3:\n\"Quality\" \"ImportanceRow 4:\n\"Rop\" 5: \"y\"Rolative\"Row 6:\n\"Picture\" , \"Absolute\"Row 7:\n\"95%\"Row 8:\n\"Raw\" 9: \"-Row 10:\n\"140/180\" (77.8%) \"78 78 (0. 0.96) \"2 \"9 Fewer\" per 100 (16 16 feder) \"HIGH\" \"CRITAL3Row 11:\n\") \"Rout 12: \"62/180 (34.4%) \"62 62 (0. 0.79) \"6 \"per per 100\" (16 16 fewer) \"High\" \"IMPORTANT3Row 13:\nST 1.07) \"Row 14:\n\"1/156 (0.64%) \"44 44 (34. 34.36) \"TO TO 2188LIGHT",
      "start_page": 455,
      "end_page": 455
    },
    {
      "heading": "heading heading transfusion (5 5 months)",
      "text": "I'm sorry. == Demographic evolution =References==",
      "start_page": 456,
      "end_page": 456
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\nadvanced advanced NSCLC",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n\"Row 2:\na a priority? \"Row 3:\n\"Row 4:\n\" JUDICES\" \"EVIDENCE EVIDENCE TESTS\" \"CONSIDERATIONS\"Row 5:\n\"No\" \"Probably not \"Yes\" ● \"Varia\" known. known.",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\nused used (RowRow 2:\n)Row 3:\nPOPULATION (ii)Row 4:\n(iii)Row 5:\nINTERVENTION (iv)Row 6:\n(v)Row 7:\nCOMPARISON (vv) row 8: (vi)Row 9:\nMAIN EXITS (v/v)",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n\"Row 2:\nSETTING: \"Row 3:\n\"Row 4:\nPROSPECTIVE: \" row 5: \"Row 6:\n\" BACKGROUND: \"row 7: \"RW 8: CONFLICTS OF \"Row 9:\nINTEREST \"Row 10:\n\"",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n Row 2:\na a priority?Row 3:\n Row 4:\nJUDICES",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\nRow",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\nRow",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading Problem (column 4)",
      "text": "Row 1:",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading Problem (column 5)",
      "text": "Row 1:\n Row 2:",
      "start_page": 458,
      "end_page": 458
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "two two phases: phase phase (in induction phase) time. time.",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"Row 2\": \"Raw 3\" effect effect (95% CI) \"participants participants (studies) \"tests tests (GRADE) \"CommentsRow 3:\n\"Rop 4\" row row 5: \" Row 6\" placebo placebo \"Risk with \"Ru 7\" zero. zero.",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nofRow 3:\n(GRADE)",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRiskRow 2:\nwithRow 3:\nplacebo",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(62 to 76)",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nEsiderRow 3:\nRow",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\nSiderable Expected?",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "phase phase (stage IIIB/IV). two two phases: phase phase (induction phase) with with cisplatin/pemetrexed (cisplatin 75 mg/500 500 mg/ mq e",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 459,
      "end_page": 459
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"100 100 (19 to 28) (PFS) rated with: 539 539 \"masked to treat\" (a a (1 RCT) ALTA 0.79) follow follow up: 472 472 \"4. 4.44\" (1 RTC) ALTAC (___MEDTERM1_) 100 100 (valued valued with: 100 (0 to 22) 34.36) rate rate (partial partial response) followed followed up: 04 04 - average average (1 Rct) BASSAd,e (_medTERM2_) quality (evaluated evaluated with: of life - 5D 5D greater",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nsurvival survival (__MEDTERM0_) evaluated with: follow follow up: 62 62 (0. 0.79)",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(19 to 28)",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 22)",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nTheRow 2:\nAverageRow 3:\nQualityRow 4:\nof life -Row 5:\nEQ-5DRow 6:\nWas 0",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nLowerRow 3:\n(RowRow 4:\nRowRow 5:\ngreater)",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\nsurvival survival (__MEDTERM0_) evaluated with: follow follow up: median 5 monthsa",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row\" 2: \"Rw\" 2: 100 100 (19 to 28) \"23\" RowRow 3:\n\" 19 to 28\"Row 4:\n\"Row 5:\n\"Row 6:\naction in studio\" \"Raw 7: \"Row 8:\n\"Rown 9: \"3 per 100\" (0 to 22) \"3\" for \"100Row 10:\n\"0\" to 22\")Row 11:\n\"Now 12: \"Wow 13: \"less less (34 34 greater) \"RowRow 14:\n\"BottomRow 15:\ny\"(RowRow 16:\n- \"RowRow 17:\nD\" major)Row 18:\n\"Row 19:\n\"",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n62 62 (0. 0.79)Row 2:\nRow",
      "start_page": 460,
      "end_page": 460
    },
    {
      "heading": "heading heading difference difference (MID= 0.08",
      "text": "==References===External links==* http://available available 88% and and 95% sources sources 95%;",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading difference difference (MID= 0.08",
      "text": "Row 1:\nlife life -VAS (QOL) assessed by: VAS - Cycle 6",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading difference difference (MID= 0.08",
      "text": "Row 1:\nRowRow 2:\nLowerRow 3:\n(RowRow 4:\nRowRow 5:\ngreater)",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (column 2)",
      "text": "Row 1:\n Row 2:\nndesidRow 3:\nRow",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (column 3)",
      "text": "Row 1:\n Row 2:\nDerabiRow 3:\nRow",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (column 4)",
      "text": "Row 1:\n Row 2:\niiRow 3:\nRow",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (column 5)",
      "text": "Row 1:\nlife life -VAS (QOL) assessed by: VAS - Cycle 6",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nWishful Expected? \"Row 4:\n\"",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (column 7)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 461,
      "end_page": 461
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\n• Large • Moderate • Irrelevant • Variant • Not so • on on PubMed/databases databases (Cochrane Library) with with cysplatin/pemetrexed (cisplatin 75 mg/v. v.; phase phase (induction phase) phase phase (maintenance phase) with Cisplatin/pethotrexed (diseased).",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\n\"Row 2\": \"Exits\" Exhibits\" = \"Related effect\" (95% CI) \"participants participants (studies) \"tests tests (GRADE) \"CommentsRow 3:\n\"Anticipated\" * (95% CI): \"Raw 5: \"Ruy 6: \"Corruption with placebo\" \"Risk\" with \"Rw 7: \"Maintenance\" \"Row 8:\n\"Therapy with \"Row 9:\n\"pemetrexed\" \"row 10: \"Row 11:\nSevere Toxicity (Non-Laboratory) \" (ST) rated by: \"N° follow follow up: months months \"RR 2.51\" (5. 5.91) \"539 (1 RCT) \" ALTA\" \"ROW 12: \"Popportation in study\" -Row 13:\n\"Row 14:\n\"Short 15: \"Power\" for 100",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nofRow 3:\n(GRADE)",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRiskRow 2:\nwithRow 3:\nplacebo",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(4 to 20)",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (column column 5)",
      "text": "Row 1:\n\"Row 2\": \"Raw 3\": Absolute effect\" = \"Rop 4\" = (CI) = \"participants participants (studies) = (GRADE) = ...\"Right with placebo\" = [Row 7]: \"Maintenance\" = (\"Row 8\") = \"Therapy\" =\"Row 9:\n\"pemetrexed\" = row 10: \"Row 11:\nSevere Toxicity (Non-Laboratory) (ST) = rated by: N° follow follow up: months months \"51 51 (5. 5.91) \"539 (1 RCT) \" ALTA\" =",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (column column 6)",
      "text": "Row 1:\n Row 2:\ni",
      "start_page": 462,
      "end_page": 462
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\n•100 100 (1 to 20) RR rated with: 539 539 • Grade 3-4 (to to (1 RCT) ALTaa follow-up: 18.25) m m • transfusion • 539 539 - follow up: 2.67 (1 Rct) • 100 100 (100 100 (7 to 27) 5.33) • G-CSF • rr rr 539",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nevaluated evaluated with: Grade 3-4 follow-up: m m esi",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(1 to 20)",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(7 to 27)",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(1 to 41)",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(1 to 47)",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n100",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(1 to 45)",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (column column 1)",
      "text": "==References===External links==* Official website* http://www.interpol.int/en/notice/search/un_en/index_en.htm",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading difference difference (MID= 0.08 (column column 2)",
      "text": "Row 1:\n•26 26 (18. 18.25)Row 2:\n•Row 3:\n•row 4: • row 5: • • 67 67 (5. 5.33)Row 6:\n♪ row 7: â row 8: ■ row 9: @Row 10:\nÂ • right 11: ¶ row 12: ‐03 03 (74. 74.13)Row 13:\n− row 14: TMRow 15:\n□Row 16:\n^Row 17:\nØRow 18:\nřRow 19:\n{53 53 (84. 84.71)Row 20:\n►",
      "start_page": 463,
      "end_page": 463
    },
    {
      "heading": "heading heading Valori",
      "text": "Row 1:\n\"Wide Wide 95% for for inaccuracision\"Row 2:\n\"Row 3:\n\"Certainness of evidence\"Row 4:\n\"safety safety tests?\"Row 5:\n\"Raw 6: \"JUDICIES\" EVIDENCE EVIDENCE TESTS\" RowRow 7:\n\"Very low\" ● Low",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "heading heading Valori",
      "text": "Row 1:\n5 5 months",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "heading heading Valori (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"the the tests\" [Row 4:\n\"safety safety tests?\"]Row 5:\n\"Raw 6: \"JUDIZI\"Row 7:\n\"Very low\" ● \"Low,\" \"Moderated,\" \"High,\" \"included, \"Rop 8\": \"Row 9:\n\"Valori\"Row 10:\n\"C\" main main outcomes?\"Row 11:\n\"Row 12:\nJUDICI\"Row 13:\n\"or or variation\" - volatility volatility ● or or variability",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "heading heading Valori (column 1)",
      "text": "Row 1:\n5 5 months",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "heading heading Valori (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "heading heading Valori (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 464,
      "end_page": 464
    },
    {
      "heading": "heading heading Equity",
      "text": "Row 1:\n\"Row\" 2: \"Budget of effects\" = \"Rop\" 3: \"or or comparison?\" = \"Row\" 4: \"Raw\" 5: \"JUDICES\" ● intervention intervention \"Wait\" operation operation \"Warring\" 7: \"Wearing\" 8: \"Right\" 9: \"of of equity? \"Rown\" 10: \"Now\" 11: \"Don't know\"",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nsiderabili",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nuità? \"Row 4:\n\"",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading Equity (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nfavor",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading Equity (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading Equity (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nor or comparison?",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading Equity (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n?",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading Equity (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 465,
      "end_page": 465
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\n\"Row\" 2: \"Acceptibility\" \"Rop 3: \"main main stakeholders?\" \"Raw 4: \"Rown 5: \"JUDICI\" \"EVIDENCE EVIDENCE TESTS\" \"ADDENTIONS\" \"Now 6: \"No\" \"Probably no\" ● \"Yes\" \"Varia\" \"I don't know\" \"found. found.\" \"Rw 7: \"Roh 8: \"Fatsibility\" \"row 9: \"intervention intervention \"Right\" 10: \"Way\" 11: \"Don't I know\" found. found.",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•AcceptabilityRow 3:\n•RowRow 4:\n•",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•Now 4:",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nMain",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nell'interve",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nstakeholders?",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nento\"? \"Raw 4: \"",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading Fatsibility (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading Fatsibility (column 12)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 466,
      "end_page": 466
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "Row 1:\nQUALITY:Row 2:\nTESTS",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "Row 1:\nBILANCIRow 2:\nORRow 3:\nEFFECTS",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading Fatsibility (column column 1)",
      "text": "Row 1:\n Row 2:\n Row 3:\nPROBLEMRow 4:\n Row 5:\n Row 6:\n Row 7:\nSIDESRow 8:\nDESIDERABLERow 9:\n Row 10:\n Row 11:\nEFFECTSRow 12:\nROWNBILRow 13:\n Row 14:\n Row 15:\n Row 16:\nQUALITYRow 17:\nTESTSRow 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\nVALUESRow 23:\n Row 24:\n Row 25:\n Row 26:\n Row 27:\nBILANCIRow 28:\nRowRow 29:\nEFFECTS row 30:",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading Fatsibility (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nARow 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\nIRow 9:\n Row 10:\n Row 11:\n Row 12:\nLIRow 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\n Row 19:\n Row 20:\n Row 21:\n Row 22:\n Row 23:\n Row 24:\n Row 25:\n Row 26:\n Row 27:\n Row 28:\n Row 29:\n Row 30:",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading Fatsibility (column column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\" No\"Row 5:\n\"Irril eva nti\"Row 6:\n\"Gra ndi\"Row 7:\n\"bass bass a\"Row 8:\nor or variability\"Row 9:\n\"of of comparison\"",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading Fatsibility (column column 4)",
      "text": "Row 1:\n Row 2:\nJUDICES",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading Fatsibility (column column 4)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nPiccoliRow 4:\nRowRow 5:\nRowRow 6:\nto to intervention",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading Fatsibility (column column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\" Raw 18: \"",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading Fatsibility (column column 7)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don't know\"Row 5:\n\"Do not know\" row 6: \"Not so\"Row 7:\n\"use use \"Row 8:\n\"Raw 9: \"Row 10:\n\"Row 11:\n\"Row 12:\n\"I don't care\"Row 13:\n\"DON'T know\"",
      "start_page": 467,
      "end_page": 467
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n\"Ridu ce l'eq uità\" reduce reduce equity: \"on on equity\" to to \"Aument a l'equity\" is fair.",
      "start_page": 468,
      "end_page": 468
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nagainst against intervention",
      "start_page": 468,
      "end_page": 468
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•Recommendation",
      "start_page": 468,
      "end_page": 468
    },
    {
      "heading": "heading heading Discontinuation rate",
      "text": "== Demographic evolution =References==",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "heading heading Discontinuation rate (column 1)",
      "text": "the the study: \"Distortion risk\" = \"Driving risk\" + \"Drive risk\" - \"Drink risk\" / \"Drained risk\" · \"Disaster risk\" * - \"Currency loss\" -\"\"Immediacy loss\" − \"Improvement\" ‐ \"Row 6:\n\"Raw 7: Overall Survival\"Row 8:\n\"Row 9:\n5,\" 2, 4\" Randomized studies\" -- \"non-important\" --\" not important\" -\" Not important - \"Not important\" ►Row 13:\n\"Overall response rate\" ^Row 14:\n\"Now 15: 5\" randomized studios \"Serium\" b b ¢non-important non-important - \"No important\" row 16: Treatment-related AE (or or 4)Row 17:\n\"More important\"",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "heading heading Discontinuation rate (column 2)",
      "text": "== Demographic evolution =References==",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "heading heading Discontinuation rate (column 3)",
      "text": "Row 1:\n Row 2:\nImportanceRow 3:",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "heading heading Discontinuation rate (column 3)",
      "text": "Row 1:",
      "start_page": 469,
      "end_page": 469
    },
    {
      "heading": "heading heading References",
      "text": "Row 1:\n7 7 minus)",
      "start_page": 470,
      "end_page": 470
    },
    {
      "heading": "heading heading X Si",
      "text": "Row 1:\n• Private: Row",
      "start_page": 471,
      "end_page": 471
    },
    {
      "heading": "heading heading X Si",
      "text": "Row 1:\n•Row 2:\na a priority? •row 3: • row 4: JUDICES •TESTS TESTS •Row 5:\n• no • probably no ♪ X X • Yes",
      "start_page": 471,
      "end_page": 471
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "desirable desirable effects?Row 5:\n\"Row 6:\n\" JUDICIS\"Row 3:\n\"Warfarable effects\"Row 4:\n\"effects effects expected?\"Row 4:\n\" be be expected?Row 5:\n- \"Row 6:\n'JUDIS'RW 3: \"ADDANTIVE TESTS\" CONDITIONS) RowRow 7:\n\"Irrelevant . \" Small \"Big Big \" Large \" Varian \" Absolute Absolute Effects* (95% CI) with with Q10: (95% (studies) (GRADE) with with CI) ___MEDTERM0.00_===__medTERM3 0;3024 3024 3024",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95%Row 4:\nCI)",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\nRowRow 2:\nevidenceRow 3:\n(GRADE)",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (from previous page)",
      "text": "Row 1:\nRowRow 2:\nchemotherapy",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (column column 2)",
      "text": "Row 1:\n Row 2:\nEvergreenRow 3:\nEverlasting",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (column column 3)",
      "text": "Row 1:\n Row 2:\nrableRow 3:\nRow",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nDesirable Those Expected? \"Row 4:\n\"",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (column column 4)",
      "text": "==References===External links==* Official website",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (column column 5)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\nE)",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (column column 6)",
      "text": "Row 1:\n\"Row 2:\nCommen\"",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (column column 7)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading X Si (column column 7)",
      "text": "Row 1:\n Row 2:\nnts",
      "start_page": 472,
      "end_page": 472
    },
    {
      "heading": "heading heading I2=61%",
      "text": "Row 1:\n\"3014 3014 • (6 to 10) (rate rate (5 RCTs) 0. 0.59) studies studies (POPLAR POPLAR studies) label label I2=61% found found (I2=82%), survival. survival.",
      "start_page": 473,
      "end_page": 473
    },
    {
      "heading": "heading heading I2=61%",
      "text": "Row 1:\nContinuation rate (47 47 (0. 0.59) = 3014 (5 RCTs) = MODERATEA, b =Row 2:\n= 100 100 (R) = 100 (6 to 10) = row 3:",
      "start_page": 473,
      "end_page": 473
    },
    {
      "heading": "heading heading I2=61%",
      "text": "Row 1:\nRowRow 2:\n(6 to 10)",
      "start_page": 473,
      "end_page": 473
    },
    {
      "heading": "heading heading I2=61% (from previous page)",
      "text": "Row 1:\n\"related related AEs\"",
      "start_page": 474,
      "end_page": 474
    },
    {
      "heading": "heading heading I2=61% (from previous page)",
      "text": "Row 1:\n... \"Discontinuation rate\"",
      "start_page": 475,
      "end_page": 475
    },
    {
      "heading": "heading heading I2=61% (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95%Row 4:\nCI)",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (from previous page)",
      "text": "Row 1:\nRowRow 2:\nevidenceRow 3:\n(GRADE)",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (from previous page)",
      "text": "Row 1:\nRowRow 2:\nchemotherapy",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (column column 1)",
      "text": "Row 1:\n•Row 2:\n• IndRow 3:\n• RowRow 4:\n•",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (column column 2)",
      "text": "Row 1:\n Row 2:\nDesiredRow 3:\nRow",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (column column 3)",
      "text": "Row 1:\n Row 2:\nerableRow 3:\nRow",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nUnwanted Tits Expected?",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (column column 4)",
      "text": "==References===External links==* Official website",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (column column 5)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\n Row 4:\nE)",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (column column 6)",
      "text": "Row 1:\n\"Row 2:\nCommen\"",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (column column 7)",
      "text": "Row 1:\n Row 2:\nnts",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61% (column column 9)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 476,
      "end_page": 476
    },
    {
      "heading": "heading heading I2=61%",
      "text": "Row 1:\n\"studies studies (OPLAR OPLAR studies) label label I2=61% found found (I2=82%), free free survival\"",
      "start_page": 477,
      "end_page": 477
    },
    {
      "heading": "heading heading I2=61% (from previous page)",
      "text": "Row 1:\n\"related related AEs\"",
      "start_page": 478,
      "end_page": 478
    },
    {
      "heading": "heading heading I2=61% (from previous page)",
      "text": "Row 1:\n\"Discontinuation rate\"Row 2:\n\"Row 3:\n\"the the tests\"Row 4:\n\"safety safety tests?\"Row 5:\n\"Rw 6: \"JUDICI\" THE THE TESTS\" ADDITIONAL CONSIDRATIONS \"Raw 7: \"Very low\" Low X \"Moderated\" High \"No study included\"detection detection bias\"",
      "start_page": 479,
      "end_page": 479
    },
    {
      "heading": "heading heading I2=61% (column column 1)",
      "text": "Row 1:\n\"Row 2\": \"RowRow 3:\n\"RowRow 4:\n\"Row Row 3\"",
      "start_page": 479,
      "end_page": 479
    },
    {
      "heading": "heading heading I2=61% (column column 2)",
      "text": "Row 1:\n\"Row 2:\nRove\"Row 3:\nsafety safety tests?",
      "start_page": 479,
      "end_page": 479
    },
    {
      "heading": "heading heading I2=61% (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 479,
      "end_page": 479
    },
    {
      "heading": "heading heading I2=61% (column column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 479,
      "end_page": 479
    },
    {
      "heading": "heading heading Effect balance",
      "text": "Row 1:\n\"Row 2\": \"Raw 3: \"C\" main main outcomes? \"Row 4:\n\" Row 5\": 'Row 5': \"Warnings\" = \"ADDATIVE CONSIDERATION\" = 6: \"or or variation\" = variability variability * \"or or variables\" = 7: \"Row 8:\n\"Budget of effects\" = 9: \"or or comparison\" = 10: \"row\" = 11: \"ROW 11: JUDITIONS\" = 8: ...\"ADDANTIVE CONSIDERATIONS = 12: \"comparison comparison \"Probably\" confrontation. confrontation.\"",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "heading heading Budget of effects (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Valori\"Row 3:\n\"C\" main main outcomes? \"Rop 4: \"Raw 5: \"JUDIZI\"Row 6:\n\"or or variation\"",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "heading heading Budget of effects (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nOnto?",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "heading heading Budget of effects (column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 480,
      "end_page": 480
    },
    {
      "heading": "heading heading Acceptability",
      "text": "Row 1:\n\"Row\" 2: \"Equity\" =Row 3:\n\"of of equity?\" = \"Right\" = 5: \"Judizi\" = 7: \"Reduce equity\" = 6: \"Freeness\" = 9: \"Probably no impact\" = 10: \"Improve equity\" / \"Vary\" = 11: \"Raw\" = 8: \"Acceptability\" = row = 9, \"No intervention\" main main stakeholders?",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•of of equity?",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n•Row 2:\n•AcceptabilityRow 3:\n•RowRow 4:\n•",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\n?",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nkeepers? \"Row 4:\n\"",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading Acceptability (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading Acceptability (column 15)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 481,
      "end_page": 481
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\n\"Row 2:\nintervention intervention feasible? \"Row 3:\n\"Row 4:\n\"JUDIZI\" TESTS TESTS \"RW 5: \"No\" \"Probably no \"Yeah\" X \"Varia\"",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\n\"Row 2:\n\"JUDIZI\"Row 3:\n\"Rop 4: \"No\"Probably not \"Probabilme nte si\" \"Si\" \"Varia\" \"Non so\"Row 5:\n\"PROBLEM\"Row 6:\n\"Rw 7: \"Irrilev anti\" \"Little\" \"Moderates\" \"Grands\" \"Great\" \"Very Large\" \"Don't know\"Row 8:\n\"Now\" [Row] 9: \"DESIDERABLES\"Row 10:\n\"Row 11:\n\"Grand i\" \"Moderati\" (Moderated) \"Small\" or \"Iron\" \"Raw\" 16: \"Qualita dele proprima\"Row 17:\n\"Wow\"",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\nRowRow 2:\nTESTS",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n Row 2:\nRow",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" PROBLEM\"Row 6:\n\"Row 7:\n\"Row 8:\n\"Shifts\"Row 9:\n\"Desiderabile\"Row 10:\n\"Raw 11: \"Whoo\" 12: \"Faces\" row 13: \"Buildables\")Row 14:\n\"Row 15:\n\"Now 16: QUALITY OF TESTS\"Row 17:\n\"Downloaded\"",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nthe the surgery?",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility (column 7)",
      "text": "Row 1:\n Row 2:\nJU",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility (column 8)",
      "text": "Row 1:\n Row 2:\nUDIZI",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility (column 10)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" row 7: \"Row 8:\n\" 'Row 9:\n\" \"Row 10:\n\" -Row 11:\n\" Now 12: \" Route 13: \"\"Row 14:\n\" Right 15: \"",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility (column 11)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility (column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading Fatsibility (column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don't know\"Row 5:\n\"Dn't so\"Row 6:\n\"Do not know\" row 7: \"stud stud io\"Row 8:\n\"Raw 9: \"",
      "start_page": 482,
      "end_page": 482
    },
    {
      "heading": "heading heading JUDIZI",
      "text": "Row 1:\n-Row 2:\n- GIUDIZI-Row 3:\n- \"Row 4:\n- \"incl. use\" -Row 5:\n- \"Row 6:\n\"Row 7:\n\"or or variability\" - \"or or variation\" - variable variable - \"or or variability\") -Row 8:\n\"Raw 9: \"Row 10:\n\"confr confr onto\" -\"\"of of comparison\" - or or \"interversv interversv ento\"",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading JUDIZI (column 1)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\nEQUITARow 12:\n Row 13:\n Row 14:\nRowRow 15:\n Row 16:\n Row 17:\nNOW NOW 18:",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\" Right 12: \" Now 13: \" Route 14: \" [Row 15:\n\"]Row 16:\n\" #Row 17:\n\"\"Row 18:\n\" Rule 19: \")Row 20:\n\" *Row 21:\n\" =Row 22:\n\" Roll 23: \"",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\nLI",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading JUDIZI (column 3)",
      "text": "Row 1:\n Row 2:\nGRow 3:\n Row 4:\n Row 5:\nRowRow 6:\nof of comparison",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading JUDIZI (column 3)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\nProbably not",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading JUDIZI (column 4)",
      "text": "Row 1:\n Row 2:\nJUDICES",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading JUDIZI (column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" row 8: \" 'Row 9:\n\" \"Row 10:\n\" the the wind\"",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading JUDIZI (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading JUDIZI (column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\" Incl. use \"Row 5:\n\"Row 6:\n\" \"Row 7:\n\" 'Row 8:\n\" row 9: \"Row 10:\n\"\" Not so \"Row 11:\n\"Varia\" \"know know \"Row 12:\n\" Varia\" Do not \"Row 13:\n\" Now 14: \")Row 15:\n\"Miscellaneous\" \"Non \"Row 16:\n\" Right 17: \"",
      "start_page": 483,
      "end_page": 483
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nintervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 484,
      "end_page": 484
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 484,
      "end_page": 484
    },
    {
      "heading": "heading heading Recommendation (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•Recommendation",
      "start_page": 484,
      "end_page": 484
    },
    {
      "heading": "heading heading Recommendation (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 484,
      "end_page": 484
    },
    {
      "heading": "heading heading QUESITO 42",
      "text": "== Demographic evolution =References==",
      "start_page": 485,
      "end_page": 485
    },
    {
      "heading": "heading heading QUESITO 42 (from previous page)",
      "text": "Row 1:\n\"Row\" 1: \"Certainty assessment\" patients patients \"Effect\" = \"Corporate effect\" = *ImportantRow 3:\n\"Rown 4: \"Row 5:\nstudies studies \"study study \"Distortion risk\" = results results \"generalization generalization \"Immediacy \" Other considerations \"cycles cycles \"QL\" QL-QL-Initially, 175 (87%) arm arm (and and ethoposide) and 179 (89%) arm arm (36 36 - no arm - QL). arm arm (mostly <10 points) 21. 21.",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading QUESITO 42 (column column 1)",
      "text": "Row 1:\n\"Row 2:\nCertainty assessment\"Row 3:\n\"Row 4:\n\"Row 5:\nthe the studies\" study study \"Risk of distortion\" results results \"RowRow 6:\n\"Raw 7: 1 1,2\" randomized studies \"Serium a non-important\"Row 8:\n\"Any discontinuation\"Row 9:\n1 1\" randomised studies \"No important\"Row 10:\nAny interruption (of of treatment) \"Row 11:\n2, 2,\" \"studies randomised\" \"No significant\"Row 14:\nToxic death (treatment related deaths)Row 15:\n1-1\" randomised study \"No major\"",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading QUESITO 42 (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" ImprecisionRow 6:\n\"Row 7:\n\"RowRow 8:\n\" row 9: \" RowRow 10:\n\"Row 11:\n\" RowRow 12:\n\" maintenance \"Row 13:\n\" d d \"Row 14:\n\" \"Row 15:\n\"",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading QUESITO 42 (column column 3)",
      "text": "Row 1:\n•Row 2:\n•patients patients •Effect •CertoRow 3:\n•Row 4:\n•row 5: Further considerations •and and •with with • treatment treatment •chemotherapy •Relative (95% CI) • Absolute (95% CI), • row 6: • Initially, 175 (87%) arm arm (and and ethoposide) and 179 (89%) arm arm (and and etoposide) 176 176 (88%) patients in week-assessments assessments • week-upper week-upper week-patients patients (48).",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading QUESITO 42 (column column 3)",
      "text": "Row 1:\n124/201 (61.7%) = 142/202 (70.3%) = 88 88 (1. 1.01) = 100 100 (1 1 more)",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading QUESITO 42 (column column 3)",
      "text": "Row 1:\n21/155 (13.5%) willows5/163 (3.1%) 42 42 (11. 11.42) + 100 (32 32 plus)",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading QUESITO 42 (column column 3)",
      "text": "Row 1:\n8/155 (5.2%) .22/163 (1.2%) •21 21 (19. 19.50) •100 100 (23 23 more)",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading QUESITO 42 (column column 3)",
      "text": "Row 1:\n3/198 (1.5%) ?3/196 (1.5%) •99 99 (4. 4.84) •100 100 (6 6 plus)",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading QUESITO 42 (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"ImportanceRow 3:\n\"CRITICRow 4:\n\"Row 5:\n\"IMPORTANTRow 6:\n\"Row 7:\n\"ImmportantRow 8:\n\"Row 9:\n\" IMPORTANTRow 10:\n\" -Row 11:\n\" CRITIC \"",
      "start_page": 486,
      "end_page": 486
    },
    {
      "heading": "heading heading Explanations",
      "text": "== Demographic evolution =References==",
      "start_page": 487,
      "end_page": 487
    },
    {
      "heading": "heading heading Explanations (column 1)",
      "text": "45. 45.",
      "start_page": 487,
      "end_page": 487
    },
    {
      "heading": "heading heading Explanations (column 2)",
      "text": "Row 1:\n Row 2:\nnza",
      "start_page": 487,
      "end_page": 487
    },
    {
      "heading": "heading heading BACKGROUND:",
      "text": "== Demographic evolution =References==",
      "start_page": 489,
      "end_page": 489
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n\"Row 2:\n\"Problem\" =Row 3:\n\"a a priority?\" =Row 4:\n\"Raw 5: \"JUDIZI\" = ADDING ADDING TESTS\" = row 6: \"No\" = probably not \" Probably no\" = X \"Varia\" = \"Non so\" = *Row 7:\n\"Now 8: \"Desirable effects\" = #Row 9:\n\"effects effects expected?",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"TheRow 3:\n\" a a priority?Row 4:\n\"",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n•Row 2:\n• RowRow 3:\n• RowRow 4:\n•",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\niRow 3:\nRow",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\ndesirable \"Row 4:\n\"",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading Problem (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nthe expected?",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading Problem (column 17)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 490,
      "end_page": 490
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n...Absolute Absolute Effect* Comments Comments (95% CI) Participants Participants (95% (Studies) (GRADE) CI) 403 403 - follow-up: 0.70 (1 RCT)100 100 (month month (44 a 63) 0.91) 403 403 + 77 77 (1 RTC) 100 100 (a a (82 a 93) 0.96) Study Population",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "== Demographic evolution =References==",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nofRow 3:\n(GRADE)",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nChemotherapy",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\nExits\"",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n\"Row\" 2: \"pros pros (GRADE) \"CreativeRow 3:\n\"Nti\" RowRow 4:\n\"GRADE\"",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n\"Row\" 2: a \"C Row\" 3: where \"Raw\" 4: \") \"",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\nComme",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\nentities",
      "start_page": 491,
      "end_page": 491
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n•100 100 (format from (51 to 70) 403 403 • (answers answers (1 RCT) 1. 1.09) and partial responses) 175 175 (87%) patients - (1 RTC) 1.2 • (_MEDTERM2_) (QoL) evaluated evaluated with: (179 179 (89%) arm arm (and and ethoposide) Core 30 (QLQ- C30 C30 visits) 176 176 (88%) and 168 (83%), cancer. cancer.",
      "start_page": 492,
      "end_page": 492
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 492,
      "end_page": 492
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(51 to 70)",
      "start_page": 492,
      "end_page": 492
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 492,
      "end_page": 492
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"arm arm (mostly <10 points) 403 403 - \"discontinuation\" (a a (1 RCT) 1. 1.01) 100 100 (53 a 71) 318 318 - \"Discontinuion\" (1 Rct) VERY VERY (11. 11.42) to to (5 a 35) treatment discontinuation) 318 318 - discontinuation (a a (1 RTT) MOLTO MOLTO (19. 19.50) to to (1 a 24) treatment suspension) - Study Study population",
      "start_page": 493,
      "end_page": 493
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 493,
      "end_page": 493
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(5 to 35)",
      "start_page": 493,
      "end_page": 493
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(1 to 24)",
      "start_page": 493,
      "end_page": 493
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row\" 2: \"the the \"Raw\" 3: \"control control arm\" \"Rop\" 4: \"Mostly <10 points\" \"Row 5:\n\"the the \"row\" 6: \"Week 21.\"\"Row 7:\n\"Rw 8: \"88 88 (1. 1.01)Row 9:\n\"Study population\" \"Row 10:\n\"Now 11: \"Wow 12: \"70\" for 100\"Row 13:\n\"53 to 71) \"Row 14:\n\"===Row 15:\n\"ROW\" 4.42 (11. 11.42)Row 16:\n\"population population \"Rown 17: \"How to study\"Row 18:\n\"Row 19:\n\"3\" for \"100\"100 100 (five to 35)Row 20:\n\"Row 21:\n\" ROW\" (19. 19.50)Row 22:\n\"Stand population\" [Row 19:\n3 for \"R.\"",
      "start_page": 493,
      "end_page": 493
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n(Toxic death) 394 394 - (a a (1 RCT) 1, 1,32) 100 100 (16 a 32) 15 15 394",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nToxic death (treatment-related deaths) 99 99 -0.20 - 4,84 - 1 RCT - b. b.",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 7)",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(9 to 22)",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(17 to 42)",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\nToxic death (treatment-related deaths)",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n•99 99 (4. 4.84)Row 2:\n•Row 3:\n• row 4: •Row 5:\n• • 93 93 (1. 1.42)Row 6:\n♪Row 7:\nRowRow 8:\nÂ â \"Row 9:\n■Row 10:\n@Row 11:\n¶Row 12:\n‐15 15 (1. 1.92)Row 13:\n·Row 14:\n−Row 15:\n¢Row 16:\n^Row 17:\nÃ Â\"Row 18:\n¬Row 19:\n?84 84 (1. 1.33)Row 20:\n\\Row 21:\n}Row 22:\n□Row 23:\n·Row 24:\n►Row 25:\n{Row 26:\n*80 80 (2. 2.83)",
      "start_page": 494,
      "end_page": 494
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nndesidRow 3:\nRow",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nDerabiRow 3:\nRow",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\niiRow 3:\nRow",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "==References===External links==* Official website",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading Problem (column column 7)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 495,
      "end_page": 495
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n• Large • Small Small • Irrelevant • Variant • Not so •early early effect* Comments Comments (95% CI) Participants Participants (95% (Studies) (GRADE) CI) and and •403 403 • Follow-up: 0.70 (1 RCT)9 9 (0. 0.91) (44 to 63) 403 403 - 77 77 (1 RTC) 1 MODERATAa (0. 0.96) (82 to 93)",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nofRow 3:\n(GRADE)",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nChemotherapy",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n\"Row\" 2: \"the the tests\" (GRADE) \"CreativeRow 3:\nTrialsRow 4:\n\"GRADE\"",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading Problem (column column 7)",
      "text": "Row 1:\n\"Row 2:\n\"Comm\" CommRow 3:\nand \"Raw 4: \"",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading Problem (column column 8)",
      "text": "Row 1:\n Row 2:\nMinds",
      "start_page": 496,
      "end_page": 496
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n•403 403 • (to to (1 RCT) 1. 1.09) Partial Partial Responses) (51 to 70) 175 175 (87%) patients - (1 RTC) 1.2 (_MEDTERM2_) (QoL) evaluated evaluated with: (and and Etoposide) and 179 (89%) arm arm (and and ethoposide) Core 30 (QLQ- C30 C30 visits) 176 176 (88%) and 168 (83%), cancer. cancer.",
      "start_page": 497,
      "end_page": 497
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 497,
      "end_page": 497
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "==See also==*Row==References===Further reading==External links==",
      "start_page": 497,
      "end_page": 497
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\narm arm (mostly <10 points) 403 403 - discontinuation (a a (1 RCT) 1. 1.01) 100 100 (53 a 71) 318 318 - breakdown (a a (1RCT) VERY VERY (11. 11.42) to to (5 a 35) discontinuation of treatment) 318 318 - discontinuance (a a (1 RTT) MUCH MUCH (19. 19.50) to to (1 a 24) interruption of treatment). - Study Study population",
      "start_page": 498,
      "end_page": 498
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==See also==*Row==References===External links==",
      "start_page": 498,
      "end_page": 498
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(5 to 35)",
      "start_page": 498,
      "end_page": 498
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(1 to 24)",
      "start_page": 498,
      "end_page": 498
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n\"Row 5\": \"control control arm\" = \"Raw 6\" (mostly <10 points) \"Row 7:\n\"row row 8: \"Week 21. \"Row 9:\n\"Rw 10: \"88 88 \" (1. 1.01) \"Row 11:\n\"Study population\" = [Row 12:\n\"Row 13:\n\"]Row 14:\n\" 100 100 \"RW 15: \"[53 to 71] \"Row 16:\n\"==Row 17:\n\"ROW 2\" (11. 11.42)Row 18:\n\"Population in study\" =",
      "start_page": 498,
      "end_page": 498
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n(Toxic death) 394 394 - (a a (1 RCT) 1, 1,32) 100 100 (16 a 32) 15 15 394",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nToxic death (treatment-related deaths) 99 99 -0.20 - 4,84 - 1 RCT - b. b.",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(0 to 7)",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(9 to 22)",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(17 to 42)",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\nToxic death (treatment-related deaths)",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n•99 99 (4. 4.84)Row 2:\n•Row 3:\n• row 4: •Row 5:\n• • 93 93 (1. 1.42)Row 6:\n♪Row 7:\nRowRow 8:\nÂ â \"Row 9:\n■Row 10:\n@Row 11:\n¶Row 12:\n‐15 15 (1. 1.92)Row 13:\n·Row 14:\n−Row 15:\n¢Row 16:\n^Row 17:\nÃ Â\"Row 18:\n¬Row 19:\n?84 84 (1. 1.33)Row 20:\n\\Row 21:\n}Row 22:\n□Row 23:\n·Row 24:\n►Row 25:\n{Row 26:\n*80 80 (2. 2.83)",
      "start_page": 499,
      "end_page": 499
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2\": \"RowRow 3:\n\"RowRow 4:\n\"Row Row 3\"",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nandRow 3:\nRow",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "==References===External links==* Official website",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 500,
      "end_page": 500
    },
    {
      "heading": "heading heading Effect balance",
      "text": "Row 1:\n\"Very low\" X \"Moderate\" X • High • included included • imprecision imprecision •Row 2:\n\"Row 3:\n\"Warnings\" • row 4: \"C\" main main outcomes? •Row 5:\n♪Row 6:\n\"JUDIZI\" ♪Row 3 ♪ Additional Considerations ♪ row 7: \"variation variation Â\" Â. Â.\" RowRow 8:\nÂRow 9:\nâ€RowRow 10:\n¢or or comparison?",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading Budget of effects (column 1)",
      "text": "Row 1:\n\"Row\" 2: \"Raw values\" 3: \"C\" RowRow 4:\n\"C.\"",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading Budget of effects (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nmain main outcomes? \"Row 4:\n\"",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nor or comparison? \"Row 4:\n\"",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading Budget of effects (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading Budget of effects (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n?",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading Budget of effects (column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 501,
      "end_page": 501
    },
    {
      "heading": "heading heading Acceptability",
      "text": "==References===External links==*Official website* Official website* http://www.interpol.int/en/notice/search/en_en/index_en.htm",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading Acceptability (column 1)",
      "text": "Row 1:\n•Row 2:\n•AcceptabilityRow 3:\n•RowRow 4:\n•",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nuità? \"Row 4:\n\"",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading Acceptability (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nstakeholders? \"Row 4:\n\"",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading Acceptability (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading Acceptability (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 502,
      "end_page": 502
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\nX Si • Varia • Non so •Row 2:\n• row 3: •necessity •Row 4:\n•the the intervention? •row 5: ♪Row 6:\nJUDICES •TESTS TESTS •Now 7: •No • Probably no •X X •Vary •I don't know • found found •",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•Now 4:",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nell'interve",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nento\"? \"Raw 4: \"",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading Fatsibility (column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading Fatsibility (column 15)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 503,
      "end_page": 503
    },
    {
      "heading": "heading heading JUDIZI",
      "text": "==References===External links==* Official website",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading JUDIZI (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" PROBLEM\"Row 6:\n\"Row 7:\n\"Row 8:\n\"Desiderable Effects\"Row 9:\n\"Rop 10: \"Row 11:\n\"Residency\"Row 12:\n\"Wow 13: \" row 14: \"Quality of Evidence\"Row 15:\n\"Now 16: \"Dow 17: \"Hearts\"Row 18:\n\"row 19: \" Now 20: \"Side Side Effects\" row 21: \"Short 22: \"ROW 23: EQUITA\"Row 24:\n\"New 25: \"The Right 26: ACCEPTABILITY\"Row 27:\n\"-Row 28:\n\" NOW 29: FACTIBILITY\"Row 30:\n\"",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading JUDIZI (column 2)",
      "text": "Row 1:\n\"Row 2:\nJUDICES\"Row 3:\n\"Rop 4: \"Probably no\" Featured: \"Si Row 5\": \"Little\" Moderators \"Moderates\"Row 6:\n\"Mode\" = \"Small\" = row 7: \"Low\" = moderate \"HighRow 8:\n\"or or variability\" = variation variation \"RowRow 9:\n\"of of comparison\" = intervention intervention \"RowRow 10:\n\"probably reduces equity\" = equity equity \"RowRow 11:\n\"Perhaps not\"",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading JUDIZI (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:\n Row 6:\n Row 7:\n Row 8:\n Row 9:\n Row 10:\n Row 11:\n Row 12:\n Row 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading JUDIZI (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading JUDIZI (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\" Raw 18: \"",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading JUDIZI (column 5)",
      "text": "Row 1:\n Row 2:",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading JUDIZI (column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading JUDIZI (column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 504,
      "end_page": 504
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nintervention intervention -++ operation operation -+-+ intervention intervention --++intervention intervention X",
      "start_page": 505,
      "end_page": 505
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 505,
      "end_page": 505
    },
    {
      "heading": "heading heading QUESITO 43",
      "text": "== Demographic evolution =References==",
      "start_page": 506,
      "end_page": 506
    },
    {
      "heading": "heading heading QUESITO 43 (column 1)",
      "text": "== Demographic evolution =References==",
      "start_page": 506,
      "end_page": 506
    },
    {
      "heading": "heading heading QUESITO 43 (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"ImportationRow 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" CRITICRow 7:\n\"Row 8:\n\" \"Row 9:\n\"CRITICRow 10:\n\" row 11: \" 'Row 12:\n\" CRITICRow 13:\n\" Route 14: \" - \"Row 15:\n\" CriticicRow 16:\n\"\"Row 17:\n\"",
      "start_page": 506,
      "end_page": 506
    },
    {
      "heading": "heading heading References",
      "text": "Row 1:\n...Row 5:\nstudies studies ...study study . ...Distortion risk ... ... ...generalization generalization ... ... ...Important ... ...More considerations ... ..._Durvalumab + ethoposide ethoposide ... ...non-important .?..",
      "start_page": 507,
      "end_page": 507
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\nShould durvalumab + platinum- disease disease •Row 2:\n♪Row 3:\nPOPULATION: ♪ from from ♪illness illness • row 4: ♪ row 5: INTERVENTION: •medTERM1_ • + RowRow 6:\n@medterm4_; AE any grade; AE grade <3; to to discontinuation;Row 10:\n□Row 11:\nSETTING: Inpatients",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n\"Row 2:\na a priority? \"Row 3:\n\"Row 4:\n\" JUDICES\" \"EVIDENCE EVIDENCE TESTS\" \"CONSIDERATIONS\"Row 5:\n\"No\" \"Probably not \"Yes\" ● \"Varia\" \"I don'out. out.\"",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n Row 4:\nPOPULATION:Row 5:\n Row 6:\nINTERVENTION:Row 7:\n Row 8:\nCOMPARISON:Row 9:\n Row 10:\nMAIN EXITS:Row 11:\n Row 12:\nWEEK:Row 13:\n Row 14:\nPROSPECT:Row 15:\n Row 16:\nBACKGROUND:Row 17:\n Row 18:\nRow",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\npriority:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\ndurvalumab + RowRow 2:\nextended extended disease",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nTà?",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\nRow Otherapes 2:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (column 4)",
      "text": "Row 1:\nRowRow 2:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (column 5)",
      "text": "Row 1:\nPlatinumRow 2:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (column 6)",
      "text": "Row 1:\nRowRow 2:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (column 7)",
      "text": "Row 1:\nRowRow 2:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (column 8)",
      "text": "Row 1:\nRow",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (column 8)",
      "text": "Row 1:\n Row 2:",
      "start_page": 508,
      "end_page": 508
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"Row 2\": \"Exits\" Precipitated absolute effect* \"Related effect (95% CI) \"participants participants (studies) \"tests tests (GRADE) \"CommentsRow 3:\n\"95% CI\" \"Rown 4: \"Raw 5: \"Ruy 6\" \"the the \"Rw 7\" \": \"Sola\" \"_MEDTERM0__ + \"Roh 8\" \"Chemotherapy\" \"chemotherapy \"RW 9: \"with platinum\" and \"Motium\" \"Now 10: \"Etoposide\" \"Ethoposide\" \"Row 11:\n\"Overall survival\" follow up: months months \"75 75 (0. 0.91) \"537\" (1 RCT) \" ALTA\" \"__MEDTERMM0_ _ + RowRow 13:\n\"Population in study\"",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nofRow 3:\n(GRADE)",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(70 to 83)",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nEsiderRow 3:\nRow",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\ndesirable effects expected?",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 509,
      "end_page": 509
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 510,
      "end_page": 510
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nsurvival survival follow-up: 1 1 months",
      "start_page": 510,
      "end_page": 510
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(79 to 89)",
      "start_page": 510,
      "end_page": 510
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(60 to 77)",
      "start_page": 510,
      "end_page": 510
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\nsurvival survival follow-up: months months •80 80 (0. 0.96) •537 (1 RCT) 1 • MODERATAaRow 2:\n• Studio population •Row 3:\n• row 4: •row 5: • 100 100 •100 100 (79 to 89) • rows 6: ♪Row 7:\nORR follow up: median",
      "start_page": 510,
      "end_page": 510
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==See also==*America==References===Further reading==out. out. ==External links==",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"Row 2:\nExits\" Precipitated absolute effect* \"Related effect (95% CI) \"participants participants (studies) \"tests tests (GRADE) \"CommentariesRow 3:\n\"95% CI\" \"Raw 4: \" Row 5\": \"Ruy 6\" \"chemotherapy chemotherapy alone\" \"Row 7\" \": \"_MEDTERM0___\"Row 8:\n\"+\"Row 9:\n\"chemotherapy\" \"ROW 10: \"Platinous and Ethoposide\" \"Now 11: \"Etoposite\" \"row 12: \"4\"Row 13:\n\"followed followed up: months months \"RR 11.01\" (1. 1.04) \"531\" (1 RCT) \"MODERATAa\" \"__MEDTERMM0__ + RowRow 14:\n\"Population in study\" (Row 15) \"1 \"Right\" for 18: \"10 \"5\" -8 \"Rown: 16\" -15 \"Rlow: \" -8 -8\" - 16 \" - 10 - 10 \" - 8 - 8\" - 100,000 - 10-10 - 10",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n Row 2:\nRelativeRow 3:\n(95%Row 4:\nCI)",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\nparticipants (studies)",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nofRow 3:\n(GRADE)",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n Row 3:\n Row 4:\nRowRow 5:\netoposide",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(95 to 100)",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nndesidRow 3:\nRow",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nDerabiRow 3:\nRow",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\niiRow 3:\nexpected undesirable effects?",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 511,
      "end_page": 511
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Rowter 1: \"grade grade <=follow follow up: 0.99 (1 RCT) 1 + 100 100 (months months (57 to 73) 1,12) 531 531 → 08 08 (1 RTC) 1+ MODERATAa follow-up: 100 100 (1 1 (6 to 17) 1,82) probably probably don'W. W., Dvorkin, M., N. N., K., Trukhin, D., Statsenko, G., Hochmair, M",
      "start_page": 512,
      "end_page": 512
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n\"any degree.\"Row 2:\n\"Row\" 3: \"Raw 4: AE grade\" <3 follow-up: months months \"99 99 (1. 1.12) \"531\" (1 RCT) 1\" \"MODERATAa\" = \"MEDTERM0__ + and and ethoposis\" RowRow 5:\n\"Study population\" =",
      "start_page": 512,
      "end_page": 512
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(57 to 73)",
      "start_page": 512,
      "end_page": 512
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(6 to 17)",
      "start_page": 512,
      "end_page": 512
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\nAE grade <3 follow-up: months months \"99 99 (1. 1.12) \" RowRow 5:\n\" Study population \"Row 6:\n\"Row 7:\n\" row 8: \" 'Row 8:\n'100 100 \" 100 100 (57 to 73) \"Row 9:\n\"",
      "start_page": 512,
      "end_page": 512
    },
    {
      "heading": "heading heading Valori",
      "text": "Row 1:\n\"Lancet Lancet Oncol; ow ow 2:",
      "start_page": 513,
      "end_page": 513
    },
    {
      "heading": "heading heading Valori (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"the the tests\" [Row 4:\n\"safety safety tests?\"]Row 5:\n\"Raw 6: \"JUDIZI\"Row 7:\n\"Very low\" ● \"Made-up\" - \"High\" - in in \"Rw 8\": \"Row 9:\n\"Valori\"Row 10:\n\"C\" main main outcomes? \"Row 11:\n\"Row 12:\nJUDICES\"Row 13:\n\"or or variable\" - variation variation ● or or variability",
      "start_page": 513,
      "end_page": 513
    },
    {
      "heading": "heading heading Valori (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 513,
      "end_page": 513
    },
    {
      "heading": "heading heading Valori (column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 513,
      "end_page": 513
    },
    {
      "heading": "heading heading Equity",
      "text": "or or comparison?",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "heading heading Equity (column 1)",
      "text": "Row 1:\n\"Row\" 2: \"Budget of effects\" = \"Raw 3: \"undesirable undesirable effects\" *Row 4:\n\"Row 5:\nJUDIZI\" = 6: \"He'of of comparison\" = 7: \"Right 8: \"Equity\" = 9: \"of of equity?\" = 10: \"Row 11:\n\"Judizi\" = 12: \"Reduce equity\" = 8: ...\"Equities\" = 5: \"on on equity?",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nor or comparison?",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "heading heading Equity (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "heading heading Equity (column 8)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 514,
      "end_page": 514
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\n\"Row\" 2: \"Acceptibility\" \"Rop 3: \"main main stakeholders?\" \"Raw 4: \"Roo 5: \"JUDICI\" \"EVIDENCE EVIDENCE TESTS\" \"ADDENTIONS\" \"ROW 6: \"No\" \"Probably no\" \"You\" ● \"Yes,\" \"Vary,\" \"I don't know,\" \"found. found. \"filled. filled.\" \"Ruh 7: \"Roh 8: \"Fatsibility\" \"Row 9:\n\"the the intervention\" \"Now 10: \"Needle\" \"Not known.\"",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•AcceptabilityRow 3:\n•RowRow 4:\n•",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•Now 4:",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Ell\" intervention? \"Row 4:\n\"",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\nders?",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading Fatsibility (column 13)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 515,
      "end_page": 515
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "== Demographic evolution =References==",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading Fatsibility (column column 1)",
      "text": "Row 1:\n Row 2:\nPROBLEMRow 3:\n Row 4:\n Row 5:\nRowRow 6:\n Row 7:\n Row 8:\nRowRow 9:\n Row 10:\n Row 11:\nRowRow 12:\n Row 13:\n Row 14:\nVALUESRow 15:\n Row 16:\n Row 17:\nRowRow 18:\n Row 19:\n Row 20:\nEQUITARow 21:\n Row 22:\n Row 23:\nACCEPTABILITYRow 24:\n Row 25:\n Row 26:\nFACTIVITY",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading Fatsibility (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Route 13: \" Now 14: \" Right 15: \" [Row 16:\n\"]Row 17:\n\" #Row 18:\n\"\"Row 19:\n\" Rule 20: \")Row 21:\n\" *Row 22:\n\"",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading Fatsibility (column column 2)",
      "text": "Row 1:",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading Fatsibility (column column 3)",
      "text": "Row 1:\n Row 2:\nJUDICES",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading Fatsibility (column column 3)",
      "text": "Row 1:\nProbably no\"RowRow 2:\nSmall\"ModerateRow 3:\nModerate\"SmallRow 4:\nLow\"MiderateRow 5:\nor or variableity\"RowRow 6:\nthe the comparison\"RowRow 7:\nPROBABLY REDUCED",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading Fatsibility (column column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"Row 7:\n\" \"Row 8:\n\" 'Row 9:\n\" row 10: \" -Row 11:\n\"row 12: \" Now 13: \" Route 14: \" Right 15: \" Roll 16: \"\"Row 17:\n\" Raw 18: \"",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading Fatsibility (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\n Row 4:\n Row 5:",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading Fatsibility (column column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Don't know\"Row 5:\n\"Done't known\"Row 6:\n\"Do't knows\"Row 7:\n\"No included studies\"Row 8:\n\"Raw 9: \"Now\" 10: \"Row 11:\n\"Row 12:\n\"Wow\" 13: \" Don't Know\"Row 14:\n\"don't really know\" row 15: \" don't knowing\"Row 16:\n\"Soon't knowledge\"",
      "start_page": 516,
      "end_page": 516
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nintervention intervention • • operation operation • surgery surgery •Row 2:\n• RowRow 3:\n• RowRow 4:\n• row 5: ●Row 6:\n•",
      "start_page": 517,
      "end_page": 517
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 517,
      "end_page": 517
    },
    {
      "heading": "heading heading Quality of life",
      "text": "==References===External links==* Official website",
      "start_page": 518,
      "end_page": 518
    },
    {
      "heading": "heading heading Explanations",
      "text": "Row 1:\n\"Row\" 2: \"Rop\" 3: \"Impered Cognitive Function\" (neurological damage) - AEs AEs - not reported \"Raw\" 7: \"Rw\" 8: \"-\"-\"‐\"-\"\"-\"-\"-\"-\"-\"\"\"-\"\"CRITICALRow 9:\n\"Fatigue and Lethargy\" (any grade) \"Row 10:\n\"\"Row 11:\n\"\"\"observational studies \"l\" not serious\" \"not serious\" (from 52 more) \"serious\" \"m\"none\"52/386 (1.5%) \"16/570\" (2.8%) \"92 92 (8. 8.44) \"000 000 (209 209 more)",
      "start_page": 519,
      "end_page": 519
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n•Row 2:\nPOPULATION: • row 3: •row 4: INTERVENTION: ♪ brain brain (PCI)Row 5:\nâ ¢Row 6:\nCONFRONT: Â\"Row 7:\n■Row 8:\nMain outcomes: − progression-free survival; overall survival; brain progression- free survival; quality of life; neurocognitive impairment (neurological damage); to to 3; RowRow 9:\n·Row 10:\nSETTING: ‐AmbulatorialRow 11:\n·Row 12:\nPROSPECTIVA: ¶Row 13:\n^Row 14:\nBACKGROUND: ♫encephalus encephalus (PCI) treatment. treatment.",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading Problem",
      "text": "Row 1:\n•Row 2:\na a priority? •row 3: • row 4: JUDICES • TESTS TESTS •Row 5:\n• no • Probably no ♪ X X • Vary • I don't know •",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n Row 2:\nPOPULATION:Row 3:\n Row 4:\nINTERVENTION:Row 5:\n Row 6:\nCOMPARISON:Row 7:\n Row 8:\nMAIN EXITS:Row 9:\n Row 10:\n Row 11:\nSETTING:Row 12:\n Row 13:\nPROSPECTIVE:Row 14:\n Row 15:\nBACKGROUND:Row 16:\n Row 17:\n Row 18:\nRow",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading Problem (column 1)",
      "text": "Row 1:\n Row 2:\nRowRow 3:\npriority:",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\" row 7: \"Row 8:\n\"",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\"Row 6:\n\"",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading Problem (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nà?",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading Problem (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading Problem (column 4)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" ADDITIONAL CONSIDERATIONS \"Row 6:\n\"",
      "start_page": 520,
      "end_page": 520
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\n•Row 2:\n• Desirable effects • row 3: • desirable desirable effects? •Row 4:\n: • Raw 5: JUDICES • TESTS TESTS •Row 6:\n• Irrelevant • Small • Large Large • Variano • Not known •Outcomes • Anticipated absolute effects* • (95% CI) • irradiation irradiation (95% (studies) brain brain • CI) (GRADE) (PCI) Brain metastases - - -- - free survival - survival survival • 7395 7395 • (to to (0. 0.66)) observational • (7 to 8) studies)a, b.",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95%Row 4:\nCI)",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nRowRow 3:\nevidenceRow 4:\n(GRADE)",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\nirradiation",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(7 to 8) b",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRow",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "Row 1:\n\"Row 2:\n\"RowRow 3:\n\"RowRow 4:\n\"",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (column column 2)",
      "text": "Row 1:\n Row 2:\nEverishRow 3:\nEverlasting",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (column column 3)",
      "text": "Row 1:\n Row 2:\nSkillfulRow 3:\nRow",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:\ndesirable tti expected?",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (column column 4)",
      "text": "==References===External links==* Official website",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (column column 5)",
      "text": "Row 1:\n\"Row\" 2: \"the the evidence\" (GRADE)Row 3:\n\"ts\"Row 4:\n\"Rown\" 5: \"Raw\" 6: \"VERY LOWc,\" \"d,\" \"f Row\" 7: \"Very Lowc, \"h,\" \"iRow 8:\n\"Highk Row\" 9: \"-",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (column column 6)",
      "text": "Row 1:\n Row 2:\nCommen",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (column column 7)",
      "text": "Row 1:\n Row 2:\nnts",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (column column 9)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 521,
      "end_page": 521
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 522,
      "end_page": 522
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nFunction (neurological damage) - not reported",
      "start_page": 522,
      "end_page": 522
    },
    {
      "heading": "heading heading Problem (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(80 to 237)",
      "start_page": 522,
      "end_page": 522
    },
    {
      "heading": "heading heading Problem (column column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 522,
      "end_page": 522
    },
    {
      "heading": "heading heading PFS:",
      "text": "Row 1:\n\"Forest plot: OS: __PFS:\"",
      "start_page": 523,
      "end_page": 523
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\n\"Fatigue or lethargy\": \"Row 2:\n\"Rown 3: \"Undesirable effects\" = \"Raw 4: \"effects effects expected? \"Row 5:\n\"Judici\" 6: \"Created evidence\" * \"ADDATIVE CONSIDERATIONS\" * (95% CI) irradiation irradiation (95% (studies) Encephalus Encephalus CI) (GRADE) (PCI) metastases metastases - - - free survival - 7395 7395 (to to (100 100 066)",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\nRelativeRow 2:\neffectRow 3:\n(95%Row 4:\nCI)",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\nRowRow 2:\nparticipantsRow 3:\n(studies)",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\nCertaintyRow 2:\nRowRow 3:\nevidenceRow 4:\n(GRADE)",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\nRowRow 2:\nirradiation",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(7 to 8) b",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (column column 1)",
      "text": "Row 1:\n•Row 2:\n• IndRow 3:\n• RowRow 4:\n•",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (column column 2)",
      "text": "Row 1:\n\"Row 2:\nDesirable\"Row 3:\neffects effects expected?",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (column column 2)",
      "text": "Row 1:\n\"Row 2:\nOutcomes\" - RowRow 3:\n\"Row 4:\n\"Row 5:\n\" no no radiation\" - RowRow 6:\n\"Raw 7: \"Row 8:\nsurvival survival - not reported \"Row 9:\n\"-\"-Row 10:\n\"Wow 11: \"Overall survival\" -Row 12:\n\"RowRow 13:\n\"Row 14:\n\"Row 15:\n\"12 per 100b\" - \"RowRow 16:\n\" row 17: Progression free survival\"",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (column column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (column column 3)",
      "text": "Row 1:\n'Row 2:\nsolute effects* (95% CI)Row 3:\n'Row 4:\n' Row 5': one 'Right with l'radiation Row 6': 'Row Row 7': - 'PCI'Row 8:\n'Raw 9': • 'Rop 10': 11: 'Row 12:\n'Now 13: n'Row 14:\n'Row 15:\n'Wow 16: '100 100 (7 to 8) 'b'RowRow 17:\n'[7 to 8] bRow 18:\n'Dow 19: 'n'Row 20:\nn\"Row 21:\n'row 22: ' Now 23: 'RowRow 24:\n'NAN to NaN)Row 25:\n'",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (column column 4)",
      "text": "Row 1:\n\"Row\" 2: \"Rolative effect (95% CI) \"participant participant (studies) \"RowRow 3:\n\"ParticipantRow 4:\n\"Raw\" 5: \"ne\" (\"Studies\")Row 6:\n\"halo\"Row 7:\n\"Rw\" 8: \"Wow\" 9: \"-\"Row 10:\n\"Row\" 11: \"Row 12:\n\"HR\" 0.62 (0. 0.66) \"Row 13:\n\" row 14: \" Row\" 15: \"row\" 16: \"How\" 17: \"TheRow 18:\n\"Rule\" 19: \"TR\" 0.76 (0. 0.89) \"Row 20:\n\" Now 21: \"Alow\" 22: \"RowRow 23:\n\"Cow\" 24: \"==References===External links==",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (column column 5)",
      "text": "Row 1:\n\"Row 2:\n\"evidence evidence (GRADE)Row 3:\n\"ts\"Row 4:\n\"Rop 5: \"-Row 6:\n\"RowRow 7:\n\"",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (column column 6)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading PFS: (column column 6)",
      "text": "Row 1:\n Row 2:\nComments",
      "start_page": 524,
      "end_page": 524
    },
    {
      "heading": "heading heading (80 to 237) studies)l VERY",
      "text": "Row 1:\n\"that that \"with with - (1 RCT)j = the quality-93. 93.7% 46. 46.3% groups groups (P = 0.10)\" Impered - - -- - - Cognitive Function (neurologically damage) - 3-5 3-5 - -",
      "start_page": 525,
      "end_page": 525
    },
    {
      "heading": "heading heading (80 to 237) studies)l VERY",
      "text": "==References===External links==* Official website",
      "start_page": 525,
      "end_page": 525
    },
    {
      "heading": "heading heading (80 to 237) studies)l VERY",
      "text": "Row 1:\nRowRow 2:\n(80 to 237)",
      "start_page": 525,
      "end_page": 525
    },
    {
      "heading": "heading heading (80 to 237) studies)l VERY (column 1)",
      "text": "Row 1:\n\"that that \"with with - (1 RCT)j = the quality-93. 93.7% 46. 46.3% groups groups (P = 0.10)\" Impered - - -- - - Cognitive Function (neurologically damage) - 3-5 3-5 - -",
      "start_page": 525,
      "end_page": 525
    },
    {
      "heading": "heading heading (80 to 237) studies)l VERY (from previous page)",
      "text": "Row 1:\n\"the the Newcastle- h. h. I2=64% RCT RCT &amp; Forest Forest plot: OS:",
      "start_page": 526,
      "end_page": 526
    },
    {
      "heading": "heading heading PFS:",
      "text": "Row 1:\n•_MEDTERM0__: Fatigue or lethargy: •Row 2:\n•Row 3:\n•tests tests • row 4: •safety safety tests? •Row 5:\n♪Row 6:\nJUDICES •TESTS TESTS • NOW 7: X • Very low • Moderate • High • included included • indirectness indirectness • •No study included",
      "start_page": 527,
      "end_page": 527
    },
    {
      "heading": "heading heading PFS: (column 1)",
      "text": "Row 1:\n\"Row 2\": \"RowRow 3:\n\"RowRow 4:\n\"Row Row 3\"",
      "start_page": 527,
      "end_page": 527
    },
    {
      "heading": "heading heading PFS: (column 2)",
      "text": "Row 1:\n\"Row 2:\nRove\"Row 3:\nsafety safety tests?",
      "start_page": 527,
      "end_page": 527
    },
    {
      "heading": "heading heading PFS: (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 527,
      "end_page": 527
    },
    {
      "heading": "heading heading PFS: (column 5)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 527,
      "end_page": 527
    },
    {
      "heading": "heading heading Effect balance",
      "text": "Row 1:\n\"Row\" 2: \"Raw\" = \"Right\" 3: \"C\" main main outcomes? \"Row 4:\n\"Row 5:\nJUDIZI\" \"RW 7: \"Rw 8: \"Budget of effects\" \"Row 9:\n\"or or comparison\" \"Now 10: \"ROW 11: JUDICES\" \"RECERCA OF TESTS\" intervention intervention \"Varia\" \"Doesn'toxicity toxicity \"the the year\" comparison comparison \"X X \"Probably\" favour. favour.\"",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "heading heading Budget of effects (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"Valori\"Row 3:\n\"C\" main main outcomes? \"Rop 4: \"Raw 5: \"JUDIZI\"Row 6:\n\"variable variable X\" major major variability",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "heading heading Budget of effects (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "heading heading Budget of effects (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\nOnto?",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "heading heading Budget of effects (column 11)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"Row 5:\n\" ADDITIONAL CONSIDERATIONS \"Row 6:\n\"Row 7:\n\"Row 8:\n\" \"Row 9:\n\" 'Row 10:\n\" row 11: \" Additional CONSIDERATION \"Row 12:\n\"toxicity. toxicity.",
      "start_page": 528,
      "end_page": 528
    },
    {
      "heading": "heading heading Fatsibility",
      "text": "Row 1:\n\"Row\" 2: \"Right\": \"Raw\" 3: \"of of equity? \"Rop\" 4: \"Rough\" 5: \"Judizi\" 5, \"Ricerca\" of \"ADDING\" TESTS\"Row 6:\n\"Reduces equity\" = \"equity equity X\" equity equity \"Improves equity,\" \"Improved equity,\" and \"Improving equity\" (not not known)Row 7:\n\"Row 8:\n\"Acceptibility\" ^Row 9:\n\"No\" main main stakeholders?",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n\"Row 2:\n\"EquityRow 3:\n\"RowRow 4:\n\"",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•AcceptabilityRow 3:\n•RowRow 4:\n•",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading Fatsibility (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•RowRow 4:\n•The",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\ni of equity?",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nRow",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading Fatsibility (column 2)",
      "text": "Row 1:\n Row 2:\n Row 3:\nnarration?",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n Row 2:\n Row 3:\n?",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\nkeepers? \"Row 4:\n\"",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading Fatsibility (column 3)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\" or \"Row 4:\n\"",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading Fatsibility (column 4)",
      "text": "Row 1:\n Row 2:\n Row 3:",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading Fatsibility (column 16)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"Row 4:\n\"",
      "start_page": 529,
      "end_page": 529
    },
    {
      "heading": "heading heading Fatsibility (from previous page)",
      "text": "==References===External links==* Official website",
      "start_page": 530,
      "end_page": 530
    },
    {
      "heading": "heading heading Fatsibility (column column 1)",
      "text": "Row 1:\n\"Row 2:\nPROBLEM\"Row 3:\n\"Raw 4: \"Rop 5\": DESIDABLE EFFECTS\"Row 6:\n\"Row 7:\n\"Wow 8: SIDE EFFECTS\"Row 9:\n\"Row 10:\n\"Now 11: QUALITY OF TESTS\"Row 12:\n\"row 13: \"Heavy 14: \"Shee 15: \"Cow 16: \"How 17: BUDGET OF EFFECTS\" row 18: \"New 19: \"TheRow 20:\nEQUITA\"Row 21:\n\"Rule 22: \"Wee 23: ACCEPTABILITY\"Row 24:\n\"ImmediateRow 25:\n\"It'sRow 26:\nFACTIVITY\"Row 27:\n\"",
      "start_page": 530,
      "end_page": 530
    },
    {
      "heading": "heading heading Fatsibility (column column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 530,
      "end_page": 530
    },
    {
      "heading": "heading heading Fatsibility (column column 3)",
      "text": "Row 1:\n Row 2:\nJUDICES",
      "start_page": 530,
      "end_page": 530
    },
    {
      "heading": "heading heading Fatsibility (column column 3)",
      "text": "Row 1:\nProbably no ...RowRow 2:\nSmall \"Moderate\"Row 3:\nModerate \"Small \"Row\" 4: Low \"Made\"Row 5:\nvariability. variability.",
      "start_page": 530,
      "end_page": 530
    },
    {
      "heading": "heading heading Fatsibility (column column 4)",
      "text": "Row 1:\n\"Row\" 2: \"Raw\" 3: \"Rop\" 4: \"Varia\" RowRow 5:\n\"Rw\" 6: \"Wow\" 7: \"Via\" doesn'RowRow 8:\n\"Row\" 9: \"Voyage\" 10: \"Do not know\"Row 11:\n\"RowRow 13:\n\"No study included\"Row 14:\n\"How\" 15: \"Heavy\" 16: \"Weapon\" 17: \"Not so\"Row 18:\n\"Snow\" 19: \"of of intervention\" \"Whoa\" 20: \"Don't really know\" row 25: \"TwoRow 26:\n\"I don't do it\"",
      "start_page": 530,
      "end_page": 530
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\nagainst against intervention",
      "start_page": 531,
      "end_page": 531
    },
    {
      "heading": "heading heading Recommendation",
      "text": "Row 1:\n•Row 2:\n• Recommendation • row 3: •",
      "start_page": 531,
      "end_page": 531
    },
    {
      "heading": "heading heading Recommendation (column 1)",
      "text": "Row 1:\n•Row 2:\n•Row 3:\n•Recommendation",
      "start_page": 531,
      "end_page": 531
    },
    {
      "heading": "heading heading Recommendation (column 2)",
      "text": "Row 1:\n\"Row 2:\n\"Row 3:\n\"",
      "start_page": 531,
      "end_page": 531
    },
    {
      "heading": "heading heading Records: 107",
      "text": "==References===External links==* Official website",
      "start_page": 535,
      "end_page": 535
    },
    {
      "heading": "heading heading Records: 238",
      "text": "Rowter 1: (?((!(([((0]((·(( \"Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcinoma, Not-Smal-CelloRow 2:\nLung /pathology\"[Mesh]) OR ((\"lung cancer\"[Title/Abstract] OR\"lungRow 4:\nneoplasms\"[Thitle/Ambs] Or \"long tumor\"[Title/Apstract].Or \"Non-small-cell] lungRow 5:\ncancer\" ([Tytle/abstract) OR \"lung lung cancer\" [Title or Abstract] OR (\"Non-normal-cell-cell) lung Row: cancer_[Tittle/App]",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "heading heading Records: 238",
      "text": "==References===External links==* Official website",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "heading heading Records: 238 (column 2)",
      "text": "Row 1:\n(?((!(([((·((0] \"Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"CarcinoRow 2:\nLung /pathology\"[Mesh]) OR ((\"lung cancer\"[Title/Abstract] Or \"lungRow 4:\nneoplasms\"[Title/Ambs] OR\"long tumor\"[Triple/Aps] or \"Non-RowRow 5:\ncancer\" [Title/abstract].",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "heading heading Records: 238 (column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "heading heading Records: 238 (column 3)",
      "text": "Row 1:\n(LungRow 2:\nract]) RowRow 3:\nungRow 4:\nC*[Title/Abstract])Row 5:\nitle/abstract) ORRow 6:\n)) AND \"radicalRow 7:\ncal Trial\" [Publica",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "heading heading Records: 238 (column 3)",
      "text": "Row 1:\nORRow 2:\nsh]) AND",
      "start_page": 536,
      "end_page": 536
    },
    {
      "heading": "heading heading Records: 171",
      "text": "ORow 1:\n((\"neoadjuvant therapy\"[MeSH Terms] OR (\"neoadiuvant\"[All Fields] AND \"therapy\"[All Fields]] ORRow 2:\n\"neoadajuvent therapy\"\"[All field] OR \"neoeadjuvant\"[Fills]",
      "start_page": 537,
      "end_page": 537
    },
    {
      "heading": "heading heading Records: 171",
      "text": "[Majr:noexp]) OR (?((·((\"Carcinoma, Non-Small-Cell Lung/radiotherapy\") OR lung tumor*[Title/Abstract]) Or lung tumour*[Title/Approach] RowRow 4:\nCancer*[Tritle/Attract] long long cancer*[thitle/abstract} OR __MEDTERM0_*[Tetle/An abstract]",
      "start_page": 537,
      "end_page": 537
    },
    {
      "heading": "heading heading Selected 6 records",
      "text": "Row 1:\n(?((!((\"Carcinoma, Non-Small-Cell Lung/radiotherapy\"[Majr:noexp]) OR ((·((¡((lungRow 2:\ncancer*[Title/Abstract]) Or lung tumor*[Title/Approach]) tumor tumor *[Tittle/abstract]] RowRow 4:\nCancer*[Tritle/Attract]), long long cancer* [Titler/Actusto])",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "heading heading Selected 6 records",
      "text": "Row 1:\n(?((!((\" \"Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcinoma, non-Smmall- CellRow 2:\nLung /pathology\"[Mesh]) OR ((\"lung cancer\"[Title/Abstract] Or \"lung neoplasms\"[Title/Ambs]Row 4:\nOR \"long tumor\"[Tritle/abstract]. OR \"Non-small-cell lung cancer\" [Titles/Apply] OR\"RowRow 5:\nCancer\"[Totle/Abbs] OR",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "heading heading Selected 6 records (column 2)",
      "text": "Row 1:\n(?((!((\"Carcinoma, Non-Small-Cell Lung/radiotherapy\"[Majr:noexp]) OR ((·((¡((lungRow 2:\ncancer*[Title/Abstract]) Or lung tumor*[Title/Approach]) tumor tumor *[Tittle/abstract]] RowRow 4:\ncancer* [Titlet/Attract]), long long cancer*[1Titler/Actusto])",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "heading heading Selected 6 records (column 2)",
      "text": "Row 1:\n(?((·((!((\" \"Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcinoma, Not-Smal-Row 2:\nLung /pathology\"[Mesh]) OR (\"Lung Neoplasms/drug theory\"[ Mesh] OR (\"LRow 3:\nNeoplasmms/pathology\") [Mesh ]) OR (\"Non-small-cell lung cancer\"[Title/Abstract] Or \"Don'RowRow 5:\ncancer\" [Titler/A abstract] OR\"Non-small -cell long cancer\"[1Titletle/abstract].",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "heading heading Selected 6 records (column 3)",
      "text": "Row 1:\n-CellRow 2:\nLungRow 3:\nract]Row 4:\nlongRow 5:\nlongRow 6:\nntary",
      "start_page": 538,
      "end_page": 538
    },
    {
      "heading": "heading heading Selected 4 record",
      "text": "Row 1:\n(?((!((\" \"Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcinoma, non-Smmall- CellRow 2:\nLung /pathology\"[Mesh]) OR ((\"lung cancer\"[Title/Abstract] OR\"lung neoplasms\"[Thitle/Ambs]Row 4:\nOR \"long tumor\"[Title/Approach] Or \"Non-small-cell lung cancer\" [Title/abstract]. OR \"RowRow 5:\ncancer\"[1Title_abs] OR",
      "start_page": 539,
      "end_page": 539
    },
    {
      "heading": "heading heading Selected 1 record",
      "text": "Row 1:\nreview ascarcinoma\"[Title/Abstract) OR __MEDTERM2_[Title/A abstract] ())) () ('))) AND (?((\"grade III\" OR \"stageRow 2:\nIII\" OR OR \"advanced disease\"))) (1))) ] OR (metastas*[Tittle/abstract])) and (( (...) ((!(\"RowRow 4:\nTopic\"[Mesh] OR \"Meta-Analysis\"[Publication Type]) OR \"meta-analysis[Tithle] RowRow 5:\nreview\"[Toly] OR",
      "start_page": 540,
      "end_page": 540
    },
    {
      "heading": "heading heading Selected 1 record",
      "text": "==References===External links==* Official website",
      "start_page": 541,
      "end_page": 541
    },
    {
      "heading": "heading heading Selected 1 record",
      "text": "([(( [((?((!(( -(( \"Carcinoma, Non-Small-Cell Lung/drug therapy\"[Mesh] OR \"Carcinoma, Not-Smal-CcellRow 2:\nLung /pathology\"[Mesh]) OR ( \"Lung Neoplasms/drug therapy\"[ Mesh] OR (\"Lung neoplasms /drug therapy\"\"[Mesh]) ] OR ((\"lung cancer\"[Title/Abstract] OR or \"lung neoplasmas\"[Text]Row 4:\nOR \"lung tumor\"[Title/A abstract] OR OR \"Non-small-cell-cell long cancer\" ([Title/absabs] [Titler/abst] ] OR \"lung lung cancer\" [Tiple/abstr] OR [Tutle/ Abstract] ] Or \"RowRow 5:\ncancer\"[1Tille] OR non-cancer cancer cancer\"\"[[T) [Tadell-length long cancer]]] [[cancer cancer ([[tle]]]. [;]]",
      "start_page": 541,
      "end_page": 541
    },
    {
      "heading": "heading heading Records: 117",
      "text": "Row 1:\n[Supplementary Concept]) OR (osimertinib[Title/Abstract])) AND (áz((⁄((\"RowRow 2:\nTopic\"[Mesh]) Or \"Meta -Analysis\"[Publication Type]) or \"meta-analysis[Title] RowRow 3:\nreview\"[Title] OR \"meta analysis*\"[Tittle] Or \"metaanalysity*\"[1Titles] OR\" Meta-Analysis\"[Trial] ORRow 4:\n(\"systemic literature review\" [Titler])",
      "start_page": 542,
      "end_page": 542
    },
    {
      "heading": "heading heading Records: 117",
      "text": "Row 1:\n\"Meta-Analysis\"[Publication Type] OR \"meta-analysis[Title] OR: systematic review\"[Title] OR 'meta analysis'*\"[Title] OR (Meta-Analysis\" [Tittle]) OR: \"Systemic literature review\" [Title]) or ([Tittle] Or ((RandomizedRow 5:\nControlled Trial) OR (Publication type) OR \"as as Topic\"[Mesh] OR (\"ClinicalRow 6:\nTrial\" [Publication Standard])",
      "start_page": 542,
      "end_page": 542
    },
    {
      "heading": "heading heading Records: 40",
      "text": "Row 1:\nAnalysis\"[Publication Type]) OR \"meta-analysis[Title] OR systemic review\"[Title] OR \"metaRow 2:\nanalysis\"*\"[Title] OR (\"Meta-Analysis\"[Tritle]) Or (\"RowRow 3:\nreview\" [Tittle])) OR (\"RowRow 4:\nTrial\"[Pubblication Type]] OR \"as as Topic\"[Mesh]) or (\"Clinical Trial'Row 5:\n[Publication type])",
      "start_page": 543,
      "end_page": 543
    },
    {
      "heading": "heading heading Records: 28",
      "text": "==References===External links==* Official website",
      "start_page": 544,
      "end_page": 544
    },
    {
      "heading": "heading heading Records: 28 (column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 544,
      "end_page": 544
    },
    {
      "heading": "heading heading Records: 9",
      "text": "Row 1:\nAnalysis as Topic\"[Mesh]) OR \"Meta-Analysis\"[Publication Type]) or \"meta-analysis[Title] OR: systemic review\"[Title] OR \"meta analysis*\"[Title] OR\"metaanalysity*\" [Tittle] OR (Meta‐Analysis\"[Triple]) Or: (\"systemic literature review\" [Title]) O (\"RandomizedRow 4:\nControlled Trial\"[Pubblication Type]] OR \"as as Topic'[Mesh])",
      "start_page": 545,
      "end_page": 545
    },
    {
      "heading": "heading heading Selected 1 record",
      "text": "Row 1:\nOR \"Meta-Analysis\"[Publication Type] OR \"meta-analysis[Title] OR systematic review\"[Title] ORRow 2:\n\"meta analysis\"[Title] OR 'metaanalysity*\"[Tritle] Or \"Mete-Analysis\" [Tittle]) OR (\"RowRow 3:\nreview\" [Title]) or (\"systemic review\" ([Title/Abstract])) OR (\"RowRow 4:\nTrial\"[Pubblication Type]] OR \"as as Topic\"[Mesh]) Or (\"Clinical Trial'Row 5:\n[PublicationType])",
      "start_page": 546,
      "end_page": 546
    },
    {
      "heading": "heading heading Records: 17",
      "text": "Row 1:\n\"Meta-Analysis\"[Publication Type] OR \"meta-analysis[Title] RowRow 3:\nreview\"[Title] OR (\"meta analysis\"*\"[Title] OR\"metaanalysity*\" [Tittle] or \"Mete-Analysis\"[1Tittle]) OR (((RandomizedRow 5:\nControlled Trial\") OR (Publication type) OR \"as as Topic\"[Mesh] OR (ClinicalRow 6:\nTrial) OR",
      "start_page": 547,
      "end_page": 547
    },
    {
      "heading": "heading heading Selected 5 records",
      "text": "==References===External links==* Official website",
      "start_page": 549,
      "end_page": 549
    },
    {
      "heading": "heading heading Records: 98",
      "text": "OR ( \"Drug Therapy/therapeutic use\"[Mesh] OR \"DrugRow 2:\nTherapy/therapy\"[Mesh] OR ([Mash] ] OR ('Drug Therapies'[Methle/Abstract] OR Chemotherapy[Title] ORRow 3:\nChemotherapies[Tittle/abstract]]) OR \"meta-analysis[Title] OR systematic review\"[Tithle] or \"metaRow 5:\nanalysity\"*\"[Tritle] Or \"Meta-analysis[Tytle]",
      "start_page": 550,
      "end_page": 550
    },
    {
      "heading": "heading heading Records: 98 (column 2)",
      "text": "Row 1:\n3475[Title/Abstract])) OR (((\"Drug Therapy/therapeutic use\"[Mesh] OR \"DrugRow 2:\nTherapy/therapy\"[Mesh]) OR (\"Drug Therapies/therapeutic use\" [Title/Approach] OR Chemotherapy[Titler/Apply]) ] AND ((!(((Ze] rait] OR Systematic review\"[Title] OR 'metaRow 5:\nanaly*\"[Totle] Or \"meta-analysis[Tittle] OR",
      "start_page": 550,
      "end_page": 550
    },
    {
      "heading": "heading heading Records: 98 (column 3)",
      "text": "Row 1:\nStract] ORRow 2:\na-",
      "start_page": 550,
      "end_page": 550
    },
    {
      "heading": "heading heading Records: 220",
      "text": "Row 1:\n(⁄((0]((?((!((.((·(([(( [((\"\"Lung Neoplasms\"[Mesh]) OR \"Carcinoma, Non-Small-Cell Lung\"[Mesh])Row 2:\nOR (\"long cancer\"[Title/Abstract] OR \"lung neoplasms\"\"[Title/Aptract] Or \"lung tumor\"[Title/Attract]Row 3:\nOR \"Non-small-cell long cancer\" [Title/abstract]. OR \"long long cancer'[Title /abs])",
      "start_page": 551,
      "end_page": 551
    },
    {
      "heading": "heading heading Selected 1 record",
      "text": "())) AND (( ((\"non-squamous\"[Title/Abstract] OR \"noRow 2:\nsquamous'[Title/Abrass] [Title/abs] OR 'nonRow 2:\nSquamous\"\"[Title/A abstract] OR nonsquamoous[Titole/Astr.])) ] ANDRow 3:\n([((?(( (!(( -(( [((· (( _ _MEDTERM0_\"[Supple/ Abstract] OR (___MEDTERMM1__[Tittle/absu] ] ] Raw Raw 4: Keytruda[Tile/At extract] OR MKMM-3475[Titule/Anstal/Austab]) ]) AND (1) AND ([]]] ORpemetrexed\"[Mesh]) ORRow 5:\n(",
      "start_page": 552,
      "end_page": 552
    },
    {
      "heading": "heading heading Selected 2 records",
      "text": "ORwain_milt: 1ORwaltif: 1 ORwaltik: 2 ORwalstif: 4 'lung lung cancer' OR 'the the lung' OR'epidermoid carcinoma'Row 3:\nOR 'lung squamous cells' OR (#1 OR #2) AND (#3 OR #4)Row 6:\n6 ('cisplatin'/exp/mj OR 'carboplatin'./exp/mJ OR 'paclitaxel'/Exp/Mj) OR OR 'cis-Row 7:\ndiAMentidichloroplatinum(ii)' OR \"Platinum diaminodichloride' or 'opdifloride' minedi-mj.",
      "start_page": 553,
      "end_page": 553
    },
    {
      "heading": "heading heading Records:21",
      "text": "==References===External links==* Official website",
      "start_page": 554,
      "end_page": 554
    },
    {
      "heading": "heading heading Records: 27",
      "text": "ORwain_milt: 1ORwaltif: 1 ORwaltik: 2 ORwalstif: 4 'lung lung cancer' OR 'the the lung' OR'epidermoid carcinoma'Row 3:\nOR 'lung squamous cells' OR (#1 OR #2) AND (#3 OR #4)Row 6:\n6 ('cisplatin'/exp/mj OR 'carboplatin'./exp/mJ OR 'paclitaxel'/Exp/Mj) OR OR 'cis-Row 7:\ndiAMentidichloroplatinum(ii)' OR \"Platinum diaminodichloride' or 'opdifloride' minedi-mj.",
      "start_page": 556,
      "end_page": 556
    },
    {
      "heading": "heading heading Selected 4 records",
      "text": "OR (\"Carcinoma, Non-Small-Cell Lung\"[Mesh])) OR (\"Non-small-cell long cancer\"[Title/Abstract] ORRow 2:\n\"lung lung cancer\" [Title/abstract]] OR NSCLC[Title/Approach]) ())) ]) ANDRow 3:\n((\"Chemoradiotherapy/therapeutic use\"[Mesh]) OR \"Chemoe radiotherapy\"[Titte/Apply] OR (\"meta-analysis\")",
      "start_page": 557,
      "end_page": 557
    },
    {
      "heading": "heading heading Selected 4 records",
      "text": "Row 1:\n() \"Lung Lung Carcinoma\"[Mesh]) OR (",
      "start_page": 557,
      "end_page": 557
    },
    {
      "heading": "heading heading Records: 86",
      "text": "Row 1:\n\"as as Topic\"[Mesh] OR (\"Clinical Trial\" [Publication Type]) ORRow 2:\n(randomized[Title/Abstract] OR randomized[Title/A abstract] OR Randomly[Title / Abstract]))",
      "start_page": 558,
      "end_page": 558
    },
    {
      "heading": "heading heading Records: 86",
      "text": "== Demographic evolution =References==",
      "start_page": 558,
      "end_page": 558
    },
    {
      "heading": "heading heading Records: 86 (column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 558,
      "end_page": 558
    },
    {
      "heading": "heading heading Records: 88",
      "text": "Row 1:\nProxel[Title/Abstract] OR Onxol[Title/Ambs] OR vinorelbina[Titte/Abbs] Or ((\"Drug Therapy\"[Mesh]) ORRow 3:\n('Drug Therapies'[Tits/Aps] or Chemotherapy[Tytle/Apps]) ] ANDRow 5:\n(( (( \"Etoposide\"[Mesh])",
      "start_page": 559,
      "end_page": 559
    },
    {
      "heading": "heading heading Records: 88",
      "text": "Row 1:\nOR ...Vépéside-Sandoz/[Title/Abstract] OR",
      "start_page": 559,
      "end_page": 559
    },
    {
      "heading": "heading heading Records: 88",
      "text": "Row 1:\n#1 'long long cancer'/exp/mjRow 2:\n#2 'lung lung cancer' OR 'lung lung Cancer' OR \"of of theung' OR'carcinoma,Row 3:\nlung lung cancer\" OR 'of of lung':RowRow 4:\n#4 'metastasis'/exp/mJ OR 'recurrent disease'/xp/mmjRow 5:\n#3 #1 OR #2Row 6:\n#5 'neoplasm metastasis'/esp/my/my-rrent disease' /exp/ml/of of ling': row row 8: #6 #4 OR #5Row 9:\n#7 'ethopide' or 'stage iv' OR OR recurence* ORRow 7:\nrelapse*:ti",
      "start_page": 559,
      "end_page": 559
    },
    {
      "heading": "heading heading Records: 88",
      "text": "Row 1:\nEtoposide isomer' OR 'etoposido ferrer farma' OR OR 'nsc-141540' OR \"RowRow 2:\nOR 'nsce141540\" OR OR 'ethoposide teva' OR OR 'RowRow 3:\n213' OR'vp16 213' or 'v p-16' OR evp 16' OR - vp16' OR (Vépéside-sandoz) OR 'vépésider sandoz' RowRow 4:\nOR OR 'ethoposide, (5a alpha)-Sor 'RowRow 5:\nfabre' OR OR 'anti-pdl1' OR anti-pd-l1'Or 'Etopospeside-endo' #46 OR 'Etoposide' r780 OR 'impq-3280 OR:",
      "start_page": 559,
      "end_page": 559
    },
    {
      "heading": "heading heading Records: 88",
      "text": "Row 1:\n'docetaxel'/exp/mj OR 'paclitaxel' /exp/mJ OR 'vinorelbine tartrate' /exp/myRow 2:\n#OR OR 'cis-diaminedichloroplatinum(ii) ' OR 'platinum diaminodichloride' ORRow 3:\n'diaminodichlorinated, platinum' OR 'cis-platelum' OR \"cis Platinum' RowRow 4:\n'OR OR 'cys diaminedi chloroplattinum' or 'cis - row 5: dichlorodiaminamineplatynum(i) 'OR 'nsc-119875' RowRow 6:\nOr Or 'cis-\"cyclobutanedicarboxylate)platinume ii' cbd OR paraplatin",
      "start_page": 559,
      "end_page": 559
    },
    {
      "heading": "heading heading Records: 83",
      "text": "Row 1:\nRowRow 2:\nercar OR 'jm-8' OR 'Jm 8' OR OR 'nsc-241240' OR \"nsc 241240' OR nsc241240 OR",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "heading heading Records: 83",
      "text": "Row 1:\npharmacology:RowRow 2:\n#12 #10 OR #11Row 3:\n#13 #3 AND #6 AND #9 AND #12",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "heading heading Records: 83",
      "text": "Row 1:\n(!((\"\"Lung Lung Carcinoma\"[Mesh]) OR ('Long Long Cancer'[Title/Abstract] OR ...\"RowRow 2:\nLung Cancer\"[Title/Ambs] OR .. Lung Lung ...RowRow 3:\n\"Lung\"[Title/Application] OR \"Etoposide\"[All Fields]) AND ((\"platinum\"[MeSH Terms] Or \"Platinum\" ([All fields]))) ANDRow 5:\n\"_MEDTERM0_\" [Supplementary Concept]",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "heading heading Records: 83",
      "text": "Row 1:\n#1 'lung lung cancer'/exp/mjRow 2:\n#2 'long long cancer' OR 'lung lung Cancer' OR \"of of theung' OR'carcinoma,Row 3:\nsmall cell lung' of of lung':ti,ab",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "heading heading Records: 83",
      "text": "Row 1:\n(!((\"\"Lung Lung Carcinoma\"[Mesh]) OR (*Cancer Cancer ... [Title/Abstract] OR --RowRow 2:\nLung Cancer ...[Title/Ambs] OR *Lung Lung ... ... ] AND (( ((\"Etoposide\"[MeSHRow 4:\nTerms] OR \"Etoposide\"[All Fields] ] AND (\"[\"Platinum\"[ MeSH Terms]] OR\"Platinum\" [All Field's]",
      "start_page": 560,
      "end_page": 560
    },
    {
      "heading": "heading heading Records: 89",
      "text": "Row 1:\n(\"Lung Lung Carcinoma\"[Mesh]) OR (",
      "start_page": 561,
      "end_page": 561
    },
    {
      "heading": "heading heading Records: 89",
      "text": "Row 1:\n(!((\"Lung Lung Carcinoma\"[Mesh]) OR ('Long Long Cancer'[Title/Abstract] OR",
      "start_page": 561,
      "end_page": 561
    },
    {
      "heading": "heading heading Records: 89 (column 2)",
      "text": "Row 1:\n(\"Lung Lung Carcinoma\"[Mesh]) OR (\"Long Long Cancer\" [Title/Abstract] OR \"RowRow 2:\nLung Cancer\"[Title/Ambs] OR",
      "start_page": 561,
      "end_page": 561
    },
    {
      "heading": "heading heading Records: 89 (column 2)",
      "text": "Row 1:\n(!((\"Lung Lung Carcinoma\"[Mesh]) OR ('Long Long Cancer'[Title/Abstract] OR ...\"RowRow 2:\nLung Cancer\"[Title/Approach] OR ..'The The Lung', \"Carcinoma,\" \"RowRow 3:\n\"Lung\"[Title/Attract] or \"of of Lung\" [Title/abstract].))) AND (( ((\"topotecan\"Row 4:\n[Supplementary Concept]) Or topotecan[Title /abs]))",
      "start_page": 561,
      "end_page": 561
    },
    {
      "heading": "heading heading C. METHODOLOGY (from previous page)",
      "text": "Row 1:\n\"Clinical\"Row 4:\nof of \"Corporate\"Row 5:\nfavour favour (selection criteria) * therapeutic therapeutic option* to to \"yyye\" alternatives alternatives (over over damages)Row 6:\nwith with (selective criteria) to to yyyi\"l \"intervention under consideration; benefit benefit (s) of \"Personalised\" or \"Cerposited\" considered. considered.",
      "start_page": 611,
      "end_page": 611
    },
    {
      "heading": "heading heading C. METHODOLOGY (from previous page)",
      "text": "Row 1:\nSituation (s) of evidence (s): (i) (ii) (iii) (iv) (v) (vi) (e) (f) (j) (h) (i); (iv), (vi). (vib) (vii) (viii) (c) (d) (a) (m) (y) (l) (w) (ix) insecure insecure (uncertain uncertain benefit) intervention intervention (less less harmful/costy comparison)Row 5:\nthe the other",
      "start_page": 613,
      "end_page": 613
    },
    {
      "heading": "heading heading INTERNATIONAL INTERNATIONAL GUIDES",
      "text": "Row 1:\nRowRow 2:\nJanuary January 2018",
      "start_page": 615,
      "end_page": 615
    },
    {
      "heading": "heading heading INTERNATIONAL INTERNATIONAL GUIDES (from previous page)",
      "text": "I'm sorry. ==References===External links==*Official website* Official website",
      "start_page": 616,
      "end_page": 616
    },
    {
      "heading": "heading heading INTERNATIONAL INTERNATIONAL GUIDES (column column 2)",
      "text": "==References===External links==* Official website",
      "start_page": 616,
      "end_page": 616
    },
    {
      "heading": "heading heading INTERNATIONAL INTERNATIONAL GUIDES (column column 3)",
      "text": "Row 1:\nCommentsRow 2:\n Row 3:\nRowRow 4:\n Row 5:\nTarget Population: Oncologist (different different figures)Row 6:\nRowRow 7:\nRowRow 8:\nTarget population: oncologue (figures figures exist)Row 9:\nRowRow 10:\n Row 11:\n Row 12:\nquestion question (PICO); appropriate appropriate engines; bibliographical bibliographical items; methodological quality assessment; evidence evidence (display table) RowRow 13:\n Row 14:\n Row 15:\n Row 16:\n Row 17:\n Row 18:\nRowRow 19:\n Row 20:\n Row 21:\nquestions questions (GRADE GRADE questions)Row 22:\n Row 23:\nRow Row project",
      "start_page": 616,
      "end_page": 616
    },
    {
      "heading": "heading heading 4. BIBLIOGRAPHY",
      "text": "== Demographic evolution ===References===External links==* Official website",
      "start_page": 617,
      "end_page": 617
    },
    {
      "heading": "heading heading 4. BIBLIOGRAPHY (column 1)",
      "text": "==References===External links==* Official website",
      "start_page": 617,
      "end_page": 617
    },
    {
      "heading": "heading heading 4. BIBLIOGRAPHY (column 2)",
      "text": "Row 1:\nESMO-ASCO-NCCNRow 2:\n√\"NRowRow 3:\nÂ\"NORRow 4:\nNR'NRRow 5:\nÃ\" NROWNRow 6:\nNR\"NRow 7:\nNRâNRRow 8:\nNR·NROWNRow 9:\nNR′NRW 10: NO'NORRow 11:\nÈ\"NrRow 12:\n√À\"NARRow 13:\n̈\"NRARow 14:\nNRÂ\"NORow 15:\nØ\"NERRow 16:\n¬\"Row 17:\ną\"NARow 18:\nČ\"NROWRow 19:\nNR \"NRownRow 20:\n̨NRaw 21: NR\\RowRow 22:\nč\"NRNRow 23:\nNR.",
      "start_page": 617,
      "end_page": 617
    },
    {
      "heading": "heading heading opinion. opinion.",
      "text": "Row 1:\n1\" individual individual RCTs\"Row 2:\n1 ++\"risk. risk.\"Row 3:\n1 +\"bias. bias.\"Row 4:\n1 -\"risk risk -> RowRow 5:\n2\"of of case/or or \"Row 6\": Single case/Raw Raw 7: 2+\"effect. effect.",
      "start_page": 621,
      "end_page": 621
    },
    {
      "heading": "heading heading  a a critic",
      "text": "Row 1:\nassessed assessed 1++ Row",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "heading heading  a a critic",
      "text": "Row 1:\nrated rated 1++ RowRow 2:\ntarget target population; or",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "heading heading  a a critic",
      "text": "Row 1:\nincludes includes 2++ RowRow 2:\nsize. size.",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "heading heading  a a critic",
      "text": "Row 1:\nincludes includes 2+ RowRow 2:\nsize. size.",
      "start_page": 622,
      "end_page": 622
    },
    {
      "heading": "heading heading Meaning Meaning Consequences",
      "text": "Row 1:\n•Row 2:\nLevel certainty • Meaning \"ConsequencesRow 3:\nresults results • RowRow 4:\nModerate •performance performance •RowRow 5:\nLow • credible credible • is is limited: estimated estimated • row 6: Very low • unreliable unreliable • effect effect • estimated estimated effect",
      "start_page": 624,
      "end_page": 624
    },
    {
      "heading": "heading heading clinical clinical recommendations",
      "text": "Row 1:\n\"Clinical\"Row 4:\nStrong at Favor: with with (selection criteria) option option (on on damage)Row 5:\nConditional at Favour: with with (screening criteria) alternatives alternatives (on on damage), 6 6 treatment: Sfavore Sfavore (selecting criteria).",
      "start_page": 626,
      "end_page": 626
    },
    {
      "heading": "heading heading Certain test",
      "text": "Row 1:\nevidence evidence SIGN/RowRow 2:\neffects. effects.",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading Certain test",
      "text": "Row 1:\n Row 2:\nHighlightRow 3:\nSIGN",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading Certain test",
      "text": "Row 1:\nRowRow 2:\nrecommendationRow 3:\nclinic",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading Certain test",
      "text": "Row 1:\nevidence evidence (or or IV) inhibitor inhibitor + melanoma. melanoma.",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading Certain test",
      "text": "Row 1:\n Row 2:\noverallRow 3:\nevidence",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading Certain test",
      "text": "Row 1:\nRowRow 2:\nrecommendationRow 3:\nclinic",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading Certain test",
      "text": "Row 1:\n\"Quesito xx: ...\"Row 2:\nRECOMMENDATION: ...Row 3:\nthe the recommendation: ...Row 4:\nMotivations/sheet sheet Benefits/Wait: been been identified: the the benefit/damage balance: .Row 5:\nfuture future research: ...\"Row 6:\njudged judged ... following following reasons: \"Row 7:\nof of evidence: ... ...Row 8:\nCOI: ...",
      "start_page": 627,
      "end_page": 627
    },
    {
      "heading": "heading heading 5. CRITICAL APPRAISAL (from previous page)",
      "text": "==References===External links==*Official website* European European Union: http://europa.eu.int/comm/RowRow 26:\nRowRow 27:\n\"Excuse me\" RowRow 28:\n\"RowRow 29:\n\"so. so.\"Row 30:\nwithout without meta-analysis\"Row 31:\n\"Certain studies\": properly properly assessed?Row 32:\n\"RowRow 34:\n\"picture picture (or tables) RowRow 33:\n\"RowRow 37:\n\"Specifically,\" studies. studies.",
      "start_page": 629,
      "end_page": 629
    },
    {
      "heading": "heading heading 5. CRITICAL APPRAISAL (from previous page)",
      "text": "Row 1:\nRowRow 2:\nwas was generated?Row 3:\nRowRow 4:\nwas was hidden?Row 5:\nbalanced balanced groups?",
      "start_page": 629,
      "end_page": 629
    },
    {
      "heading": "heading heading 5. CRITICAL APPRAISAL (from previous page)",
      "text": "Row 1:\nRowRow 2:\n(first two)Row 3:\n Row 4:\nbaseline baseline table: results. results.",
      "start_page": 629,
      "end_page": 629
    },
    {
      "heading": "heading heading 5. CRITICAL APPRAISAL (from previous page)",
      "text": "Row 1:\nRowRow 2:\nCONSORT. CONSORT.",
      "start_page": 629,
      "end_page": 629
    },
    {
      "heading": "heading heading 5. CRITICAL APPRAISAL (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\npcs.",
      "start_page": 629,
      "end_page": 629
    },
    {
      "heading": "heading heading 5. CRITICAL APPRAISAL (from previous page)",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\npicture picture (or tables)Row 4:\nRowRow 5:\nDiscussion.",
      "start_page": 629,
      "end_page": 629
    },
    {
      "heading": "heading heading  ASSOCIATION",
      "text": "Row 1:\n\"heterogenity\" analysis, meta-...Row 2:\n\"explored. explored.\"",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "heading heading  ASSOCIATION",
      "text": "as as eligible: 000 000 million: 000, 000,000; 25,000,000m; 15,000,000; population population (the the \"Row\" is referred; 5,000,000: the the \"Row\" the the \"ROW\": only difference = under under study; 10,000: the the \" Row\": accepted accepted / invited; the the \"Fow\" and \"Rown\" factors: factor factor (Row 13:\n•Row 14:\n Row 15:\nMEASURINGRow 16:\n^detection detection factor: 000, 000,000===References==External links=* Official website",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "heading heading  ASSOCIATION",
      "text": "Row 1:\npopulations populations (single difference =Row 2:\nrisk factor studied)",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "heading heading  ASSOCIATION",
      "text": "Row 1:\nsubjects subjects /Row 2:\ninvited subjects",
      "start_page": 630,
      "end_page": 630
    },
    {
      "heading": "heading heading  ASSOCIATION",
      "text": "Row 1:\nRowRow 2:\nRowRow 3:\n(exposure exposure factor)",
      "start_page": 630,
      "end_page": 630
    }
  ]
}